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This thesis is composed of two chapters reporting contributions to two different projects. 
The first chapter presents a research project aiming to develop a new class of helical molecules 
which, upon activation from an external stimulus, would be able to reversibly switch from one 
screw-sense to the other. All-syn methyl-substituted hydrocarbons, as described by Aggarwal1 in 
2014, were shown to adopt helical conformations with very high levels of control. More im-
portantly, one of these unique molecules could access either the M or the P screw-sense, depend-
ing on its physical state. Therefore, all-syn methyl-substituted hydrocarbons seemed to be prom-
ising candidates for the design of a new class of molecular switches. A diamond lattice-based 
analysis revealed that the number of syn-pentane and gauche interactions in the chain was one of 
the key parameters that dictated its conformational preference. A series of six compounds of 
different chain lengths was designed and synthesised using an efficient bidirectional iterative 
homologation of C2-symmetric boronic esters. A QM/NMR approach was employed to quantita-
tively describe the conformational landscape of these molecules and confirmed the diamond lat-
tice-based model with a good degree of confidence. A screening of different substituents at the 
termini revealed that alkyne, hydroxyl, amino or aromatic groups could be considered as ‘small’ 
groups, favouring the helical conformer with both terminal dihedral angles in a gauche confor-
mation. However, the combined effects of two tert-butyl groups might force both terminal dihe-
dral angles to adopt an antiperiplanar conformation, thus favouring the opposite screw-sense. 
These findings set the experimental basis to design a new molecular switch. 
The first part of the second chapter describes the development of a new decarboxylative boryla-
tion methodology2 and its application to the synthesis of -amino boronic esters. Some medicinal 
chemistry-type examples and three additional natural products have been added to the substrate 
scope. Key mechanistic experiments were conducted to prove the radical pathway and provide 
support for an outer sphere radical trapping process. In the second part, a study on the decarbox-
ylative borylation of amino acids was conducted. First, the reaction conditions were optimised 
on a proline derivative. With these new conditions in hand, other activated amino acids were 
tested. However, most of them did not afford the desired products. To identify the cause of fail-
ure, a number of parameters were investigated (the effects of free N–H bonds, redox potentials 
and protecting groups). A different mode of activation involving the use of hypervalent iodine 
derivatives was attempted but failed to provide the desired products. Finally, a limited substrate 
scope composed of proline derivatives was subjected to the reaction conditions. Unfortunately, 
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CHAPTER 1 – TOWARDS THE SYNTHESIS OF NEW MOLECULAR 
SWITCHES 
1.1. Introduction 
1.1.1. Reactivity of organoboron compounds 
The history of asymmetric synthesis is indubitably linked to the development of organoboron 
chemistry. After the publication of the first example of enantioselective hydroboration of alkenes 
by Brown in 1961,3 a variety of methods have been explored to introduce boron atoms into or-
ganic molecules in a stereocontrolled manner.4 These efforts find their justification in that the 
boryl functional group can serve as a useful handle to further functionalise a molecule through 
stereospecific carbon–boron bond transformations.5 Most of these stereospecific reactions rely 
on the ability of organoborons to accept a nucleophilic electron pair into their boron-centred 
empty p-orbital to form boronate complexes6 (Scheme 1a).  
 
Scheme 1. a. Boronate complex formation. b. Stereospecific 1,2-metallate rearrangement. Nu = nucleo-
phile; LG = Leaving group. 
If a leaving group is geminal to the negatively-charged boron atom, the boronate complex can 
undergo a 1,2-metallate rearrangement, which is defined as the 1,2-migration of a boron-bound 
substituent to the adjacent atom, with concomitant release of the leaving group (Scheme 1b). The 
migration only proceeds when the -orbital of the migrating group is aligned with the -orbital 
of the leaving group (i.e., when the migrating and leaving groups adopt an antiperiplanar rela-
tionship).7 Such a concerted mechanism usually leads to the complete inversion of configuration 
at the -boryl carbon centre, and retention of configuration of the migrating group.8 
This mechanism is encountered in the hydrogen peroxide-mediated stereospecific oxidation of 
organoboron derivatives.9 Here, an organoboron species (4) reacts with a peroxide anion to form 
boronate complex 5, which undergoes 1,2-metallate rearrangement to deliver the corresponding 
alcohol 8, after hydrolysis of the boron–oxygen bond (Scheme 2). Through this concerted pro-
cess, the chiral information is transferred from organoboron species 4 to alcohol 8 with the high-




Scheme 2. Hydrogen peroxide-mediated oxidation of organoboron compounds. 
At its early stage, organoboron chemistry focussed mainly on organoboranes (9). These species, 
composed of a boron atom linked to three carbon atoms, are highly electrophilic and can react 
with a wide range of nucleophiles; however, such reactivity comes with disadvantages in terms 
of air and moisture sensitivity. In fact, boranes are generally unstable compounds, prone to oxi-
dation and cannot be isolated by column chromatography. To circumvent this problem, new 
methodologies involving boronic esters such as 10 (i.e., a boron atom bound to one carbon and 
two oxygen substituents) have been developed during recent decades. In particular, due to their 
higher stability, pinacol boronic esters (RBpin) have become the functional group of choice in 
modern organoboron chemistry.10,11 Indeed, -donation from the lone pair of an oxygen atom 
into the empty p-orbital of the boron centre (Chart 1) reduces its electrophilic character with 
respect to boranes and renders pinacol boronic esters stable at room temperature, under air and 
compatible with silica gel purification. 
 
Chart 1. Boronic esters are less electrophilic than organoboranes due to -donation from a lone-pair of 
one oxygen to the empty p-orbital on boron. 
 
1.1.2. Functionalisation of boronic esters 
Although boronic esters are less electrophilic than boranes, they still exhibit the same type of 
reactivity towards nucleophiles. Not only can they easily be derivatised to their corresponding 
alcohols using basic peroxide, they also give access to other classes of molecules, such as alkene 
derivatives. Inspired by seminal work by Zweifel on organoboranes,12 Matteson and Evans inde-
pendently showed that boronic esters could successfully be converted to E- or Z-alkenes.13–16 In 
this transformation (Scheme 3), negatively-charged vinyl boronate complex 11 reacts with iodine 
to form iodonium intermediate 12. Both charges are neutralised when the alkyl group attached to 
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boron migrates, with concomitant ring-opening of the iodonium moiety. The resulting -io-
doboronic ester 13 undergoes anti-elimination upon treatment with sodium methoxide to deliver 
the corresponding alkene 14. 
 
Scheme 3. Mechanism of Zweifel olefination using boronic esters as substrates. 
Recently, Aggarwal and co-workers developed a related methodology17 to synthesise alkyne de-
rivatives from boronic esters (Scheme 4). They reacted boronic esters 17 with -lithiated vinyl 
carbamate 16 to form vinyl boronate complexe 18. When treated with iodine and methanol, these 
species undergo a Zweifel olefination-type iodination/elimination sequence to give the corre-
sponding 1,1-disubstituted alkene 21. Addition of a base (tert-BuLi or LDA) leads to elimination 
of the leaving group and gives rise to alkyne anion 22. These nucleophiles can be quenched by 
addition of electrophiles to give corresponding internal alkynes 23 or with water to obtain termi-
nal alkynes. 
 
Scheme 4. Mechanism of Aggarwal alkynylation. 
The concept of electrophile-triggered 1,2-metallate rearrangement observed in the Zweifel ole-
fination has been extended to aryl boronate complexes by Aggarwal,18–26 who engaged lithiated 
(hetero)aryl derivatives and boronic esters in a successful enantiospecific sp2–sp3 cross-coupling 
to obtain substituted (hetero)aryl compounds in good to excellent yields and perfect enantiospec-
ificity. In the proposed mechanism, 1-naphthyl lithium 25 attacks boronic ester 17 to generate 
boronate complex 26. Upon addition of N-bromosuccinimide 27, the electron-rich aromatic group 
undergoes a bromination reaction with concomitant 1,2-migration of the alkyl substituent from 
 
4 
the boron centre to the aromatic moiety. A subsequent nucleophile-assisted elimination leads to 
the re-aromatisation of the system and delivers cross-coupling product 30 (Scheme 5). 
 
Scheme 5. Mechanism of Aggarwal’s transition metal-free cross-coupling. 
Another example of useful derivatisation of boronic esters was proposed by Morken and co-
workers in 2012,27 who reported a stereospecific amination methodology. Specifically, boronic 
ester 17 is treated with methoxyamine-derived lithium nitrenoid 32 to form a boronate complex. 
Then, a stereospecific 1,2-metallate rearrangement occurs at 60 °C to give, after addition of 
Boc2O, protected amine 36 (Scheme 6a). However, this methodology was limited to primary and 
secondary boronic esters. Presumably, in the case of more sterically-demanding tertiary boronic 
esters, lithiated methoxyamine 32 fails to efficiently bind the boron centre and undergoes decom-
position to nitrene 33 upon heating. 
 
Scheme 6. a. Morken stereospecific amination using first-generation conditions. b. Morken stereospecific 
amination using second-generation conditions. 
The same research group reported alternative conditions28 which involved mixing boronic ester 
17, methoxyamine 31 and potassium tert-butoxide in toluene at 80 °C. Under these conditions, 
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methoxyamine is deprotonated after coordination to the organoboron substrate (Scheme 6b). 
Hence, the formation of highly unstable nitrenoid is avoided and the desired product is formed 
in good yield with excellent enantiospecificity. 
In all these previous examples (Schemes 2–6), the initial boronic ester moiety is not present in 
the final molecule (cleavage by hydrolysis or by nucleophile-triggered elimination). A different 
approach consists of utilising the boronic ester functional group to form new carbon–carbon 
bonds while maintaining the boryl moiety in the final product for further functionalisation. This 
process is commonly referred to as homologation of boronic esters. 
 
1.1.3. Homologation of boronic esters 
1.1.3.1. Seminal studies 
In 1963, Matteson and co-workers reported an unusual nucleophilic substitution.29 In this exper-
iment (Scheme 7), they reacted -bromoboronic ester 39 with different Grignard reagents (40), 
forming boronate complex (41) that rearranged upon warming to room temperature to displace 
the -halogen and generate a new boronic ester (42). 
 
Scheme 7. Boron-assisted nucleophilic substitution reaction. 
Twenty years later, drawing on this observation, Matteson developed a new methodology for 
carbon–carbon bond formation, involving sp3 carbenoids such as 43.30 Due to their nucleophilic-
ity, they can react with boronic esters at low temperature to form boronate complexes. As de-
scribed above, these boronates can undergo stereospecific 1,2-migration, with concomitant dis-
placement of the chloride leaving group.8 The product is an -chloroboronic ester that can be 
further elaborated through addition of a Grignard reagent (Scheme 8). By treating boronic ester 
17 with (dichloromethyl)lithium 43, Matteson and co-workers could form boronate complex 44 
that underwent 1,2-migration to give homologated -chloroboronic ester 45. Subsequently, an-
other nucleophile could be added, forming a new boronate (46) that rearranged upon warming, 





Scheme 8. First examples of homologation of boronic esters by Matteson. 
Matteson also showed that this method can be rendered asymmetric by using chiral boronic esters 
such as 51 (Scheme 9), which allowed the formation of contiguous stereocentres with high levels 
of stereocontrol when performed iteratively.32 As this method operates under substrate control, 
there are associated drawbacks. The main drawback of this methodology appears when one 
wishes to create two stereocentres with opposite chirality: before the second homologation, a 
ligand-exchange sequence is necessary to remove the chiral diol ligand on the boronic ester and 
replace it with its opposite enantiomer.33 
 
Scheme 9. First example of substrate-controlled asymmetric homologation of boronic esters. 
This problem can be overcome by employing a reagent-controlled approach, where the stereo-
chemical information is transferred through the use of a chiral reagent (Scheme 10). A variety of 
methods can be used to generate chiral carbenoids, such as deprotonation of sulfonium salts34–36 




Scheme 10. Example of homologation by reagent control. M = Metal; LG = Leaving group. 
 
1.1.3.2. Sparteine-mediated asymmetric deprotonation 
Selective deprotonation of O-alkyl carbamates 64 has been widely explored by Hoppe and co-
workers.39–42 In the presence of ()-sparteine, s-BuLi could generate enantioenriched -lithiated 
carbamates (67), which were found to be chemically and configurationally stable at –78 °C. 
These chiral organolithium compounds then react with electrophiles with retention of configura-
tion40 (Scheme 11).  
 
Scheme 11. (–)-Sparteine-mediated asymmetric deprotonation of O-alkyl carbamates, followed by stere-
oretentive electrophilic trapping. Brackets have been omitted for clarity. 
Later, Hoppe and co-workers described the electrophilic trapping of their lithiated carbamates 70 
with triisopropyl borate to generate boronic ester intermediate 71, which was transesterified with 
pinacol under acidic conditions.7 The resulting pinacol boronic ester 72 was then treated with a 
Grignard reagent (73) at low temperature to form boronate complex 74. Upon warming to room 
temperature, the 1,2-metallate rearrangement took place to deliver homologated boronic ester 76 
and released the carbamate moiety (Scheme 12). In this particular case, the carbamate plays two 
crucial roles: first, it acts as a directing group in the deprotonation step, forming a pre-lithiated 




Scheme 12. Asymmetric synthesis of boronic esters developed by Hoppe and co-workers. 
 
1.1.3.3. Homologations using -lithiated carbamates or benzoates 
In 2006, Kociensky and co-workers reported the first one-step homologation of a boronic ester, 
using Hoppe’s lithiated carbamates in the synthesis of (S)-(−)-N-acetylcolchinol.43 More gener-
ally, this method was found to be an efficient way to access chiral secondary alcohols 81, as 
proven by Aggarwal and co-workers shortly afterwards44 (Scheme 13). 
 
Scheme 13. Synthesis of chiral secondary alcohols using Hoppe’s lithiated carbamates. 
The presence of weak Lewis acids, such as MgBr2, can promote this 1,2-migration, and are some-
times added when this process is slow.45 Inspired by the work of Hammerschmidt,46 Aggarwal 
also showed that sparteine-mediated deprotonation of O-alkyl 2,4,6-triisopropylbenzoates (O-al-
kyl TIB) 82, as described by Beak and co-workers,47 leads to suitable carbenoids 83 for the ho-
mologation of boronic esters.48 As the benzoate moiety is a better leaving group than the carba-




Scheme 14. Synthesis of chiral secondary alcohols using Beak’s lithiated benzoates. 
 
1.1.3.4. Iterative homologation of boronic esters 
In 2007, Blakemore and co-workers used sulfoxide-derived enantioenriched carbenoids 88 to 
homologate boronic ester 87 three times38 (Scheme 15). Depending on the configuration of the 
carbenoid used, they could selectively synthesise four diastereoisomers of alcohol 90 in excellent 
enantiomeric ratio (e.r.) and low diastereoisomeric ratio (d.r.) due to chiral amplification. Nota-
bly, in this sequence, each intermediate was purified by column chromatography. 
 
Scheme 15. Iterative reagent-controlled homologation using sulfoxide-derived carbenoids. 
The first example of fully stereocontrolled iterative homologation of boronic esters was reported 
by Aggarwal and co-workers.1 In this report, nine iterative homologations were performed by 
using enantiopure carbenoids derived from corresponding -stannyl benzoates 93, which were 
synthesised by sparteine-mediated asymmetric deprotonation of O-ethyl benzoate 91, electro-
philic trapping with trimethyltin chloride and recrystallisation in methanol. (Scheme 16a). 
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This process thereby converts a simple boronic ester into a highly complex molecule with just a 
single purification step and can be assimilated to a molecular assembly line (Scheme 16b). Prac-
tically, -stannyl methyl benzoate 93 is subjected to tin–lithium exchange, using n-BuLi, to re-
veal carbenoid 94. Boronic ester 17 is then added and quickly forms a boronate complex. Upon 
warming to room temperature, the 1,2-migration occurs, releasing the benzoate moiety and gen-
erating a new boronic ester that can be engaged in the next homologation. Very high levels of 
purity were observed because each homologation reaction occurs with >99% efficiency and with 
>99% stereocontrol. 
 
Scheme 16. a. Synthesis of enantiopure (S)- and (R)--stannyl benzoates 93. b. ‘Assembly-line synthesis’ 
as described by Aggarwal and co-workers in 2014. 
Interestingly, the conformation of the final molecules was found to be highly dependent on the 
relative configuration of the methyl substituents along their main carbon chains. These com-





1.1.4. Conformational analysis of flexible molecules 
1.1.4.1. Syn-pentane interactions and conformational control 
Hoffmann devoted an important part of his career to the study of flexible molecules with defined 
shape.49–69 Considering that the conformation of a molecule is closely related to its function in 
biological systems, his research contribution aimed to understand and rationalise the rules that 
nature employs to confer specific spatial arrangements on active compounds. He articulated a 
useful description of the conformation of hydrocarbons as being defined by a sequence of dihe-
dral angles involving the carbon atoms of the principal chain, with the terms g+, g–, and t, denoting 
dihedral angles of about +60°, –60°, and 180°, respectively (Figure 1a). 
According to this notation, a syn-pentane interaction appears when a g+ dihedral angle is directly 
followed by a g– dihedral angle. In this case, the distance between both groups of atoms is about 
2.5 Å and the resulting steric penalty can reach 3.5 kcal mol–1.70 An emblematic example of syn-
pentane interactions is encountered between two axial methyl groups in cyclohexane chair-type 
structures.58,71 
The energy cost associated with such interactions is high enough to constrain flexible molecules 
to avoid syn-pentane-containing conformations. For example, in the case of n-pentane (Figure 
1b), the only conformer bearing a syn-pentane interaction represents 0.5% of the overall confor-
mational landscape at room temperature.70 This general principle found applications in confor-
mational analysis and molecular design. 
 
Figure 1. a. Hoffmann’s description of dihedral angles. b. Analysis of steric interactions in n-pentane. 
MP4SDQ 6-31G(d) level of theory was used to calculate the relative energies.70 
A thorough theoretical analysis brought Hoffmann and co-workers to predict that a disyndiotactic 
(alternating syn–anti) hydrocarbon such as 97 would adopt a (t)n dihedral angle sequence (i.e., a 
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linear conformation) to avoid syn-pentane interactions. For the same reason, the researchers sug-
gested that the lowest-energy conformer of threo-diisotactic (all-syn) isomer 98 would be helical 
with a (t g+)n dihedral angle sequence (Chart 2). 
 
Chart 2. As predicted by Hoffmann and proved by Aggarwal, the substitution pattern of contiguously 
methyl-substituted hydrocarbons dictates the conformational behaviour of these molecules in solution and 
solid state. 
Based on this seminal work, Aggarwal and co-workers predicted that the avoidance of syn-pen-
tane interactions would force alternating syn–anti diastereoisomer 99 to display a linear shape in 
solution, and all-syn isomer 100 to adopt a helical conformation. The authors could confirm Hoff-
mann’s predictions by synthesising both molecules and analysing them using a combined exper-
imental and computational approach. 
 
1.1.4.2. Quantum Mechanics/Nuclear Magnetic Resonance approach 
The rate of conformational interconversion of a small flexible molecule is generally faster than 
the nuclear magnetic resonance (NMR) timescale. As a consequence, only time-average signals 
can be observed by NMR spectroscopy. Due to this limitation, it is not trivial to quantify con-
former populations of a given flexible molecule by NMR analysis. Such a precise conformational 
description would require information about NMR parameters (chemical shifts (), scalar cou-
pling constants (J) and inter-nuclear distances) of individual conformers. 
To estimate these NMR parameters, theoretical values can be generated using quantum mechan-
ical calculations for each conformer. One of the quickest ways to find low-energy conformers is 
to perform a molecular mechanics (MM) conformational search calculation. In this ‘ball and 
spring’ model, the overall energy of a molecule is defined by the sum of bond stretching energy 
(Estrech), bond angle bending energy (Ebend), torsional angle rotations energy (Etorsion), electrostatic 
interactions energy (Ecoulomb) and van der Waals interactions energy (EvdW).72 This steps finds the 
local minima and the global minimum within a given energy threshold. 
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Once low-energy conformers have been generated, quantum mechanics (QM), and more specif-
ically density functional theory (DFT), is employed to optimise their geometries and estimate 
their Gibbs free energies (considering zero-point energy correction, entropy and solvation),73 
which are used to calculate the Boltzmann-averaged populations of conformers at room temper-
ature. These DFT-computed geometries are then used to calculate NMR parameters (, J and 
NOE-derived interproton distances) of each individual conformer. These values are subsequently 
Boltzmann-averaged to access the ensemble-averaged NMR properties of the compound. Finally, 
this theoretical picture is quantitatively compared to the experimental data to establish the con-
formational landscape of the molecule. This methodology was called Quantum Mechanics/Nu-
clear Magnetic Resonance (QM/NMR) approach (Figure 2). 
 
Figure 2. Workflow of QM/NMR approach for the conformational analysis of molecules in solution. 
As mentioned above, Aggarwal and co-workers successfully applied this method to contiguously 
methyl-substituted hydrocarbons (99 and 100).1 They used molecular mechanics (MM3 force 
field), followed by DFT calculations (DF-LMP2-F12 VDZ-F12//B3LYP-D2 6-311+G(d)) to 
generate the optimised conformers. The Boltzmann-averaged population of isomer 99 showed 
that 95% of the conformers would adopt a linear conformation, while 74% of the conformers of 
isomer 100 would adopt a helical conformation (Chart 2). JH–H, JH–C and NOE-derived distances 
were calculated by DFT (mPW1PW91 6-311G(d,p)//B3LYP-D2 6-311+G(d)), Boltzmann-aver-
aged, and compared to experimental data. In both cases, computed values were in good agreement 
with measured parameters, with 1 Hz error in the comparison of coupling constant values and 
5% error in the comparison of NOE-derived distances. 
 
1.1.4.3. Vibrational Circular Dichroism 
The QM/NMR approach is not the only methodology available to obtain information about the 
structural features of a flexible molecule. Conformational behaviour of foldamers is generally 
determined by a complementary set of analytical techniques, such as NMR,74–78 single crystal X-
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ray crystallography79–82 or circular dichroism (CD).83–85 Although less frequently employed, vi-
brational circular dichroism (VCD) has also been found to be very useful to probe the confor-
mation of organic compounds. 
 
Figure 3. Concept of VCD analysis. In this example, an optically-active molecule absorbs preferentially 
right-hand polarised light. 
This technique measures the differential absorption of left- and right-handed circularly polarised 
radiation (Figure 3) in the infrared region,86 where vibrational transitions occur in the ground 
electronic state of a molecule. The combination of measured vibrational spectra and theoretical 
calculations provides unambiguous insights on the absolute configuration and the conformation 
of the compound of interest.87–89 For example, this method was used to determine the major con-
formation of dialkyl tartrates in different solvents,89–91 in complexation equilibrium with cy-
clodextrins92 or confined in micelles.93 One could imagine that VCD analysis could give addi-
tional evidence for the conformational control observed by Aggarwal and co-workers in the case 
of methyl-substituted hydrocarbons.1 
 
1.1.5. Definition and applications of molecular switches 
Miniaturisation appears to be one of the main challenges for future technology.94–100 Engineering 
organic materials at the molecular level benefits from the possibility to adjust a wide range of 
physical properties by subtle changes in the structure, as well as the opportunity to address fun-
damental problems through the isolation and full characterisation of single molecular compo-
nents.101–103 Amongst a variety of possible applications, transport systems,104–106 control of na-
noscale architectures,107–109 catalysts,110,111 surface properties of materials,106,112–118 mechanical 
devices,119–128 target-directed delivery systems129 or nano-sensors130–132 can be envisioned. 
As an illustration of the potential of organic materials for miniaturisation purposes, the Nobel 
Prize in Chemistry was jointly awarded to Feringa, Sauvage and Stoddart in 2016 for the design 
and synthesis of molecular machines. In parallel to their contributions, key discoveries in the 
fields of nano-structures133–135 and patterned surfaces136–142 with defined organisation of discrete 
entities, according to the principles of self-assembly phenomena,143–151 have also emerged. 
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A compound can be defined as a molecular switch if it can exist in two different forms, which 
can be interconverted. This unusual feature is called bistability and finds its origin in a range of 
physical properties such as complexation affinities, rate of isomerisations or electron transfers. 
The interconversion process can be triggered by a change in pH, pressure, temperature, light 
irradiation, magnetic or electric fields, or by chemical modification of the molecular structure.152–
157 
When the interconversion occurs upon modifications of light irradiation, one can speak of pho-
tochromism. Photoreversible molecules usually exist in two different states presenting distinct 
absorption spectra.158–163 The properties of a range of photoreversible compounds have been ex-
plored, including azulenes, stilbenes, fulgides, diarylethenes, azobenzenes, spiropyrans, vio-
logens or salicylideneimines (Chart 3). The photochromic processes associated with these types 
of molecules are photocyclisation, isomerisation, keto–enol tautomerism or photoinduced elec-
tron transfer.150–161 
 
Chart 3. Selection of photoreversible compounds. 
A remarkable application of these concepts was reported by Clayden and co-workers in 2016.164 
The control of stereoisomerism by light irradiation, in combination with foldamer chemistry, 
allowed the authors to synthesise a biomimetic system, bound in a phospholipid bilayer, in which 
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an azobenzene moiety was attached to a helical peptide. In its trans form, the azobenzene group 
forced the peptide chain to adopt a left-handed (M) helical conformation. Upon irradiation at 
365 nm, the photoisomerisation of the N=N double bond occurred, switching from trans to cis, 
and the conformational control of the helical peptide decreased dramatically (i.e., more equal 
populations of left- (M) and right-handed (P) helices were observed). Irradiation at 455 nm 
caused the azobenzene moiety to switch back to its initial state (trans), restricting the peptide 
oligomer in its M form (Figure 4). As shown by this example, the inherent screw-sense reversi-
bility of helical molecules establishes them as privileged scaffolds for the design of molecular 
switches. 
 
Figure 4. Clayden and co-workers reported that the isomerisation of an azobenzene moiety can induce the 
helical switch of a synthetic peptide embedded in a phospholipid bilayer. 
Among a large variety of geometrically defined molecular shapes, helical structures have been 
widely studied since the fundamental discoveries of the helical architectures of proteins by Pau-
ling165 and DNA by Watson and Crick166 in the early 50’s. In the same decade, Natta demon-
strated that synthetic polyhydrocarbons could also adopt a helical conformation.167 Following his 
pioneering investigations on the synthesis and tacticity of polypropylene, other helical molecular 
scaffolds, such as annulated arenes, oligoarylamides, polyisocyanates, polyolefins, polyacety-
lenes, synthetic polypeptides, polysilanes and para-terphenyls, have been designed, synthesised 
and thoroughly studied.168 These helical macromolecules have become synthetic targets of choice 
due to their interesting optical and electronic properties,169,170 their ability to induce asymmetry 
in chemical reactions,171 and to display functionality in a predictable pattern.172 Most of these 
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valuable properties strongly rely on screw-sense control.173,174 Therefore, scientists have devel-
oped useful tools to influence the helicity of such molecules. For example, the incorporation of 
one enantiomeric form of an additional element of chirality either at the termini81,175,176 or as part 
of a repeating substituent along the chain177 can lead to a preference for either M (left-handed) or 
P (right-handed) screw-sense. 
Small molecules do not benefit from the same amplification rules observed in polymers178 and 
therefore chemists had to adopt different strategies to synthesise smaller helical entities. For in-
stance, hydrogen bond networks in polyamides,179 salt, disulfide and lactam bridges in oligopep-
tides180 or electrostatic interactions in polyfluoroalkanes181 were successfully employed to impart 
or reinforce the helical conformation of such molecules. Another challenge appears if one wants 
to design small helical hydrocarbons. The propensity of non-functionalised small chains to fold 
into helices in a constrained environment has been studied by Rebek and co-workers through the 
encapsulation-induced folding of n-alkanes.182,183 In these examples, linear hydrocarbons prefer 
adopting a helical conformation to fit in the cavity of self-assembled host capsules. However, in 
the absence of external constraints, conformational control must arise from a subtle combination 
of steric interactions brought by a precise substitution pattern along the chain, as shown by the 
invaluable work conducted by Hoffmann and co-workers50,55,58,64,184  in the 90’s. 
 
Chart 4. Compounds 100 and 110 have the same absolute configuration. Although they both adopt helical 
conformations, 100 folds into an M helix in solution while 110 crystallises as a P helix. 
Interestingly, Aggarwal and co-workers observed that all-syn isomer 100 with hydroxyl and bi-
phenyl terminal groups adopted an M helix in solution, while its crystalline benzoate derivative 
110 adopted a P helix in the solid state1 (Chart 4). This result showed that both P and M helical 
forms were accessible to the molecule. Although a single helical form was favoured in solution, 
this preference could be over-ridden by crystal packing forces in the solid state. This research 
project is aimed at understanding the origin of the sense of helicity, particularly in solution, and 
design a new class of molecular helical switches, thereby building a theoretical framework from 






1.1.6. Research proposal 
Based on the fact that a single chiral centre at one extremity of a foldamer can induce a strong 
conformational preference on the whole structure,81 it has been suggested by Huc and co-workers 
that, at the stereogenic centre of the end-group, the largest group points away from the helix, the 
medium group aligns itself with the helical backbone and the small group points towards the 
helix. Therefore, by assigning a new configuration (RS and SS) to the stereogenic centre based on 
steric hindrance (helix > aryl > methyl > H)—rather than on the classic Cahn–Ingold–Prelog 
rules—, RS and SS chirality favours M and P helicity, respectively (Figure 5). 
 
Figure 5. Huc’s model: The large group (L) points away from the helix. The medium group (M) aligns 
itself with the helical backbone. The small group (H) points to the helix. 
Such an analysis brings up an important consideration for helical compounds such as 111 and 
112 (Chart 5). For compounds in which the terminal groups are separated by an even number of 
methyl-substituted methines, both end-groups will favour the same helical screw-sense and 
changing the relative size of the end-groups should not induce helical switching. However, for 
compounds in which the end-groups are separated by an odd number of carbon atoms, the termini 
will have different configurations (RS and SS) and the sense of helicity will presumably depend 
on which end-group is dominant, thus allowing switching to be possible. As a corollary, mole-
cules with an even number of methine units, should adopt more stable helical forms than those 
with an odd number of methine units because the termini will have the same configuration and 
thus will cooperate to enforce the same sense of helicity. 
 
Chart 5. Huc’s analysis applied to theoretical model compounds. 
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To determine whether Huc’s model can be used to reliably predict the helical screw-sense of 
these molecules, compounds 116 and 119 will be prepared (Scheme 17). Although these com-
pounds could be prepared by elaborating a precursor one carbon unit at a time, a building-block 
strategy,185 which the Aggarwal group has previously employed in the context of the total syn-
thesis of natural products,186–189 will be attempted here. Compounds will be prepared by the stitch-
ing together, through lithiation–borylation, of advanced intermediates. The boryl group in 115 
and 118 will be transformed into a methyl group using the Matteson homologation followed by 
protodeboronation.190 
 
Scheme 17. Building-block strategy to synthesise target compounds 116 and 119. 
Advanced intermediates 113 and 117 will be prepared using iterative reagent-controlled homol-
ogation of boronic ester (R)-120 involving enantiopure lithiated benzoates 94 generated through 
tin–lithium exchange of the corresponding -stannyl benzoates 93 (Scheme 18). The aryl bro-
mide, which will form part of the left-hand end-group, can later be functionalised through Buch-
wald–Hartwig, Stille, or Suzuki–Miyaura coupling to introduce varying degrees of steric hin-




Scheme 18. Synthetic plan to access boronic esters 113 and 117. 
Advanced intermediate 114 (respectively, ent-114) will be generated using a novel iterative bi-
directional lithiation–borylation191 of C2-symmetric bis(boronic ester) 122 (respectively, 
ent-122), which will in turn be prepared through Morken asymmetric diboration192,193 of 
trans-butene 121 (Scheme 19). C2-symmetric bis(boronic ester) intermediate 123 (respectively, 
ent-123) will be oxidized to the corresponding diol and esterified using Mitsunobu conditions. 
The naphthyl-based right-hand end-group will be introduced through lithiation–borylation using 
MeBpin 125, followed by metal-free stereoretentive cross-coupling18 of boronic ester 126 (re-
spectively, ent-126).  
 
Scheme 19. Synthetic plan to access benzoates 114 or ent-114. 
The QM/NMR approach (Section 1.1.4.2.) will be used to exhaustively explore the conforma-
tional space for all compounds. In parallel, attempts will be made to crystallise the compounds, 
so that their helical structure and screw-sense can also be determined through X-ray crystallog-
raphy. The expectation is that 116 should fold into an M helix. On the other hand, the naphthyl 
group in compound 119 is expected to be the dominant group and thus force the molecule to 
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adopt a P-helical conformation. The percentage of helical conformers is predicted to be higher 
for 116, owing to the end-groups having matched helical preferences. 
To confer helical switchability to these molecules, an azobenzene moiety will be introduced (Sec-
tion 1.1.5.) into the left-hand end-group by using a methodology developed by Cho and co-work-
ers,194 that is, Buchwald–Hartwig-type hydrazination of aryl bromide 119 to give a diaryl N-Boc 
hydrazine, followed by oxidation to reveal the N=N bond (Scheme 20). The conformational 
space, vicinal coupling constant values, and NOE-derived interproton distances for the cis and 
trans azobenzene isomers of 127 will be estimated computationally and compared with experi-
mental values obtained from NMR experiments of the compound kept in the dark (the trans iso-
mer) and that exposed to in situ laser irradiation195 (the photostationary cis isomer). For the cis 
isomer, the left-hand end-group should have the greater steric impact on the helix, thus enforcing 
an M screw-sense. However, the right-hand naphthyl group should be dominant when the azo-
benzene is trans, thus maintaining a P screw-sense. 
 







With a design for a polymethylated linear hydrocarbon with switchable helicity that can tolerate 
at least one large substituent in the middle of the chain in hand, a triarylphosphine derivative will 
be prepared and tested as a switchable ligand in asymmetric Pd-catalysed hydrosilylation. In a 
related application,196 Suginome and co-workers showed that helical poly(quinoxaline-2,3-diyl) 
copolymers 128, that contain chiral and achiral units, can switch from one helical form to another 
by changing the solvent, a characteristic that was exploited in catalysis by incorporating tri-
arylphosphine-appended monomers.197 In one helical form, the polymer mediated a palladium-
catalysed hydrosilylation of styrenes to give the desired product with very high levels of enanti-
oselectivity. In the other helical form, the product of opposite configuration was obtained 
(Scheme 21) with similar selectivity. 
 
Scheme 21. By introducing triarylphosphine moieties to a switchable polymer, Suginome and co-workers 
developed a switchable ligand for palladium-catalysed asymmetric hydrosilylation of styrenes. 
The phosphine moiety at C6 will be introduced through stereoretentive cross-coupling: the Ag-
garwal group has recently developed conditions allowing the boryl group to be retained in such 
a process through its migration into an ortho position.20 The boryl group will then be hydrolysed 
to the boronic acid and transformed into a triaryl phosphine moiety using a nickel-catalysed P–H 
activation of a secondary phosphine oxide,198 followed by copper-catalysed reduction199 (Scheme 




Scheme 22. Synthetic plan for the preparation of a new photo-responsive ligand for the asymmetric hy-
drosilylation of styrenes. 
The conformation and switching behaviour of 131 will be analysed by computation and NMR 
analysis. Once the helicity switching is confirmed, the compound will be ligated to a palladium 
centre and the resulting complex analysed. The Pd–131 complex will then be tested for its ability 
to asymmetrically catalyse the hydrosilylation of styrene 129, both in the dark and under UV 
light irradiation. The sense of enantioinduction in the dark and under UV light will be determined 
through chiral HPLC analysis of the corresponding silanes (S)-130. 
 
1.2. Results and discussion 
1.2.1. Synthesis of the first targets 
The first task of this project was to prepare both enantiomers of stannane 93 to serve as building 
blocks for the iterative homologation of boronic esters.1 Benzoate 91 was successfully synthe-
sised using a known phase-transfer catalysis method (Scheme 23). Pleasingly, increasing the 
scale of this reaction up to 40 grams of starting material did not affect the yield, which remained 
quantitative. This material was subsequently engaged in asymmetric stannylation reactions, on 
large scales (i.e., 10.00 g of sarting material), using ()- or ()-sparteine 65 as chirality inducers 
to generate (R)- or (S)-93, respectively. Both species were recrystallised from methanol to im-
prove their enantiomeric ratios up to 99.9:0.1. These masked carbenoids can then be stored, or 
treated with n-butyllithium to undergo a stereospecific tin–lithium exchange reaction, revealing 




Scheme 23. Preparation of enantiopure building block (R)-93 for the iterative homologation of boronic 
esters. The enantiomer (S)-93 was synthetised using ()-sparteine instead of ()-sparteine. 
To test whether secondary benzylic boronate complex formation was faster than an aromatic 
brominelithium exchange reaction, boronic ester (R)-120 was synthesised in two steps from 
commercially available 3-bromo-4-methoxybenzaldehyde. First, a Wittig reaction gave alkene 
133, which was successfully converted to enantioenriched boronic ester (R)-120, using an effi-
cient asymmetric hydroboration methodology developed by Yun and co-workers.200 It is im-
portant to emphasise that a thorough purification of all the reagents involved in this chemical 
reaction was key to obtain the desired product with the required enantiomeric ratio (i.e., >98:2 
e.r.). The first attempt of the homologation reaction on (R)-120 gave an inseparable mixture of 
extended boronic esters 134a and 134b in a 70:30 ratio (Scheme 24). 
 
Scheme 24. Yun’s asymmetric hydroboration applied to 3-bromo-4-methoxystyrene. 
These results suggested that the boronate complex formation was the first reaction to take place, 
but the excess of lithium carbenoid (R)-94 used (0.30 equiv.) was subsequently engaged in a 
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brominelithium exchange process to generate the de-halogenated product 134b. An easy way 
to circumvent this problem would be to reduce the number of carbenoid equivalents (i.e., from 
1.30 to 1.00 equiv.). However, it has been reported that an excess of lithiated benzoate was crucial 
to obtain a full conversion of the starting material.1 Another synthetic plan was therefore envi-
sioned, where the bromine atom would be introduced at a later stage. 
 
Scheme 25. Preparation of fragments 136 and 137 using Aggarwal’s iterative homologation methodology. 
Yun’s asymmetric hydroboration procedure was applied to 4-methoxystyrene to generate boronic 
ester (R)-135 in 99.4:0.6 e.r. This molecule served as a starting point for a three–round iterative 
homologation sequence, using (R)-, (S)- and (R)-94 successively, to deliver boronic ester 136 in 
61% yield over three homologations without intermediate purification (Scheme 25). Part of this 
material was then converted to fragment 137, using the same homologation methodology. 
 
Scheme 26. Morken’s asymmetric diboration methodology applied to trans-butene. 
A unidirectional assembly-line synthesis was required to obtain fragments 136 and 137 as the 
4-methoxyphenyl moiety could not be installed in a stereospecific manner at a later stage. How-
ever, a more efficient bidirectional chain-extension process was investigated to access fragment 
114. First, trans-butene 121 was subjected to Morken’s asymmetric diboration methodol-
ogy.192,193 Despite the relatively small size of its substituents, this gaseous substrate gave C2-
symmetric boronic ester 122a in good yield (Scheme 26). Interestingly, a substantial amount of 
isomer 122b was obtained, however with poor e.r. This side product most likely arose from the 
isomerisation of the double bond in the presence of the rhodium catalyst prior to the diboration 
 
26 
reaction. The lack of stereocontrol around this terminal olefin is in line with Morken’s results, 
when this methodology was applied to monosubstituted alkenes. The mixture of isomers was 
directly engaged in the next step to give, after recrystallisation, pure boronic ester 138 in perfect 
d.r. The relative configuration of the methyl groups was confirmed by X-ray crystallography. 
 
Scheme 27. Bidirectional synthesis of dibenzoate 124. 
A bidirectional Matteson homologation,201 followed by oxidation and double Mitsunobu reaction, 
delivered benzoate 124 in 82% yield over three steps (Scheme 27). Compound 124 was then 
desymmetrised by ()-sparteine-mediated asymmetric deprotonation and subsequent trapping of 
the carbenoid intermediate with methyl boronic ester 125, which itself was easily synthesised in 
one step from methyl pinacol boronic acid.202 Unfortunately, the first attempt gave the desired 
product (126) in only 18% yield (Scheme 28a). 
 
Scheme 28. Desymmetrisation of dibenzoate 124. a. Conditions and yield before in situ IR spectroscopy-
assisted optimisation. b. Conditions and yield after in situ IR spectroscopy-assisted optimisation. 
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In situ IR spectroscopy was used to monitor and optimise this lithiation–borylation reaction, as 
the starting material 124, carbenoid intermediate Li-124 and boronate-complex ate-124 have 
strong and sharp  C=O bands at 1728, 1634 and 1667 cm1, respectively, which importantly did 
not overlap with any other signals.203 The experiment showed that the full deprotonation of ben-
zoate 124 was achieved in only one hour after the addition of of s-BuLi (1.00 equiv.). However, 
the boronate-complex formation was found to be slower than the usual borylation reaction times 
and reached a plateau three hours after the addition of the solution of boronic ester 125 
(1.00 equiv.) in diethyl ether (Figure 6). 
 
 
Figure 6. Lithiation–borylation reaction monitored by in situ IR spectroscopy. Concentrations of starting 
material 124 (in blue), carbenoid Li-124 (in green) and boronate complex ate-124 (in red) over time. 
In their recent study on the borylation of diamine-ligated -lithiated benzoates,203 Myers and 
Aggarwal determined that solvent had a dramatic impact on the borylation reaction time. They 
showed that by adding the boronic ester in tetrahydrofuran (THF) instead of diethyl ether, they 
could facilitate the borylation step through displacement of the bulky diamines coordinated to the 
lithium carbenoid, with no erosion of e.r. This solvent effect was successfully employed to 
shorten the problematic borylation step and promote the formation of boronate-complex ate-124. 
However, in the above case, the migration step seemed to be troublesome too: after sixteen hours 




Figure 7. When the migrating group is a methyl group, the required antiperiplanar conformation is disfa-
voured. Therefore, the migration step becomes slower than usual. Charges have been omitted for clarity. 
The poor migrating ability of the methyl group can be rationalised by analysing steric interactions 
within the boronate-complex6 (Figure 7). In fact, the 1,2-migration only occurs when the migrat-
ing group and the leaving group are antiperiplanar. Generally, in the case of large R1 groups, the 
migrating group positions itself antiperiplanar to the leaving group to prevent any steric clash 
between them, thus enhancing the rate of the migration step. However, in the case of the small 
methyl group, this steric clash is reduced. More importantly, the pinacol moiety, which is now 
bulkier than the migrating group, sits antiperiplanar to the benzoate moiety, favouring the wrong 
conformation for alkyl 1,2-migration.204 
 
Scheme 29. Transition metal-free cross-coupling between 1-bromonaphthalene and boronic ester 126. 
It has been shown that a solvent switch from diethyl ether or tetrahydrofuran to a less coordinat-
ing solvent such as chloroform or toluene allows the Lewis acidic lithium counter cation to bind 
more efficiently to the leaving group and thus increase the effectiveness of the 1,2-metallate re-
arrangement.187 This second solvent effect was also used in the above case to increase the rate of 
the migration. After optimisation, this desymmetrisation reaction delivered boronic ester 126 in 
68% yield (Scheme 28b). Finally, a transition-metal-free cross-coupling methodology18 was uti-
lised to obtain fragment 114 (Scheme 29). 
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The coupling reaction between 114 and 137 was expected to be challenging, as lithiation–boryla-
tion methodology was sensitive to steric hindrance. For this reason, the reaction was again fol-
lowed by in situ IR spectroscopy. It turned out that the lithiation step was quite slow (seven hours) 
and the borylation step inefficient (no boronate-complex formation was observed after two 
hours). These results can easily be understood by looking at the structure of carbenoid/(+)-spar-
teine complex 146 (Scheme 30). The reactive centre is flanked by the triisopropylbenzoate moi-
ety, the methylated backbone and the sparteine ligand. In these conditions, there is no room for a 
bulky boronic ester such as 137 to approach the carbanion and form a boronate-complex. Adding 
boronic ester 137 in THF helped to form the desired boronate complex. However, the yield of 
the reaction remained very low. 
 
Scheme 30. Due to steric hindrance, the coupling reaction between carbenoid 146 and boronic ester 137 
was not successful. 
Due to the unsuccessful coupling of fragments 114 and 137, the first convergent strategy was 
abandoned. Instead, a more familiar linear sequence1,205 was employed to generate intermediate 
148. Boronic ester 135 was subjected to nine rounds of homologation (Scheme 31), alternating 
between the enantiomers of stannane 93, to deliver intermediate 148 in 48% yield over nine steps. 
One more homologation step was necessary to access intermediate 150. Using the same transi-
tion-metal-free cross-coupling methodology as described above,18 both targets 149 and 151 were 
synthesised in 66% and 57% yield, respectively. With both compounds in hand, their conforma-




Scheme 31. Preparation of target compounds 149 and 151, using unidirectional iterative homologation of 
boronic ester methodology. 
 
1.2.2. Preliminary NMR analysis and Molecular Mechanics 
For both compounds, 3JH–H coupling constant values were studied by 1H NMR analysis. In the 
case of 149, most of the core CH signals were overlapped, and a constrained rotation, due to 
steric effects of the naphthyl group, broadened signals 22 and 24 (Chart 6). Nevertheless, 
3JH6–H8 = 9.9 Hz and 3JH8–H10 = 2.8 Hz could be obtained. 
 
Chart 6. Atom numbering of target compound 149. 
According to Karplus equation,206 the first value (9.9 Hz) suggested that H6 and H8 were likely 
to be in an antiperiplanar relationship in the major conformer, and thus depicted C5–C6–C8–C10 
as a gauche dihedral angle. The second coupling constant (2.8 Hz) showed that H8 and H10 stood 
in a gauche relationship, indicating that C6–C8–C10–C12 was an antiperiplanar dihedral angle 
in the major conformer. Despite the lack of information concerning the other dihedral angles, 
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these initial results indicated that compound 149 presented a certain conformational preference 
in solution. 
The same analysis was applied to compound 151 (Chart 7): the first and the last coupling con-
stant values, 3JH6–H8 = 7.0 Hz and 3JH24–H26 = 6.9 Hz, were extracted from the 1H NMR spectrum. 
These values of 7.0 and 6.9 Hz were unexpected but can be interpreted in two different ways. 
 
Chart 7. Atom numbering of target compound 151. 
The first explanation is that dihedral angle C5–C6–C8–C10 (respectively, C22–C24–C26–C27) 
can adopt two different conformations in solution: a gauche conformation with 3JH6–H8 > 7 Hz 
(respectively, 3JH24–H26 > 7 Hz) and an antiperiplanar conformation with 3JH6–H8 < 7 Hz (respec-
tively, 3JH24–H26 < 7 Hz), with each conformation accounting for 50% of the overall dihedral angle 
population. The NMR spectrum would then represent the average of both conformations, with 
the resulting average coupling constant of 7 Hz. This interpretation could suggest that the mole-
cule exists as a 50:50 mixture of the left-handed (M) helix and the right-handed (P) helix. A 
second explanation is that both dihedral angles do not have any conformational preference. This 
would also result in an average coupling constant of 7 Hz. Assuming that the other dihedral an-
gles behave in the same way, this second interpretation could imply that the molecule does not 
adopt any controlled conformation in solution. 
Molecular mechanics was employed to confirm the presumed conformational preference of 149 
and better interpret the results obtained in the case of compound 151. Pleasingly, a Monte Carlo 
molecular mechanics conformational search (using the MMFFs force field, 500,000 itera-
tions and in the gas phase) corroborated the strong conformational preference expected for 
149. As shown in Figure 8, molecular mechanics predicted that the most populated conform-
ers of 149 would exhibit backbones with an alternating gauche/antiperiplanar dihedral angle 
sequence. The three-dimensional structure of the molecule can be represented on a diamond 
lattice (Figure 9a), with dihedral angle values rounded to 60° for each gauche dihedral angle 
and 180° for each antiperiplanar dihedral angle. As a result, an M helix is obtained, as pre-





Figure 8. Bubble plots representing the different populations of dihedral angles in the backbone. The size 
of the bubble is proportional to the percentage of the corresponding calculated Boltzmann population. 
These data were extracted and processed by Dr. Siying Zhong. 
However, in opposition to Huc’s model, Newman projections along C6→C8 or C24→C22 axes 
(Figure 9b) show that the larger groups (i.e., para-methoxyphenyl and naphthyl groups) are not 
pointing away from the helix but instead are set themselves as if they are part of the continued 
backbone. Therefore, the accordance between the prediction of Huc’s model and the observed 
screw-sense is assumed to be a coincidence. 
 
Figure 9. a. Compound 149 represented as a left-handed helix on a diamond lattice, according to its bubble 
plot showed above. b. The Newman projections at both chain-ends showed that the aromatic groups were 
not pointing away from the helix. PMP = para-methoxy-phenyl. 
Moreover, in the case of compound 151, Huc’s model predicts that if the end-groups have differ-
ent absolute configurations, the biggest end-group (here, the naphthyl group) would dominate 
and dictate the screw-sense. However, the same molecular mechanics conformational search of 
151 predicted that 12% of the overall population would exist as a left-handed helix, 8% as a right-
handed helix and 80% would adopt non-helical conformations (Figure 8). These results are in 
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line with the coupling constant values obtained by 1H NMR. This indicates that the second inter-
pretation is correct and discredits, once again, the applicability of Huc’s model to such molecules. 
Therefore, the development of a new stereochemical model accounting for the experimental ob-
servations is essential to better understand the conformational preference of these all-syn methyl-
substituted compounds. 
 
1.2.3. Towards a new stereochemical model 
A diamond lattice analysis reveals that, for a chain containing ten stereocentres such as ent-111, 
only two conformers bear no syn-pentane interaction (Figure 10). One of these conformers is a 
left-handed (M) helix and the other conformer a right-handed (P) helix. 
 
Figure 10. Equilibrium between left- and right-handed helices bearing an even number (10) of stereocen-
tres in the backbone drawn on a diamond lattice. 
From this initial three-dimensional analysis, it appears that any antiperiplanar dihedral angle 
(t = 180°) in the M helix becomes a gauche dihedral angle (g = 60°) in the P helix after a 
conformational switch. Similarly, any gauche dihedral angle (g = 60°) in the M helix becomes 
an antiperiplanar dihedral angle (t = 180°) in the P helix. The dihedral angle sequence in the M 
conformer could then be described as t, g, t, g, t, g, t, g, t, whereas the dihedral angle sequence 




Figure 11. Newman projections of t, gand g dihedral angles. The gauche interactions are represented 
by red steric clash signs. 
Newman projections of t, gand g dihedral angles (Figure 11) reveal that each t dihedral angle 
generates three gauche interactions, while each g (g or gdihedral angle generates only two 
gauche interactions. Based on this observation, the dihedral angle sequence in the M helix (5 × t 
+ 4 × g) creates 23 gauche interactions, whereas the dihedral angle sequence in the P helix 
(5 × g + 4 × t) creates only 22 gauche interactions. Consequently, according to these numbers, 
the P conformer is expected to be dominant in this case (i.e., for this specific absolute configura-
tion). More generally, for any given absolute configuration and assuming that all the gauche 
interactions are equivalent in terms of energy penalty, an all-syn methyl-substituted chain with 
an even number of stereocentres should favour the conformer which bears no syn-pentane inter-
actions and with the smallest number of t dihedral angles in the backbone. 
 
Figure 12. Equilibrium between left-handed helix, right-handed helix and non-helical conformers with an 
odd number (11) of stereocentres in the backbone drawn on a diamond lattice. 
The same diamond lattice analysis on a chain composed of eleven stereocentres shows that only 
two conformers can exist with no syn-pentane interactions (Figure 12). As for a chain with an 
even number of stereocentres, one of these conformers is an M helix, while the other is a P helix. 
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The same dihedral angle interconversions from g to t and from t to g is observed when the 
molecule switches from M to P. The dihedral angle sequence in the M form can be described as 
g, t, g, t, g, t, g, t, g, t, whereas the dihedral angle sequence in the P form can be described as 
t, g, t, g, t, g, t, g, t, g. However, in this case, the number of gauche interactions is identical 
for both helices (5 × t + 5 × g = 25). As a consequence, the ratio between the population of helical 
conformers adopting a M-helical conformation and the population of helical conformers adopting 
a P-helical conformation should be close to 50:50.  
Interestingly, a molecular mechanics (MM) conformational search of 112 (eleven stereocentres) 
predicted that only 20% of the overall population would adopt a helical conformation (Figure 8), 
in a 60:40 M:P ratio. This suggests that, with eleven stereocentres, the helical conformers (i.e., 
conformers with no syn-pentane and 25 gauche interactions) are very close in energy to the non-
helical structures which necessarily contain a syn-pentane interaction. Most likely, both C–C 
bonds involved in this syn-pentane interaction do not lie in the exact same plane to reduce the 
energetic cost of the steric clash (this type of interaction could be described as a pseudo- or re-
laxed syn-pentane interaction). 
Assuming that any all-syn methyl-substituted hydrocarbon with an even number (respectively, 
odd number) of stereocentres possesses the same conformational behaviour as compound 149 
(respectively, compound 151), an initial model can be established (Table 1) to predict the screw-
sense of such molecules. 
 






    
Predicted 
screw-sense 
Right-handed    
helix (P) 
Left-handed      
helix (M) 
Mixture of M, P and non-helical        
conformers 
Table 1. Screw-sense prediction table. 
However, this new model relies only on a combination of molecular mechanics results and highly 
congested 1H NMR spectra of only two compounds with two different chain lengths (ten and 
eleven stereocentres). Therefore, to confirm the general applicability of the model, it was neces-





1.2.4. Design of new targets 
The objective was to design and synthesise a series of compounds with different chain lengths to 
study their conformations using the QM/NMR approach.1,188 One of the limitations of this tech-
nique appears when NMR spectra are too congested, preventing the extraction of NMR parame-
ters, such as chemical shifts or coupling constants. To avoid this issue, only C2-symmetric and 
meso compounds were selected. Indeed, introducing symmetry elements creates pairs of chemi-
cally equivalent atoms, reducing the number of NMR signals and, therefore, lowers the risk of 
spectrum congestion. 
The nature of the end-groups would certainly play a role in the conformational behaviour of these 
molecules. To avoid any steric interactions with the backbone, terminal alkynyl groups were 
chosen as the end-groups. Their linear geometry and small size (dC≡C  1.2 Å) would prevent 
terminal alkynes from generating any steric hindrance and the electron density of the C≡C triple 
bond would spread the NMR chemical shifts and thus reduce the number of overlapping NMR 
signals. 
Finally, in terms of synthesis, the target molecules would ideally be accessible from the same 
synthetic intermediate, using the iterative homologation of boronic esters. According to all of the 
requirements listed above, a series of six molecules (three C2-symmetric and three meso com-
pounds) were chosen (Chart 8) to validate the new stereochemical model. 
 
Chart 8. Two series of target molecules were designed to study the impact of the chain length on the 
conformation in solution. 
According to the proposed model, one could represent the three C2-symmetric compounds C6, 
C8 and C10 on a diamond lattice (Figure 13a). The scalar coupling constant value 3JH–H for each 
pair of consecutive protons attached to the backbone could then be theoretically estimated, based 
on the Karplus equation.206 According to Karplus’ graph, an antiperiplanar (t) H–C–C–H dihedral 
angle would give a coupling constant value > 8 Hz (large), whereas a gauche (g) H–C–C–H 
dihedral angle would give a coupling constant value < 6 Hz (small). For example, in compound 
C10, the predicted H–C–C–H dihedral angle sequence being t, g, t, g, t, g, t, g, t, the 3JH–H 
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sequence was expected to be large, small, large, small, large, small, large, small, large. If the 
experimental measurements showed the opposite 3JH–H sequence (i.e., small, large, small, large, 
small, large, small, large, small), it would suggest that the opposite helix was dominant in solu-
tion (Figure 13b). If the experimental values were all about 7 Hz, the conclusion would be that 
there was no dominant conformer in solution. Consequently, a simple 1H NMR measurement 
would establish the accuracy of the model. After these theoretical considerations, the next task 
was to synthesise the target compounds. 
 
Figure 13. a. Predicted conformers for compounds C6, C8 and C10 drawn on a diamond lattice. b. Ex-
pected coupling constant values for both helical conformers of compound C10. 
 
1.2.5. Synthesis and preliminary NMR results 
Boronic ester 138 was bidirectionally homologated once to give intermediate 152 (containing six 
stereocentres), twice to obtain compound 153 (with eight stereocentres) and, finally, three times 
to access boronic ester 154 bearing ten stereocentres. Remarkably, compounds 153 and 154 were 
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generated in an iterative manner, with only one purification step at the end of the homologation 
sequence (Scheme 32). The extraction of the 3JH–H values by 1H NMR analysis revealed that the 
conformational behaviour of the three compounds was in line with the prediction of the new 
model. Surprisingly however, an X-ray crystal structure of 154 (Scheme 31) showed that the 
molecule underwent a helical switch from P helix in solution to M helix in the solid state. It 
would seem that for efficient crystal packing, the pinacol boronic ester moieties adopt an ex-
tended conformation, forcing the chain to switch (as a consequence of the avoidance of syn-
pentane interactions). 
 
Scheme 32. Preparation of C2-symmetric boronic esters 152, 153 and 154 using bidirectional iterative 
homologation methodology. 
 
Figure 14. a. X-ray crystal structure of boronic ester 154 Ellipsoids shown at 50% probability. Hydrogen 
atoms and solvent molecules have been omitted for clarity. b. Conformation of compound 154 in the solid 





Scheme 33. Example of desymmetrisation of a C2-symmetric boronic ester (here 152) to access two target 
compounds (here, C6 and C7). Carbamate 15 was synthesised in one step from the corresponding car-
bamoyl chloride.207 
The C2-symmetric intermediates were then desymmetrised using the alkynylation methodology 
developed in the Aggarwal group in 2016.17 Each desymmetrisation reaction resulted in a mixture 
of starting material, monoalkyne and dialkyne. After isolation of each of these three species, 
monoalkyne intermediates were protected, homologated, alkanylated and finally deprotected to 
access the last three target molecules (Scheme 33). 
 
Figure 15. a. HA and HA’ are chemically equivalent but magnetically inequivalent. b. 1H NMR signal of 
the proton pair HA/HA’. 
Pleasingly, no signal overlap was observed when NMR spectra were recorded in deuterated tol-
uene. In the case of C2-symmetric molecules, measurements of 3JH–H were relatively straightfor-
ward, except for the HA–HA’ proton pair depicted in Figure 15a. HA couples to HB with 3JHA–HB 
and to HB’ with 4JHA–HB’ whereas HA’ couples to HB with 4JHA’–HB and to HB’ with 3JHA’–HB’. 
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Therefore, HA and HA’ are chemically equivalent but not magnetically equivalent to each other. 
As a consequence, the 1H NMR signal of HA/HA’ appears as a complex multiplet (Figure 15b) 
from which no 3JH–H could be extracted. This limitation was not observed for meso compounds 
where all the coupling constants could be obtained. Gratifyingly, these preliminary results (Table 
2) are in accordance with the proposed model (Table 1). Unlike boronic ester 154, dialkyne C10 
was found to adopt the same conformation in solution and in the solid state, as shown by its X-
ray crystal structure (Figure 16). 
 C6 C7 C8 C9 C10 C11 
3JH1–H2 9.2 Hz 6.8 Hz 9.2 Hz 6.9 Hz 9.2 Hz 6.9 Hz 
3JH2–H3 2.8 Hz 5.6 Hz 3.4 Hz 5.3 Hz 3.6 Hz 6.9 Hz 
3JH3–H4 - 6.5 Hz 8.5 Hz 6.7 Hz 8.8 Hz 6.8 Hz 
3JH4–H5   - 6.1 Hz 3.1 Hz 6.8 Hz 
3JH5–H6     - 6.6 Hz 
Major   
conformer 
P helix ? M helix ? P helix ? 
Table 2. Extraction of 3JH–H values from 1H NMR spectra of compounds C6, C7, C8, C9, C10 and C11. 
The atom numbering refers to Figure 13a. 
 
Figure 16. a. X-ray crystal structure of dialkyne C10. Ellipsoids shown at 50% probability. Hydrogen 
atoms and solvent molecules have been omitted for clarity. b. Conformation of compound C10 in the solid 
state drawn on a diamond lattice. 
As expected, the simultaneous addition of two stereocentres at both ends of 152 to give 153 led 
to an inversion of screw-sense from C6 (P helix) to C8 (M helix). The same interesting phenom-
enon was observed when 153 was bidirectionally homologated to deliver 154, resulting in a sec-
ond screw-sense inversion from C8 (M helix) to C10 (P helix). According to the model, this 
phenomenon can be rationalised by the tendency of the chain to reduce the number of gauche 
interactions (Figure 17). This iterative bidirectional homologation process can therefore be de-




Figure 17. Helical switching by bidirectional chain extension. [B] = Bpin. 
Pleasingly, the same analysis revealed that compounds with an odd number of carbon atoms in 
the backbone (C7, C9 and C11) exhibited an average coupling constant value (3JH–H  7 Hz) for 
each proton pair. As discussed in Section 1.2.3., one interpretation could be that both helical 
conformers were dominant in solution and present in a 50:50 ratio, or a second explanation could 
be that the conformational ensemble did not have a preferred conformation. 
 
42 
At that time, all of these results only relied on preliminary 1H NMR measurements. To support 
them, a more thorough quantitative conformational analysis was required. In the case of fully 
flexible molecules with controlled conformations, one of the most powerful techniques to confi-
dently describe the populations of conformers in solution was the QM/NMR approach, as shown 
by Butts and Aggarwal1,188 over the last few years. This approach was employed to validate the 
conclusions depicted above and obtain the structures and ratios of the different populations of 
conformers of the target compounds. 
 
1.2.6. Application of the QM/NMR approach 
This part of the project was conducted by Dr. Siying Zhong who extracted all the required NMR 
parameters, including NOE-distances, and performed all the molecular mechanics (MM) and 
density functional theory (DFT) calculations. Her results208 were included in this thesis to pro-
vide a complete picture of the project. 
First, the conformational landscape of compound C10 was explored by molecular mechanics 
(MM). A Monte Carlo MM conformational search predicted that 90% of the overall population 
would adopt a helical conformation (Figure 18). The energy difference between both P and M 
conformers was found to be quite small (E  1.0 kJ mol−1), resulting in a 50:50 ratio of right- 
and left-handed helices. 
 
Figure 18. Dihedral angle populations of dialkyne C10 predicted by MM (left) and DFT (right) and rep-
resented as bubble plots. Red dots belong to a P helix, blue dots belong to an M helix, orange dots belong 
to non-helical conformers. 
By contrast, DFT geometry optimisation and frequency calculations using B3LYP-D2/6-311G(d) 
level of theory gave a different outcome. According to this method, 65% of the overall population 
would fold into a P helix, 14% would exist as an M helix and 21% would present non-helical 
conformations. The energy difference between both helical populations was predicted to be about 
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1 kcal mol–1, a difference that is in line with the expected energy penalty for the one extra gauche 
interaction between methyl groups in the M conformers.70 
Prior to performing DFT calculations to predict the ensemble-average scalar coupling constants, 
it was necessary to find the optimal level of theory for calculating conformer geometries and 
energies. The predictions of eleven sets of DFT methods, involving four different functionals 
(mPW1PW91, B3LYP, B3LYP-D2 and M06-2X), in combination with five basis sets (6-31G(d), 
6-311G(d), 6-311+G(d), 6-311G(d,p) and 6-311+G(d,p)), were compared to experimentally-
derived NOE-distances. Pleasingly, B3LYP-D2/6-311G(d) level of theory in gas phase pro-
vided the best fit to the experimental values. 
After optimisation of the DFT method to calculate conformer geometries and energies, the cou-
pling constant values of the major conformers (making up 90% of the overall population) were 
subjected to DFT calculations using mPW1PW91/6-311G(d,p) level of theory, with implicit tol-
uene (IEFPCM), to establish the ensemble-averaged scalar coupling constants. The 4JH–H cou-
pling constant between the terminal alkyne proton and the first CH of the chain was not included 
in this analysis because it did not give any information about the conformation of the backbone. 
Moreover, this computed 4JH–H value (4.2 Hz) deviated significantly from the experimental value 
(2.4 Hz), probably because the sp orbitals of the alkyne bond were not described accurately by 
the level of theory employed here. Apart from this coupling constant, all the NMR parameters 
were in good agreement with the measured values (Table 3 and Figure 19). 
 MAD StDev 2 (reduced) 
1H–1H scalar coupling 0.6 Hz 0.7 Hz 0.44 
NOE distances 3.8% 4.9% 1.97 
Table 3. Mean averaged deviation (MAD), standard deviation (StDev) and 2 (reduced) values for calcu-
lated NMR parameters of C10. 
 
Figure 19. a. Comparison of DFT-computed ensemble- averaged 1H–1H scalar coupling constants and  
1H–1H distances to the experimental values. b. DFT-predicted lowest energy conformer (P helix) of C10. 
c. X-ray crystal structure of C10 Ellipsoids shown at 50% probability. Hydrogen atoms and solvent mole-
cules have been omitted for clarity. 













































Encouraged by these results, the same Monte Carlo MM conformational search was applied to 
compounds C6 and C8. The resulting conformations were then subjected to DFT geometry opti-
misation and energy calculations, using the appropriate level of theory B3LYP-D2/6-311G(d), 
with a correction derived from single point energy calculations with a bigger basis set 
6-311G(d,p) and solvation (toluene, IEFPCM). About 86% of the overall conformer population 
of C6 and 80% of the overall conformer population of C8 were predicted to be helical. As antic-
ipated by the diamond lattice-based model, compound C6 mainly existed as a P helix, whereas 
compound C8 preferred to fold into an M helix (Figure 20). The energy difference between M 
and P helices was, in both cases, around 1 kcal mol–1. For both compounds, the calculated aver-
aged NMR parameters were in good agreement with experimental data (Table 4). 
 
Figure 20. a. Dihedral angle numbering for compound C6 (left) and C8 (right). b. Dihedral angle popu-
lations of dialkynes C6 (left) and C8 (right) represented as bubble plots. Red dots belong to a P helix, 
blue dots belong to an M helix, green dots belong to non-helical conformers. c. Comparisons of DFT-
computed ensemble-averaged 1H–1H scalar coupling constants and 1H–1H distances to the experimental 
values for C6 (left) and C8 (right). 
Interestingly, the fraction of helical conformers in the overall population was inversely propor-
tional to the chain length of the compound. Presumably, adding more rotatable bonds to the mol-
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1H–1H scalar    
coupling 
0.5 Hz 0.7 Hz 0.80 0.1 Hz 0.1 Hz 0.02 
NOE distances 2.9% 1.8% 1.6 4.3% 5.4% 2.6 
Table 4. Mean averaged deviation (MAD), standard deviation (StDev) and 2 (reduced) values of calcu-
lated NMR parameters for compounds C6 (left) and C8 (right). 
The next step was the QM/NMR analysis of compounds with an odd number of stereocentres. 
C7 was subjected to the same methodology as described above. Although helical conformers still 
remained the lowest-energy conformers, DFT calculations predicted that only 63% of the overall 
conformer population would adopt a helical shape, with a 50:50 ratio of M and P helices, as 
symmetry rules require (Figure 21). Helical conformations still represented the local minima but 
were really close in energy to non-helical structures (<1 kcal mol–1). The computed ensemble-
averaged 1H–1H coupling constants were in agreement with the experimental values (i.e., the 
mean averaged deviation (MAD) and the standard deviation (StDev) were both lower than 
0.25 Hz with a 2 (reduced) value of 0.08). However, the same calculations applied to an artificial 
population containing only helical conformers (with the same 50:50 ratio of M and P helices) 
also gave an ensemble-averaged 1H–1H coupling constants in good agreement with the measure 
JH–H values (both MAD and StDev <0.36 Hz and 2 (reduced) = 0.24). Hence, the analysis of 
coupling constants alone was not enough to determine whether non-helical conformers were pre-
sent in the population or not. 
             
 
Figure 21. Dihedral angle populations of dialkyne C7 predicted by DFT and represented as a bubble plot. 




To face this problem, two distinct sets of ensemble-averaged NMR parameters (H, C, J values 
and NOE-derived 1H–1H distances) were calculated by DFT. The first set of parameters derived 
from the initial predicted population—consisting of 63% of helical conformers (50:50 M:P ratio) 
and 37% of non-helical conformers—whereas the second set of parameters was based on a pop-
ulation containing only helical conformers (with the same 50:50 M:P ratio). The comparison of 
both sets of data to the experimental values revealed that computed chemical shifts (H and C) 
and coupling constants (J) were insensitive to the change in conformer population, giving similar 
2 (reduced) values in both cases. By contrast, the calculated NOE-derived 1H–1H distances were 
found to be affected by the presence of non-helical conformers in the population. Indeed, the 2 
(reduced) value for NOE distances generated from the population containing non-helical con-
formers was 3.76 while the other set of NOE distances derived from a population containing only 
helical conformers gave a 2 (reduced) value of 6.08. These values indicated that non-helical 
conformers were present in solution. DFT calculations showed that helical conformations still 
represented the local minima but were really close in energy to non-helical structures 
(<1 kcal mol–1). 
         
 
Figure 22. Dihedral angle populations of dialkynes C9 and C11 predicted by DFT and represented as 
bubble plots. Red dots belong to a P helix, blue dots belong to an M helix, green, purple and turquoise dots 
belong to non-helical conformers. 
The same computational analysis was applied to compounds C9 and C11. In both cases, DFT 
results showed a mixture of non-helical and helical conformers (Figure 22). As expected for 
meso compounds, the helical population was composed of a 50:50 ratio of M and P helices. In-
terestingly, the percentage of helical conformers (i.e., combined M and P helices) dramatically 
decreased as the chain length increased (from 63% for C7 to 27% for C11) (Figure 23). Once 
again, the entropic cost associated with the conformational control of a higher number of rotatable 




Figure 23. Combined helical conformer population of C6, C7, C8, C9, C10 and C11. 
In conclusion, a thorough QM/NMR approach confirmed the theoretical results predicted by the 
new diamond lattice-based model. It showed that C2-symmetric compounds such as C6, C8 and 
C10 had a strong conformational preference towards helical conformations, P helix for C6 and 
C10, M helix for C8. These observations proved that the remarkable ‘helical switching by bidi-
rectional chain extension’ described in Section 1.2.5. indeed occurred. Meso compounds such as 
C7, C9 and C11, displayed a very different conformational behaviour. Interestingly, this series 
of molecules revealed a rare odd–even effect in alkanes that is not associated with bulk intermo-
lecular interactions. To further confirm the QM/NMR results, vibrational circular dichroism was 
employed. 
 
1.2.7. Vibrational Circular Dichroism analysis 
This part of the project was conducted by Márton Baglyas and György Tarczay who performed 
the calculations to access the vibrational circular dichroism (VCD) theoretical spectra and 
measured the experimental VCD response of compound C10. Their results were included in this 
thesis to provide a complete picture of the project. 
With the optimised geometries of both helical conformers of C10 in hand, the vibrational circular 
dichroism (VCD) spectra of both helices could be simulated in silico. Surprisingly, although both 
conformers did not form a pair of enantiomeric structures, their calculated VCD spectra were 
almost mirror images of each other. They displayed maximal absorptions at the same wave-
numbers (1420, 1065 and 980 cm–1) but with opposite intensities (Figure 24). The measured 
experimental response showed the same pattern of absorption, slightly shifted towards the higher 
wavenumbers (1450, 1080 and 1010 cm–1). The sign of these signals clearly indicated the pres-
ence of a P helix in solution. These results confirmed the previous QM/NMR studies performed 














































Figure 24. Comparison of calculated and experimental VCD spectra. a. Calculated VCD spectrum of the 
optimised lowest energy M conformer of C10. b. Calculated VCD spectrum of the optimised lowest en-
ergy P conformer of C10. c. Experimental VCD response of C10 in chloroform-d (the signals between 
1150 and 1200 cm1 correspond to the solvent). 
 
1.2.8. Influence of the end-groups on the conformation 
Having established the rules that dictated the conformation preference of the backbone itself, the 
next task of the project was to study the influence of the end-groups on the conformation of the 
chain. In the previous part of the study, all the gauche interactions were considered to be equiv-
alent in terms of energy penalty. In this section, it was necessary to distinguish the different types 
of gauche interactions encountered in such molecules. To do so, a more careful inventory was 
made based on the proposed model. To simplify the analysis, C2-symmetric molecule were cho-




Figure 25. Detailed inventory of the different gauche interactions present in both helical conformers of a 
C2-symmetric compound bearing an even number (10) of stereocentres in the backbone. 
For example, in the case of a compound with ten stereocentres in the backbone and with the 
absolute configuration depicted in Figure 25, one could count nine Methyl–Methyl, two R–Me-
thyl, eight Chain–Methyl and four Chain–Chain gauche interactions in the M conformer. On the 
other hand, in the P conformer, one could identify nine Methyl–Methyl, two R–Chain, eight 
Chain–Methyl and three Chain–Chain gauche interactions. By crossing out the interactions pre-
sent in both helices, it was established that the P form would be favoured if the energy penalty 
(E ) of two R–Chain gauche interactions was lower than the sum of the energy penalty of two R–
Methyl gauche interactions and one Chain–Chain gauche interaction. Conversely, the M form 
would be favoured if the energy penalty of two R–Chain gauche interactions was higher than the 
sum of the energy penalty of two R–Methyl gauche interactions and one Chain–Chain gauche 
interaction, as summarised by these two equations:  
(I) 𝑃 helix favoured ⟺ 2 × 𝐸(R – Chain) < 2 × 𝐸(R – Methyl) + 1 × 𝐸(Chain – Chain) 
(II) 𝑀 helix favoured ⟺ 2 × 𝐸(R – Chain) > 2 × 𝐸(R – Methyl) + 1 × 𝐸(Chain – Chain) 
Intuitively, it seemed really difficult to find an end-group (R) able to satisfy equation (II). A first 
idea to reach this goal was to install large groups at the end of the chain to generate a steric clash 
with the backbone and make the helix switch. It was important to notice that compounds such as 
158 did not show any helicity change, in spite of bulky TIPS groups attached to their alkyne 
moieties. However, in these examples, the sterically demanding silyl group was separated from 
the backbone by a 4.6 Å-long linear spacer composed of one C–C single bond ( 1.5 Å), one 
C≡C triple bond ( 1.2 Å) and one C–Si bond ( 1.9 Å). The bulky group needed to be closer to 
the chain to interact in an efficient manner. 
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One of the easiest ways to increase the size of the alkyne terminal group was to make it react 
with an azide-containing molecule to generate a triazole ring. According to this strategy, com-
pound C10 was engaged in a 1,3-dipolar cycloaddition reaction with phenyl azide to obtain tria-
zole 168 (Scheme 34). Unfortunately, 1H NMR analysis revealed that both end-groups were in a 
predominantly gauche conformation, characteristic of a P helix for this absolute configuration. 
 
Scheme 34. Synthesis of triazole 168 using a 1,3-dipolar cycloaddition methodology. 
Having one large group at the end of the chain was not enough to make the screw-sense change. 
Therefore, the next molecule synthesised from boronic ester 154 via the transition metal-free 
cross-coupling reaction described above was compound 169 (Scheme 35).The bicyclic naphthyl 
ring was thought to be substantially bigger than a triazole ring and therefore have a better chance 
to interact significantly with the chain. Sadly, the first two CHs of the backbone gave very broad 
signals by 1H NMR—probably because of constrained rotation of the aromatic rings—and their 
3JH–H values could not be extracted from the spectrum. 
 
Scheme 35. Preparation of compound 169 using a transition metal-free cross-coupling methodology. 
Yet, an X-ray structure of compound 169 could be obtained (Figure 26) and showed that the 
aromatic rings presented their flat face to the chain, reducing their steric hindrance. In this con-




Figure 26. a. X-ray crystal structure of 169. Ellipsoids shown at 50% probability. Hydrogen atoms and 
solvent molecules have been omitted for clarity. b. Conformation of compound 169 in the solid state drawn 
on a diamond lattice. 
According to the model, for compounds with an odd number of stereocentres in the chain, the 
helical conformers would have one end-group in a gauche conformation and the other in an anti 
conformation. One could then design a molecule with a bulky end-group which would prefer to 
stand in an anti conformation and a small group which would adopt a gauche conformation. 
Based on this analysis, compound 172 was synthesised in three steps from boronic ester 154 
(Scheme 36). 1H NMR showed that the naphthyl group oriented the first dihedral angle towards 
the gauche conformation (3JH–H = 7.9 Hz) and the second angle towards the antiperiplanar con-
formation (3JH–H = 4.6 Hz). However, apart from these two bonds, the rest of the chain did not 
exhibit any conformational preference (5.1 Hz < 3JH–H < 7.0 Hz). As shown by QM/NMR results 
in Section 1.2.6., the effect of entropy might have been too strong in this case (eleven rotatable 
C–C bonds). The desired control might be achieved using the same end-group design but on a 
small chain (i.e., containing seven or nine stereocentres). 
 
Scheme 36. Preparation of alkyne 172 from C2-symmetric boronic ester 154. 
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The previous results clearly showed that an aromatic group was not large enough to verify equa-
tion (II). Consequently, the next objective was to install a bulkier end-group, such as a tert-butyl 
group. Steric hindrance was not the only advantage of the tert-butyl moiety. A few years ago, 
Hoffmann pointed out that having a tert-butyl group at the end of a non-substituted aliphatic 
chain could control the conformation of the first three bonds by avoidance of syn-pentane inter-
actions, forcing the first dihedral angle of the chain to adopt an antiperiplanar confor-
mation.64,184,209,210 This conformation was in agreement with equation (II). From these consider-
ations, attaching a tert-butyl group to the chain seemed to be the best option to observe the op-
posite helicity (M). However, from a more practical point of view, 1H NMR signals of an aliphatic 
molecule with no heteroatom were likely to be overlapped and thus the extraction of NMR pa-
rameters might be difficult. Therefore, one oxygen atom was included in the target molecule via 
oxidation of desymmetrised boronic ester 163 (Scheme 37). Finally, the tert-butyl group was 
installed using the methodology developed by Bartoli and co-workers.211 
 
Scheme 37. Synthesis of alkyne 174 via oxidation of boronic ester 163 and alkylation of intermediate 173. 
Preliminary 1H NMR analysis revealed that the switch did not occur. Starting from the alkyne 
group, the first four coupling constant values were 7.9 Hz, 4.5 Hz, 7.6 Hz and 4.0 Hz. This large, 
small, large, small sequence accounted for a P helix. However, it was important to notice that 
these constants were significantly different from the values observed for dialkyne C10. By direct 
comparison of these numbers, one could infer that the conformational preference towards the P 
conformer was reduced due to the presence of a tert-butyl group. 
To obtain more information about the effect of the tert-butyl group on the conformation of the 
chain, the QM/NMR approach described in Section 1.1.4.2. was applied to compound 174 in 
collaboration with Dr. Siying Zhong. Once again, a significant difference was observed between 
MM and DFT results (Figure 27b). Although MM predicted that 86% of the overall population 
would adopt a helical shape with an 81:19 M:P ratio, DFT geometry and energy calculations 
 
53 
showed that only 50% of the conformers would be helical with a strong conformational bias 
towards the opposite screw-sense (16:84 M:P ratio). The DFT-derived ensemble-averaged JH–H 
coupling constants were in good agreement with the measured values (MAD = 0.7 Hz; 
StDev = 0.9 Hz, 2 (reduced) = 0.9 Hz). Yet, the calculated ensemble-averaged 1H–1H distances 
did not fit the experimental values, with a 2 (reduced) value of 4.60 (Figure 27c). At this stage, 
two explanations were plausible: either DFT inaccurately estimated the ratio between M and P 
helices, or inaccurately predicted the ratio between helical and non-helical populations. 
 
Figure 27. a. Dihedral angle numbering for compound 174. b. Dihedral angle populations of compound 
174 predicted by MM (left) and DFT (right) and represented as a bubble plot. Red dots belong to a P helix, 
blue dots belong to an M helix, orange dots belong to non-helical conformers. c. Comparisons of DFT-
computed ensemble-averaged 1H–1H scalar coupling constants and 1H–1H distances to the experimental 
values. 
To better understand the effect of a tert-butyl group on the conformation of the chain, an analogue 
bearing two tert-butyl groups, compound 176, was synthesised in two steps from boronic ester 
154 (Scheme 38). Intermediate diol 175 was isolated and analysed by NMR in a non-protic sol-
vent to establish whether the propensity of the hydroxyl group to make intermolecular hydrogen 
bonds would encourage the molecule to aggregate and thus force the backbone to stand in an 
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extended conformation (i.e., M helix). Unfortunately, once again, a P helix was observed in tol-
uene-d8, with the following coupling constant sequence: 8.1 Hz (large), 3.4 Hz (small) and 
8.5 Hz (large). An X-ray structure (Figure 28) showed that hydrogen bonding was still allowed, 
despite the P-helical conformation of the chain. 
 
 
Scheme 38. Oxidation of boronic ester 154 to obtain diol 175 and subsequent double alkylation to give 
ether 176. 
Concerning compound 176, the extraction of chemical shits, JH–H values and NOE distances was 
very difficult due to spectrum congestion. All the protons of the backbone were overlapped ex-
cept the ones geminal to the oxygen atoms, which coupled to the next protons with a constant of 
5.8 Hz. This rather small coupling constant might be indicative of a conformational change. At 
least, by comparison with compounds C10 and 174, one could infer that the P form was even 
more destabilised by the presence of a second tert-butyl group. Unfortunately, due to the lack of 
information about experimental NMR parameters (H, C, JH–H, NOE distances), the QM/NMR 
approach was not applied to compound 176 and therefore the effect of the tert-butyl groups re-
mains unclear. 
 
Figure 28. a. X-ray crystal structure of 175. Ellipsoids shown at 50% probability. Hydrogen atoms and 
solvent molecules have been omitted for clarity. b. Conformation of compound 175 in the solid state drawn 
on a diamond lattice. 
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To summarise, the proposed theoretical model was refined based on the identification of different 
types of gauche interactions. These qualitative observations were translated into two equations 
which describe the relationship between the screw-sense of the molecule and the steric interac-
tions involving end-groups and backbone. Six additional compounds with different combinations 
of end-groups were synthesised and analysed by 1H NMR. This non-exhaustive “structure–con-
formation relationship” screening revealed that small substituents such as an alkyne group or a 
hydroxyl group verified equation (I). According to this study, aromatic groups could also be con-
sidered as small groups. The presence of one tert-butyl group seemed to decrease the helical 
preference described by equation (I). Interestingly, a molecule with two tert-butyl groups might 
verify equation (II) and therefore display the opposite screw-sense. Unfortunately, this hypothe-
sis could not be validated nor refuted due to the lack of structural information about compound 
176. Nevertheless, the comparison of coupling constant values of compounds C10, 174 and 176 
suggested that the combined effects of two tert-butyl groups could be used to design a switchable 
system. 
 
1.2.9. Towards a new helical switch 
The ultimate goal of this project was to design a helical molecule with the ability to switch from 
one screw-sense to another, in response to an external stimulus. In this section, the ability of such 
a compound to switch after chemical modification of its chain-ends was studied. In terms of 
potential applications, a reversible helical switch seemed to be more appealing than a non-re-
versible system. For this reason, only high-yielding reversible reactions were investigated. 
 
Figure 29. Hypothetical reversible helical switching from diketone 177 to diacetal 178. 
Based on previous results, the design of a switchable all-syn methyl-substituted chain might be 
achieved using the effect of tert-butyl groups. Ideally, a small end-group favouring one helical 
conformation would be transformed into a bulky tert-butyl group to induce a conformational 
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change. After that, the reverse conformational switch could be triggered by converting the 
tert-butyl group back to the initial small group. According to the previous section, end-groups 
with a sp2 geometry could be considered as small groups and therefore should verify equation 
(I). They were generally easy to install by C–B bond derivatisation. However, the addition and 
removal of a tert-butyl group was more challenging in terms of synthesis. It appeared more prac-
tical to design a target molecule bearing an analogous end-group (i.e., with the same geometry as 
the tert-butyl group), which could be efficiently installed and cleaved under mild conditions. 
Actually, the formation of an acetal from a ketone met all of the requirements. Indeed, in the 
course of this reversible reaction, the hybridisation of the carbon centre is modified from sp2 in 
the ketone to sp3 in the acetal, the latter acting as a tert-butyl mimic to force the first dihedral 
angle to adopt an antiperiplanar conformation (Figure 29). With this strategy in mind, diketone 
177 was prepared in three steps, starting from dialkyne C10, in 58% overall yield (Scheme 39). 
 
Scheme 39. Synthesis of diketone 177 via double alkylation of C10, followed by hydroboration and sub-
sequent oxidation. 
1H NMR analysis of compound 177 was extremely surprising. Contrary to the predictions, the 
observed 3JH–H sequence was 4.1 Hz (small), 7.8 Hz (large), 4.0 Hz (small), 7.8 Hz (large). For 
the first time with this absolute configuration, a strong preference towards the M form was clearly 
identified. Counting the number of gauche interactions in both helical conformers of 177 did not 
fully rationalise this observation. In fact, these numbers depended on the position of the methyl-
ketone group. To avoid syn-pentane interactions, the end-group could adopt two different orien-
tations in each conformer (Figure 30). In the P helix, the end-group could generate either one or 
two gauche interactions; therefore, the overall number of gauche interactions in the molecule 
could be 24, 25 or 26. However, in the M helix, both orientations of the end-group created only 
one gauche interaction and therefore the overall number of gauche interactions was invariably 
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25. As a result, the molecule preferred adopting a M-helical conformation, which meant the end-
group had a reduced steric impact. 
 
Figure 30. The end-group of compound 177 could adopt four different conformations to avoid syn-pentane 
interactions. The rotation of the end-group in the P helix was more constrained than in the M helix. 
To test whether one directing group could dictate the screw-sense of the chain in the presence of 
another directing group with the opposite induction effect, an asymmetric compound (183) bear-
ing one alkyne group, which favoured the P form, and one methylketone group, which was an 
M-helix inducer, was designed and synthesised (Scheme 40). 1H NMR analysis revealed that, 
starting from the alkyne group, the first and the last coupling constants were close to 7 Hz 
(5.9 Hz < 3JH–H < 7.0 Hz). Unfortunately, all the other CH signals were overlapped. Nevertheless, 
these average values indicated that compound 183 was likely to exist as a 50:50 mixture of P and 
M helices in solution. 
 
Scheme 40. Preparation of ketone 183 by desymmetrisation of dialkyne C10. 
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With diketone 177 being an M helix, the initial strategy to form the acetal group and trigger a 
helical switch was abandoned. Alternatively, another approach was envisaged in which diol 175 
(P helix) would be converted to diacetate 184 (Figure 31). This diester was structurally very 
similar to diketone 177 and, therefore, was expected to display the same conformational prefer-
ence (M helix). To switch back to the P-helical conformation, a simple hydrolysis under basic 
conditions would then regenerate the starting diol. Pleasingly, a DMAP-catalysed esterification 
reaction with acetic anhydride delivered diacetate 184 in quantitative yield (Scheme 41).  
 
Figure 31. Hypothetical reversible helical switching from diol 175 to diacetate 184. 
Once again, 1H NMR analysis was surprising. Instead of the expected small, large, small, large 
sequence, the first three coupling constant values were 7.8 Hz (large), 4.2 Hz (small) and 7.8 Hz 
(large), characteristic of a right-handed (P) screw-sense for this absolute configuration. This re-
sult might be rationalised by considering the A-value of an acetate group. According to the liter-
ature,212,213 this ester possesses an A-value between 0.60 and 0.79 kcal mol1. For comparison, 
the A-value of a methyl group is about 1.70 kcal mol1. These numbers showed that the acetate 
group was very small in terms of steric hindrance. For this reason, compound 184 verified equa-
tion (I) and thus folded into a P helix. 
 
Scheme 41. Synthesis of diacetate 184 by esterification of diol 175. 
A different strategy was then envisaged based on the helical switching by chain extension de-
scribed in Section 1.2.5. Indeed, the conformational preference of the backbone changed each 
time that two new stereocentres were added at both extremities. The chain switched from P to M 
to P as it grew from six to eight to ten stereocentres. One more bidirectional homologation would 
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then give an M helix with twelve stereocentres. From this observation, a new plan was designed 
involving diamine 185 (Figure 32). This primary amine bore ten stereocentres. According to its 
absolute configuration, it should behave like dialkyne C10 and exist as a P helix in solution. 
Then, after alkylation, the molecule would be structurally analogous to a compound with twelve 
stereocentres and, therefore, should favour the M form to avoid syn-pentane interactions. In other 
words, the alkylation reaction would mimic a bidirectional chain extension. 
 
Figure 32. Hypothetical reversible helical switching from primary amine 185 to tertiary amine 186. 
Boronic ester 154 was subjected to Morken’s amination conditions to obtain, after basic work-
up, desired diamine 185 (Scheme 42). However, the crude compound was too polar to be purified 
and was converted to dicarbamate 187 to facilitate isolation. Finally, a palladium-catalysed hy-
drogenolysis gave the desired molecule in 50% yield over three steps. 
 
Scheme 42. Synthesis of primary amine 185 using Morken’s methodology. The crude primary amine was 
directly transformed into carbamate 187 to facilitate purification. 
1H NMR confirmed that the molecule adopted a right-handed helical conformation in solution, 
with the following coupling constant sequence: 7.9 Hz (large), 3.7 Hz (small), 8.3 Hz (large) and 
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3.3 Hz (small). Then, treatment with benzyl bromide afforded tertiary amine 186 in 64% yield. 
Unfortunately, 1H NMR showed that the molecule still folded into a P helix, with an unusually 
high level of control. The first three 3JH–H values were 10.0 Hz (large), 2.4 Hz (small) and 9.9 Hz 
(large). Once again, the number of gauche interactions was key to understanding this result. The 
initial hypothesis relied on the fact that, for this absolute configuration, a chain containing twelve 
stereocentres bore 28 gauche interactions in the P-helical conformation and only 27 gauche in-
teractions in the M form. Therefore, a left-handed helix was expected in solution. However, a 
closer look at the benzyl moieties revealed that the phenyl groups were involved in four additional 
gauche interactions in the P conformer and generated six additional gauche interactions in the M 
conformer (Figure 33a). As a consequence, the overall number of gauche interactions in the M 
helix (33) was higher than in the P helix (32), which became the lowest energy conformer, both 
in solution and in the solid state (Figure 33b,c). 
 
Figure 33. a. Phenyl groups were also involved in steric conflicts. They created four more gauche inter-
actions in the P conformer and six more gauche interactions in the M helix. b. Major conformer (P helix) 
of amine 186 in solution, drawn on a diamond lattice. c. X-ray crystal structure of 186. Ellipsoids shown 
at 50% probability. Hydrogen atoms and solvent molecules have been omitted for clarity. 
In 1999, Hoffmann and co-workers showed that the conformation of 4-methylpentan-2-amine 
depended on the protonation state of the amino group.59 They observed the conformational 
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switching of the C–C–C–N dihedral angle, from gauche to antiperiplanar, when acetic acid was 
added in the NMR tube. Based on this study, another strategy was proposed (Figure 34). Ac-
cording to Hoffmann’s results, one could imagine that the P conformer of diamine 185 could 
undergo a helical switching in the presence of acid. Such a compound would therefore be de-
scribed as a pH-responsive molecular switch and could eventually find practical applications. 
 
Figure 34. Hypothetical reversible helical switching from primary amine 188 to ammonium 189. 
To test this hypothesis, compound 185 was mixed with two equivalents of acetic acid in deuter-
ated DMSO. Unfortunately, only the first coupling constant (5.0 Hz) could be extracted due to 
spectrum congestion. To face this problem, a shorter version of the molecule, diamine 188, was 
synthesised (Scheme 43), using the same methodology as mentioned above. 1H NMR confirmed 
that it adopted a right-handed conformation in solution. Addition of acetic acid in DMSO-d6 led 
to the same overlap issues. Moreover, this time, the first coupling constant reached 5.9 Hz, which 
was less encouraging. In previous examples, the use of deuterated toluene improved the quality 
of the 1H NMR spectrum. Therefore, diamine 188 was solubilised in toluene-d8 and two equiva-
lents of acetic acid were added. Immediately, a white precipitate formed, rending the NMR anal-
yses impossible. At that point, it seemed more sensible to replace acetic acid with a more organic 
proton source to improve the solubility of the resulting ammonium salt. Hence, two equivalents 
of nonafluorobutanesulfonic acid were added to a solution of diamine 188 in deuterated toluene. 
Pleasingly, no precipitation was observed and 3JH–H values could be obtained. The first two cou-
pling constants were found to be 6.3 Hz and 5.0 Hz. Sadly, these values were not indicative of 
an M helix. They showed that either the molecule was present as a mixture of both conformers 









This research project aimed to develop a new class of helical molecules which, upon activation 
from an external stimulus, would be able to reversibly switch from one screw-sense to the other. 
All-syn methyl-substituted hydrocarbons, as described by Aggarwal1 in 2014, were shown to 
adopt helical conformations with very high levels of control. More importantly, one of these 
unique molecules could access either the M or the P screw-sense, depending on its physical state. 
Therefore, all-syn methyl-substituted hydrocarbons seemed to be promising candidates for the 
design of a new class of molecular switches. 
To achieve this goal, it was necessary to understand what controlled the conformation of such 
molecules. A first assumption suggested that a link existed between the absolute configuration of 
the termini, the relative size of the end-groups and the screw-sense of the backbone. To test this 
hypothesis, two target molecules (with ten and eleven stereocentres in their backbones) were 
designed and synthesised. Unfortunately, the initial convergent synthetic route failed due to the 
unsuccessful lithiation–borylation coupling between two bulky advanced intermediates. Conse-
quently, a more linear approach was employed, involving nine or ten iterative homologations of 
boronic ester via a methodology called ‘assembly-line synthesis’, to prepare both target com-
pounds. Their analysis by 1H NMR and MM was surprising. While the first molecule with an 
even number of stereocentres displayed the expected controlled helical conformation, the second 
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compound with an odd number of stereocentres showed a more disordered conformational land-
scape. This observation served as a starting point to establish a new stereochemical model able 
to predict the screw-sense of such helical hydrocarbons. 
 






    
Predicted 
screw-sense 
Right-handed    
helix (P) 
Left-handed      
helix (M) 
Mixture of M, P and non-helical        
conformers 
Table 5. Screw-sense prediction table. 
A diamond lattice-based analysis revealed that the number of gauche interactions in the chain 
was one of the key parameters that dictated its conformational preference. The model established 
that, to completely avoid syn-pentane interactions, these compounds could adopt two confor-
mations, an M helix or a P helix. However, in the case of a molecule with an even number of 
stereocentres, one of these two helical conformers possessed one more gauche interaction and 
therefore was higher in energy. In the case of a molecule with an odd number of stereocentres, 
both helical conformers showed the same number of gauche interactions. They could reduce this 
number by allowing their terminal dihedral angles to adopt a gauche conformation. However, by 
doing so, the helicity of the chain was broken, diminishing the percentage of helical conformers 
in the overall population. Therefore, by minimizing the number of gauche interactions, molecules 
with an even number of stereocentres increased their conformational preference towards one hel-
ical form, whereas molecules with an odd number of stereocentres tended to expand their non-
helical conformer populations. 
To validate this model, the relationship between conformational control and chain length was 
studied. A series of six compounds of different chain lengths (from six to eleven stereocenters) 
was designed and synthesised using an efficient bidirectional iterative homologation of C2-sym-
metric boronic esters. A QM/NMR approach was employed to quantitatively describe the con-
formational landscape of these molecules. This technique relies on the comparison of DFT-
derived NMR parameters (H, C, JH–H, NOE distances) to experimental values. Once all the 
predicted parameters are in good agreement with the measured values, the corresponding DFT-
derived conformational population has a high probability to reflect the reality. Pleasingly, this 
approach confirmed the theoretical model with a good degree of confidence. Another analytical 
technique, VCD analysis, also corroborated these results. 
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In this study, the link between screw-sense and end-groups was investigated. Based on the dif-
ferent types of gauche interactions present in the backbone, two equations were established to 
model this relationship.  
(I) 𝑃 helix favoured ⟺ 2 × 𝐸(R – Chain) < 2 × 𝐸(R – Methyl) + 1 × 𝐸(Chain – Chain) 
(II) 𝑀 helix favoured ⟺ 2 × 𝐸(R – Chain) > 2 × 𝐸(R – Methyl) + 1 × 𝐸(Chain – Chain) 
A screening of different substituents at the termini revealed that alkyne, hydroxyl, amino or aro-
matic groups could be considered as ‘small’ groups, favouring the helical conformer with both 
terminal dihedral angles in a gauche conformation. In line with Hoffmann’s work,64,184 tert-butyl 
groups were found to have a dramatic impact on the backbone conformation. According to 
QM/NMR analysis, one of these bulky end-group was not enough to induce the helical switching. 
However, the combined effects of two tert-butyl groups might force both terminal dihedral angles 
to adopt an antiperiplanar conformation, thus favouring the opposite screw-sense. 
These findings set the experimental basis to design a new molecular switch. Several strategies 
were attempted, involving reversible chemical reactions (ketone to acetal, alcohol to acetate, 
amine to benzyl-protected amine, amine to ammonium). However, none of them were successful, 
due to a series of unexpected and surprising results. To avoid these issues in the future, more 
computation is required to refine the proposed stereochemical model. A more systematic screen-




CHAPTER 2 – DECARBOXYLATIVE BORYLATION 
METHODOLOGY AND ITS APPLICATION TO -AMINO BORONIC 
ESTERS 
The data presented in this chapter has been partially published in: Fawcett A., Pradeilles J., 
Wang Y., Mutsuga T., Myers E. L., Aggarwal V. K., Science 2017, 357, 283.2 Where indicated 
(†), the data presented was obtained by Dr. Alexander Fawcett,214 Dr Yahui Wang or Dr Tatsuya 
Mustuga, and is included in this thesis to provide a complete picture of the work. 
2.1. Introduction 
2.1.1. Applications and synthesis of -amino boronates 
In the early 1970s, boronic acids were found to inhibit enzymatic processes.215–222 More precisely, 
they showed promising activities against serine proteases, a class of enzymes involved in the 
cleavage of peptidic bonds. Since then, boron-containing molecules have become an important 
class of anticancer agents, as exemplified by two marketed drugs: bortezomib (192) and ixazomib 
(193). These protease inhibitors are prescribed to treat lymphoma and myeloma, respectively. 
Oncology is not the only field of medicinal chemistry in which boronic acid-derived approved 
drugs can be found (Chart 9). Vaborbactam (194) is used in combination with -lactam-type 
antibiotics to treat bacterial infections due to its ability to inhibit bacterial -lactamases. And 
tavaborole (195), an antifungal compound, has applications in the treatment of onychomycosis. 
 
Chart 9. Four examples of boron-containing marketed drugs. 
The typical mode of action by which boron-containing bioactive compounds inhibit enzymatic 
processes is via the formation of boronate complexes as described in Section 1.1.1. For example, 
in the case of serine proteases,223–225 the pendant hydroxyl group on the side chain of a serine 
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residue in the active site of the enzyme can interact with the sp2-hybridised boron centre of the 
drug to form a stable tetrahedral boronate complex which prevents the natural substrate of the 
protease entering the active site226 (Scheme 44). 
 
Scheme 44. a. Cleavage of peptide bonds by serine proteases. b. Inhibition of serine proteases by boron-
containing drug molecules. 
Interestingly, the improved specificity of bortezomib and ixazomib was achieved by thorough 
design of their peptide chains.227,228 Based on this observation, methodologies providing access 
to -amino boronic acids (or esters) appear to be valuable synthetic tools to develop potent and 
selective anticancer molecules. 
Matteson contributed to this field in the early 1980s, reporting that -amido-boronic esters could 
be synthesised by nucleophilic substitution of the chlorine atom in -chloro-boronic esters, such 
as 204, with lithium hexamethyldisilazane, followed by cleavage of N–Si bonds and protection 
of the free amine with acetic anhydride229 (Scheme 45a). In a related application, Molander and 
co-workers described the alkylation of primary and secondary amines with potassium tri-
fluoro(iodomethyl)borate (210)230 (Scheme 45b). More recently, Bode also reported the synthe-
sis of -amino trifluoroborate salts from potassium acyltrifluoroborates (213). This reaction pro-
ceeds via the initial formation of trifluoroborate-iminium zwitter ions (214) by condensation with 
secondary amines.231 Then, a nucleophile attacks the electrophilic sp2-hybridised carbon centre 




Scheme 45. a. Matteson’s methodology to synthesise -amido-boronic esters. b. Molander’s methodology 
to synthesise -amino trifluoroborates. c. Bode’s methodology to synthesise -amino trifluoroborates. 
Brackets have been omitted for clarity. 
Another strategy, initially developed by Ellman232,233 and further explored by Zhihua,234–236 in-
volved a copper-catalysed addition of a diboron reagent to chiral N-tert-butanesulfinyl imines 
216 (Scheme 46). The resulting boronic ester 218, generally obtained in almost perfect d.r. 
(>98:2), gives, after acid-mediated cleavage of the chiral auxiliary, the -amino boronic ester in 
excellent e.r. 
 
Scheme 46. Ellman’s synthesis of chiral -amino boronic esters. 
Other methodologies to access chiral -amino boronic esters from achiral starting materials have 
also been reported. For instance, the addition of B2pin2 to aldimines 220 or 223,237–241 -arylena-
mides 225242 or -amidoacrylates 227243,244 can be rendered highly enantioselective when a chiral 
ligand is used in combination with copper, platinum or rhodium catalysts (Scheme 47). Alterna-
tively, a copper-catalysed enantioselective hydroamination of vinyl boronates reported by Hirano 




Scheme 47. Selection of reported methodologies for the synthesis of -amino boronic esters from achiral 
starting materials. 
Although all these procedures give access to -amino boronates, they often require starting ma-
terials which are not easy to synthesise. Therefore, a more general synthetic method to convert 
inexpensive, widely available carboxylic acids into useful boronic ester building blocks (see 
Chapter 1) would be a valuable tool for medicinal chemists. One could imagine that a late stage 
sequence, including the transformation of a carboxylate into a boronic ester with subsequent C–B 
bond derivatisation to a broad range of functional groups,5 would be highly beneficial for any 
structure–activity relationship (SAR) study. 
 
2.1.2. Development of a new decarboxylative borylation methodology 
In 2016, Baran and co-workers reported that alkyl carboxylic acids—activated as their corre-
sponding tetrachloro-N-hydroxyphthalimide redox-active esters246–250—and aryl boronic acids 
could be engaged in a nickel-catalysed alkyl–aryl cross-coupling.251 The substrate scope was 
found to be broad, including primary and secondary carboxylic acids, and substituted (hetero)ar-
omatic boronic acids. In the proposed mechanism (Scheme 48), bipyridine–nickel(I) complex 
229 undergoes transmetalation with aryl boronic acid 230 in the presence of triethylamine and 
water to generate complex 232. This species reduces activated ester 233, through single-electron 
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transfer (SET), which then undergoes a radical cascade leading to the decarboxylation event and, 
eventually, to the formation of alkyl radical 236. This radical adds to positively-charged nickel(II) 
complex 235 to afford a nickel(III) centre which, upon a reductive elimination process, is reduced 
to nickel(I) and delivers the cross-coupled product 239. 
 
Scheme 48. Proposed mechanism of Baran’s nickel-catalysed cross-coupling of redox-active esters with 
boronic acids. Brackets have been omitted for clarity. 
Inspired by this interesting study, one could envisage an analogous mechanism in which the aryl 
boronic acid coupling partner could be replaced with a diboron reagent (B2(OR)2) to synthesise 
alkyl boronic esters. Such a two-step methodology (i.e., activation of the carboxylic acid sub-
strate, followed by borylation of the corresponding activated ester) would be described as a net 
decarboxylative borylation process. To test this hypothesis, an initial screening of reaction con-
ditions involving model compound 249 and a variety of diboron sources, nickel catalysts, ligands, 
organic and inorganic bases, solvents and temperatures was conducted.† Unfortunately, no de-
sired product was observed under these different sets of conditions. 
Another strategy was then explored in which a diboron reagent is activated by complexation to a 
nucleophile or a Lewis base to generate an electron-rich boronate complex prone to oxidation.252–
254 This species would transfer an electron255–257 to a redox-active ester, thus enhancing the de-
carboxylation process. The resulting alkyl radical would then recombine with a stabilised boryl 
radical (or with another molecule of activated diboron reagent) to afford the desired alkyl boronic 
ester. The key redox step would be facilitated by light irradiation. Indeed, N-phthalimide esters 
are known to easily undergo single electron transfers in their photoexcited state, with a redox 
potential of +1.6 V vs SCE.258–260 For example, Fu and co-workers used these activated esters 
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(240) to oxidise thiolate anions (243) in the presence of cesium carbonate, under visible-light 
irradiation, in the absence of a photocatalyst261 (Scheme 49). 
 
Scheme 49. Proposed mechanism of Fu’s decarboxylative arylthiation reaction. 
A second screening of conditions was carried out by Dr. Alexander Fawcett according to this 
strategy. Model compound 249 was mixed with various boron sources (1.00 equiv.) and cesium 
carbonate (1.50 equiv.) in N,N-dimethylformamide (DMF) under blue light irradiation at room 
temperature. After 14 hours, pinacol and triethylamine were added to form a more stable pinacol 
boronic ester before GCFID analysis. Pleasingly, desired boronic ester 250 was formed in 8% 
yield when bis(catecholato)diboron (B2cat2) was used as the boron source. Further optimisation 
screening† showed that cesium carbonate was inhibiting the transformation. In fact, when the 
reaction was conducted in the absence of this inorganic base, the desired product was formed in 
69% yield. This observation quickly led to the discovery of optimised conditions (Scheme 50) 
which, after isolation by column chromatography, gave pinacol boronic ester 250 in 87% yield. 
Interestingly, the reaction only took place when amide- or urea-based solvents, such as N,N-
dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N,N′-dimethylpropyleneurea 
(DMPU), tetramethylurea (TMU) or 1,3-dimethyl-2-imidazolidinone (DMI), were used. Degas-
sing the solvent and purging the reaction vessel with nitrogen or argon was necessary to obtain 
high yields and reproducible results. Finally, light irradiation was found to be crucial for the 




Scheme 50. Optimised conditions for transition metal-free photoinduced decarboxylative borylation.† 
In terms of substrate scope, this new methodology successfully converted a broad range of pri-
mary and secondary alkyl activated esters to the corresponding boronic esters in high yields. In 
addition, the reaction conditions showed excellent functional group tolerance, which allowed the 
transformation of carboxylic acid-containing natural products into their previously-unreported 
boronic ester analogues (Chart 10). Unfortunately, aryl, vinyl, allyl and flexible tertiary alkyl 
activated esters failed to deliver the decarboxylative borylation products. The reaction was also 
unsuccessful when the starting material bore a heteroatom in the -position, making -amino 
acids unsuitable substrates. 
 
Chart 10. Selection of pinacol boronic esters synthesised according to Aggarwal’s decarboxylative boryla-
tion methodology.† 
The mechanistic investigation started with the identification of the light-absorbing species in so-
lution. A UV–visible spectroscopy study† revealed that isolated reagents in solution (DMAc) 
only absorbed in the UV region (303 nm for B2cat2 and 314 nm for activated ester 249). Knowing 
that blue LEDs used in the reaction emit between 452 and 475 nm, it seemed unlikely that any of 
the reagents absorbed light independently. However, when both reagents were mixed together in 
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DMAc according to the optimised reaction conditions (i.e., 0.125 M for B2cat2 and 0.10 M for 
activated ester 249), a bathochromic shift was observed in the absorption spectrum (Figure 35a), 
suggesting the presence of a new species in solution absorbing in the blue light domain. Interest-
ingly, the intensity of this new absorption shoulder linearly increased with B2cat2 concentration 
(Figure 35b). 
 
Figure 35. a. UV–visible absorbance spectra of activated ester 249, B2cat2, and the two combined, in 
DMAc.† b. Effect of the concentration of B2cat2 on the absorbance spectrum.† 
Further 11B NMR studies showed that B2cat2 gave a single signal at 29.7 ppm in dichloromethane. 
Interestingly however, in DMAc, this diboron reagent gave two different signals, at 25.7 and 
13.8 ppm (Figure 36). This observation indicated that, in amide-based solvents, B2cat2 existed 
in an equilibrium between a non-coordinated form (free B2cat2) and a solvent-complexed form 
(DMAc–B2cat2 adduct). When activated ester 249 was added to a solution of B2cat2 in DMAc, 
the 11B NMR spectrum remained the same. 
 
Figure 36. 11B NMR spectrum of B2cat2 (0.125 M) in DMAc. 1 = 25.7 ppm; 2 = 13.8 ppm. 
Based on these UV–visible and NMR spectroscopy experiments, it has been suggested that a blue 
light-absorbing -stacking electron donor–acceptor (EDA) complex262–264 (263) was formed be-














catechol aromatic ring of B2cat2 when both species are mixed in DMAc (Scheme 51). After ab-
sorbing a photon, excited EDA complex 264 undergoes intra-complex electron transfer from a 
catechol moiety to the phthalimide ring. After diffusive separation of both charged radical spe-
cies, compound 265 fragments to afford phthalimide by-product 266, carbon dioxide and alkyl 
radical 236. In parallel, the B–B bond in radical 271 is cleaved to generate stabilised boryl radical 
268 and positively-charged DMAc adduct 272, which can eventually recombine with phthalimide 
by-product 266 to give compound 270. Alkyl radical 236 then reacts with B2cat2266 to provide 
desired alkyl boronic ester 267 and another stabilised boryl radical 268. This highly reactive 
species can reduce a molecule of activated ester 240, thus initiating a chain reaction process. 
 
Scheme 51. Proposed mechanism of Aggarwal’s decarboxylative borylation. Brackets have been omitted 
for clarity. 
Evidence for a radical pathway was identified when substrates 273 and 274 were subjected to the 
reaction conditions (Scheme 52). In the case of 273, only linear boronic ester 253 could be ob-
served and isolated after work-up, suggesting that the initially-generated radical intermediate un-
derwent ring opening (rate constant = 1.3 × 108 s−1) before being trapped by the boron source. In 
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addition, activated ester 274, engaged as a single diastereoisomer (>95:5 d.r.), gave correspond-
ing boronic ester 275 in only 57:43 d.r. This erosion of diastereopurity also suggested that the 
reaction proceeds though a radical pathway. 
 
Scheme 52. Experimental proofs of a radical reaction pathway.† 
 
2.1.3. Other decarboxylative borylation methodologies 
A few other examples of decarboxylative borylation were reported in the literature shortly after 
submission of the manuscript describing Aggarwal’s methodology.267 Further investigations on 
nickel-catalysed cross-couplings led Baran and co-workers to discover a related procedure268 in 
which an in situ-activated carboxylic acid (280) is reduced by a nickel(I)–bipyridine complex in 
the presence of a pre-activated boron source and magnesium bromide to afford alkyl radical 283 
which, after recombination with the nickel centre and subsequent reductive elimination gives the 
desired pinacol boronic ester 285 (Scheme 53). The substrate scope was found to be very broad, 
for example, valuable -amino boronic esters could be accessed using this method. However, the 
borylation step involved the use of six different reagents (including sensitive methyl lithium), 
which must be mixed in different reaction vessels, sonication and transfer of suspensions from 
one flask to another. To improve the practicability of the method, Baran and co-workers reported 
a simpler copper-catalysed decarboxylative borylation reaction269 one year after their initial pub-
lication. This transformation follows the same reaction pathway as the nickel-catalysed method. 
However, -amino acids could not be converted to the corresponding -amino boronic esters 




Scheme 53. Mechanism of nickel-catalysed (M = Ni, R2 = Me, X = Br) and copper-catalysed (M = Cu, 
R2 = OH, X = Cl) decarboxylative borylations. Z = Cl or phthalimide anion 266. Brackets have been omit-
ted for clarity. 
A different approach involving the use of an iridium photocatalyst was developed by Li and co-
workers270 (Scheme 54). Upon light irradiation, the catalyst reaches an excited state and can then 
transfer an electron to activated ester 240. After decarboxylation, alkyl radical 236 is trapped by 
the boron source to afford the desired product. The authors suggested that boryl radical 292 is 
able to reduce iridium(IV) to iridium(III), thus closing the catalytic cycle. Interestingly, no ex-
ample of tertiary boronic ester or -amino boronic ester was reported in this article and most of 
the final products were isolated as potassium trifluoroborate salts. 
 




Additional complementary strategies for the decarboxylative borylation of aryl carboxylic acids 
were also disclosed. A first report by Glorius and co-workers271 showed that aryl activated esters 
undergo decarboxylation under purple light irradiation in the presence of a boron source, pyridine 
and cesium carbonate in ethyl acetate (Scheme 55a). Fu and co-workers272 also described an 
analogous thermal process involving aryl activated esters, a boron source and a catalytic amount 
of tert-butyl isonicotinate ester at 110 °C (Scheme 55b). These methodologies could not be used 
to convert alkyl carboxylic acids into alkyl boronic esters. 
 
Scheme 55. a. Proposed mechanism of Glorius’ decarboxylative borylation. b. Proposed mechanism of 
Fu’s decarboxylative borylation. Brackets have been omitted for clarity. 
 
2.1.4. Research proposal 
The first objective of this project was to improve the substrate scope of the decarboxylative 
borylation methodology developed in the Aggarwal lab and this was achieved before its publica-
tion.2 As the main idea of this research program was to provide a new synthetic tool to be used 
in medicinal chemistry, it was necessary to include substrates containing some structural motifs 
commonly encountered in drug-like molecules. In addition, a few more examples of natural prod-
ucts had to be tested under the reaction conditions, notably to test the functional group tolerance 
of the method and to prove that it could be used in a late-stage functionalisation. 
 
77 
The second task, also completed before publication,2 was to perform more experiments to con-
firm the postulated radical mechanism. Usual radical trap experiments or radical cyclisation ex-
periments were investigated to obtain additional evidences in favour of a radical pathway. 
Finally, the ultimate ambition of applying this new methodology to -amino acids will be recon-
sidered. Two issues needed to be addressed here: first, the purification procedure had to be opti-
mised to isolate amino boronic esters as pure compounds; then, new conditions allowing for the 
decarboxylative borylation of proteogenic amino acids had to be discovered through optimisation 
studies. 
 
2.2. Results and discussion 
2.2.1. Improvement of the substrate scope 
To prove the general applicability of this new methodology, a broader substrate scope was ex-
plored. More precisely, some medicinal chemistry-type building blocks such as fluorine-substi-
tuted cyclohexanes, phenylcyclopropanes and pyridine derivatives were tested under the reaction 
conditions (Scheme 56). Carboxylic acids 304 and 307 were successfully activated and converted 
to the corresponding boronic esters 306 and 309 in 66% and 60% yield, respectively. 
 
Scheme 56. Photoinduced decarboxylative borylation applied to medicinal chemistry-type building 
blocks. (a) N-hydroxyphthalimide 1.00 equiv., DIC 1.00 equiv., DMAP 0.10 equiv., CH2Cl2, r.t.; (b) 
B2cat2 1.25 equiv., DMAc, blue LEDs, then pinacol 4.00 equiv., Et3N 25.00 equiv., r.t.; (c) N-hydroxy-
phthalimide 1.00 equiv., DCC 1.00 equiv., THF, r.t. 
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Interestingly, boronic ester 309 was obtained in a 98:2 d.r. This result suggested that the trapping 
of the cyclopropyl radical was very sensitive to steric hindrance. Pyridine derivative 310 was 
activated using slightly different activation conditions. DCC (dicyclohexylcarbodiimide) cou-
pling reagent was employed instead of DIC to circumvent previously observed purification is-
sues. Subsequent borylation step gave the desired boronic ester 312 in 42% NMR yield. Unfor-
tunately, this molecule was highly unstable on silica gel and decomposed upon purification, re-
sulting in a 16% isolated yield. 
To expand the scope even more, natural products such as arachidonic acid, succinic acid, 
lithocholic acid or penicillin G were activated and subjected to the optimised conditions (Scheme 
57). Pleasingly, boronic ester 315 was isolated in 58% yield. As predicted by Baldwin’s rules, 4-
exo-trig or 5-endo-trig intra-molecular cyclisations were not observed. Succinic acid gave bis(bo-
ronic ester) 318 in 41% yield, showing that the reaction could occur twice on the same substrate 
molecule. 
 
Scheme 57. Photoinduced decarboxylative borylation applied to natural products. (a) N-hydroxy-
phthalimide 1.00 equiv., DIC 1.00 equiv., DMAP 0.10 equiv., CH2Cl2, r.t.; (b) B2cat2 1.25 equiv., DMAc, 
blue LEDs, then pinacol 4.00 equiv., Et3N 25.00 equiv., r.t.; (c) N-hydroxyphthalimide 2.00 equiv., DIC 
2.00 equiv., DMAP 0.20 equiv., CH2Cl2, r.t.; (d) B2cat2 5.50 equiv., DMAc, blue LEDs, then pinacol 
8.00 equiv., Et3N 25.00 equiv., r.t. 
 
2.2.2. Unsuccessful substrates 
Unfortunately, activated penicillin G 326 decomposed under the reaction conditions (Scheme 
58). Presumably, generating a radical next to a strained system (-lactam) and in -position with 
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respect to the sulphur atom led to an intramolecular side-reaction pathway which degraded the 
molecule before the boron trapping step. 
 
Scheme 58. Unsuccessful decarboxylative borylation of penicillin G. (a) N-hydroxyphthalimide 
1.00 equiv., DCC 1.00 equiv., THF, r.t.; (b) B2cat2 1.25 equiv., DMAc, blue LEDs, then pinacol 
4.00 equiv., Et3N 25.00 equiv., r.t. 
Penicillin G was not the only substrate which could not be converted to the desired product. 
Although benzylic starting materials 329 and 332 were fully consumed, no corresponding boronic 
esters could be identified after 14 hours of reaction (Scheme 59). 
 
Scheme 59. Unsuccessful substrates. (a) N-hydroxyphthalimide 1.00 equiv., DIC 1.00 equiv., DMAP 
0.10 equiv., CH2Cl2, r.t.; (b) B2cat2 1.25 equiv., DMAc, blue LEDs, then pinacol 4.00 equiv., Et3N 
25.00 equiv., r.t.; (c) oxalyl chloride 1.10 equiv., DMF cat., CH2Cl2, 0 °C then N-hydroxyphthalimide 
1.00 equiv., DIPEA 1.50 equiv., CH2Cl2, 0 °C to r.t.; (d) N-hydroxyphthalimide 1.00 equiv., DIPEA 
1.00 equiv., CH2Cl2, 0 °C to r.t. 
An explanation might be that, in both cases, the intermediate benzylic radical species had been 
oxidised to the benzylic carbocation before being trapped by the boron source. The nature of the 
oxidant remains unknown. Similarly, the radical intermediate derived from the decarboxylation 
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of activated ester 335 could be too unstable to be trapped or maybe the desired product itself 
might decompose under the reaction conditions. 
 
2.2.3. Optimisation study on cyclopropane derivatives 
Considering all the unsuccessful examples, another optimisation study was conducted on phe-
nylcyclopropane derivative 308. Its average yield of 60% obtained under standard conditions 
seemed to be a good starting point to observe substantial changes in reaction outcome. 
Phthalimide substitution, boron sources, light sources, solvents, concentrations and transesterifi-
cation conditions were investigated (Table 6). 
 








H B2cat2 1.25 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
60% 
H B2cat2 1.50 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
28% 
H B2cat2 1.00 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
38% 
H B2cat2 0.50 equiv., 
B2(OH)4 1.00 equiv. 
blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
41% 
H B2cat2 1.25 equiv. blue LEDs DMAc 0.20 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
47% 
H B2cat2 1.25 equiv. blue LEDs DMAc 0.05 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
50% 
H B2cat2 1.25 equiv. blue LEDs DMF 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
44% 
H B2cat2 1.25 equiv. 40W blue 
lamp 
DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
50% 
H B2cat2 1.25 equiv. white 
bulb 
DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
25% 
Cl B2cat2 1.25 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 1.5 h, r.t. 
25% 
H B2cat2 1.25 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,               
Et3N 25.00 equiv., 3.0 h, r.t. 
57% 
H B2cat2 1.25 equiv. blue LEDs DMAc 0.10 M pinacol 4.00 equiv.,              
AcOH 4.00 equiv., 4.0 h, r.t. 
47% 
Table 6. Second optimisation study using activated ester 308 as a model substrate. 
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Unfortunately, none of the attempted modifications afforded the desired boronic ester in better 
yield (i.e., greater than 60%). Nevertheless, this second optimisation table confirmed that the 
conditions used to build up the substrate scope were the optimal conditions. At that point, the 
remaining task was to provide experimental evidences to validate the proposed reaction mecha-
nism. 
 
2.2.4. Further mechanistic investigations 
In terms of mechanism elucidation, an additional experiment was carried out to prove the postu-
lated radical pathway. Carboxylic acid 338, bearing a terminal C=C double bond, was activated 
and subjected to the optimised borylation conditions. The presence of cyclized product 341b in 
the resulting mixture confirmed the hypothesis of a radical pathway, with the 5-exo-trig cyclisa-
tion (rate constant = 1.0 × 105 s−1) occurring rapidly after the formation of intermediate radical 
340 before trapping with boron (Scheme 60). 
 
Scheme 60. Radical cyclisation experiment. (a) N-hydroxyphthalimide 1.00 equiv., DIC 1.00 equiv., 
DMAP 0.10 equiv., CH2Cl2, r.t.; (b) B2cat2 1.25 equiv., DMAc (0.10 M), blue LEDs, then pinacol 
4.00 equiv., Et3N 25.00 equiv., r.t. 
This experiment was repeated at different concentrations (from 0.01 M to 1.00 M). It clearly ap-
peared that the cyclisation reaction was favoured at lower concentrations (Table 7). This result 
was in line with an outer-sphere trapping of the alkyl radical with the boron source. Presumably, 
the diboron molecule responsible for the reduction of the activated ester (with subsequent frag-
mentation and decarboxylation) was not the same as the diboron species which trapped radical 
intermediate 340. This could be indicative of a radical chain reaction. 
 
Concentration 341a 341b Ratio 341a:341b 
1.00 M 36.5% 6.3% 85:15 
0.50 M 41.1% 9.1% 82:18 
0.20 M 48.6% 20.3% 71:29 
0.01 M 34.3% 48.8% 41:59 
Table 7. Effect of the concentration on a radical cyclisation reaction.† 
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2.2.5. Decarboxylative borylation of proline 
As mentioned above, the optimised reaction conditions developed in the Aggarwal lab2 failed to 
afford -amino boronic esters. Considering the value of these building blocks (for example, in 
medicinal chemistry223–225), this limitation had to be addressed. To solve this issue, 22 sets of 
reaction conditions were screened,† using proline derivative (S)-342 as a model substrate. Yields 
were determined by calibrated GCFID with trimethoxybenzene as the internal standard. 
 
Scheme 61. a. Optimised conditions† for the decarboxylative borylation of proline-derived activated ester 
(S)-342. b. Proposed reaction mechanism using 4-methoxypyridine. B(OR)2 = B(OH)2 or Bcat. Brackets 
have been omitted for clarity. 
The best conditions (Scheme 61a) involved a mixture of two different boron sources (B2cat2, 
0.50 equiv. and B2(OH)4, 1.00 equiv.) and a Lewis base, 4-methoxypyridine (4-MeOPy, 
2.00 equiv.), which presumably formed a complex with either diboron species and enhanced the 
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reaction (Scheme 61b). These conditions did not require any light irradiation to deliver the de-
sired boronic ester. 
Despite a GC-yield of 82%,† boronic ester 343 could not be separated from other reaction by-
products, such as B2pin2 or phthalimide. A screening of purification conditions was conducted to 
find the best method to isolate the compound. Two column chromatography steps on deactivated 
silica gel with two different eluent systems were necessary to obtain it pure. However, due to the 
instability of compound 343 on silica gel, the isolated yield dropped to 41%. 
 
Scheme 62. Decarboxylative borylation of glycine and leucine derivatives 353 and (S)-356 under new 
optimised conditions. (a) N-Hydroxyphthalimide 1.00 equiv., DCC 1.00 equiv., THF, r.t.; (b) B2cat2 
0.50 equiv., B2(OH)4 1.00 equiv., 4-MeOPy 2.00 equiv., DMAc, dark, then pinacol 4.00 equiv., AcOH 
4.00 equiv., r.t. 
Other amino acids were then activated and tested under these new reaction and purification con-
ditions (Scheme 62). Glycine derivative 353 gave a promising spot by TLC, but the product could 
not be separated from impurities. Unfortunately, when the same conditions were applied to other 
amino acids, no desired product was observed. For example, leucine derivative (S)-356 did not 
afford corresponding boronic ester 357 and was mostly recovered after work-up. 
 
2.2.6. Effect of N–H bonds 
The main difference between compound (S)-342 and other Boc-protected amino acids is the ab-
sence of free N–H bond in the proline derivative. One could test whether a free N–H bond was 
inhibiting the reaction pathway by spiking the reaction mixture with an additive bearing a free 
N–H bond. A selection of protected benzylamine derivatives were synthesised (Chart 11) and 
engaged into decarboxylative borylation reactions. By screening different protecting groups, this 




Chart 11. Additives 358–363. Conditions: (a) BnNH2 1.00 equiv., TrCl 1.10 equiv., DMAP 0.10 equiv., 
CH2Cl2, r.t., (49%); (b) BnNH2 1.00 equiv., CbzCl 1.20 equiv., I2 0.02 equiv., MeOH, r.t., (48%); (c) 
BnNH2 1.00 equiv., Boc2O 1.10 equiv., EtOH, 30 °C, (88%); (d) BnNH2 1.00 equiv., ClCO2C(CH3)2CCl3 
1.00 equiv., Et3N 2.00 equiv., CH2Cl2, r.t., (30%); (e) BnNH2 1.00 equiv., Ac2O 1.00 equiv., Et3N 
2.00 equiv., DMAP 0.10 equiv., CH2Cl2, r.t., (74%); (f) Commercially available. 
These spiking experiments (Table 8) indicated that the reaction was not affected by the presence 
of additives bearing a free N–H bond. More precisely, no intermolecular inhibition of the reaction 
was observed when mono-substituted carbamates, amides or di-substituted amines were added 
to the reaction medium. 
 
Additive none 358 359 360 361 362 363 
GC Yield 73% 68% 75% 71% 76% 75% 59% 
Table 8. Spiking experiments. The crude mixtures were analysed by GC directly after work-up. Activated 
ester 249 and boronic ester 250 were previously synthesised, isolated and characterised by Dr. Alexander 
Fawcett. 
An additional experiment was carried out to determine whether there was an intramolecular in-
hibition of the reaction by subjecting fully substituted carbamate (S)-366 to the second-genera-
tion conditions (Scheme 63). Unfortunately, no desired product was observed and most of the 
starting activated ester was recovered. These results showed that the free N–H bond in Boc-pro-
tected amino acids was not the inhibiting factor and suggested that another property of amino 




Scheme 63. Disubstituted carbamate (S)-366 did not undergo decarboxylative borylation under second-
generation reaction conditions. NHPI = N-hydroxyphthalimide. 
 
2.2.7. Effect of redox potentials 
Based on the proposed radical mechanism (Scheme 51), one would suggest that amino acids 
failed to provide the desired boronic esters because a reaction component (either starting material 
or by-product) could oxidise the intermediate radical species before it was trapped by the boron 
source. One way to face this issue would be to modify the redox potential of the starting material 
or postulated by-product 270. Hence, Boc-protected alanine (S)-370 was activated by a coupling 
reaction with methyl-substituted phthalimide 369, easily synthesised in one step273 from methyl-
substituted phthalic anhydride 368, and subjected to the optimised conditions (Scheme 64). A 
control experiment was performed in parallel, using compound 373. 
Unfortunately, in both cases, about 90% of the intermediate activated ester ((S)-371 or 373) was 
recovered by column chromatography. The control experiment showed that the -nitrogen of 
alanine was not the cause of failure. Presumably, the presence of a methyl group on the 
phthalimide moiety could lead to an inefficient formation of the light-absorbing complex for-
mation due to steric hindrance or could change the redox potential of the activated ester itself, 
thus preventing the decarboxylation step from taking place. 
An alternative strategy was envisaged to change the redox potential of the radical intermediate. 
Indeed, having a second electron-withdrawing group (i.e., Boc group) attached to the nitrogen 
atom would make the reactive radical less prone to oxidation. Therefore, compounds 377 and 




Scheme 64. Attempt to change the redox potential of the phthalimide derivatives by using methyl-substi-
tuted N-hydroxyphthalimide 369 as an activating group. (a) 369 1.00 equiv., DIC 1.00 equiv., DMAP 
0.10 equiv., CH2Cl2, r.t.; (b) B2cat2 1.25 equiv., DMAc, blue LEDs, then pinacol 4.00 equiv., Et3N 
25.00 equiv., r.t.; (c) B2cat2 0.50 equiv., B2(OH)4 1.00 equiv., 4-MeOPy 2.00 equiv., DMAc, dark, then 
pinacol 4.00 equiv., AcOH 4.00 equiv., r.t. 
After work-up, TLC revealed that starting materials were still present. Unfortunately, no desired 
product could be isolated in both cases. At that point, it seemed sensible to use a different meth-
odology to synthesise an -amino boronate, which could then serve as a reference for optimisa-
tion studies. 
 
Scheme 65. Preparation of doubly Boc-protected activated esters 377 and (S)-382. (a) B2cat2 1.25 equiv., 
DMAc, blue LEDs, then pinacol 4.00 equiv., Et3N 25.00 equiv., r.t.; (c) B2cat2 0.50 equiv., B2(OH)4 





2.2.8. Optimisation study on activated glycine 
Inspired by Matteson’s seminal investigations (Scheme 45a), Ley described an easy methodol-
ogy274 to access -amino boronate 354 from boronic ester 385. In this one-pot reaction (Scheme 
66), NaHMDS acted as a nucleophile to displace the chloride. Then, addition of methanol cleaved 
both N–Si bonds to release a free -amino boronate. Finally, treatment with Boc2O yielded the 
desired product which could be isolated by column chromatography. Pleasingly, the desired com-
pound could be synthesised according to this methodology and subjected to gas chromatography. 
 
Scheme 66. Synthesis of -amino boronic ester 354 according to Ley’s methodology to serve as a GC 
reference in subsequent optimisation study. 
With the reference compound in hand, the decarboxylative borylation of activated ester 353 was 
investigated. Three parameters were screened, including boron source, additive and transesteri-
fication conditions (Table 9). 
 




B2cat2 0.50 equiv.,      
B2(OH)4 1.00 equiv. 
4-MeOPy pinacol 4.00 equiv.,  
AcOH 4.00 equiv., 4 h, r.t. 
67% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-MeOPy pinacol 4.00 equiv., 4 h, 
r.t. 
46% 
B2cat2 1.25 equiv. 4-MeOPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
20% 
B2pin2 1.25 equiv. 4-MeOPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
7% 
B2(OH)4 1.25 equiv. 4-MeOPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
25% 
B2(OH)4 1.50 equiv. 4-MeOPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
29% 
B2(OH)4 2.00 equiv. 4-MeOPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
24% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-AcPy pinacol 4.00 equiv.,    




B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4,4'-bipyridine pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
8% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-tert-BuPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
38% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-NCPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
8% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
DMAP pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
6% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-PhPy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
23% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
pyridine pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
15% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
4-MePy pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
11% 
B2cat2 0.50 equiv.,       
B2(OH)4 1.00 equiv. 
Methyl isonicotinate pinacol 4.00 equiv.,    
AcOH 4.00 equiv., 4 h, r.t. 
10% 
Table 9. Optimisation study using Boc-protected glycine derivative 353 as a model substrate. 
4-MeOPy = 4-methoxypyridine; 4-AcPy = 4-acetylpyridine; 4-tert-BuPy = 4-tert-butylpyridine; 
4-NCPy = 4-cyanopyridine; 4-MePy = 4-methylpyridine. 
The best conditions matched those discovered by Dr. Alexander Fawcett after his first optimisa-
tion study on proline derivative (S)-342 and gave the desired boronic ester 354 in 67% GC-yield 
(Scheme 67). Unfortunately, as explained in Section 2.2.5., in the case of glycine, the desired 
product could not be separated from the reaction by-products, even when the optimised purifica-
tion procedure was used. Sadly, no new spot was observed by TLC when leucine derivative (S)-
356 was subjected to the optimised reaction conditions. 
 
Scheme 67. Optimised conditions for the decarboxylative borylation of Boc-protected glycine 353 failed 
to convert Boc-protected valine (S)-356. 
 
2.2.9. Hypervalent iodine derivatives 
In 2015, Chen and co-workers published an interesting study275 about the ability of hypervalent 
iodine reagents to enable chemoselective decarboxylative alkenylation in the presence of a pho-
tocatalyst. They proposed a mechanism (Scheme 68) in which a ruthenium(II) photocatalyst was 
sequentially excited with light and oxidised to ruthenium(III) by an O-centred radical, derived 
from the radical decomposition of hypervalent iodine species 387 or 388. The catalyst could then 
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be reduced with trifluoroborate salt 389 or boronic acid 390 to complete the catalytic cycle and 
generate alkyl radical 392. This highly reactive species added to in situ-activated ester 388 to 
give benzylic radical 394 (R’ = aryl). At this stage, a radical fragmentation occurred to deliver 
alkene 395 with concomitant release of carbon dioxide and O-centred radical 396. 
 
Scheme 68. Chen’s mechanistic proposal for the hypervalent iodine-mediated alkenylation reaction. 
R1 = alkyl; R2 = aryl, heteroaryl, acyl. Brackets have been omitted for clarity. 
Inspired by this methodology, a reaction mechanism for the hypervalent iodine-mediated decar-
boxylative borylation was proposed (Scheme 69). Carboxylic acid 399 would be activated in situ 
by ligand exchange at the hypervalent iodine centre. The corresponding activated ester would 
form a light-absorbing complex 400 in the presence of B2cat2 and DMAc. Under light irradiation, 
an electron could be transferred from the boron source to the activated ester to give putative 
radical intermediate 401. This unstable species would then undergo a radical fragmentation re-
sulting in the reduction of the iodine centre with concomitant release of boron carboxyate by-
product 403, carbon dioxide and alkyl radical 236. After that, a chain reaction mechanism would 
take place, in which radical 236 would be trapped by B2cat2 in the presence of DMAc to deliver 
the desired borylated compound 267 and a stabilised boryl radical 268. This radical could then 
add to another molecule of activated ester 402 to form unstable intermediate 401, which would 




Scheme 69. Proposed mechanism of decarboxylative borylation using hypervalent iodine reagent 387 as 
activating agent. Brackets have been omitted for clarity. 
To test this hypothesis, a stoichiometric amount of hypervalent iodine derivative 387276 was 
added to a solution of B2cat2 and carboxylic acid (S)-370 or 307 in DMAc to trigger the decar-
boxylation event (Scheme 70). Interestingly, the order of introduction of the reagents was im-
portant. In fact, when compound 387 was mixed with B2cat2 in DMAc in the absence of carbox-
ylic acid, the colourless solution rapidly turned black and released heat. However, in the present 
of a carboxylic acid, a yellow solution was formed and the resulting mixture could be irradiated 





Scheme 70. a. Preparation of compound 387. b. Unsuccessful decarboxylative borylation reactions using 
398 as activating agent. 
Interestingly, Chen and co-workers managed to synthesise activated ester intermediate 388 by 
refluxing a mixture of carboxylic acid 386 and hypervalent iodine derivative 387 in xylenes at 
70 °C under reduced pressure. Under these conditions, the equilibrium was shifted towards the 
formation of the product by constant removal of acetic acid from the reaction mixture. Similar 
conditions were applied to carboxylic acids 307 and 406 (Scheme 71). In the first case, pure 
compound 405 was obtained as a white solid after recrystallisation. However, the other substrates 
led to an inseparable mixture of starting materials and decomposition products. Intermediate 405 
was then mixed with B2cat2 in DMAc and stirred overnight under blue light irradiation. TLC 
showed traces of product which, after chromatography, was obtained in only 2% yield. 
 




Scheme 72. Unsuccessful activation of Boc-protected alanine (S)-370 and valine (S)-409 using hyperva-
lent iodine reagent 387. 
Boc-protected alanine and valine were subjected to the same activation conditions (Scheme 72) 
but the corresponding activated intermediates could not be isolated. An alternative route was 
attempted, which involved mixing the amino acid with hypervalent iodine derivative 412—easily 
made in one step277 from 2-iodobenzoic acid 404—in the presence of a base (Scheme 73). Un-
fortunately, the desired activated esters could not be formed under these conditions and this strat-
egy was abandoned. 
 
Scheme 73. a. Preparation of hypervalent iodine compound 412. b. Unsuccessful activation of Boc-pro-
tected valine (S)-409. 
 
2.2.10. Limited substrate scope 
Despite repeated efforts, only -amino boronate (S)-343 could be synthesised and isolated. An 
unidentified key feature of the pyrrolidine ring was crucial for the reaction to succeed. Based on 
this observation, some proline derivatives were synthesised and subjected to the second set of 
conditions developed by Dr. Alexander Fawcett to build a new substrate scope. Three substituted 
pyrrolidine rings (413, (S)-416 and 420), one bicyclic system (423) and one piperidine ring (426) 




Scheme 74. Activation and decarboxylative borylation of proline derivatives. (a) N-hydroxyphthalimide 
1.00 equiv., DIC 1.00 equiv., DMAP 0.10 equiv., CH2Cl2, r.t.; (b) B2cat2 0.50 equiv., B2(OH)4 1.00 equiv., 
4-MeOPy 2.00 equiv., DMAc, dark, r.t.  
Surprisingly, none of the five substrates gave the corresponding boronic ester. Instead, complex 
mixtures were obtained when fluorinated analogues 414 and (S)-417 were used and starting ac-
tivated esters were recovered in the case of compounds 421, 424 and 427. These results showed 
that the reaction was very sensitive to steric hindrance or the conformation of the 5-membered 
ring and, maybe, to electronic effects of the substituents. 
 
2.3. Conclusion 
The decarboxylative borylation of carboxylic acids has been investigated. The substrate scope of 
this new methodology was improved by including some medicinal chemistry-type examples, 
such as a fluorine-containing cyclohexane, a pyridine derivative and a substituted cyclopropane. 
Three additional natural products were successfully converted to the corresponding boronic es-
ters. Key mechanistic experiments were conducted to prove the radical pathway and provide sup-
port for an outer sphere radical trapping process. 
To improve the applicability of this methodology, a study on the decarboxylative borylation of 
amino acids was conducted. First, the reaction conditions were optimised on a proline derivative 
by Dr. Alexander Fawcett. Unfortunately, he could not separate the material from other by-prod-
ucts. A purification screening was performed to address this issue. With these new conditions in 
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hand, other activated amino acids were tested. However, most of them did not afford the desired 
product. 
To face this problem, the effect of free N–H bonds on the reaction outcome was studied. Spiking 
experiments showed that the reaction was not affected by the presence of additives bearing free 
N–H bonds. Moreover, a fully protected alanine derivative could not be converted to the corre-
sponding boronic ester. Therefore, the presence of a N–H bond was removed from the list of 
potential inhibiting factors. An investigation on redox potentials was carried out to determine 
whether changing the substitution pattern of the activated ester (either at the nitrogen atom or at 
the phthalimide moiety) could lead to an improvement. Unfortunately, doubly protected amino 
acids or methyl-substituted activated esters failed to deliver the desired boronic esters. 
At this stage, another optimisation study on glycine revealed that this amino acid could also be 
converted to the desired product under the conditions developed earlier for proline. Yet, the cor-
responding boronic ester could not be separated from the reaction by-product. To overcome this 
problem, a different mode of activation was envisaged. 
Inspired by the work of Chen and co-workers on hypervalent iodine-mediated decarboxylative 
alkenylation,275 different sets of conditions involving the use of hypervalent iodine derivatives 
were tested. Attempts to activate carboxylic acids in and ex situ showed that these species were 
very unstable and difficult to make. This strategy was abandoned after several unsuccessful re-
sults. 
Finally, as proline seemed to be the only amino acid to be transformed into a boronic ester which 
could be successfully purified, a limited substrate scope composed of proline derivatives was 
subjected to the reaction conditions. Sadly, none of these examples gave the desired product. 





3.1. General experimental 
3.1.1. Computation 
Molecular mechanics calculations were performed using the MacroModel software package278 
(version 9.9) accessed through the Maestro279 (version 9.2) program. All geometry optimisations, 
frequency calculations and NMR calculations were performed using the Gaussian 09 Software 
package.280 All molecular mechanics calculations were performed using the Unix computational 
resource of the School of Chemistry, University of Bristol. All DFT calculations were performed 
using either the Unix computational resource or the computational facilities of the advanced com-
puting research centre at the University of Bristol (http://www.bris.ac.uk/acrc). 
 
3.1.2. Solvents and reagents 
All air- and water-sensitive reactions were carried out in flame-dried glassware under a nitrogen 
or argon atmosphere using standard Schlenk manifold technique. Anhydrous solvents were com-
mercially supplied or provided and dried using a purification column composed of activated alu-
mina and stored over thoroughly dried 3 Å molecular sieves by the communal stills of the School 
of Chemistry, University of Bristol.281 
n-Butyl lithium [CAS: 109-72-8] was purchased from Acros (181271000) as a 1.60 M solution 
in n-hexane. s-Butyl lithium [CAS: 598-30-1] was purchased from Acros (187541000) as a 
1.30 M solution in cyclohexane:n-hexane 98:2. tert-Butyl lithium [CAS: 594-19-4] was pur-
chased from Sigma-Aldrich (186198) as a 1.70 M solution in n-pentane. (+)-Sparteine and 
(−)-sparteine were obtained from the commercially available sulphate pentahydrate salt (99%, 
Acros) and isolated according to literature procedure.282 The sparteine free base readily absorbs 
atmospheric carbon dioxide (CO2) and so should be stored under argon/nitrogen at −20 °C in a 
sealed Schlenk-tube. The molarity of organolithium solutions was regularly determined by titra-
tion using N-benzyl benzamide as an indicator.283 B2cat2 [CAS: 13826-27-2] was purchased either 
from Sigma-Aldrich (473286) or Fluorochem (211650), and both yielded the same results (de-
spite their appearances differing). We have noticed that different batches contain differing 
amounts of catechol, however this does not appear to affect the yield. Anhydrous N,N-dimethyla-
cetamide [CAS: 127-19-5] was purchased from Sigma-Aldrich (271012).  
All other reagents were purchased from various commercial sources and used as received or syn-
thesised according to the procedures given. 
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3.1.3. Chromatography and data analysis  
Analytical TLC was performed on aluminium backed silica plates (Merck, Silica Gel 60 F254, 
0.25 mm). Compounds were visualised by fluorescence quenching or by staining the plates with 
either 5% solution of phosphomolybdic acid (H3PMo12O40) in EtOH, KMnO4, ninhydrin, or 
anisaldehyde followed by heating. 
Flash column chromatography was performed on either silica gel (Merk, Silica Gel 60, 40‒
63 μm). All mixed solvent eluents are reported as v/v solutions. 
1H, 13C, 11B and 19F NMR spectra were recorded using JEOL ECS 300 MHz, JEOL ECS 
400 MHz, Varian 400 MR or Varian VNMRS 500 MHz NMR spectrometers equipped with di-
rect observe two-channel probes, or Bruker AVANCE III HD 500 MHz NMR spectrometer with 
5 mm DCH 13C1H/D Cryo Probe. Chemical shifts () are given in parts per million (ppm) and 
referenced to the residual protio-solvent resonances (Chloroform = [1H] 7.26 ppm, [13C] 77.0 
ppm; Dimethyl sulfoxide = [1H] 2.50 ppm, [13C] 39.5 ppm; Toluene = [1H] 2.09 ppm, [13C] 20.4 
ppm). Coupling constants (J) are given in Hertz (Hz), rounded to the nearest 0.1 Hz. 1H NMR 
spectra are reported as follows:  (number of protons, multiplicity, coupling constants, assign-
ment) ppm. Multiplicity is reported as follows: s = singlet, br. s = broad singlet, d = doublet, 
t = triplet, q = quartet, pent = pentet, sext = sextet, hept = heptet, m = multiplet, dd = doublet of 
doublet, etc. The abbreviation app. is added when apparent multiplicities and corresponding ap-
parent coupling constants are reported. NMR assignments are made according to spin systems, 
using two-dimensional NMR spectroscopy (COSY, HSQC, HMBC), where appropriate, to assist 
the assignment. 11B NMR spectra were measured using Norell S-200-QTZ quartz NMR tubes at 
96 or 128 MHz with complete proton decoupling. 13C signals adjacent to boron are generally not 
observed due to quadrupolar relaxation. 
High resolution mass spectra (HRMS) were recorded by the University of Bristol, School of 
Chemistry departmental mass spectrometry service using a Bruker Daltonics MicrOTOF II by 
Electrospray Ionisation (ESI) or on a VG Micromass Autospec (Triple-sector) by Electronic Im-
pact (EI) or on a Bruker Daltonics UltrafleXtreme (MALDI).  
IR spectra were recorded on a Perkin Elmer Spectrum One FTIR as a thin film, if a liquid, or 
in the solid state, if solid. Only selected absorption maxima (νmax) are reported.  
Melting points were recorded in degrees Celsius (°C) using a Kofler hot-stage microscope ap-
paratus or a Stuart SMP30 melting point apparatus and are uncorrected. 
Optical rotation ([𝜶]𝑫
𝑻 ) was measured on a Bellingham and Stanley Ltd. ADP220 polarimeter 
at 589 nm (Na D-line) in a cell with a path length of 1 dm. Specific rotation values are given in 
° cm3 g1 dm1.  
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Gas Chromatography (GC) was performed on an Agilent 7890A using an Agilent HP-5 column 
(15 m × 0.25 mm × 0.25 μm).  
GCMS was performed using an Agilent HP-5MS column (15 m × 0.250 mm), an Agilent 6890 
GC, and Agilent 5973 MS system. Compounds were identified through extract ion chromatogram 
and molecular ion analysis. Method 70-1X: Inlet temperature 250 °C; Flow rate: 1.00 mL min1; 
hold at 70 °C for 0 min; ramp 20 °C min1 to 200 °C; ramp 45.0 °C min1 to 300 °C; hold at 
300 °C for 2 min.  
Chiral high-performance liquid chromatography (HPLC) separations were performed on an 
Agilent 1100 Series HPLC unit equipped with UV-vis diode-array detector monitored at 
210.8 nm, using Daicel Chiralpak IA, IB or IC columns (4.6 × 250 mm2, 5 μm) fitted with re-
spective guards (4 × 10 mm2). 
Supercritical fluid chromatography (SFC) was performed on a Thar SFC investigator using a 
Daicel Chiralpak IA, IB, IC columns or a Whelk-O1 column (4.6 × 250 mm2, 5 μm). 
UV-visible spectroscopy was performed using a Lambda 35 spectrometer with standard glass 
cells with a 1 cm path length at wavelengths 200−800 nm.  
Single crystal X-ray diffraction experiments on C10, 154, 169, 175 and 186 were carried out 
at 100(2) K on a Bruker APEX II CCD diffractometer using Mo-K  radiation (λ = 0.71073 Å). 
Single crystal X-ray diffraction experiments on 138 were carried out at 100(2) K on a Bruker 
Microstar rotating anode CCD diffractometer using Cu-K  radiation (λ = 1.54184 Å). Intensities 
were integrated in SAINT284 and absorption corrections were based on equivalent reflections us-
ing SADABS.285 The structure was solved using either Superflip286,287 or SHELXT288,289 and re-
fined by full matrix least squares against F2 in SHELXL288,289 using Olex2.290 All of the non-
hydrogen atoms were refined anisotropically, while all of the hydrogen atoms were located geo-
metrically and refined using a riding model. 
 
3.1.4. Naming of compounds  
Compound names are those generated by ChemDraw Professional 16.0 software (PerkinElmer 
Informatics, Inc.), following the IUPAC nomenclature. 
 
3.1.5. Photoreactor  
Photoreactors comprised of a 5.0 m strip of Fluxia blue SMD3528 LEDs coiled around a glass 
crystallising dish. The average power output per LED was recorded at 3.05 mW on a Coherent 
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LabMax-TOP laser power meter equipped with a Coherent Power/Max PS10 sensor with a 
10 mm diameter aperture, 10 mm from aperture. The emission spectra of the blue LEDs were 
recorded on an Ocean Optics HR4000CG-UV-NIR spectrometer. The spectrum was normalised 
to 1.0 at the maximum (450 nm). 
 
Figure 37. Photoreactor setup and emission spectrum of LEDs. 
 
3.2. Supplementary materials – Chapter 1 
3.2.1. General procedures 
General procedure 1 (GP1): A premixed aqueous solution of NaOH (2 M) and H2O2 (30%) 
(2:1, 6.00 mL) was added dropwise to a solution of the boronic ester (1.00 equiv.) in THF 
(4.00 mL) at 0 °C. The reaction mixture was vigorously stirred at room temperature for 4–16 h. 
The reaction mixture was diluted with water (10.00 mL) and Et2O (10.00 mL). The layers were 
separated and the aqueous phase extracted with Et2O (3 × 10.00 mL). The combined organic lay-
ers were washed with brine, dried over MgSO4 and concentrated under reduced pressure. Resid-
ual pinacol was sublimed under high vacuum for 18 h to give the desired product. 
 
General procedure 2 (GP2): In a flame-dried Schlenk tube, stannane 93 (1.30 or 2.30 equiv.) 
was dissolved in anhydrous Et2O (0.20 M) under an atmosphere of nitrogen. The reaction mixture 
was cooled to –78 °C (a white precipitate of stannane appeared) and a solution of n-BuLi (1.50–
1.60 M in n-hexane, 1.30 or 2.30 equiv.) was added dropwise via syringe. After the addition, the 
reaction mixture was stirred at –78 °C for 1.5 h. A solution of the boronic ester (1.00 equiv.) in 
anhydrous Et2O (0.20 M) was then added dropwise via syringe. The reaction mixture was stirred 
at –78 °C for 30 min. The acetone/dry ice bath was removed, and the reaction mixture was al-
lowed to stir at room temperature for 1 h. The white suspension was filtered through silica (2 cm 
depth of wetted (Et2O) silica, using a filter frit connected directly to a flame-dried receiving ves-
sel). The filter was washed with Et2O and the filtrate was concentrated under reduced pressure. 
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The crude boronic ester was analysed by GC chromatography and could be re-dissolved in anhy-
drous Et2O (to make a 0.20 M solution) and used in further homologations or isolated and purified 
by flash column chromatography. 
 
General procedure 3 (GP3): Part A: In a flame-dried Schlenk tube, the boronic ester 
(1.00 equiv.) and vinyl carbamate 15 (1.10 equiv.) were dissolved in anhydrous THF (0.15 M) at 
–78 °C under an atmosphere of nitrogen. A freshly prepared solution of LDA (0.86 M in THF, 
1.10 equiv.) was added and the reaction mixture was stirred at the same temperature for 1 h. The 
acetone/dry ice bath was replaced with an acetonitrile/dry ice bath and the reaction mixture was 
stirred at –40 °C for 1 h. After cooling the reaction mixture back to –78 °C, a freshly prepared 
solution of iodine (1.10 equiv.) in MeOH (0.20 M) was added dropwise at via syringe. After the 
addition, the reaction mixture was allowed to stir at room temperature for 1 h. A saturated aque-
ous solution of NH4Cl was added and the biphasic mixture was extracted 3 times with Et2O. The 
organic layers were combined, washed with brine, dried over MgSO4, filtered through silica 
(2 cm depth of dry silica, using a filter frit connected directly to a flame-dried receiving vessel), 
concentrated under reduced pressure and dried under high vacuum for (at least) 1 h. Part B: The 
dried crude residue was dissolved in anhydrous Et2O (0.10 M) at –78 °C under an atmosphere of 
nitrogen. A freshly prepared solution of LDA (0.86 M in THF, 2.50 equiv.) was added and the 
reaction mixture was allowed to stir at room temperature for 1 h. A saturated aqueous solution of 
NH4Cl was added via syringe and the biphasic mixture was extracted 3 times with Et2O. The 
organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated 
under reduced pressure. The residue was purified by flash column chromatography to give the 
desired product(s). 
 
General procedure 4 (GP4): In a flame-dried Schlenk tube, the alkyne (1.00 equiv.) and TIPSCl 
(1.10 equiv.) were dissolved in anhydrous THF (0.20 M) at –78 °C under an atmosphere of ni-
trogen. A freshly prepared solution of LDA (0.86 M in THF, 1.10 equiv.) was added and the 
mixture was stirred at the same temperature for 1 h. The white suspension was allowed to warm 
to room temperature and gently heated with a heat-gun (50 °C) until the white solid dissolved. 
The clear solution was stirred at room temperature for 16 h, quenched with a saturated aqueous 
solution of NH4Cl and extracted 3 times with Et2O. The organic layers were combined, washed 
with brine, dried over MgSO4, filtered and concentrated under reduced pressure. The residue was 
purified by flash column chromatography to give the desired product. 
 
General procedure 5 (GP5): In a Schlenk tube, the protected alkyne (1.00 equiv.) was dissolved 
in THF (0.20 M) at 0 °C under an atmosphere of nitrogen. A solution of TBAF (1.00 M in THF, 
 
100 
2.00 equiv.) was added via syringe and the mixture was stirred at room temperature for 2 h. A 
saturated aqueous solution of NH4Cl was added and the biphasic mixture was extracted 3 times 
with Et2O. The organic layers were combined, washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash column chromatography 
to give the desired product. 
 
3.2.2. Experimental procedures and characterisation data 
Vinyl diisopropylcarbamate (15) 
 
In a flame-dried Schlenk tube, THF (12.00 mL) was cooled to –78 °C under an atmosphere of 
nitrogen. A solution of n-BuLi (1.60 M in n-hexane, 11.46 mL, 18.33 mmol, 1.50 equiv.) was 
added via syringe. After the addition, the acetone/dry ice bath was removed, and the reaction 
mixture was stirred at room temperature for 16 h. A solution of N,N-diisopropylcarbamoyl chlo-
ride (2.00 g, 12.22 mmol, 1.00 equiv.) in anhydrous DMPU (7.00 mL) was added via syringe and 
the reaction mixture was stirred at room temperature for 4 h. A saturated aqueous solution of 
NH4Cl (20.00 mL) was added, followed by water (5.00 mL) and Et2O (20.00 mL). The phases 
were separated, and the aqueous layer was extracted with Et2O (3 × 20.00 mL). The organic lay-
ers were combined, washed with brine, dried over MgSO4, filtered and concentrated under re-
duced pressure. The orange residue was purified by flash column chromatography (n-pen-
tane:Et2O 95:5) to give carbamate 15 (1.34 g, 64%) as a colourless liquid. 
TLC: Rf = 0.47 (n-pentane:Et2O 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 7.24 (1H, dd, J = 14.1, 6.3 Hz, H3), 4.75 (1H, dd, 
J = 14.1, 1.4 Hz, H1b), 4.41 (1H, dd, J = 6.3, 1.4 Hz, H1a), 4.04 (1H, br. s, H5), 3.84 (1H, br. s, 
H5’), 1.24 (12H, d, J = 6.9 Hz, H6 & H6’) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 152.9 (C4), 142.5 (C3), 94.7 (C2), 46.8 (C5), 45.9 (C5’), 
21.7 (C6), 20.5 (C6’) ppm 







Ethyl 2,4,6-triisopropylbenzoate (91) 
 
In a 2-L round-bottomed flask, 2,4,6-triisopropylbenzoic acid (40.00 g, 161.10 mmol, 
1.00 equiv.) and 1-bromoethane (60.10 mL, 805.30 mmol, 5.00 equiv.) were dissolved in CHCl3 
(800.00 mL) at room temperature. A solution of NaOH (20.00 g, 499.30 mmol, 3.10 equiv.) and 
n-Bu4N(HSO4) (4.40 g, 12.90 mmol, 0.08 equiv.) in water (640.00 mL) was added and the bi-
phasic mixture was vigorously stirred at room temperature for 18 h. The phases were separated, 
and the aqueous layer was extracted with CH2Cl2 (3 × 200.00 mL). The organic phases were 
combined, washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
crude product was suspended in n-pentane (120.00 mL) and the insoluble salts were filtered off. 
The filtrate was concentrated under reduced pressure to give benzoate 91 (44.50 g, 99%) as a 
colourless liquid. 
TLC: Rf = 0.32 (n-pentane:EtOAc 97:3) 
1H NMR (400 MHz, Chloroform-d): δ 7.00 (2H, s, H4), 4.37 (2H, q, J = 7.1 Hz, H8), 3.01 – 
2.71 (3H, m, H2 & H10), 1.37 (3H, t, J = 7.1 Hz, H9), 1.31 – 1.15 (18H, m, H1 & H11) ppm 
13C NMR (101 MHz, Chloroform-d): δ 14.4 (C9), 24.1 (C1), 24.2 (C11), 31.6 (C10), 34.6 (C2), 
60.9 (C8), 121.0 (C4), 130.8 (C6), 144.95 (C5), 150.2 (C3), 170.9 (C7) ppm 
Spectral data were in accordance with that reported in the literature.47  
 
(S)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate ((S)-93) 
 
In a flame-dried 1-L round-bottomed flask, ethyl 2,4,6-triisopropylbenzoate 91 (10.00 g, 
36.20 mmol, 1.00 equiv.) and (–)-sparteine (10.80 mL, 47.00 mmol, 1.30 equiv.) were dissolved 
in anhydrous Et2O (200.00 mL). The solution was cooled to –78 °C and allowed to equilibrate 
for 10 min. A solution of s-BuLi (1.30 M in hexanes, 36.20 mL, 47.00 mmol, 1.30 equiv.) was 
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added dropwise via syringe to the reaction mixture at –78 °C over 20 min (colour change: col-
ourless → dark brown). The reaction mixture was stirred at –78 °C for 4 h. A solution of trime-
thyltin chloride (1.00 M in n-hexane, 47.00 mL, 47.00 mmol, 1.30 equiv.) was added dropwise 
to the reaction mixture via syringe over 10 min (colour change: dark brown → pale yellow). The 
reaction mixture was stirred at –78 °C for 20 min before being warmed to room temperature and 
stirred for 1 h. The reaction mixture was quenched with an aqueous solution of HCl (2.00 M, 
100.00 mL) and stirred for a further 20 min. The phases were separated, and the organic layer 
was washed with an aqueous solution of HCl (2.00 M, 3 × 100.00 mL). The combined aqueous 
layers were extracted with Et2O (3 × 100.00 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure to give crude stannane (S)-93 (16.25 g). The 
opposite enantiomer ((R)-93) was synthesised in identical yields by substituting (–)-sparteine for 
(+)-sparteine. 
Sparteine recovery282  
The combined aqueous layers were basified (~ pH 12) by addition of an aqueous solution of 
NaOH (20% w/w). The aqueous phase was extracted with Et2O (3 × 100.00 mL). The combined 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated under re-
duced pressure to give crude sparteine. Distillation* of the residual oil over CaH2 gave (–)-spar-
teine (9.90 g, 92%) as a colourless liquid. 
*Distillation conditions: bulb-to-bulb; 10 cm Vigreux column; pressure: 2 mbar; oil bath: 
150 °C; CaH2 (100 mg mL1); b.p.: 137 – 138 °C (1.33 mbar). 
Recrystallisation of enantioenriched stannane  
MeOH (3.00 mL g–1) was added to the crude stannane in a one neck round-bottomed flask. A 
condenser was fitted to the round-bottom flask and the solution was brought to reflux (heat gun) 
until all the solids had dissolved. The solution was then allowed to cool to room temperature. 
Crystals appeared after 10 min to 5 h depending on the purity of crude stannane. The crystals 
were then filtered and dried under reduced pressure to give a white solid (10.31 g, 99.2:0.8 e.r.). 
The product was then recrystallised once more from MeOH (3.00 mL g–1) to give, after two crops, 
(S)-93 (8.41 g, 53%, 99.9:0.1 e.r.) as a white solid. 
TLC: Rf = 0.42 (n-pentane:Et2O 97:3) 
1H NMR (400 MHz, Chloroform-d): δ 7.00 (2H, s, H4), 5.04 (1H, q, J = 7.6 Hz, H8), 2.94 – 2.76 
(3H, m, H2 & H10), 1.59 (3H, d, J = 7.6 Hz, H9), 1.25 – 1.23 (18H, m, H1 & H11), 0.18 (9H, d, 
J119Sn–1H = 54.2 Hz, d, J117Sn–1H = 51.7 Hz and s, H12) ppm 
13C NMR (101 MHz, Chloroform-d): δ 171.4 (C7), 150.1 (C3), 145.0 (C5), 130.9 (C6), 120.9 
(C4), 67.2 (C8), 34.6 (C2), 31.5 (C10), 24.5 (C1 or C11 or C11’), 24.2 (C1 or C11 or C11’), 24.1 
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(C1 or C11 or C11’), 19.4 (C9), –9.8 (d, J119Sn–13C = 333.5 Hz, d, J117Sn–13C = 319.3 Hz and s, C12) 
ppm 
Spectral data were in accordance with that reported in the literature.1  
Chiral HPLC: Daicel Chiralpak IB column (25 cm) with guard, 100% n-hexane, 0.90 mL min1, 
room temperature, 210 nm: tR = 4.9 min (major), 7.1 min (minor), 99.9:0.1 e.r. 
 













In a flame-dried Schlenk tube, 1-bromonaphthalene (0.01 mL, 0.08 mmol, 1.20 equiv.) was dis-
solved in anhydrous Et2O (0.50 mL) at 0 °C under an atmosphere of nitrogen. A solution of 
n-BuLi (1.55 M in n-hexane, 0.05 mL, 0.08 mmol, 1.20 equiv.) was added dropwise and the re-
sulting white suspension was stirred at 0 °C for 1 h. A solution of boronic ester 126 (36 mg, 
0.07 mmol, 1.00 equiv.) in anhydrous Et2O (0.25 mL) was added dropwise and the resulting pale 
yellow solution was stirred at 0 °C for 2 h. Solvents were removed under vacuum and the white 
residue was re-dissolved in anhydrous MeOH (1.00 mL) at –78 °C. A solution of NBS (29 mg, 
0.16 mmol, 2.40 equiv.) in anhydrous MeOH (1.50 mL) was added dropwise over 20 min. After 
the addition, the acetone/dry ice bath was removed and the reaction mixture was allowed to stir 
at room temperature for 1 h. A saturated aqueous solution of Na2S2O3 (1.00 mL) was added. The 
cloudy mixture was vigorously stirred for 5 min, diluted with water (10.00 mL) and extracted 
with Et2O (3 × 5.00 mL). The organic layers were combined, washed with brine, dried over 
MgSO4, filtered and concentrated to afford a yellow residue. The crude material was purified by 
flash column chromatography (n-pentane:Et2O 98:2) to give benzoate 114 (17 mg, 47%) as a 
colourless liquid. 
TLC: Rf = 0.51 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 8.17 (1H, d, J = 9.4 Hz, H23), 7.86 (1H, m, H26), 7.69 
(1H, d, J = 8.0 Hz, H28), 7.40 – 7.52 (3H, m, H24, H25 & H29), 7.36 (1H, d, J = 7.2 Hz, H30), 
7.03 (2H, s, H4), 4.10 – 4.14 (2H, m, H10), 3.53 (1H, m, H19), 2.84 – 2.94 (3H, m, H2 & H6), 
2.09 – 2.13 (2H, m, H11 & H17), 1.56 (1H, m, H13), 1.31 (3H, d, J = 6.9 Hz, H20), 1.27 (18H, 
m, H1 & H7), 1.10 (1H, m, H15), 0.93 (3H, d, J = 6.7 Hz, H18), 0.70 (3H, d, J = 6.8 Hz, H16), 
0.62 (3H, d, J = 6.9 Hz, H14), 0.53 (3H, d, J = 6.8 Hz, H12) ppm 
13C NMR (101 MHz, Chloroform-d): δ 171.4 (C9), 150.1 (C3), 144.9 (C5), 144.1 (C21), 134.1 
(C27), 131.9 (C22), 130.9 (C8), 129.2 (C26), 126.3 (C28), 125.7 (C25 or C29), 125.6 (C25 or 
C29), 125.3 (C24), 124.0 (C30), 123.3 (C23), 121.0 (C4), 69.7 (C10), 39.8 (C17), 36.9* (C19), 
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36.2 (C13 or C15), 36.1 (C15 or C13), 34.6 (C2), 32.9 (C11), 31.7 (C6), 24.4 (C7’), 24.3 (C7), 
24.1 (C1), 20.7 (C20), 12.1 (C16), 11.9 (C18), 11.6 (C14), 11.1 (C12) ppm 
*shift value determined by HSQC correlation. 
HRMS (m/z): (ESI+) calc’d. for C37H52NaO2 [M+Na]+: 551.3860; found 551.3867 
IR (νmax): 2962, 2873, 1722, 1606, 1460, 1383, 1250, 1136, 1069, 778, 732 cm1 
[𝛂]𝑫





In a flame-dried Schlenk vessel, freshly purified CuCl (29 mg, 0.30 mmol, 0.03 equiv.), 
tert-BuOK (44 mg, 0.39 mmol, 0.04 equiv.) and (S)-DTBM-SEGPHOS (348 mg, 0.30 mmol, 
0.03 equiv.) were mixed in degassed (i.e., sparged with nitrogen for 1 h) anhydrous toluene 
(5.00 mL) at room temperature under an atmosphere of nitrogen. Freshly distilled pinacolborane 
(1.71 mL, 11.80 mmol, 1.20 equiv.) was added and the yellow solution turned brown. After 
10 min, a solution of 2-bromo-1-methoxy-4-vinylbenzene (2.10 g, 9.84 mmol, 1.00 equiv.) in 
degassed anhydrous toluene (4.00 mL) was added and the reaction mixture was stirred under an 
atmosphere of nitrogen for 16 h. The dark suspension was filtered through Celite®, washed with 
n-pentane (50.00 mL) and the filtrate was concentrated under reduced pressure. The residue was 
purified by flash column chromatography (n-pentane:Et2O 90:10) to give boronic ester (R)-120 
(2.94 g, 88%, 98.9:1.1 e.r.) as a pale yellow liquid. 
TLC: Rf = 0.20 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 7.39 (1H, d, J = 2.2 Hz, H4), 7.11 (1H, dd, J = 8.4, 2.2 Hz, 
H6), 6.81 (1H, d, J = 8.4 Hz, H7), 3.85 (3H, s, H1), 2.34 (1H, q, J = 7.5 Hz, H8), 1.28 (3H, d, 
J = 7.5 Hz, H9), 1.21 (6H, s, H11), 1.20 (6H, s, H11’) ppm 
13C NMR (101 MHz, Chloroform-d): δ 153.6 (C2), 138.8 (C5), 132.6 (C4), 127.8 (C6), 112.1 
(C7), 111.5 (C3), 83.5 (C10), 56.4 (C1), 24.8 (C11), 24.7 (C11’), 17.3 (C9) ppm 
The signal corresponding to C8 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C15H22B79BrNaO3 [M+Na]+: 363.0740; found 363.0746 




𝟐𝟑: –8 (CHCl3, c = 1.0) 
Boronic ester (R)-120 (about 20 mg) was oxidised to the corresponding alcohol according to GP1 
for chiral SFC analysis. 
Chiral SFC: Daicel Chiralpak IA column (25 cm), 20.0% co-solvent (n-hexane:IPA 90:10), 





2,2'-((2R,3R)-Butane-2,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (122a) and (S)-
2,2'-(Butane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (122b) 
 
In a flame-dried Schlenk tube, Rh(nbd)(acac) (124 mg, 0.42 mmol, 0.05 equiv.) and (S)-
QUINAP (185 mg, 0.42 mmol, 0.05 equiv.) were dissolved in anhydrous THF (10.00 mL) at 
room temperature under an atmosphere of nitrogen. A solution of B2cat2 (2.00 g, 8.41 mmol, 
1.00 equiv.) in anhydrous THF (30.00 mL) was added and the yellow solution turned brown. The 
reaction mixture was then cooled to –10 °C. In a separated flame-dried Schlenk tube, a solution 
of trans-but-2-ene in THF was made by slow addition of anhydrous THF (3.00 mL) to condensed 
trans-but-2-ene (3.00 mL, 32.08 mmol, 3.80 equiv.) at –78 °C under an atmosphere of nitrogen. 
This colourless solution was then quickly transferred to the reaction mixture via syringe and the 
dark solution was stirred at –10 °C for 10 min. The NaCl/ice bath was removed, and the reaction 
mixture was stirred at room temperature for 18 h under an atmosphere of nitrogen. Pinacol 
(1.99 g, 16.82 mmol, 2.00 equiv.) was then added and the reaction was stirred at room tempera-
ture for 16 h. The dark suspension was concentrated under reduced pressure to afford a brown 
 
107 
oil. The crude residue was purified by flash column chromatography (n-hexane:EtOAc 95:5) to 
give 1.80 g of a 74:26 mixture* of boronic ester 122a (1.33 g, 51%, >99.5:0.5 e.r., >95:5 d.r.) 
and boronic ester 122b (0.47 g, 18%, 77.8:22.2 e.r.) as a colourless liquid. 
*The corresponding regioisomeric ratio (74:26 r.r.) was determined by 1H NMR analysis. 
Note 1: Both products are unstable under air and on silica. 
Note 2: For full characterisation and e.r. determination of both products, a few fractions contain-
ing pure materials could be obtained by multiple slow chromatography steps (n-pentane:Et2O 
98:2). However, this iterative purification process led to a massive loss of products. For this rea-
son, the 74:26 mixture of products was directly engaged in the next homologation step after the 




TLC: Rf = 0.62 (n-pentane:Et2O 80:20) 
1H NMR (400 MHz, Chloroform-d): δ 1.22 (12H, s, H1), 1.21 (12H, s, H1’), 1.12 (2H, m, H3), 
0.95 (6H, d, J = 7.1 Hz, H4) ppm 
13C NMR (101 MHz, Chloroform-d): δ 82.9 (C2), 24.8 (C1), 25.0 (C1’), 14.0 (C4) ppm 
The signal corresponding to C3 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C16H32B2NaO4 [M+Na]+: 333.2385; found: 333.2385 
IR (νmax): 2977, 2927, 2873, 1457, 1370, 1307, 1214, 1140, 969 cm1 
[𝛂]𝑫
𝟐𝟒: +9 (CHCl3, c = 1.0; 99.7:0.3 e.r.) 
Enantiomeric ratio (e.r.) determination: 
Part A: A solution of pure boronic ester 122a (35 mg, 0.11 mmol, 1.00 equiv.) in THF (2.00 mL) 
was slowly added into a mixture NaOH (2.00 M in water, 2.00 mL) and H2O2 (30% in water, 
1.00 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 4 h. Na2SO4 (614 mg) was added 
and the biphasic mixture was stirred at room temperature for 16 h. The layers were separated, 
and the aqueous phase was extracted with EtOAc 5 times. The organic phases were combined, 
dried over MgSO4, filtered and the volume of solvent was reduced to 0.20 mL by rotary evapo-
ration. n-Pentane (0.20 mL) was added and the colourless solution was loaded on column chro-
matography. The desired diol was separated from pinacol using n-hexane:EtOAc 50:50 as eluent. 
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Pure fractions were combined and concentrated at 45 °C under atmospheric pressure (volatile 
material) to a volume of solvent of about 0.20 mL. Part B: Tosyl chloride (42 mg, 0.22 mmol, 
2.00 equiv.) and triethylamine (0.03 mL, 0.22 mmol, 2.00 equiv.) were added and the reaction 
mixture was stirred at room temperature for 16 h. The brown solution was diluted with CH2Cl2 
(1.00 mL) and water (1.00 mL). The layers were separated, and the aqueous phase was extracted 
with CH2Cl2 (3 × 1.00 mL). The organic phases were combined, dried over MgSO4, filtered and 
concentrated. The crude residue was purified by flash column chromatography (n-hexane:EtOAc 
85:15) to give the desired bis(tosylate), which was analysed by chiral HPLC. 
Note: A commercially available mixture of (2R,3S)-, (2R,3R)- and (2S,3S)-butane-2,3-diol was 
tosylated according to the same procedure (Part B) to give the analytical reference for e.r. deter-
mination by chiral HPLC. 
Chiral HPLC: Daicel Chiralpak IA column (25 cm) with guard, n-hexane:IPA 90:10, 
0.70 mL min1, room temperature, 210 nm: tR = 27.0 min (meso), 33.5 min (major), 35.3 min 
(minor), >99.5:0.5 e.r.  
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(2R,3S)-Butane-2,3-diyl bis(4-methylbenzenesulfonate), (2R,3R)-Butane-2,3-diyl bis(4-














TLC: Rf = 0.58 (n-pentane:Et2O 80:20) 
1H NMR (500 MHz, Chloroform-d): δ 1.47 (1H, ddq, J = 13.5, 8.4, 7.4 Hz, H4), 1.37 (1H, dqd, 
J = 13.5, 7.4, 5.7 Hz, H4’), 1.23 (24H, m, H1, H1’, H8 & H8’), 1.06 (1H, m, H3), 0.92 – 0.83 
(4H, m, H5 & H6), 0.78 (1H, dd, J = 15.7, 5.8 Hz, H6’) ppm 
13C NMR (126 MHz, Chloroform-d): δ 82.9 (C2), 82.9 (C7), 26.9 (C4), 25.1 (C1), 25.0 (C8), 
24.9 (C1’), 24.9 (C8’), 20.5 (C3), 13.5 (C5), 12.5 (C6) ppm 
HRMS (m/z): (ESI+) calc’d. for C16H33B2O4 [M+H]+: 311.2565; found: 311.2577 
IR (νmax): 2977, 2929, 2874, 1370, 1311, 1141, 968 cm1 
[𝛂]𝑫
𝟐𝟒: +1 (CHCl3, c = 1.0; 77.8:22.2 e.r.) 
Enantiomeric ratio (e.r.) determination: 
Part A: A solution of pure boronic ester 122b (53 mg, 0.17 mmol, 1.00 equiv.) in THF (2.00 mL) 
was slowly added into a mixture of NaOH (2.00 M in water, 2.00 mL) and H2O2 (30% in water, 
1.00 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 4 h. Na2SO4 (614 mg) was added 
and the biphasic mixture was stirred at room temperature for 16 h. The layers were separated, 
and the aqueous phase was extracted with EtOAc 5 times. The organic phases were combined, 
dried over MgSO4, filtered and the volume of solvent was reduced to 0.20 mL by rotary evapo-
ration. n-Pentane (0.20 mL) was added and the colourless solution was loaded on column chro-
matography. The desired diol was separated from pinacol using n-hexane:EtOAc 50:50 as eluent. 
Pure fractions were combined and concentrated at 45 °C under atmospheric pressure (volatile 
material) to a volume of solvent of about 0.20 mL. Part B: Tosyl chloride (65 mg, 0.34 mmol, 
2.00 equiv.) and triethylamine (0.05 mL, 0.34 mmol, 2.00 equiv.) were added and the reaction 
mixture was stirred at room temperature for 16 h. The brown solution was diluted with CH2Cl2 
(1.00 mL) and water (1.00 mL). The layers were separated, and the aqueous phase was extracted 
with CH2Cl2 (3 × 1.00 mL). The organic phases were combined, dried over MgSO4, filtered and 
concentrated. The crude residue was purified by flash column chromatography (n-hexane:EtOAc 
85:15) to give the desired bis(tosylate), which was analysed by chiral HPLC. 
Note: Commercially available (+/–)-Butane-1,2-diol was tosylated according to the same proce-
dure (Part B) to give the analytical reference for e.r. determination by chiral HPLC. 
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Chiral HPLC: Daicel Chiralpak IA column (25 cm) with guard, n-hexane:IPA 90:10, 















In a flame-dried Schlenk vessel, boronic ester 138 (75 mg, 0.20 mmol, 1.00 equiv.) and bromo-
chloromethane (0.08 mL, 1.23 mmol, 6.00 equiv.) were dissolved in anhydrous Et2O (0.80 mL) 
at –78 °C under an atmosphere of nitrogen. A solution of n-BuLi (1.50 M in n-hexane, 0.68 mL, 
1.02 mmol, 5.00 equiv.) was added dropwise and the reaction mixture was stirred at –78 °C for 
30 min. The acetone/dry ice bath was removed and the reaction mixture was stirred at room tem-
perature for 1 h. The white suspension was filtered through silica (~10 mm depth of wetted (Et2O) 
silica, using a filter frit connected directly to a receiving vessel) to give a yellow translucent 
solution. The silica was washed with Et2O (reagent grade) and the filtrate was concentrated under 
reduced pressure to give boronic ester 123 (80 mg, quantitative yield, >95:5 d.r.) as a colourless 
liquid. 
TLC: Rf = 0.29 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 1.88 (2H, dqdd, J=8.6, 6.8, 4.1 Hz, H4), 1.31 – 1.17 (26H, 
m, H1 & H6), 0.81 (2H, dd, J = 15.4, 6.4 Hz, H3), 0.80 (6H, d, J = 6.8 Hz, H5), 0.70 (6H, d, 
J = 6.6 Hz, H7), 0.67 (2H, dd, J=15.4, 8.6 Hz, H3’) ppm 
13C NMR (101 MHz, Chloroform-d): δ 82.9 (C2), 41.1 (C6), 30.8 (C4), 25.1 (C1), 24.9 (C1’), 
18.5 (C3), 17.6 (C5), 11.5 (C7) ppm 
HRMS (m/z): (ESI+) calc’d. for C22H44B2NaO4 [M+Na]+: 417.3326; found 417.3316 
IR (νmax): 2975, 2877, 1369, 1310, 1145, 969, 846 cm1 
[𝛂]𝑫
𝟐𝟒: +9 (CHCl3, c = 1.0) 
 
(2S,3R,4R,5S)-3,4-Dimethylhexane-2,5-diyl bis(2,4,6-triisopropylbenzoate) (124) 
 
In a flame-dried Schlenk vessel, 2,4,6-triisopropylbenzoic acid (383 mg, 1.54 mmol, 
2.10 equiv.), triphenylphosphine (405 mg, 1.54 mmol, 2.10 equiv.) and diol 139 (128 mg, 
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0.73 mmol, 1.00 equiv.) were dissolved in anhydrous THF (4.00 mL) at 0 °C under an atmos-
phere of nitrogen. DIAD (0.30 mL, 1.54 mmol, 2.10 equiv.) was added dropwise and the colour-
less solution turned yellow. After the addition, the reaction mixture was stirred at room temper-
ature for 18 h. The reaction mixture was diluted with water (10.00 mL) and extracted with Et2O 
(3 × 10.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, fil-
tered and concentrated to afford a yellow oil. The crude residue was purified by flash column 
chromatography (n-pentane:Et2O 99:1) to give benzoate 124 (397 mg, 85%, >95:5 d.r.) as a 
white solid. 
TLC: Rf = 0.31 (n-pentane:Et2O 90:10) 
m.p.: 76 – 81 °C (methanol) 
1H NMR (400 MHz, Chloroform-d): δ 7.01 (4H, s, H4), 4.24 (2H, dd, J = 10.9, 6.8 Hz, H10’), 
4.13 (2H, dd, J = 10.9, 7.3 Hz, H10), 2.79 – 2.85 (6H, m, H2 & H6), 2.09 (2H, m, H11), 1.62 
(2H, m, H13), 1.24 – 1.26 (36H, m, H1 & H7), 0.87 (6H, d, J = 6.8 Hz, H12), 0.85 (6H, d, 
J = 5.9 Hz, H14) ppm 
13C NMR (101 MHz, Chloroform-d): δ 171.3 (C9), 150.1 (C3), 144.8 (C5), 130.8 (C8), 121.0 
(C4), 69.2 (C10), 35.8 (C11), 34.5 (C13), 33.3 (C2), 31.7 (C6), 24.4 (C7), 24.3 (C7’), 24.1 (C1), 
11.6 (C12), 11.4 (C14) ppm 
HRMS (m/z): (ESI+) calc’d. for C42H66NaO4 [M+Na]+: 657.4853; found 657.4833 
IR (νmax): 2960, 2870, 1723, 1460, 1282, 1248, 1136, 1068, 876 cm1 
[𝛂]𝑫




MgSO4 (3.02 g, 25.10 mmol, 1.00 equiv.) was dried in a flame-dried Schlenk vessel at 500 °C 
(heat gun) under high vacuum until gas evolution ceased. After cooling at room temperature, the 
flask was refilled with nitrogen and charged with a solution of methylboronic acid (1.50 g, 
25.10 mmol, 1.00 equiv.) and pinacol (3.11 g, 26.30 mmol, 1.05 equiv.) in anhydrous Et2O 
(70.00 mL). The flask was sealed and the white suspension was vigorously stirred at room tem-
perature for 20 h. The reaction was filtered and the solid was washed several times with Et2O. 
The filtrate was concentrated at 35 °C under atmospheric pressure to afford a colourless liquid. 
The 1H NMR spectrum revealed that pinacol was still present. The product was filtered through 
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~10 mm depth of wetted silica (n-pentane:Et2O 90:10), using a filter frit connected directly to a 
flame-dried receiving vessel). The silica was washed with a mixture n-pentane:Et2O 90:10 and 
the filtrate was concentrated at 35 °C under atmospheric pressure to give boronic ester 125 
(1.97 g, 55%) as a colourless liquid. 
TLC: Rf = 0.39 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 1.22 (12H, s, H3), 0.21 (3H, s, H1) ppm 
13C NMR (101 MHz, Chloroform-d): δ 83.1 (C2), 25.0 (C3) ppm 
The signal corresponding to C3 was not observed due to quadrupolar relaxation. 
Spectral data were in accordance with that reported in the literature.202  
 
(2S,3R,4S,5R,6R)-2,3,4,5-Tetramethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hep-
tyl 2,4,6-triisopropylbenzoate (126) 
 
In a flame-dried Schlenk vessel, compound 124 (505 mg, 0.80 mmol, 1.00 equiv.) and (+)-spar-
teine (0.20 mL, 0.87 mmol, 1.10 equiv.) were dissolved in anhydrous Et2O (5.00 mL) at –78 °C 
under an atmosphere of nitrogen. A solution of s-BuLi (1.30 M in hexanes, 0.67 mL, 0.87 mmol, 
1.10 equiv.) was added dropwise and the reaction was stirred at –78 °C for 4.5 h. A solution of 
methyl pinacol boronic ester 125 (158 mg, 1.11 mmol, 1.40 equiv.) in anhydrous THF (1.60 mL) 
was added dropwise over 25 min and the reaction mixture was stirred at –78 °C for 3.5 h. The 
acetone/dry ice bath was removed and the reaction mixture was stirred at room temperature. Sol-
vents were removed in situ under reduced pressure and the residue was re-dissolved in CHCl3 
(10.00 mL). The yellow solution was stirred at 40 °C for 18 h under an atmosphere of nitrogen. 
The white suspension was diluted an aqueous solution of HCl (1.00 M, 3 × 10.00 mL). The aque-
ous layers were combined and extracted with CH2Cl2 (3 × 30.00 mL). The organic layers were 
combined and washed with brine, dried over MgSO4, filtered and concentrated to afford a col-
ourless oil. The residue was purified by flash column chromatography (n-pentane:CH2Cl2 
80:20→60:40) to give boronic ester 126 (287 mg, 68%) as a colourless liquid. 
TLC: Rf = 0.40 (n-pentane:CH2Cl2 50:50) 
1H NMR (400 MHz, Chloroform-d): δ 7.00 (2H, s, H4), 4.24 (1H, dd, J = 10.8, 6.7 Hz, H10’), 
4.11 (1H, dd, J = 10.8, 7.4 Hz, H10), 2.82 – 2.92 (3H, m, H2 & H6), 1.67 (1H, m, H13), 2.10 
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(1H, m, H11), 1.53 (1H, m, H15), 1.38 (1H, m, H17), 1.19 – 1.27 (30H, m, H1, H7, H22 & H22’), 
1.02 (1H, m, H19), 0.88 – 0.92 (6H, m, 2 × CH3), 0.68 – 0.82 (9H, m, 3 × CH3) ppm 
13C NMR (101 MHz, Chloroform-d): δ 171.4 (C9), 150.0 (C3), 144.9 (C5), 130.9 (C8), 120.9 
(C4), 82.9 (C21), 69.5 (C10), 39.1 (CH), 36.2 (CH), 36.0 (CH), 34.5 (CH), 33.3 (C2), 31.7 (C6), 
25.0 (C22), 24.8 (C22’), 24.4 (C7), 24.3 (C7’), 24.1 (C1), 12.8 (CH3), 12.6 (CH3), 11.9 (CH3), 
11.7 (CH3), 11.6 (CH3) ppm 
The signal corresponding to C19 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C33H57BNaO4 [M+Na]+: 551.4248; found 551.4267 
IR (νmax): 2961, 2874, 1725, 1460, 1382, 1313, 1250, 1143, 1069, 876 cm1 
[𝛂]𝑫




In a flame-dried Schlenk vessel, methyltriphenylphosphonium bromide (1.83 g, 5.10 mmol, 
1.10 equiv.) was suspended in anhydrous THF (10.00 mL) at 0 °C under an atmosphere of nitro-
gen. A solution of n-BuLi (1.53 M in n-hexane, 3.41 mL, 5.10 mmol, 1.10 equiv.) was added 
dropwise and the reaction was stirred at 0 °C for 30 min (white suspension → orange solution). 
A solution of 3-bromo-4-methoxybenzaldehyde (1.00 g, 4.70 mmol, 1.00 equiv.) in anhydrous 
THF (10.00 mL) was added dropwise at 0 °C (orange solution → yellow suspension). After the 
addition, the suspension was stirred at room temperature for 2 h. The reaction was slowly 
quenched with water (100.00 mL), extracted with CH2Cl2 (3 × 100.00 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure. The resulting yellow oil was triturated in cold 
Et2O. The resulting white solid was removed by filtration, washed with cold Et2O and the filtrate 
was concentrated under reduced pressure. The yellow residue was purified by flash column chro-
matography (n-hexane:EtOAc 95:5) to give 2-bromo-1-methoxy-4-vinylbenzene 133 (0.94 g, 
95%) as a pale yellow liquid. 
TLC: Rf = 0.43 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 7.62 (1H, d, J = 2.2 Hz, H4), 7.29 (1H, dd, J = 8.5, 2.2 Hz, 
H6), 6.85 (1H, d, J = 8.5 Hz, H7), 6.60 (1H, dd, J = 17.6, 10.9 Hz, H8), 5.62 (1H, dd, J = 17.6, 
0.7 Hz, H10), 5.18 (1H, dd, J = 10.9, 0.7 Hz, H11), 3.90 (3H, s, H1) ppm 
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13C NMR (101 MHz, Chloroform-d): δ 155.6 (C2), 135.1 (C8), 131.9 (C5), 131.0 (C4), 126.6 
(C6), 113.1 (C9), 112.0 (C3), 111.8 (C7), 56.4 (C1) ppm 




In a flame-dried Schlenk vessel, freshly purified CuCl (33 mg, 0.34 mmol, 0.03 equiv.), 
tert-BuOK (51 mg, 0.45 mmol, 0.04 equiv.) and (S)-DTBM-SEGPHOS (398 mg, 0.34 mmol, 
0.03 equiv.) were mixed in degassed (i.e., sparged with nitrogen for 1 h) anhydrous toluene 
(5.00 mL) at room temperature under an atmosphere of nitrogen. Freshly distilled pinacolborane 
(1.96 mL, 13.50 mmol, 1.20 equiv.) was added and the yellow solution turned brown. After 
10 min, a solution of 1-methoxy-4-vinylbenzene (1.51 g, 11.25 mmol, 1.00 equiv.) in degassed 
anhydrous toluene (4.00 mL) was added and the reaction was stirred under an atmosphere of 
nitrogen for 16 h. The dark suspension was filtered through Celite®, washed with n-pentane 
(50.00 mL) and the filtrate was concentrated under reduced pressure. The residue was purified 
by flash column chromatography (n-pentane:Et2O 90:10) to give boronic ester (R)-135 (2.07 g, 
77%, 99.4:0.6 e.r.) as a pale yellow liquid. 
TLC: Rf = 0.20 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 7.13 (2H, dd, J = 8.4, 2.2 Hz, H4), 6.81 (2H, d, J = 8.4 Hz, 
H3), 3.78 (3H, s, H1), 2.37 (1H, q, J = 7.5 Hz, H6), 1.30 (3H, d, J = 7.5 Hz, H7), 1.21 (6H, s, 
H9), 1.20 (6H, s, H9’) ppm 
13C NMR (101 MHz, Chloroform-d): δ 157.4 (C2), 137.2 (C5), 128.8 (C4), 113.9 (C3), 83.4 
(C8), 55.3 (C1), 25.0 (C9), 24.8 (C9’), 17.5 (C7) ppm 
The signal corresponding to C6 was not observed due to quadrupolar relaxation. 
Spectral data were in accordance with that reported in the literature.292  
Boronic ester (R)-135 (about 20 mg) was oxidised to the corresponding alcohol according to GP1 
for chiral SFC analysis. 
Chiral SFC: Whelk-01 column (25 cm), 20.0% co-solvent (n-hexane:IPA 90:10), 
4.00 mL min1, 41.6 °C, 130 mbar, 210.0 nm): tR = 4.80 min (minor), 5.13 min (major), 









Boronic ester (R)-135 (156 mg, 0.49 mmol, 1.00 equiv.) was homologated with stannane (R)-93, 
(S)-93 and (R)-93 (281 mg, 0.64 mmol, 1.30 equiv.) and n-BuLi (1.55 M in n-hexane, 0.42 mL, 
0.64 mmol, 1.30 equiv.) according to GP2. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 100:0→95:5) to give boronic ester 136 (104 mg, 61% over 3 steps, 
>95:5 d.r.) as a colourless liquid. 
TLC: Rf = 0.47 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 7.09 (2H, d, J = 8.6 Hz, H4), 6.82 (2H, d, J = 8.7 Hz, H3), 
3.79 (3H, s, H1), 2.65 (1H, app. pent, Japp. = 7.1 Hz, H6), 1.64 (1H, m, H8), 1.46 (1H, m, H10), 
1.27 (6H, s, H15), 1.25 (6H, s, H15’), 1.15 (3H, d, J = 7.1 Hz, H7), 1.07 (1H, app. pent, 
Japp. = 7.0 Hz, H12), 0.85 (3H, d, J = 7.3 Hz, CH3), 0.81 (3H, d, J = 6.8 Hz, CH3), 0.73 (3H, d, 
J = 7.0 Hz, CH3) ppm 
13C NMR (101 MHz, Chloroform-d): δ 157.6 (C2), 139.8 (C5), 128.5 (C4), 113.6 (C3), 82.8 
(C14), 55.3 (C1), 43.0 (C8), 42.1 (C6), 36.3 (C10), 25.0 (C15), 24.9 (C15’), 19.0 (C11), 12.8 
(C7), 12.4 (C9), 11.6 (C13) ppm 
The signal corresponding to C12 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C21H35BNaO3 [M+Na]+: 369.2575; found 369.2575 
IR (νmax): 2967, 2933, 2834, 1612, 1512, 1456, 1369, 1312, 1245, 1144, 1035, 830 cm1 
[𝛂]𝑫






Boronic ester 136 (46 mg, 0.13 mmol, 1.00 equiv.) was homologated with stannane (S)-93 
(79 mg, 0.18 mmol, 1.35 equiv.) and n-BuLi (1.55 M in n-hexane, 0.13 mL, 0.17 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:CH2Cl2 100:0→70:30) to give boronic ester 137 (41 mg, 84%, >95:5 d.r.) as a white 
solid. 
TLC: Rf = 0.23 (n-pentane:CH2Cl2 70:30) 
m.p.: 59 – 63 °C (amorphous) 
1H NMR (400 MHz, Chloroform-d): δ 7.08 (2H, d, J = 8.6 Hz, H4), 6.82 (2H, d, J = 8.6 Hz, H3), 
3.79 (3H, s, H1), 2.69 (1H, app. pent., Japp. = 7.2 Hz, H6), 1.69 (2H, app. sext., Japp. = 6.9 Hz, H8 
& H10), 1.24 (6H, s, H17), 1.23 (6H, s, H17’), 1.12 – 1.18 (5H, m, H7, H12 & H14), 0.74 – 0.79 
(6H, m, 2 × CH3), 0.62 – 0.72 (6H, m, 2 × CH3) ppm 
13C NMR (101 MHz, Chloroform-d): δ 157.6 (C2), 139.9 (C5), 128.4 (C4), 113.6 (C3), 82.9 
(C16), 55.3 (C1), 41.3 (C6), 40.8 (C8 or C10), 37.1 (C12), 36.0 (C8 or C10), 25.1 (C17’), 24.7 
(C17), 18.2 (C7), 14.46 (CH3), 11.7 (CH3), 11.4 (CH3), 10.0 (CH3) ppm 
The signal corresponding to C14 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C23H39BNaO3 [M+Na]+: 397.2889; found 397.2884 
IR (νmax): 2962, 2904, 1512, 1459, 1371, 1310, 1238, 1150, 1036, 828, 703, 554 cm1 
[𝛂]𝑫





A mixture of boronic ester 122a (1.30 g, 4.20 mmol, 0.74 equiv.) and boronic ester 122b (0.46 g, 
1.48 mmol, 0.26 equiv.) was homologated with stannane (R)-93 (5.74 g, 13.06 mmol, 
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2.30 equiv.) and n-BuLi (1.52 M in n-hexane, 8.59 mL, 13.06 mmol, 2.30 equiv.) according to 
GP2. The crude residue was purified by flash column chromatography (n-pentane:Et2O 97:3) 
and recrystallisation from n-hexane to give boronic ester 138 (0.94 g, 61%, >95:5 d.r.) as a white 
crystalline solid. 
TLC: Rf = 0.39 (n-pentane:Et2O 90:10) 
m.p.: 131 – 137 °C (n-hexane) 
1H NMR (400 MHz, Chloroform-d): δ 1.60 (2H, m, H5), 1.22 (12H, s, H1), 1.22 (12H, s, H1’), 
1.12 (2H, m, H3), 0.86 (6H, d, J = 7.4 Hz, H4), 0.80 (6H, d, J = 6.5 Hz, H6) ppm 
13C NMR (101 MHz, Chloroform-d): δ 82.8 (C2), 37.8 (C5), 25.0 (C1), 24.9 (C1’), 14.2 (C6), 
10.9 (C4) ppm 
The signal corresponding to C3 was not observed due to quadrupolar relaxation. 
HRMS: (ESI+) calc’d for C20H40B2NaO4 [M+Na]+: 389.3012; found: 389.3012 
IR (νmax): 2958, 2877, 1456, 1360, 1310, 1151, 1081, 850, 693 cm1 
[𝛂]𝑫
𝟐𝟏: –5 (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. 
 
Identification code 138 
Empirical formula C10H20BO2 
Formula weight 183.07 
Temperature/K 100(2) 
Crystal system orthorhombic 














Crystal size/mm3 0.457 × 0.451 × 0.3 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 10.642 to 134.042 
Index ranges -11 ≤ h ≤ 11, -19 ≤ k ≤ 18, -8 ≤ l ≤ 8 
Reflections collected 14852 
Independent reflections 2063 [Rint = 0.0455, Rsigma = 0.0264] 
Data/restraints/parameters 2063/0/124 
Goodness-of-fit on F2 1.088 
Final R indexes [I>=2σ (I)] R1 = 0.0446, wR2 = 0.1185 
Final R indexes [all data] R1 = 0.0448, wR2 = 0.1188 
Largest diff. peak/hole / e Å–3 0.31/-0.20 





Boronic ester 123 (156 mg, 0.39 mmol, 1.00 equiv.) was oxidised according to GP1 to give diol 
139 (66 mg, 96%, >95:5 d.r.) as a colourless wax. 
TLC: Rf = 0.37 (CH2Cl2:MeOH 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 3.61 (2H, dd, J = 10.8, 5.2 Hz, H2), 3.45 (2H, dd, 
J = 10.8, 4.6 Hz, H2’), 2.59 (2H, br. s, H1), 1.46 – 1.72 (4H, m, H3 & H5), 0.86 (6H, d, 
J = 6.6 Hz, H6), 0.74 (6H, d, J = 6.5 Hz, H4) ppm 
13C NMR (101 MHz, Chloroform-d): δ 66.7 (C2), 36.9 (C3), 34.5 (C5), 13.2 (C6), 11.5 (C4) 
ppm 
HRMS (m/z): (ESI+) calc’d. for C10H22NaO2 [M+Na]+: 197.1512; found 197.1513 
IR (νmax): 3284, 2953, 2933, 2878, 1459, 1381, 1035, 1005, 713 cm1 
[𝛂]𝑫








dodecan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (148)  
 
Boronic ester (R)-135 (142 mg, 0.54 mmol, 1.00 equiv.) was homologated nine times with stan-
nane (R)- or (S)-93 (309 mg, 0.70 mmol, 1.30 equiv.) and n-BuLi (1.55 M in n-hexane, 0.45 mL, 
0.70 mmol, 1.30 equiv.) according to GP2. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 100:0→99.5:0.5) to give boronic ester 148 (132 mg, 48% over 9 
steps) as a colourless liquid. 
TLC: Rf = 0.54 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Chloroform-d): δ 7.06 (2H, d, J = 8.6 Hz, H4), 6.81 (2H, d, J = 8.6 Hz, H3), 
3.79 (3H, s, H1), 2.55 (1H, dq, J = 9.7, 6.9 Hz, H6), 1.74 (1H, dqd, J = 9.7, 7.0, 3.2 Hz, H8), 1.69 
(1H, dqd, J = 9.5, 6.8, 3.9 Hz, CH), 1.51 – 1.38 (4H, m, 4 × CH), 1.31 (1H, dqd, J = 10.9, 6.8, 
3.4 Hz, CH), 1.23 (6H, s, H27), 1.23 (6H, s, H27’), 1.18 (3H, d, J = 6.9 Hz, CH3), 1.10 (1H, m, 
CH), 1.01 (1H, m, CH), 0.92 (3H, d, J = 7.1 Hz, CH3), 0.82 (3H, d, J = 6.7 Hz, CH3), 0.77 – 0.64 
(15H, m, 5 × CH3), 0.59 (3H, d, J = 6.5 Hz, CH3), 0.43 (3H, d, J = 6.1 Hz, CH3) ppm 
13C NMR (101 MHz, Chloroform-d): δ 157.7 (C2), 140.0 (C5), 128.3 (C4), 113.7 (C3), 82.8 
(C26), 55.3 (C1), 42.6 (C6), 40.0 (CH), 39.9 (CH), 36.0 (CH), 35.7 (CH), 35.7 (CH), 35.6 (CH), 
35.5 (CH), 35.2 (CH), 25.1 (C27), 24.7 (C27’), 20.3 (C7), 13.2 (CH3), 12.6 (CH3), 12.1 (CH3), 
12.0 (CH3), 12.0 (CH3), 11.8(9) (CH3), 11.9(1) (CH3), 11.7 (CH3), 11.5 (CH3) ppm 
The signal corresponding to C24 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C33H59BNaO3 [M+Na]+: 537.4455; found 537.4464 
IR (νmax): 2967, 2877, 1612, 1512, 1454, 1381, 1312, 1245, 1115, 829 cm1 
[𝛂]𝑫







In a flame-dried Schlenk tube, 1-bromonaphthalene (0.02 mL, 0.15 mmol, 1.20 equiv.) was dis-
solved in anhydrous Et2O at 0 °C under an atmosphere of nitrogen. A solution of n-BuLi (1.60 M 
in n-hexane, 0.09 mL, 0.15 mmol, 1.20 equiv.) was added and the resulting suspension was 
stirred at the same temperature for 1 h. A solution of boronic ester 148 (64 mg, 0.12 mmol, 
1.00 equiv.) in anhydrous Et2O (0.60 mL) was added dropwise at 0 °C over 10 min. After the 
addition, the mixture was stirred at the same temperature for 2 h. Solvents were removed in situ 
and the residue was dissolved in dry MeOH (1.00 mL) at –78 °C under an atmosphere of nitrogen. 
A solution of NBS (53 mg, 0.30 mmol, 2.40 equiv.) in dry MeOH (1.50 mL) was added dropwise 
at the same temperature. After the addition, the acetone/dry ice bath was removed and the reaction 
mixture was stirred at room temperature for 1 h. A saturated aqueous solution of Na2S2O3 
(4.00 mL) was added. After 5 min, the suspension was extracted with Et2O (3 × 10.00 mL). The 
organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated 
under reduced pressure. The yellow residue was purified by flash column chromatography 
(n-pentane:Et2O 100:0→99.5:0.5) to give compound 149 (42 mg, 66%) as a white solid. 
TLC: Rf = 0.66 (n-pentane:Et2O 90:10) 
m.p.: 105 – 109 °C (acetonitrile) 
1H NMR (500 MHz, Chloroform-d): δ 8.19 (1H, d, J = 8.3 Hz, H34), 7.87 (1H, dd, J = 7.6, 
2.0 Hz, H31), 7.70 (1H, d, J = 8.0 Hz, H29), 7.54 – 7.42 (3H, m, H28, H32 & H33), 7.38 (1H, d, 
J = 7.1 Hz, H27), 7.06 (2H, d, J = 8.7 Hz, H4), 6.83 (2H, d, J = 8.6 Hz, H3), 3.81 (3H, s, H1), 
3.51 (1H, m, H24), 2.53 (1H, dq, J = 9.9, 6.9 Hz, H6), 2.14 (1H, m, H22), 1.74 (1H, dqd, J = 9.9, 
6.8, 2.8 Hz, H8), 1.52 – 1.38 (3H, m, 3 × CH), 1.37 – 1.29 (4H, m, H25 & CH), 1.19 (3H, d, 
J = 6.9 Hz, H7), 1.12 – 1.04 (2H, m, H10 & H20), 0.96 (3H, d, J = 6.7 Hz, H23), 0.82 (3H, d, 
J = 6.8 Hz, H9), 0.72 – 0.67 (6H, m, H11 & H21), 0.63 (3H, d, J = 6.8 Hz, CH3), 0.54 (3H, d, 
J = 6.8 Hz, CH3), 0.41 (3H, d, J = 6.6 Hz, CH3), 0.35 (3H, d, J = 6.4 Hz, CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 157.7 (C2), 144.3 (C26), 140.0 (C5), 134.1 (C30), 132.0 
(C35), 129.1 (C31), 128.3 (C4), 126.1 (C29), 125.7 (C28 or C32), 125.6 (C32 or C28), 125.2 
(C33), 124.1 (C27), 123.4 (C34), 113.7 (C3), 55.3 (C1), 42.8 (C6), 39.6 (C8), 39.4 (C22), 37.1* 
(C24), 36.3 (C20), 36.0 (C10), 35.5 (CH), 35.5 (CH), 35.5 (CH), 35.3 (CH), 20.9 (C25), 20.7 
(C7), 12.3 (CH3), 12.2 (CH3), 11.9 (CH3), 11.9 (CH3), 11.9 (CH3), 11.8 (CH3), 11.7 (CH3), 11.6 
(CH3) ppm 
*shift value determined by HSQC correlation.  
HRMS (m/z): (MALDI+) calc’d. for C37H54NaO [M+Na]+: 537.4067; found 537.4077 
IR (νmax): 2967, 2926, 1512, 1452, 1382, 1244, 1040, 778 cm1 
[𝛂]𝑫






Boronic ester 148 (66 mg, 0.13 mmol, 1.00 equiv.) was homologated with stannane (S)-93 
(73 mg, 0.17 mmol, 1.30 equiv.) and n-BuLi (1.60 M in n-hexane, 0.10 mL, 0.17 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:Et2O 100:0→99.5:0.5) to give boronic ester 150 (61 mg, 88%) as a colourless liquid. 
TLC: Rf = 0.55 (n-pentane:Et2O 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 7.07 (2H, d, J = 8.6 Hz, H4), 6.82 (2H, d, J = 8.6 Hz, H3), 
3.79 (3H, s, H1), 2.63 (1H, dq, J = 8.5, 7.0 Hz, H6), 1.77 – 1.63 (2H, m, 2 × CH), 1.56 – 1.35 
(6H, m, 6 × CH), 1.24 (6H, s, H29), 1.23 – 1.20 (7H, m, H29’ & CH), 1.20 – 1.13 (4H, m, CH & 
CH3), 0.87 (3H, d, J = 7.3 Hz, CH3), 0.84 – 0.77 (6H, m, 2 × CH3), 0.74 – 0.66 (15H, m, 5 × CH3), 
0.65 (3H, d, J = 6.4 Hz, CH3), 0.48 (3H, d, J = 6.0 Hz, CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 157.7 (C2), 140.0 (C5), 128.4 (C4), 113.7 (C3), 82.9 
(C28), 55.3 (C1), 41.9 (C6), 40.7 (CH), 37.2 (CH), 36.1 (CH), 36.1 (CH), 36.1 (CH), 35.8 (CH), 
35.8 (CH), 35.4 (CH), 35.4 (CH), 25.1 (C29), 24.8 (C29’), 19.0 (C7), 14.5 (CH3), 12.3 (CH3), 
12.2 (CH3), 12.1 (CH3), 11.9 (2 × CH3), 11.8 (CH3), 11.6 (CH3), 11.4 (CH3), 10.6 (CH3) ppm 
The signal corresponding to C26 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d. for C35H63BNaO3 [M+Na]+: 565.4769; found 565.4748 
IR (νmax): 2965, 2870, 1599, 1511, 1454, 1306, 1249, 1113, 828 cm1 
[𝛂]𝑫





In a flame-dried Schlenk tube, 1-bromonaphthalene (0.02 mL, 0.13 mmol, 1.20 equiv.) was dis-
solved in anhydrous Et2O at 0 °C under an atmosphere of nitrogen. A solution of n-BuLi (1.60 M 
in n-hexane, 0.08 mL, 0.13 mmol, 1.20 equiv.) was added and the resulting suspension was 
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stirred at the same temperature for 1 h. A solution of boronic ester 150 (61 mg, 0.11 mmol, 
1.00 equiv.) in anhydrous Et2O (0.60 mL) was added dropwise at 0 °C over 10 min. After the 
addition, the mixture was stirred at the same temperature for 2 h. Solvents were removed in situ 
and the residue was dissolved in dry MeOH (1.00 mL) at –78 °C under an atmosphere of nitrogen. 
A solution of NBS (48 mg, 0.27 mmol, 2.40 equiv.) in dry MeOH (1.50 mL) was added dropwise 
at the same temperature. After the addition, the acetone/dry ice bath was removed and the reaction 
mixture was stirred at room temperature for 1 h. A saturated aqueous solution of Na2S2O3 
(4.00 mL) was added. After 5 min, the suspension was extracted with Et2O (3 × 10.00 mL). The 
organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated 
under reduced pressure. The yellow residue was purified by flash column chromatography 
(n-pentane:Et2O 100:0→99.5:0.5) to give compound 151 (35 mg, 57%) as a white solid. 
TLC: Rf = 0.67 (n-pentane:Et2O 90:10) 
m.p.: 75 – 79 °C (acetonitrile) 
1H NMR (500 MHz, Chloroform-d): δ 8.17 (1H, d, J = 8.4 Hz, H30), 7.86 (1H, d, J = 7.7 Hz, 
H33), 7.69 (1H, d, J = 8.0 Hz, H35), 7.52 – 7.42 (3H, m, H31, H32 & H36), 7.39 (1H, d, 
J = 7.1 Hz, H37), 7.08 (2H, d, J = 8.6 Hz, H4), 6.83 (2H, d, J = 8.6 Hz, H3), 3.80 (3H, s, H1), 
3.66 (1H, app. pent, Japp. = 6.9 Hz, H26), 2.68 (1H, dq, J = 7.0, 6.9 Hz, H6), 2.01 (1H, dqd, 
J = 6.9, 6.7, 4.6 Hz, H24), 1.68 (1H, dqd, J = 7.0, 6.3, 4.4 Hz, H8), 1.59 (1H, app. sext, 
Japp. = 6.3 Hz, H20), 1.55 – 1.39 (3H, m, 3 × CH), 1.37 (1H, m, H22), 1.32 (3H, d, J = 6.9 Hz, 
H27), 1.28 (1H, m, CH), 1.22 (1H, m, H10), 1.17 (3H, d, J = 6.9 Hz, H7), 0.89 (3H, d, J = 6.7 Hz, 
H25), 0.80 (3H, d, J = 6.7 Hz, H9), 0.72 – 0.64 (12H, m, 4 × CH3), 0.62 (3H, d, J = 6.2 Hz, CH3), 
0.54 – 0.48 (6H, m, 2 × CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 157.6 (C2), 143.9 (C28), 139.9 (C5), 134.1 (C34), 132.0 
(C29), 129.1 (C33), 128.4 (C4), 126.2 (C35), 125.6 (C32 or C36), 125.5 (C36 or C32), 125.2 
(C31), 124.3 (C37), 123.4 (C30), 113.6 (C3), 55.4 (C1), 41.5 (C6), 41.0 (C8), 40.2 (C24), 36.7 
(C20), 36.6* (C26), 36.3 (CH), 36.2 (CH), 36.0 (C22), 35.7 (C10), 35.5 (CH), 35.3 (CH), 18.3 
(C7 & C27), 12.5 (C25), 12.5 (CH3), 12.4 (CH3), 12.1 (CH3), 11.9 (C9), 11.8 (CH3), 11.8 (CH3), 
11.7 (CH3), 11.6 (CH3), 11.4 (CH3) ppm 
*shift value determined by HSQC correlation. 
HRMS (m/z): (MALDI+) calc’d. for C39H58NaO [M+Na]+: 565.4380; f665.ound 565.4387 
IR (νmax): 2967, 2926, 2877, 1511, 1452, 1382, 1246, 1178, 1038, 830, 778 cm1 
[𝛂]𝑫







Boronic ester 138 (158 mg, 0.43 mmol, 1.00 equiv.) was homologated with stannane (S)-93 
(436 mg, 0.99 mmol, 2.30 equiv.) and n-BuLi (1.58 M in n-hexane, 0.63 mL, 0.99 mmol, 
2.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:Et2O 99:1) to give 152 (165 mg, 91%) as a white crystalline solid. 
TLC: Rf = 0.50 (n-pentane:Et2O 90:10) 
m.p.: 115 – 118 °C (n-hexane) 
1H NMR: (400 MHz, Chloroform-d) δ 1.70 (2H, dqd, J = 8.6, 6.7, 4.1 Hz, H5), 1.33 (2H, m, 
H7), 1.22 (12H, s, H1), 1.22 (12H, s, H1’), 1.03 (2H, dq, J = 8.6, 7.1 Hz, H3), 0.91 (6H, d, 
J = 7.1 Hz, H4), 0.78 (6H, d, J = 6.7 Hz, H6), 0.72 (6H, d, J = 6.5 Hz, H8) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 82.8 (C2), 39.5 (C7), 35.8 (C5), 25.0 (C1), 24.7 (C1’), 
21.6 (C3), 12.8 (C4), 12.6 (C6), 11.9 (C8) ppm 
HRMS (m/z): (MALDI+) calc’d for C24H48B2NaO4 [M+Na]+: 445.3639; found: 445.3630 
IR (νmax): 2974, 2932, 2865, 2877, 1456, 1370, 1311, 1146, 1078, 861 cm–1 
[𝜶]𝑫





Boronic ester 138 (75 mg, 0.20 mmol, 1.00 equiv.) was homologated with stannane (S)-93 and 
(R)-93 (207 mg, 0.47 mmol, 2.30 equiv.), and n-BuLi (1.54 M in n-hexane, 0.31 mL, 0.47 mmol, 
2.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:Et2O 99:1) to give 153 (80 mg, 84% over 2 steps) as a white solid. 
TLC: Rf = 0.50 (n-pentane:Et2O 90:10) 
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m.p.: 82 – 85 °C (acetonitrile) 
1H NMR: (400 MHz, Chloroform-d) δ 1.69 (2H, dqd, J = 8.7, 6.8, 4.3 Hz, H5), 1.51 (2H, m, 
H9), 1.31 (2H, dqd, J = 7.4, 6.8, 4.3 Hz, H7), 1.23 (12H, s, H1), 1.22 (12H, s, H1’), 1.05 (2H, 
dq, J = 8.7, 7.2 Hz, H3), 0.91 (6H, d, J = 7.2 Hz, H4), 0.76 (6H, d, J = 6.8 Hz, H6), 0.75 (6H, d, 
J = 6.8 Hz, H8), 0.74 (6H, d, J = 6.5 Hz, H10) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 82.8 (C2), 39.5 (C7), 35.8 (C5), 35.8 (C9), 25.1 (C1), 
24.7 (C1’), 21.8 (C3), 12.9 (C6), 12.8 (C4), 12.0 (C8), 11.9 (C10) ppm 
HRMS (m/z): (MALDI+) calc’d for C28H56B2NaO4 [M+Na]+: 501.4267; found: 501.4276 
IR (νmax): 2973, 2930, 2877, 1456, 1380, 1312, 1145, 967, 687 cm–1 
[𝜶]𝑫
𝟐𝟎: –11 (CHCl3, c = 1.0) 
 
2,2'-((2R,3R,4S,5R,6S,7S,8R,9S,10R,11R)-3,4,5,6,7,8,9,10-Octamethyldodecane-2,11-
diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (154)  
 
Boronic ester 138 (75 mg, 0.20 mmol, 1.00 equiv.) was homologated with stannane (S)-93, 
(R)-93 and (S)-93 (207 mg, 0.47 mmol, 2.30 equiv.), and n-BuLi (1.54 M in n-hexane, 0.31 mL, 
0.47 mmol, 2.30 equiv.) according to GP2. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 99:1) to give 154 (82 mg, 75% over 3 steps) as a crystalline white 
solid. 
TLC: Rf = 0.32 (n-pentane:Et2O 95:5) 
m.p.: 179 – 181 °C (n-hexane) 
1H NMR: (500 MHz, Chloroform-d) δ 1.70 (2H, dqd, J = 8.6, 6.8, 4.5 Hz, H5), 1.54 (2H, m, 
H11), 1.47 (2H, dqd, J = 7.7, 6.7, 3.7 Hz, H9), 1.32 (2H, dqd, J = 7.7, 6.8, 4.5 Hz, H7), 1.23 
(12H, s, H1), 1.23 (12H, s, H1’), 1.05 (2H, dq, J = 8.6, 7.3 Hz, H3), 0.91 (6H, d, J = 7.3 Hz, H4), 
0.75 (6H, d, J = 6.8 Hz, H6), 0.73 (12H, d, J = 6.8 Hz, H8 & H12), 0.69 (6H, d, J = 6.7 Hz, H10) 
ppm 
13C NMR: (126 MHz, Chloroform-d) δ 82.8 (C2), 39.5 (C7), 35.8 (C5 or C9), 35.8 (C9 or C5), 




HRMS (m/z): (ESI+) calc’d for C32H64B2NaO4 [M+Na]+: 557.4894; found: 557.4886 
IR (νmax): 2970, 1452, 1362, 1307, 1204, 1146, 1076, 967, 855, 702 cm1 
[𝜶]𝑫
𝟐𝟐: +12 (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. 
 
Identification code  154  
Empirical formula  C32H64B2O4  
Formula weight  534.45  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  C2  
a/Å  17.4769(9)  
b/Å  6.6261(3)  
c/Å  14.4394(8)  
α/°  90  
β/°  91.494(3)  
γ/°  90  
Volume/Å3  1671.57(15)  
Z  2  
ρcalc/g cm–3  1.062  
μ/mm–1  0.066  
F(000)  596.0  
Crystal size/mm3  0.527 × 0.337 × 0.248  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  4.662 to 56.014  
Index ranges  -22 ≤ h ≤ 14, -8 ≤ k ≤ 7, -18 ≤ l ≤ 19  
Reflections collected  7533  
Independent reflections  3755 [Rint = 0.0236, Rsigma = 0.0344]  
Data/restraints/parameters  3755/1/181  
Goodness-of-fit on F2  1.025  
Final R indexes [I>=2σ (I)]  R1 = 0.0499, wR2 = 0.1271  
Final R indexes [all data]  R1 = 0.0548, wR2 = 0.1314  
Largest diff. peak/hole / e Å–3  0.41/-0.23  





(3R,4S,5R,6R,7S,8R)-3,4,5,6,7,8-Hexamethyldeca-1,9-diyne (C6) and 4,4,5,5-Tetramethyl-
2-((2R,3R,4S,5R,6S,7R)-3,4,5,6,7-pentamethylnon-8-yn-2-yl)-1,3,2-dioxaborolane (155) 
 
Boronic ester 152 (166 mg, 0.39 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(74 mg, 0.43 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.50 mL, 0.43 mmol, 1.10 equiv.), io-
dine (110 mg, 0.43 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 1.14 mL, 0.98 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give C6 (7 mg, 8%) as a colourless volatile liquid, followed by (n-pen-
tane:CH2Cl2 80:20) to give 155 as a colourless liquid (59 mg, 47%). 
Note: Due to the volatility of compound C6, all solvents and volatiles were removed on rotary 




TLC: Rf = 0.31 (n-pentane) 
1H NMR: (500 MHz, Toluene-d8) δ 2.21 (2H, dqd, J = 9.3, 6.9, 2.4 Hz, H3), 1.94 (2H, m, H7), 
1.83 (2H, d, J = 2.4 Hz, H1), 1.63 (2H, dqd, J = 9.3, 6.9, 2.5 Hz, H5), 1.09 (6H, d, J = 6.9 Hz, 
H4), 0.76 (6H, d, J = 6.9 Hz, H6), 0.76 (6H, d, J = 6.5 Hz, H8) ppm 
13C NMR: (126 MHz, Toluene-d8) δ 88.7 (C2), 69.5 (C1), 38.9 (C5), 37.1 (C7), 30.0 (C3), 18.9 
(C4), 11.7 (C8), 11.2 (C6) ppm 
HRMS (m/z): (MALDI+) calc’d for C16H26 [M+H]+: 219.2107; found: 219.2100 
IR (νmax): 3309, 2972, 2924, 2879, 1455, 1383, 1087, 627 cm–1 
[𝜶]𝑫










TLC: Rf = 0.44 (n-pentane:Et2O 95:5) 
1H NMR: (400 MHz, Chloroform-d) δ 2.35 (1H, dqd, J = 9.2, 6.9, 2.4 Hz, H3), 2.03 (1H, d, 
J = 2.4 Hz, H1), 1.83 (1H, dqd, J = 8.4, 6.9, 4.1 Hz, H7), 1.68 (1H, dqd, J = 9.3, 6.8, 4.3 Hz, 
H11), 1.65 (1H, dqd, J = 9.2, 6.8, 4.1 Hz, H5), 1.29 (1H, dqd, J = 8.4, 6.9, 4.3 Hz, H9), 1.23 (6H, 
s, H16), 1.22 (6H, s, H16’), 1.17 (3H, d, J = 6.9 Hz, H4), 1.03 (1H, m, H13) 0.92 (3H, d, 
J = 7.1 Hz, H14), 0.81 (3H, d, J = 6.8 Hz, H6), 0.77 (3H, d, J = 6.8 Hz, H12), 0.76 (3H, d, 
J = 6.9 Hz, H10), 0.73 (3H, d, J = 6.9 Hz, H8) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 89.4 (C2), 82.9 (C15), 68.8 (C1), 39.7 (C9), 38.7 (C5), 
36.9 (C7), 35.8 (C11), 29.6 (C3), 25.0 (C16), 24.7 (C16’), 21.8 (C13), 18.5 (C4), 13.1 (C14), 
12.3 (C12), 11.8 (C8), 11.7 (C10), 11.5 (C6) ppm 
HRMS (m/z): (MALDI+) calc’d for C20H37BNaO2 [M+Na]+: 343.2782; found: 343.2788 
IR (νmax): 3311, 2972, 2931, 2878, 1455, 1381, 1311, 1144, 1095, 854, 625 cm–1 
[𝜶]𝑫





Alkyne 155 (70 mg, 0.22 mmol, 1.00 equiv.) was protected with LDA (0.86 M in THF, 0.28 mL, 
0.24 mmol, 1.10 equiv.) and TIPSCl (0.05 mL, 0.24 mmol, 1.10 equiv.) according to GP4. The 
crude residue was purified by flash column chromatography (n-pentane:CH2Cl2 90:10) to give 
156 (79 mg, 75%) as a colourless liquid. 
TLC: Rf = 0.34 (n-pentane:CH2Cl2 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 2.36 (1H, dq, J = 8.9, 6.8 Hz, H5), 1.92 (1H, dqd, J = 8.7, 
6.8, 3.8 Hz, H9), 1.66 (1H, dqd, J = 9.4, 6.8, 3.9 Hz, H13), 1.60 (1H, dqd, J = 8.9, 6.8, 3.8 Hz, 
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H7), 1.27 (1H, dqd, J = 8.7, 6.9, 3.9 Hz, H11), 1.22 (12H, s, H18 & H18’), 1.17 (3H, d, 
J = 6.8 Hz, H6), 1.10 – 0.95 (22H, m, H1, H2 & H15), 0.92 (3H, d, J = 6.9 Hz, H16), 0.80 (3H, 
d, J = 6.8 Hz, H8), 0.76 (3H, d, J = 6.8 Hz, H14), 0.75 (3H, d, J = 6.9 Hz, H12), 0.74 (3H, d, 
J = 6.8 Hz, H10) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.7 (C4), 82.8 (C17), 80.5 (C3), 40.0 (C11), 38.7 (C7), 
37.4 (C9), 35.7 (C13), 31.2 (C5), 25.0 (C18), 24.7 (C18’), 22.0 (C15), 19.2 (C6), 18.8 (C1), 13.4 
(C16), 12.1 (C14), 11.8 (C10 or C12), 11.8 (C12 or C10), 11.5 (C2), 11.3 (C8) ppm 
HRMS (m/z): (MALDI+) calc’d for C29H57BNaO2Si [M+Na]+: 499.4119; found: 499.4111 
IR (νmax): 2963, 2942, 2865, 2162, 1459, 1381, 1312, 1145, 1096, 882, 859, 663 cm–1 
[𝜶]𝑫





Boronic ester 156 (79 mg, 0.17 mmol, 1.00 equiv.) was homologated with stannane (R)-93 
(95 mg, 0.22 mmol, 1.30 equiv.) and n-BuLi (1.52 M in n-hexane, 0.14 mL, 0.22 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:CH2Cl2 95:5) to give 157 (70 mg, 82%) as a colourless liquid. 
TLC: Rf = 0.34 (n-pentane:CH2Cl2 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 2.46 (1H, dq, J = 7.3, 6.9 Hz, H5), 1.85 (1H, dqd, J = 7.1, 
6.8, 4.9 Hz, H9), 1.67 (1H, app. pentd, Japp. = 6.8, 5.7 Hz, H15), 1.59 (1H, dqd, J = 7.3, 6.8, 
4.9 Hz, H7), 1.43 (1H, dqd, J = 7.1, 6.6, 5.1 Hz, H11), 1.40 (1H, dqd, J = 6.8, 5.1, 6.6 Hz, H13), 
1.23 (6H, s, H20), 1.22 (6H, s, H20’), 1.18 (1H, m, H17), 1.14 (3H, d, J = 6.9 Hz, H6), 1.09 – 
0.96 (21H, m, H1 & H2), 0.86 (3H, d, J = 7.4 Hz, H18), 0.83 (3H, d, J = 6.8 Hz, H8), 0.80 (3H, 
d, J = 6.8 Hz, H16), 0.77 (3H, d, J = 6.7 Hz, H10), 0.75 – 0.72 (6H, m, H12 & H14) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 114.0 (C4), 82.9 (C19), 80.3 (C3), 39.0 (C7), 36.9 (C13), 
36.6 (C9), 36.2 (C11), 35.9 (C15), 30.6 (C5), 25.1 (C20), 24.8 (C20’), 20.0 (C17), 18.8 (C1), 
18.1 (C6), 14.7 (C16), 12.2 (C8), 11.9 (C12 or C14), 11.7 (C10), 11.6 (C14 or C12), 11.5 (C2), 
10.4 (C18) ppm 
HRMS (m/z): (ESI+) calc’d for C31H61BNaO2Si [M+Na]+: 527.4432; found: 527.4426 
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IR (νmax): 2965, 2941, 2865, 2163, 1461, 1381, 1311, 1146, 883, 676 cm–1 
[𝜶]𝑫





Boronic ester 157 (69 mg, 0.14 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(26 mg, 0.15 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.17 mL, 0.15 mmol, 1.10 equiv.), io-
dine (38 mg, 0.15 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 0.40 mL, 0.34 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give 158 (46 mg, 84%) as a colourless liquid. 
TLC: Rf = 0.35 (n-pentane) 
1H NMR: (400 MHz, Chloroform-d) δ 2.52 (1H, qdd, J = 6.9, 6.8, 2.4 Hz, H17), 2.48 (1H, qd, 
J = 7.2, 6.9 Hz, H5), 2.03 (1H, d, J = 2.4 Hz, H20), 1.83 (1H, dqd, J = 7.0, 6.8, 5.1 Hz, H9), 1.70 
(1H, dqd, J = 6.7, 6.5, 6.3 Hz, H13), 1.61 (1H, app. pentd, Japp. = 6.8, 6.3 Hz, H15), 1.58 (1H, 
dqd, J = 7.2, 6.8, 5.1 Hz, H7), 1.35 (1H, ddq, J = 7.0, 6.7, 6.5 Hz, H11), 1.13 (3H, d, J = 6.9 Hz, 
H6), 1.10 (3H, d, J = 6.9 Hz, H18), 1.10 – 0.95 (21H, m, H1 & H2), 0.88 (3H, d, J = 6.8 Hz, 
H16), 0.84 (3H, d, J = 6.8 Hz, H8), 0.78 (3H, d, J = 6.5 Hz, H12), 0.77 (3H, d, J = 6.8 Hz, H10), 
0.76 (3H, d, J = 6.5 Hz, H14) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.8 (C4), 89.6 (C19), 80.4 (C3), 68.5 (C20), 39.4 
(C15), 39.0 (C7), 36.6 (C11), 36.4 (C9), 35.7 (C13), 30.4 (C5), 28.5 (C17), 18.8 (C1), 17.9 (C6), 
16.5 (C18), 12.7 (C16), 12.3 (C8), 11.9 (C12), 11.5 (C10), 11.5 (C2), 11.5 (C14) ppm 
HRMS (m/z): (MALDI+) calc’d for C27H50NaSi [M+Na]+: 425.3579; found: 425.2768 
IR (νmax): 3312, 2967, 2941, 2865, 2162, 1462, 1382, 1089, 996, 883, 664, 627 cm–1 
[𝜶]𝑫









Protected alkyne 158 (45 mg, 0.11 mmol, 1.00 equiv.) was deprotected with TBAF (1.00 M in 
THF, 0.22 mL, 0.22 mmol, 2.00 equiv.) according to GP5. The crude residue was purified by 
flash column chromatography (pure n-pentane) to give C7 (25 mg, 91%) as a colourless liquid. 
TLC: Rf = 0.28 (n-pentane) 
1H NMR: (500 MHz, Toluene-d8) δ 2.37 (2H, dqd, J = 7.1, 6.9, 2.4 Hz, H3), 1.83 (2H, d, 
J = 2.4 Hz, H1), 1.81 (2H, qdd, J = 6.8, 6.7, 5.6 Hz, H7), 1.62 (2H, dqd, J = 7.1, 6.9, 5.6 Hz, H5), 
1.24 (1H, qt, J = 6.8, 6.5 Hz, H9), 1.04 (6H, d, J = 6.9 Hz, H4), 0.79 (6H, d, J = 6.9 Hz, H6), 0.76 
(6H, d, J = 6.8 Hz, H8), 0.70 (3H, d, J = 6.8 Hz, H10) ppm 
13C NMR: (126 MHz, Toluene-d8) δ 88.9 (C2), 69.3 (C1), 39.4 (C5), 36.8 (C9), 36.1 (C7), 29.1 
(C3), 17.0 (C4), 12.4 (C6), 11.7 (C10), 11.4 (C8) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
IR (νmax): 3309, 2972, 2937, 2880, 1454, 1383, 1088, 627 cm–1 
 




Boronic ester 153 (152 mg, 0.32 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(60 mg, 0.35 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.41 mL, 0.35 mmol, 1.10 equiv.), io-
dine (89 mg, 0.35 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 0.92 mL, 0.79 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give C8 (8 mg, 9%) as a colourless liquid; followed by (n-pentane:CH2Cl2 







TLC: Rf = 0.34 (n-pentane) 
1H NMR: (500 MHz, Toluene-d8) δ 2.22 (2H, dqd, J = 9.2, 6.9, 2.4 Hz, H3), 2.05 (2H, dqd, 
J = 8.5, 6.8, 3.4 Hz, H7), 1.84 (2H, d, J = 2.4 Hz, H1), 1.67 (2H, dqd, J = 9.2, 6.8, 3.4 Hz, H5), 
1.49 (2H, m, H9), 1.10 (6H, d, J = 6.9 Hz, H4), 0.88 (6H, d, J = 6.7 Hz, H10), 0.75 (6H, d, 
J = 6.8 Hz, H8), 0.70 (6H, d, J = 6.9 Hz, H6) ppm 
13C NMR: (126 MHz, Toluene-d8) δ 88.6 (C2), 69.6 (C1), 38.8 (C5), 37.1 (C7), 35.8 (C9), 30.1 
(C3), 18.9 (C4), 11.9 (C8), 11.6 (C10), 11.4 (C6) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
IR (νmax): 3310, 2970, 2921, 2879, 1453, 1383, 1086, 623 cm–1 
[𝜶]𝑫





TLC: Rf = 0.49 (n-pentane:Et2O 95:5) 
1H NMR: (400 MHz, Chloroform-d) δ 2.36 (1H, dqd, J = 8.8, 6.9, 2.4 Hz, H3), 2.04 (1H, d, 
J = 2.4 Hz, H1), 1.84 (1H, dqd, J = 8.2, 6.8, 3.8 Hz, H7), 1.69 (1H, dqd, J = 9.0, 6.8, 4.1 Hz, 
H15), 1.62 (1H, dqd, J = 8.8, 6.8, 3.8 Hz, H5), 1.49 (1H, dqd, J = 8.2, 6.8, 4.2 Hz, H9), 1.47 (1H, 
dqd, J = 8.0, 6.6, 4.2 Hz, H11), 1.32 (1H, dqd, J = 8.0, 6.8, 4.1 Hz, H13), 1.23 (6H, s, H20), 1.23 
(6H, s, H20’), 1.17 (3H, d, J = 6.9 Hz, H4), 1.04 (1H, m, H17), 0.92 (3H, d, J = 7.2 Hz, H18), 
0.78 (3H, d, J = 6.8 Hz, H6), 0.77 (3H, d, J = 6.8 Hz, H10), 0.75 (3H, d, J = 6.8 Hz, H8), 0.75 
(3H, d, J = 6.8 Hz, H14), 0.74 (3H, d, J = 6.8 Hz, H16), 0.73 (3H, d, J = 6.6 Hz, H12) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 89.4 (C2), 82.9 (C19), 68.8 (C1), 39.7 (C13), 38.7 (C5), 
36.8 (C7), 35.8 (C11), 35.7 (C15), 35.5 (C9), 29.7 (C3), 25.1 (C20), 24.7 (C20’), 21.9 (C17), 




HRMS (m/z): (MALDI+) calc’d for C24H45BNaO2 [M+Na]+: 399.3441; found: 399.3434 
IR (νmax): 3311, 2970, 2931, 2878, 1455, 1381, 1312, 1145, 1086, 851, 626 cm–1 
[𝜶]𝑫





Alkyne 159 (50 mg, 0.13 mmol, 1.00 equiv.) was protected with LDA (0.86 M in THF, 0.17 mL, 
0.28 mmol, 1.10 equiv.) and TIPSCl (0.03 mL, 0.28 mmol, 1.10 equiv.) according to GP4. The 
crude residue was purified by flash column chromatography (n-pentane:CH2Cl2 95:5) to give 160 
(50 mg, 71%) as a colourless liquid. 
TLC: Rf = 0.32 (n-pentane:CH2Cl2 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 2.37 (1H, dq, J = 9.0, 6.8 Hz, H5), 1.93 (1H, dqd, J = 8.4, 
6.8, 3.7 Hz, H9), 1.70 (1H, dqd, J = 9.2, 6.8, 3.7 Hz, H17), 1.57 (1H, dqd, J = 9.0, 6.8, 3.7 Hz, 
H7), 1.49 (1H, dqd, J = 8.4, 6.6, 3.7 Hz, H11), 1.45 (1H, dqd, J = 8.5, 6.7, 3.7 Hz, H13), 1.30 
(1H, dqd, J = 8.5, 6.8, 4.0 Hz, H15), 1.24 (6H, s, H22), 1.23 (6H, s, H22’), 1.18 (3H, d, 
J = 6.8 Hz, H6), 1.10 – 0.96 (22H, m, H1, H2 & H19), 0.93 (3H, d, J = 7.0 Hz, H20), 0.77 (3H, 
d, J = 6.8 Hz, H8), 0.77 (3H, d, J = 6.7 Hz, H12), 0.76 (3H, d, J = 6.8 Hz, H10), 0.75 (3H, d, 
J = 6.8 Hz, H16), 0.74 (3H, d, J = 6.8 Hz, H18), 0.72 (3H, d, J = 6.7 Hz, H14) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.7 (C4), 82.9 (C21), 80.5 (C3), 40.0 (C15), 38.6 (C7), 
37.2 (C9), 35.8 (C13), 35.6 (C11), 35.6 (C17), 31.3 (C5), 25.1 (C22), 24.7 (C22’), 22.2 (C19), 
19.3 (C6), 18.8 (C1), 13.4 (C20), 12.4 (CH3), 12.0 (CH3), 11.8 (CH3), 11.8 (CH3), 11.7 (CH3), 
11.6 (CH3), 11.5 (C2) ppm 
HRMS (m/z): (ESI+) calc’d for C33H65BNaO2Si [M+Na]+: 555.4745; found: 555.4736 
IR (νmax): 2966, 2942, 2865, 2163, 1461, 1381, 1311, 1146, 1078, 883, 676 cm–1 
[𝜶]𝑫








Boronic ester 160 (45 mg, 0.08 mmol, 1.00 equiv.) was homologated with stannane (S)-93 
(56 mg, 0.13 mmol, 1.30 equiv.) and n-BuLi (1.58 M in n-hexane, 0.08 mL, 0.13 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:CH2Cl2 95:5) to give 161 (41 mg, 87%) as a colourless liquid. 
TLC: Rf = 0.33 (n-pentane:CH2Cl2 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 2.46 (1H, dq, J = 7.6, 6.9 Hz, H5), 1.84 (1H, dqd, J = 7.1, 
6.8, 4.7 Hz, H9), 1.68 (1H, dqd, J = 6.9, 6.8, 5.8 Hz, H19), 1.60 (1H, dqd, J = 7.6, 6.8, 4.7 Hz, 
H7), 1.52 (1H, dqd, J = 7.0, 6.5, 4.6 Hz, H15), 1.46 (1H, dqd, J = 7.0, 6.4, 6.8 Hz, H13), 1.42 
(1H, dqd, J = 7.1, 6.7, 6.8 Hz, H11), 1.41 (1H, dqd, J = 6.9, 6.7, 4.6 Hz, H17), 1.23 (6H, s, H24), 
1.23 (6H, s, H24’), 1.18 (1H, m, H21), 1.14 (3H, d, J = 6.9 Hz, H6), 1.07 – 0.98 (21H, m, H1 & 
H2), 0.87 (3H, d, J = 7.3 Hz, H22), 0.82 (3H, d, J = 6.8 Hz, H8), 0.80 (3H, d, J = 6.8 Hz, H20), 
0.75 (3H, d, J = 6.8 Hz, H10), 0.74 (3H, d, J = 6.7 Hz, H12), 0.74 (3H, d, J = 6.5 Hz, H16), 0.72 
(3H, d, J = 6.7 Hz, H18), 0.71 (3H, d, J = 6.4 Hz, H14) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 114.0 (C4), 82.9 (C23), 80.4 (C3), 39.1 (C7), 37.3 (C17), 
36.7 (C9), 36.1 (C11 & C19), 36.0 (C13), 35.3 (C15), 30.7 (C5), 25.1 (C24), 24.8 (C24’), 20.2 
(C21), 18.8 (C1), 18.2 (C6), 14.6 (C20), 12.2 (C8), 12.1 (2 × CH3), 11.8 (CH3), 11.8 (CH3), 11.7 
(CH3), 11.5 (C2), 10.6 (C22) ppm 
HRMS (m/z): (ESI+) calc’d for C35H69BNaO2Si [M+Na]+: 583.5059; found: 583.5052 
IR (νmax): 2966, 2941, 2865, 2162, 1461, 1381, 1311, 1146, 1078, 883, 676 cm–1 
[𝜶]𝑫







Boronic ester 161 (34 mg, 0.06 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(12 mg, 0.07 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.08 mL, 0.07 mmol, 1.10 equiv.), io-
dine (17 mg, 0.07 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 0.17 mL, 0.15 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give 162 (21 mg, 75%) as a colourless liquid. 
TLC: Rf = 0.32 (n-pentane) 
1H NMR: (400 MHz, Chloroform-d) δ 2.51 (1H, app. pentd, Japp. = 6.9, 2.4 Hz, H21), 2.49 (1H, 
app. pent, Japp. = 6.9 Hz, H5), 2.03 (1H, d, J = 2.4 Hz, H24), 1.82 (1H, app. pentd, Japp = 7.0, 
5.0 Hz, H9), 1.73 (1H, app. pentd, Japp = 6.6, 6.0 Hz, H17), 1.61 (1H, app. sext, Japp. = 6.7 Hz, 
H19), 1.59 (1H, dqd, J = 7.0, 6.8, 5.0 Hz, H7), 1.50 (1H, dqd, J = 6.5, 6.8, 5.5 Hz, H13), 1.47 – 
1.34 (2H, m, H11 & H15), 1.14 (3H, d, J = 6.9 Hz, H6), 1.11 (3H, d, J = 6.9 Hz, H22), 1.08 – 
0.98 (21H, m, H1 & H2), 0.87 (3H, d, J = 6.8 Hz, H20), 0.84 (3H, d, J = 6.8 Hz, H8), 0.77 – 0.72 
(15H, m, 5 × CH3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.9 (C4), 89.7 (C23), 80.4 (C3), 68.5 (C24), 39.6 
(C19), 39.2 (C7), 36.5 (C9), 36.3 (C11 or C15), 36.2 (C15 or C11), 35.9 (C17), 35.4 (C13), 30.5 
(C5), 28.6 (C21), 18.8 (C1), 18.0 (C6), 16.7 (C22), 12.6 (C20), 12.3 (C8), 12.2 (CH3), 12.1 (CH3), 
11.7 (CH3), 11.6 (CH3), 11.6 (CH3), 11.5 (C2) ppm 
HRMS (m/z): (MALDI+) calc’d for C31H58NaSi [M+Na]+: 481.4200; found: 481.4205 
IR (νmax): 3312, 2968, 2941, 2965, 2162, 1463, 1383, 1085, 883, 676, 628 cm–1 
[𝜶]𝑫




Protected alkyne 162 (21 mg, 0.05 mmol, 1.00 equiv.) was deprotected with TBAF (1.00 M in 
THF, 0.09 mL, 0.09 mmol, 2.00 equiv.) according to GP5. The crude residue was purified by 
flash column chromatography (pure n-pentane) to give C9 (12 mg, 87%) as a colourless liquid. 
TLC: Rf = 0.26 (n-pentane) 
1H NMR: (500 MHz, Toluene-d8) δ 2.39 (2H, qdd, J = 7.0, 6.9, 2.4 Hz, H3), 1.86 (2H, qdd, 
J = 6.9, 6.7, 5.3 Hz, H7), 1.84 (2H, d, J = 2.8 Hz, H1), 1.65 (2H, qdd, J = 7.0, 6.9, 5.3 Hz, H5), 
1.57 (1H, qt, J = 7.0, 6.1 Hz, H11), 1.41 (2H, app. pentd, Japp. = 6.7, 6.1 Hz, H9), 1.07 (6H, d, 
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J = 7.0 Hz, H4), 0.84 (3H, d, J = 7.0 Hz, H12), 0.82 (6H, d, J = 7.0 Hz, H6), 0.73 (6H, d, 
J = 6.9 Hz, H8), 0.72 (6H, d, J = 6.7 Hz, H10) ppm 
13C NMR: (126 MHz, Toluene-d8) δ 89.0 (C2), 69.3 (C1), 39.6 (C5), 36.4 (C9), 36.2 (C7), 35.6 
(C11), 29.2 (C3), 17.2 (C4), 12.4 (C6), 12.1 (C10), 11.6 (C8), 11.5 (C12) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
IR (νmax): 3310, 2971, 2921, 2880, 1453, 1383, 1084, 627 cm–1 
 
(3R,4S,5R,6S,7R,8R,9S,10R,11S,12R)-3,4,5,6,7,8,9,10,11,12-Decamethyltetradeca-1,13-
diyne (C10) and 4,4,5,5-Tetramethyl-2-((2R,3R,4S,5R,6S,7R,8S,9R,10S,11R)-
3,4,5,6,7,8,9,10,11-nonamethyltridec-12-yn-2-yl)-1,3,2-dioxaborolane (163) 
 
Boronic ester 154 (208 mg, 0.39 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(73 mg, 0.43 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.50 mL, 0.43 mmol, 1.10 equiv.), io-
dine (109 mg, 0.43 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 1.13 mL, 0.97 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give C10 (31 mg, 24%) as a white solid, followed by (n-pentane:CH2Cl2 





TLC: Rf = 0.38 (n-pentane:CH2Cl2 90:10) 
m.p.: 88 – 92 °C (acetonitrile) 
1H NMR: (500 MHz, Toluene-d8) δ 2.24 (2H, dqd, J = 9.2, 6.9, 2.4 Hz, H3), 2.05 (2H, dqd, 
J = 8.6, 6.8, 3.3 Hz, H7), 1.85 (2H, d, J = 2.4 Hz, H1), 1.71 (2H, dqd, J = 9.2, 6.8, 3.3 Hz, H5), 
1.62 (2H, m, H11), 1.52 (2H, dqd, J = 8.6, 6.8, 3.2 Hz, H9), 1.11 (6H, d, J = 6.9 Hz, H4), 0.87 
(6H, d, J = 6.2 Hz, H12), 0.81 (6H, d, J = 6.8 Hz, H10), 0.77 (6H, d, J = 6.8 Hz, H8), 0.74 (6H, 
d, J = 6.8 Hz, H6) ppm 
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13C NMR: (126 MHz, Toluene-d8) δ 88.7 (C2), 69.9 (C1), 38.8 (C5), 37.2 (C7), 35.7 (C9), 35.7 
(C11), 30.1 (C3), 18.8 (C4), 12.0 (C10), 11.9 (C8), 11.8 (C12), 11.6 (C6) ppm 
HRMS (m/z): (MALDI) calc’d for C24H41 [M–H]–: 329.3214; found: 329.3210 
IR (νmax): 3310, 2971, 2922, 2879, 1452, 1383, 1083 cm–1 
[𝜶]𝑫
𝟐𝟑: +7 (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. 
 
Identification code  C10  
Empirical formula  C24H42  
Formula weight  330.57  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21  
a/Å  9.6821(3)  
b/Å  8.6852(3)  
c/Å  13.3264(4)  
α/°  90  
β/°  94.759(2)  
γ/°  90  
Volume/Å3  1116.77(6)  
Z  2  
ρcalc/g cm–3  0.983  
μ/mm–1  0.054  
F(000)  372.0  
Crystal size/mm3  0.453 × 0.398 × 0.299  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  3.066 to 55.91  
Index ranges  -12 ≤ h ≤ 12, -11 ≤ k ≤ 11, -17 ≤ l ≤ 17  
Reflections collected  20700  
Independent reflections  5341 [Rint = 0.0352, Rsigma = 0.0337]  
Data/restraints/parameters  5341/1/227  
Goodness-of-fit on F2  1.043  
Final R indexes [I>=2σ (I)]  R1 = 0.0384, wR2 = 0.0935  
Final R indexes [all data]  R1 = 0.0442, wR2 = 0.0973  
Largest diff. peak/hole / e Å–3  0.26/-0.13  






TLC: Rf = 0.41 (n-pentane:Et2O 95:5) 
1H NMR: (500 MHz, Chloroform-d) δ 2.36 (1H, dqd, J = 8.8, 6.9, 2.5 Hz, H3), 2.04 (1H, d, 
J = 2.5 Hz, H1), 1.85 (1H, dqd, J = 8.2, 6.8, 3.9 Hz, H7), 1.70 (1H, dqd, J = 8.7, 6.7, 4.1 Hz, 
H19), 1.63 (1H, dqd, J = 8.8, 6.9, 3.9 Hz, H5), 1.55 (1H, dqd, J = 7.5, 6.8, 4.1 Hz, H11), 1.51 – 
1.43 (2H, m, H13 & H15), 1.44 (1H, dqd, J = 8.2, 6.8, 4.1 Hz, H9), 1.32 (1H, dqd, J = 7.5, 6.8, 
4.1 Hz, H17), 1.23 (6H, s, H24), 1.23 (6H, s, H24’), 1.17 (3H, d, J = 6.9 Hz, H4), 1.03 (1H, m, 
H21), 0.92 (3H, d, J = 7.2 Hz, H22), 0.78 (3H, d, J = 6.9 Hz, H6), 0.77 – 0.72 (18H, m, 6 × CH3), 
0.69 (3H, d, J = 6.7 Hz, H14 or H16) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 89.4 (C2), 82.9 (C23), 68.9 (C1), 39.7 (C17), 38.7 (C5), 
36.9 (C7), 35.8 (CH), 35.7(3) (C19), 35.6(5) (CH), 35.4(4) (C11), 35.4(2) (CH), 29.6 (C3), 25.1 
(C24), 24.7 (C24’), 21.9 (C21), 18.5 (C4), 12.9(4) (C22), 12.8(6) (CH3), 12.0(4) (CH3), 12.0(3) 
(2 × CH3), 12.0 (CH3), 11.9 (C14 or C16), 11.7(4) (C6), 11.7(3) (CH3) ppm 
HRMS (m/z): (MALDI+) calc’d for C28H53BNaO2 [M+Na]+: 455.4036; found: 455.4032 
IR (νmax): 3311, 2970, 2932, 2879, 1454, 1382, 1313, 1146, 1081, 967 cm–1 
[𝜶]𝑫





Alkyne 163 (74 mg, 0.17 mmol, 1.00 equiv.) was protected with LDA (0.86 M in THF, 0.22 mL, 
0.19 mmol, 1.10 equiv.) and TIPSCl (0.04 mL, 0.19 mmol, 1.10 equiv.) according to GP4. The 
crude residue was purified by flash column chromatography (n-pentane:CH2Cl2 95:5) to give 164 
(77 mg, 76%) as a colourless liquid. 
TLC: Rf = 0.31 (n-pentane:CH2Cl2 80:20) 
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1H NMR: (400 MHz, Chloroform-d) δ 2.38 (1H, dq, J = 8.8, 6.8 Hz, H5), 1.93 (1H, dqd, J = 8.5, 
6.9, 3.8 Hz, H9), 1.70 (1H, dqd, J = 8.9, 6.8, 3.8 Hz, H21), 1.58 (1H, dqd, J = 8.8, 6.8, 3.8 Hz, 
H7), 1.55 (1H, m, CH), 1.52 – 1.36 (3H, m, 3 × CH), 1.31 (1H, dqd, J = 8.1, 6.8, 3.8 Hz, H19), 
1.24 (6H, s, H26), 1.23 (6H, s, H26’), 1.17 (3H, d, J = 6.8 Hz, H6), 1.10 – 0.96 (22H, m, H1, H2 
& H23), 0.92 (3H, d, J = 7.1 Hz, H24), 0.79 – 0.71 (21H, m, 7 × CH3), 0.69 (3H, d, J = 6.7 Hz, 
CH3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.7 (C4), 82.8 (C25), 80.6 (C3), 40.0 (C19), 38.7 (C7), 
37.3 (C9), 35.8 (CH), 35.7 (C21), 35.7 (CH), 35.4 (CH), 35.4 (CH), 31.2 (C5), 25.1 (C26), 24.7 
(C26’), 22.1 (C23), 19.2 (C6), 18.8 (C1), 13.2 (C24), 12.7 (CH3), 12.1 (CH3), 12.1 (CH3), 12.0 
(CH3), 11.9 (CH3), 11.8 (CH3), 11.8 (CH3), 11.7 (CH3), 11.5 (C2) ppm 
HRMS (m/z): (ESI+) calc’d for C37H73BNaO2Si [M+Na]+: 611.5372; found: 611.5373 
IR (νmax): 2967, 2942, 2866, 2163, 1459, 1382, 1313, 1146, 1081, 883 cm–1 
[𝜶]𝑫





Boronic ester 164 (70 mg, 0.12 mmol, 1.00 equiv.) was homologated with stannane (R)-93 
(68 mg, 0.15 mmol, 1.30 equiv.) and n-BuLi (1.54 M in n-hexane, 0.10 mL, 0.15 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:CH2Cl2 95:5) to give 165 (66 mg, 90%) as a colourless wax. 
TLC: Rf = 0.31 (n-pentane:CH2Cl2 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 2.46 (1H, dq, J = 7.5, 6.9 Hz, H5), 1.85 (1H, dqd, J = 7.5, 
6.9, 4.7 Hz, H7), 1.68 (1H, m, H21), 1.59 (1H, dqd, J = 7.5, 6.9, 4.7 Hz, H23), 1.54 – 1.44 (4H, 
m, H11, H13, H15 & H17), 1.44 – 1.38 (2H, m, H9 & H19), 1.24 (6H, s, H28), 1.23 (6H, s, 
H28’), 1.19 (1H, m, H25), 1.14 (3H, d, J = 6.9 Hz, H4), 1.09 – 0.96 (21H, m, H1 & H2), 0.87 
(3H, d, J = 7.4 Hz, H26), 0.82 (3H, d, J = 6.9 Hz, H6), 0.80 (3H, d, J = 6.8 Hz, H22), 0.75 (3H, 
d, J = 6.7 Hz, H8), 0.74 – 0.69 (18H, m, 6 × CH3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.9 (C4), 82.9 (C27), 80.4 (C3), 39.0 (C7), 37.3 (C21), 
36.7 (C9), 36.1 (C11), 36.1 (C23), 36.1 (CH), 35.7 (CH), 35.5 (CH), 35.4 (CH), 30.7 (C5), 25.1 
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(C28), 24.8 (C28’), 20.3 (C25), 18.8 (C1), 18.2 (C6), 14.5 (C24), 12.3 (CH3), 12.2 (CH3), 12.1(2) 
(CH3), 12.1(1) (CH3), 11.9(3) (CH3), 11.9(1) (CH3), 11.8 (C10), 11.8 (CH3), 11.5 (C2), 10.7 
(C26) ppm 
HRMS (m/z): (MALDI+) calc’d for C39H77BNaO2Si [M+Na]+: 639.5685; found: 639.5689 
IR (νmax): 2966, 2941, 2866, 2163, 1461, 1381, 1311, 1145, 1077, 883, 675 cm–1 
[𝜶]𝑫





Boronic ester 165 (66 mg, 0.11 mmol, 1.00 equiv.) was alkynylated with vinyl carbamate 15 
(20 mg, 0.12 mmol, 1.10 equiv.), LDA (0.86 M in THF, 0.14 mL, 0.12 mmol, 1.10 equiv.), io-
dine (30 mg, 0.12 mmol, 1.10 equiv.) and LDA (0.86 M in THF, 0.31 mL, 0.27 mmol, 
2.50 equiv.) according to GP3. The crude residue was purified by flash column chromatography 
(pure n-pentane) to give 166 (38 mg, 69%) as a colourless liquid. 
TLC: Rf = 0.29 (n-pentane) 
1H NMR: (400 MHz, Chloroform-d) δ 2.50 (1H, qdd, J = 6.9, 6.6, 2.4 Hz, H25), 2.48 (1H, dq, 
J = 7.6, 6.9 Hz, H5), 2.03 (1H, d, J = 2.4 Hz, H28), 1.83 (1H, dqd, J = 7.0, 6.8, 4.9 Hz, H9), 1.74 
(1H, qdd, J = 6.7, 6.3, 5.9 Hz, H21), 1.61 (1H, qdd, J = 6.8, 6.6, 6.3 Hz, H23), 1.59 (1H, dqd, 
J = 7.6, 6.8, 4.9 Hz, H7), 1.55 – 1.44 (3H, m, H13, H15 & H17), 1.48 – 1.37 (2H, m, H11 & 
H19), 1.14 (3H, d, J = 6.9 Hz, H6), 1.11 (3H, d, J = 6.9 Hz, H26), 1.10 – 0.94 (21H, m, H1 & 
H2), 0.87 (3H, d, J = 6.8 Hz, H24), 0.83 (3H, d, J = 6.8 Hz, H8), 0.77 – 0.70 (21H, m, 7 × CH3) 
ppm 
13C NMR: (101 MHz, Chloroform-d) δ 113.9 (C4), 89.6 (C27), 80.4 (C3), 68.6 (C28), 39.5 
(C23), 39.2 (C7), 36.6 (C9), 36.4 (CH), 36.2 (CH), 36.0 (C21), 35.8 (CH), 35.5 (CH), 35.4 (CH), 
30.5 (C5), 28.7 (C25), 18.8 (C1), 18.0 (C6), 16.8 (C26), 12.5 (C24), 12.4 (CH3), 12.2 (C8), 12.2 
(CH3), 12.1 (CH3), 11.8 (CH3), 11.8 (CH3), 11.7 (CH3), 11.7 (CH3), 11.5 (C2) ppm 
HRMS (m/z): (MALDI+) calc’d for C35H66NaSi [M+Na]+: 537.4826; found: 537.4818 
IR (νmax): 3312, 2967, 2941, 2865, 2162, 1462, 1383, 1082, 883, 664, 628 cm–1 
[𝜶]𝑫






Protected alkyne 166 (22 mg, 0.04 mmol, 1.00 equiv.) was deprotected with TBAF (1.00 M in 
THF, 0.09 mL, 0.09 mmol, 2.00 equiv.) according to GP5. The crude residue was purified by 
flash column chromatography (pure n-pentane) to give C11 (12 mg, 78%) as a colourless liquid. 
TLC: Rf = 0.24 (n-pentane) 
1H NMR: (400 MHz, Toluene-d8) δ 2.39 (2H, dqd, J = 7.0, 6.9, 2.4 Hz, H3), 1.89 (2H, dqd, 
J = 7.1, 6.8, 5.3 Hz, H7), 1.85 (2H, d, J = 2.4 Hz, H1), 1.67 (2H, dqd, J = 7.0, 6.9, 5.3 Hz, H5), 
1.60 (2H, qdd, J = 6.6, 6.2, 5.3 Hz, H11), 1.56 (1H, qt, J = 6.4, 6.2 Hz, H13), 1.44 (2H, dqd, 
J = 7.1, 6.8, 5.3 Hz, H9), 1.08 (6H, d, J = 6.9 Hz, H4), 0.83 (6H, d, J = 6.9 Hz, H6), 0.81 (6H, d, 
J = 6.6 Hz, H12), 0.76 (6H, d, J = 6.8 Hz, H10), 0.75 (6H, d, J = 6.6 Hz, H8), 0.74 (3H, d, 
J = 6.4 Hz, H14) ppm 
13C NMR: (101 MHz, Toluene-d8) δ 89.0 (C2), 69.3 (C1), 39.6 (C5), 36.5 (C9), 36.4 (C7), 36.1 
(C13), 35.8 (C11), 29.3 (C3), 17.3 (C4), 12.4 (C14), 12.3 (C6), 12.2 (C10), 11.7 (C8), 11.7 (C12) 
ppm 
HRMS (m/z): (MALDI+) calc’d for C26H46Na [M+Na]+: 381.3492; found: 381.3503 





In a vial, alkyne C10 (12 mg, 0.04 mmol, 1.00 equiv.) was dissolved in THF (0.20 mL) at room 
temperature. A solution of copper sulphate pentahydrate (0.18 M in water, 0.01 mL, 2 μmol, 
0.05 equiv.) was added, followed by a solution of sodium ascorbate (0.04 M in water, 0.20 mL, 
8 μmol, 0.20 equiv.). The colour of the solution evolved from blue to green to orange. A solution 
of phenyl azide (0.88 M in THF, 0.05 mL, 0.04 mmol, 1.20 equiv.) was added. The vial was 
capped and the reaction mixture was stirred at 50 °C for 16 h. The suspension was concentrated 
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under reduced pressure and the residue was purified by flash column chromatography (n-pen-
tane:Et2O 100:0→85:15) to give triazole 168 (7 mg, 43%) as a colourless liquid. 
TLC: Rf = 0.33 (n-pentane:Et2O 80:20) 
1H NMR (500 MHz, Chloroform-d): δ 7.73 (2H, m, H26), 7.67 (1H, s, H24), 7.51 (2H, m, H27), 
7.42 (1H, m, H28), 3.03 (1H, dq, J = 8.6, 7.0 Hz, H21), 2.37 (1H, dqd, J = 8.5, 6.9, 2.4 Hz, H3), 
2.04 (1H, d, J = 2.4 Hz, H1), 1.98 (1H, dqd, J = 8.6, 6.8, 4.0 Hz, H19), 1.84 (1H, dqd, J = 7.9, 
6.9, 4.1 Hz, H7), 1.60 (1H, dqd, J = 8.5, 6.8, 4.1 Hz, H5), 1.55 – 1.43 (4H, m, 4 × CH), 1.30 (3H, 
d, J = 7.0 Hz, H22), 1.28 (1H, m, H17), 1.15 (3H, d, J = 6.9 Hz, H4), 0.87 (3H, d, J = 6.8 Hz, 
H20), 0.80 – 0.72 (15H, m, 5 × CH3), 0.67 (3H, d, J = 6.6 Hz, H16), 0.54 (3H, d, J = 6.1 Hz, H12 
or H14) ppm 
13C NMR (126 MHz, Chloroform-d): δ 154.3 (C23), 137.5 (C25), 129.8 (C27), 128.5 (C28), 
120.5 (C26), 118.2 (C24), 89.3 (C2), 68.9 (C1), 39.3 (C19), 38.8 (C5), 36.7 (C7), 36.3 (C17), 
35.6 (CH), 35.5 (CH), 35.4 (2 × CH), 34.3 (C21), 29.5 (C3), 18.3 (C4), 18.0 (C22), 12.0 (CH3), 
12.0(1) (CH3), 12.0(0) (CH3), 11.9(4) (CH3), 11.8(8) (CH3), 11.8(5) (CH3), 11.8(4) (CH3), 11.8(0) 
(CH3), 11.7 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C30H47N3Na [M+Na]+: 472.3662; found 472.3655 
IR (νmax): 3310, 3136, 3065, 2969, 2925, 2878, 1603, 1504, 1453, 1383, 1038, 758 cm1 
[𝛂]𝑫





In a flame-dried Schlenk tube, 1-bromonaphthalene (0.03 mL, 0.20 mmol, 2.10 equiv.) was dis-
solved in anhydrous Et2O (1.00 mL) at 0 °C under an atmosphere of nitrogen. A solution of 
n-BuLi (1.60 M in n-hexane, 0.12 mL, 0.20 mmol, 2.10 equiv.) was added and the resulting sus-
pension was stirred at the same temperature for 1 h. A solution of boronic ester 154 (50 mg, 
0.09 mmol, 1.00 equiv.) in anhydrous Et2O (1.00 mL) was added dropwise at 0 °C over 10 min. 
After the addition, the mixture was stirred at the same temperature for 2 h. Solvents were removed 
in situ and the residue was dissolved in a mixture of dry MeOH and anhydrous THF (2:1) at 
–78 °C under an atmosphere of nitrogen. A solution of NBS (80 mg, 0.45 mmol, 4.80 equiv.) in 
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dry MeOH (2.50 mL) was added dropwise at the same temperature. After the addition, the ace-
tone/dry ice bath was removed and the reaction mixture was stirred at room temperature for 1 h. 
A saturated aqueous solution of Na2S2O3 (5.00 mL) was added. After 5 min, the suspension was 
extracted with Et2O (3 × 5.00 mL). The organic layers were combined, washed with brine, dried 
over MgSO4, filtered and concentrated under reduced pressure. The yellow residue was purified 
by flash column chromatography (n-pentane:Et2O 100:0→99.5:0.5) to give compound 169 
(12 mg, 24%) as a white solid. 
TLC: Rf = 0.69 (n-pentane:Et2O 95:5) 
m.p.: 157 – 159 °C (acetonitrile) 
1H NMR (500 MHz, Chloroform-d): δ 8.17 (2H, dd, J = 8.2, 1.6 Hz, H2), 7.85 (2H, dd, J = 7.6, 
2.0 Hz, H5), 7.68 (2H, dd, J = 8.0, 1.2 Hz, H7), 7.48 (2H, ddd, J = 8.2, 6.6, 2.0 Hz, H3), 7.45 
(2H, ddd, J = 7.6, 6.7, 1.6 Hz, H4), 7.43 (2H, dd, J = 8.0, 7.3 Hz, H8), 7.36 (2H, dd, J = 7.2, 
1.2 Hz, H9), 3.50 (2H, m, H11), 2.10 (2H, m, H13), 1.46 (2H, dqd, J = 8.8, 6.8, 2.5 Hz, H17), 
1.37 (2H, m, H19), 1.30 (6H, d, J = 6.9 Hz, H12), 1.07 (2H, dqd, J = 8.8, 6.8, 2.9 Hz, H15), 0.92 
(6H, d, J = 6.7 Hz, H14), 0.67 (6H, d, J = 6.8 Hz, H16), 0.55 (6H, d, J = 6.8 Hz, H18), 0.33 (6H, 
m, H20) ppm 
13C NMR (126 MHz, Chloroform-d): δ 144.3 (C10), 134.1 (C6), 132.0 (C1), 129.1 (C5), 126.1 
(C7), 125.7 (C4 or C8), 125.6 (C8 or C4), 125.2 (C3), 124.1 (C9), 123.4 (C2), 39.4 (C13), 37.2* 
(C11), 36.3 (C15), 35.6 (C17), 35.5 (C19), 20.8 (C12), 12.3 (C16), 12.1 (C14), 11.9 (C18 or 
C20), 11.9 (C20 or C18) ppm 
*shift value determined by HSQC correlation. 
HRMS (m/z): (MALDI+) calc’d. for C40H54Na [M+Na]+: 557.4118; found 557.4110 
IR (νmax): 3049, 2966, 2925, 1453, 1382, 1260, 1083, 778 cm1 
[𝛂]𝑫
𝟐𝟓: +45 (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. The compound undergoes a phase transition be-
tween 180 and 160 K. The cell above the transition is monoclinic, P21 with half the volume, Z'=2. 
 
Identification code  169 
Empirical formula  C40H54  
Formula weight  534.83  
 
145 
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21  
a/Å  13.1097(3)  
b/Å  36.9860(9)  
c/Å  14.5028(4)  
α/°  90  
β/°  112.8517(14)  
γ/°  90  
Volume/Å3  6480.1(3)  
Z  8  
ρcalc/g cm–3  1.096  
μ/mm–1  0.061  
F(000)  2352.0  
Crystal size/mm3  0.458 × 0.304 × 0.287  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  3.048 to 52.742  
Index ranges  -16 ≤ h ≤ 16, -40 ≤ k ≤ 46, -17 ≤ l ≤ 18  
Reflections collected  80431  
Independent reflections  25125 [Rint = 0.0539, Rsigma = 0.0639]  
Data/restraints/parameters  25125/1/1481  
Goodness-of-fit on F2  1.013  
Final R indexes [I>=2σ (I)]  R1 = 0.0498, wR2 = 0.0963  
Final R indexes [all data]  R1 = 0.0818, wR2 = 0.1102  
Largest diff. peak/hole / e Å–3  0.16/-0.20  






In a flame-dried Schlenk tube, 1-bromonaphthalene (30 μL, 0.20 mmol, 1.05 equiv.) was dis-
solved in anhydrous n-hexane (1.00 mL) with one drop of anhydrous THF at 0 °C under an at-
mosphere of nitrogen. A solution of n-BuLi (1.60 M in n-hexane, 0.12 mL, 0.20 mmol, 
1.05 equiv.) was added and the reaction mixture was stirred at 0 °C for 40 min. Anhydrous Et2O 
(0.30 mL) was slowly added to dissolve the white precipitate. In a second flame-dried Schlenk 
tube, boronic ester 154 (100 mg, 0.19 mmol, 1.00 equiv.) was dissolved in anhydrous Et2O 
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(2.00 mL) at 0 °C under an atmosphere of nitrogen. The previously prepared solution of naph-
thyllithium was added via syringe and the suspension was stirred at 0 °C for 1 h. Solvents were 
removed under reduced pressure in situ and the residue was re-dissolved in a mixture of anhy-
drous MeOH (2.00 mL) and anhydrous THF (2.20 mL) at 78 °C under an atmosphere of nitro-
gen. A solution of NBS (70 mg, 0.39 mmol, 2.10 equiv.) in anhydrous MeOH (2.50 mL) was 
added dropwise, the acetone/dry ice bath was removed and the reaction mixture was allowed to 
warm to room temperature for 1 h. A saturated aqueous solution of Na2S2O3 (1.00 mL) was added 
and the biphasic mixture was extracted with Et2O (3 × 10.00 mL). The organic layers were com-
bined, washed with brine, dried over MgSO4, filtered and concentrated. The crude residue was 
purified by flash column chromatography (n-pentane:Et2O 100:0→99.5:0.5) to give boronic ester 
170 (34 mg, 34%) as a colourless liquid. 
TLC: Rf = 0.21 (n-pentane:CH2Cl2 80:20) 
1H NMR: (500 MHz, Chloroform-d) δ 8.18 (1H, dd, J = 8.2, 1.6 Hz, H25), 7.85 (1H, dd, J = 7.6, 
1.7 Hz, H28), 7.68 (1H, dd, J = 8.2, 1.3 Hz, H30), 7.48 (1H, ddd, J = 8.2, 6.6, 1.7 Hz, H26), 7.45 
(1H, ddd, J = 7.6, 6.6, 1.6 Hz, H27), 7.44 (1H, dd, J = 8.0, 7.3 Hz, H31), 7.38 (1H, dd, J = 7.3, 
1.3 Hz, H32), 3.54 (1H, dq, J = 9.4, 6.9 Hz, H21), 2.12 (1H, dqd, J = 9.4, 6.8, 3.3 Hz, H19), 1.67 
(1H, dqd, J=9.0, 6.7, 4.0 Hz, H5), 1.54 – 1.41 (4H, m, 4 × CH), 1.32 (3H, d, J = 6.9 Hz, H22), 
1.30 (1H, m, H7), 1.24 (6H, s, H1), 1.23 (6H, s, H1’), 1.13 (1H, dqd, J = 9.1, 6.8, 3.3 Hz, H17), 
1.03 (1H, dq, J = 9.0, 7.2 Hz, H3), 0.94 (3H, d, J = 6.8 Hz, H20), 0.91 (3H, d, J = 7.2 Hz, H4), 
0.75 – 0.70 (12H, m, 4 × CH3), 0.68 (3H, d, J = 6.8 Hz, H18), 0.55 (3H, d, J = 6.7 Hz, CH3), 
0.38 (3H, d, J = 6.0 Hz, CH3) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 144.3 (C23), 134.1 (C29), 132.0 (C24), 129.1 (C28), 
126.1 (C30), 125.6(3) (CHAr), 125.5(8) (CHAr), 125.2 (CHAr), 124.1 (C32), 123.4 (25), 82.8 (C2), 
39.8 (C7), 39.6 (C19), 37.2 (C21), 36.3 (C17), 35.8 (2 × CH), 35.7 (C5), 35.6 (CH), 35.4 (CH), 
25.1 (C1), 24.7 (C1’), 21.9 (C3), 20.4 (C22), 13.1 (C4), 12.7 (CH3), 12.3 (C20), 12.2 (CH3), 12.1 
(C18), 12.0(2) (CH3), 11.9(8) (CH3), 11.9(6) (CH3), 11.8 (CH3) ppm 
HRMS (m/z): (MALDI+) calc’d for C36H59BNaO2 [M+Na]+: 557.4507; found: 557.4500 
IR (νmax): 2968, 2876, 1451, 1378, 1362, 1358, 1307, 1205, 1146, 1077 cm–1 
[𝜶]𝑫









Boronic ester 170 (55 mg, 0.10 mmol, 1.00 equiv.) was homologated with stannane (R)-93 
(59 mg, 0.13 mmol, 1.30 equiv.) and n-BuLi (1.60 M in n-hexane, 0.08 mL, 0.13 mmol, 
1.30 equiv.) according to GP2. The crude residue was purified by flash column chromatography 
(n-pentane:CH2Cl2 100:0→20:80) to give 171 (49 mg, 85%) as a white solid. 
TLC: Rf = 0.22 (n-pentane:CH2Cl2 80:20) 
m.p.: 181 – 185 °C (n-hexane) 
1H NMR: 500 MHz, Chloroform-d) δ 8.17 (1H, dd, J = 8.6, 1.7 Hz, H27), 7.85 (1H, dd, J = 7.9, 
1.7 Hz, H30), 7.68 (1H, dd, J = 8.0, 1.3 Hz, H32), 7.48 (1H, ddd, J = 8.6, 6.7, 1.7 Hz, H28), 7.45 
(1H, ddd, J = 7.9, 6.7, 1.7 Hz, H29), 7.44 (1H, dd, J = 8.0, 7.2 Hz, H33), 7.38 (1H, dd, J = 7.2, 
1.3 Hz, H34), 3.61 (1H, dq, J = 8.4, 6.9 Hz, H23), 2.05 (1H, dqd, J = 8.4, 6.8, 4.2 Hz, H21), 1.67 
(1H, qdd, J = 6.8, 6.7, 6.2 Hz, H5), 1.57 (1H, dqd, J = 8.9, 6.8, 4.4 Hz, H17), 1.54 – 1.43 (3H, 
m, 3 × CH), 1.42 – 1.34 (2H, m, 2 × CH), 1.31 (3H, d, J = 6.9 Hz, H24), 1.25 (1H, dqd, J = 8.9, 
6.8, 4.2 Hz, H19), 1.24 (6H, s, H1), 1.23 (6H, s, H1’), 1.16 (1H, qd, J = 7.3, 6.2 Hz, H3), 0.90 
(3H, d, J = 6.8 Hz, H22), 0.87 (3H, d, J = 7.3 Hz, H4), 0.79 (3H, d, J = 6.8 Hz, H6), 0.73 (3H, 
d, J = 6.5 Hz, CH3), 0.71 – 0.66 (12H, m, 4 × CH3), 0.62 (3H, d, J = 6.8 Hz, H18), 0.45 (3H, d, 
J = 6.7 Hz, CH3) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 144.1 (C25), 134.1 (C31), 132.0 (C26), 129.1 (C30), 
126.2 (C32), 125.6 (2 × CHAr), 125.2 (CHAr), 124.2 (C34), 123.4 (C27), 82.9 (C2), 39.9 (C21), 
37.3 (CH), 36.8 (C23), 36.3 (C17), 36.2 (C19), 36.1 (CH), 36.0 (C5), 35.8 (CH), 35.5 (CH), 35.4 
(CH), 25.1 (C1), 24.8 (C1’), 20.3 (C3), 19.1 (C24), 14.4 (C6), 12.3 (3 × CH3), 12.0(4) (CH3), 
12.0(3) (CH3), 11.9 (CH3), 11.8 (CH3), 11.7 (CH3), 10.8 (C4) ppm 
HRMS (m/z): (MALDI+) calc’d for C38H63BNaO2 [M+Na]+: 585.4820; found: 585.4828 
IR (νmax): 2966, 2876, 1450, 1381, 1362, 1307, 1149, 1077, 1016, 965 cm–1 
[𝜶]𝑫








Part A: In a flame-dried Schlenk tube, boronic ester 171 (47 mg, 0.08 mmol, 1.00 equiv.) and 
vinyl carbamate 15 (18 mg, 0.11 mmol, 1.33 equiv.) were dissolved in anhydrous THF (0.50 mL) 
at –78 °C under an atmosphere of nitrogen. A freshly prepared solution of LDA (0.86 M in THF, 
0.12 mL, 0.11 mmol, 1.33 equiv.) was added and the reaction mixture was stirred at the same 
temperature for 1 h. The acetone/dry ice bath was replaced with an acetonitrile/dry ice bath and 
the reaction mixture was stirred at –40 °C for 1 h. After cooling the reaction mixture back to 
–78 °C, a freshly prepared solution of iodine (27 mg, 0.11 mmol, 1.33 equiv.) in MeOH 
(0.40 mL) was added dropwise at via syringe. After the addition, the reaction mixture was al-
lowed to stir at room temperature for 1 h. A saturated aqueous solution of NH4Cl was added and 
the biphasic mixture was extracted 3 times with Et2O. The organic layers were combined, washed 
with brine, dried over MgSO4, filtered through silica (2 cm depth of dry silica, using a filter frit 
connected directly to a flame-dried receiving vessel), concentrated under reduced pressure and 
dried under high vacuum for (at least) 1 h. Part B: The dried crude residue was dissolved in 
anhydrous Et2O (0.80 mL) at –78 °C under an atmosphere of nitrogen. A solution of tert-BuLi 
(1.70 M in n-pentane, 0.12 mL, 0.20 mmol, 2.50 equiv.) was added and the reaction mixture was 
allowed to stir at room temperature for 1 h. A saturated aqueous solution of NH4Cl was added 
via syringe and the biphasic mixture was extracted 3 times with Et2O. The organic layers were 
combined, washed with brine, dried over MgSO4, filtered and concentrated under reduced pres-
sure. The residue was purified by flash column chromatography (pure n-pentane) to give 172 
(24 mg, 65%) as a colourless liquid. 
TLC: Rf = 0.46 (n-pentane:CH2Cl2 80:20) 
1H NMR: (500 MHz, Chloroform-d) δ 8.16 (1H, dd, J = 8.3, 1.5 Hz, H27), 7.85 (1H, dd, J = 7.9, 
1.8 Hz, H30), 7.69 (1H, dd, J = 8.1, 1.3 Hz, H32), 7.48 (1H, ddd, J = 8.3, 6.8, 1.8 Hz, H28), 7.45 
(1H, ddd, J = 7.9, 6.8, 1.5 Hz, H29), 7.44 (1H, dd, J = 8.1, 7.3 Hz, H33), 7.38 (1H, dd, J = 7.3, 
1.3 Hz, H34), 3.63 (1H, dq, J = 7.9, 6.9 Hz, H23), 2.49 (1H, dqd, J = 6.9, 6.8, 2.4 Hz, H3), 2.03 
(1H, d, J = 2.4 Hz, H1), 2.02 (1H, dqd, J = 7.9, 6.8, 4.6 Hz, H21), 1.71 (1H, qdd, J = 6.8, 6.0, 
5.8 Hz, H7), 1.61 (1H, qdd, J = 6.8, 6.9, 5.8 Hz, H5), 1.58 (1H, dqd, J = 7.0, 6.8, 5.1 Hz, H17), 
1.54 – 1.43 (2H, m, H11 & H15), 1.40 (1H, qdd, J = 6.8, 6.3, 6.0 Hz, H9), 1.35 (1H, qdd, J = 6.8, 
6.5, 6.0 Hz, H13), 1.32 (3H, d, J = 6.9 Hz, H24), 1.29 (1H, dqd, J = 7.0, 6.8, 4.6 Hz, H19), 1.11 
(3H, d, J = 6.9 Hz, H4), 0.90 (3H, d, J = 6.8 Hz, H22), 0.85 (3H, d, J = 6.9 Hz, H6), 0.74 – 0.71 
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(6H, m, 2 × CH3), 0.71 – 0.67 (9H, m, 3 × CH3), 0.65 (3H, d, J = 6.8 Hz, H18), 0.47 (3H, d, 
J = 6.8 Hz, CH3) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 144.0 (C25), 134.1 (C31), 132.0 (C26), 129.1 (C30), 
126.2 (C32), 125.6(0) (C28), 125.5(6) (C29), 125.2 (C33), 124.3 (C34), 123.4 (C27), 89.6 (C2), 
68.6 (C1), 40.1 (C21), 39.3 (C5), 36.8 (C23), 36.5 (C17), 36.2 (C19), 36.0(8) (C7), 35.9(8) (C9 
& C13), 35.4(8) (C11 or C15), 35.4(6) (C15 or C11), 28.7 (C3), 18.8 (C24), 16.9 (C4), 12.5 
(CH3), 12.4(1) (CH3), 12.3(9) (CH3), 12.3(8) (CH3), 12.0 (CH3), 11.9 (CH3), 11.7(0) (CH3), 
11.6(8) (CH3), 11.6(7) (CH3) ppm 
HRMS (m/z): (MALDI+) calc’d for C34H52Na [M+Na]+: 483.3961; found: 483.3968 
IR (νmax): 3309, 3047, 2969, 2923, 2878, 2111, 1451, 1382, 1081, 777 cm–1 
[𝜶]𝑫





Part A: Boronic ester 163 (29 mg, 0.07 mmol, 1.00 equiv.) was oxidised according to GP1 to 
give crude intermediate 173. Part B: Freshly-dried Mg(ClO4)2 (1 mg, 5 μmol, 0.10 equiv.) 
(WARNING: shock sensitive!) was charged in a separated flask at room temperature, under an 
atmosphere of nitrogen. A solution of alcohol 173 in anhydrous CH2Cl2 (0.10 mL) was added, 
followed by Boc2O (23 mg, 0.11 mmol, 2.30 equiv.). The reaction mixture was stirred at 
40 °C for 48 h. Water (5.00 mL) was added and the biphasic mixture was extracted with Et2O 
(3 × 5.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, filtered 
and concentrated. The residue was purified by flash column chromatography (n-pentane:Et2O 
95:5) to give ether 174 (9 mg, 36% over 2 steps) as a colourless liquid. 
TLC: Rf = 0.57 (n-pentane:Et2O 95:5) 
1H NMR (500 MHz, Chloroform-d): δ 3.47 (1H, app. pent, Japp. = 6.2 Hz, H21), 2.32 (1H, dqd, 
J = 7.9, 6.9, 2.4 Hz, H3), 1.97 (1H, dqd, J = 7.6, 6.8, 4.5 Hz, H7), 1.84 (1H, d, J = 2.4 Hz, H1), 
1.78 (1H, dqd, J = 7.6, 6.8, 4.8 Hz, H17), 1.73 – 1.66 (2H, m, H5 & H19), 1.65 – 1.58 (3H, m, 
H11, H13 & H15), 1.50 (1H, dqd, J = 7.6, 6.8, 4.0 Hz, H9), 1.14 (9H, s, H24), 1.11 – 1.08 (6H, 
m, H4 & H22), 0.87 – 0.83 (12H, m, 4 × CH3), 0.81 – 0.78 (9H, m, 3 × CH3), 0.77 (3H, d, 
J = 6.8 Hz, H8) ppm 
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13C NMR (126 MHz, Chloroform-d): δ 88.8 (C2), 72.8 (C23), 69.5 (C1), 68.9 (C21), 41.4 (C19 
or C5), 39.2 (C19 or C5), 36.7 (C7), 36.2 (CH), 36.2 (CH), 35.9 (CH), 35.7 (CH), 35.1 (C17), 
29.6 (C3), 29.0 (C24), 20.1 (C4 or C22), 18.0 (C22 or C4), 12.7 (CH3), 12.1 (CH3), 12.1 (CH3), 
12.0 (CH3), 12.0 (CH3), 11.8 (CH3), 11.8 (CH3), 11.0 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C26H50NaO [M+Na]+: 401.3754; found 401.3753 
IR (νmax): 3312, 2971, 2931, 2879, 1454, 1383, 1197, 1080, 1018 cm1 
[𝛂]𝑫




Boronic ester 154 (70 mg, 0.13 mmol, 1.00 equiv.) was oxidised according to GP1. The crude 
residue was purified by flash column chromatography (CH2Cl2:Et2O 90:10) to give diol 175 
(39 mg, 95%) as a white solid. 
TLC: Rf = 0.26 (CH2Cl2:Et2O 90:10) 
m.p.: 136 – 140 °C (n-hexane) 
1H NMR (400 MHz, Chloroform-d): δ 3.65 (2H, dq, J = 8.1, 6.1 Hz, H2), 1.75 (2H, dqd, J = 8.5, 
6.8, 3.4 Hz, H6), 1.57 (2H, dqd, J = 8.1, 7.0, 3.4 Hz, H4), 1.55 – 1.39 (4H, m, H8 & H10), 1.28 
(2H, br. s, H1), 1.19 (6H, d, J = 6.1 Hz, H3), 0.77 (6H, d, J = 6.8 Hz, H7), 0.76 – 0.73 (12H, m, 
H9 & H11), 0.72 (6H, d, J = 7.0 Hz, H5) ppm 
13C NMR (126 MHz, Chloroform-d): δ 70.0 (C2), 41.1 (C4), 35.5 (CH), 35.2 (CH), 34.7 (C6), 
21.6 (C3), 12.0 (CH3), 11.9 (CH3), 11.8 (CH3), 10.5 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C20H42NaO2 [M+Na]+: 337.3077; found 337.3088 
IR (νmax): 3307, 2968, 2919, 2879, 1454, 1382, 1084, 1053, 918 cm1 
[𝛂]𝑫
𝟐𝟑: 5 (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. The molecule is a weak anomalous scatterer and 
therefore the absolute structure parameter is meaningless and has been removed from the .cif file. 
Hydrogen atoms on the oxygen atoms were found by difference map, disorder was present and 
these hydrogen atoms were both modelled in two positions with a constrained occupancy of 0.5. 
Due to the disorder, rotating group refinement was used. All other hydrogens were geometrically 
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placed and refined using a riding model. Density is slightly lower than expected (0.9978 g cm3) 
and solvent accessible voids (41 Å3) are present. Only water is small enough to fit in these voids 
and there is no electron density visible within these voids. The space group was checked and the 
slightly low density is believed to be due to the voids. 
 
Identification code  175  
Empirical formula  C20H42O2  
Formula weight  314.53  
Temperature/K  100  
Crystal system  trigonal  
Space group  P3121  
a/Å  16.3491(3)  
b/Å  16.3491(3)  
c/Å  13.5683(3)  
α/°  90  
β/°  90  
γ/°  120  
Volume/Å3  3140.82(13)  
Z  6  
ρcalc/g cm–3  0.998  
μ/mm–1  0.061  
F(000)  1068.0  
Crystal size/mm3  0.524 × 0.17 × 0.102  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  2.876 to 54.312  
Index ranges  -20 ≤ h ≤ 20, -20 ≤ k ≤ 20, -17 ≤ l ≤ 17  
Reflections collected  53962  
Independent reflections  4647 [Rint = 0.0890, Rsigma = 0.0416]  
Data/restraints/parameters  4647/0/213  
Goodness-of-fit on F2  1.046  
Final R indexes [I>=2σ (I)]  R1 = 0.0407, wR2 = 0.0827  
Final R indexes [all data]  R1 = 0.0625, wR2 = 0.0928  








In a flame-dried vial, Mg(ClO4)2 (2 mg, 0.01 mmol, 0.20 equiv.) (WARNING: shock sensitive!) 
was dried under high vacuum at 130 °C for 2 h without magnetic stirrer. The solid was allowed 
to cool down under nitrogen and a solution of alcohol 175 (15 mg, 0.05 mmol, 1.00 equiv.) in 
anhydrous CH2Cl2 (0.10 mL) was added, followed by Boc2O (48 mg, 0.22 mmol, 4.60 equiv.) 
and a small magnetic stirred. The vial was capped and the reaction mixture was stirred at 45 °C 
for 18 h before being diluted with Et2O (5.00 mL) and water (5.00 mL). The layers were sepa-
rated and the aqueous phase was extracted with Et2O (2 × 5.00 mL). The organic layers were 
combined, washed with brine, dried over MgSO4, filtered and concentrated. The crude residue 
was purified by flash column chromatography (n-hexane:Et2O 97:3) to give ether 176 (8 mg, 
39%) as a colourless liquid. 
TLC: Rf = 0.47 (n-hexane:Et2O 95:5) 
1H NMR (500 MHz, Toluene-d8): δ 3.60 (2H, dq, J = 5.8, 6.1 Hz, H3), 1.77 – 1.58 (8H, m, 
8 × CH), 1.14 (18H, s, H1), 1.10 (6H, d, J = 6.1 Hz, H4), 0.92 (6H, d, J = 6.7 Hz, CH3), 0.87 
(6H, d, J = 5.1 Hz, CH3), 0.86 (6H, d, J = 4.8 Hz, H12), 0.81 (6H, d, J = 6.5 Hz, CH3) ppm 
13C NMR (126 MHz, Toluene-d8): δ 72.8 (C2), 68.3 (C3), 41.9 (CH), 36.3 (CH), 36.0 (CH), 35.3 
(CH), 28.9 (C1), 19.0 (C4), 12.4 (CH3), 12.2 (CH3), 12.1 (CH3), 11.3 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C28H58NaO2 [M+Na]+: 449.4329; found 449.4324 
IR (νmax): 2970, 2924, 2878, 1457, 1382, 1198, 1077, 1019, 804 cm1 
[𝛂]𝑫





Alkyne 179 (38 mg, 0.11 mmol, 1.00 equiv.) was charged in a flame-dried vial at room temper-
ature under an atmosphere of nitrogen. A solution of 9-BBN-H (0.50 M in THF, 42 μL, 
0.02 mmol, 0.20 equiv.) was added, followed by catechol borane (25 μL, 0.23 mmol, 
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2.20 equiv.). The vial was capped and the reaction mixture was stirred at 75 °C for 18 h. The 
reaction mixture was diluted with THF (2.00 mL) and the pale-yellow solution was transferred 
to a round-bottom flask containing a mixture of NaOH (2.00 M in water, 2.00 mL) and H2O2 
(30% in water, 1.00 mL) at 0 °C. The biphasic mixture was vigorously stirred at 0 °C for 4 h. The 
layers were separated and the aqueous phase was extracted with Et2O (3 × 5.00 mL). The organic 
layers were combined, washed with brine, dried over MgSO4, filtered and concentrated. The 
crude residue was purified by flash column chromatography (n-pentane:EtOAc 95:5) to give ke-
tone 177 (25 mg, 60%) as a colourless liquid. 
TLC: Rf = 0.44 (n-pentane:EtOAc 90:10) 
1H NMR (500 MHz, Toluene-d8): δ 2.29 (2H, dqdd, J = 7.5, 6.8, 6.1, 4.1 Hz, H4), 2.08 (2H, dd, 
J = 16.3, 6.1 Hz, H3), 1.91 (2H, dd, J = 16.3, 7.5 Hz, H3’), 1.71 (6H, s, H1), 1.67 (2H, dqd, 
J = 7.8, 6.7, 4.0 Hz, H10), 1.61 (2H, m, H12), 1.53 (2H, dqd, J = 7.8, 6.8, 4.0 Hz, H8), 1.31 (2H, 
dqd, J = 7.8, 6.9, 4.1 Hz, H6), 0.83 (6H, d, J = 6.7 Hz, H11), 0.81 (6H, d, J = 6.3 Hz, H13), 0.78 
(6H, d, J = 6.8 Hz, H9), 0.76 (6H, d, J = 6.8 Hz, H5), 0.70 (6H, d, J = 6.9 Hz, H7) ppm 
13C NMR (126 MHz, Toluene-d8): δ 205.6 (C2), 49.6 (C3), 39.1 (C6), 36.0(1) (C8 or C10), 
36.0(2) (C10 or C8), 35.8 (C12), 29.8 (C1), 29.7 (C4), 14.6 (C5), 12.2(0) (CH3), 12.1(7) (CH3), 
11.9 (CH3), 11.8 (C7) ppm 
HRMS (m/z): (ESI+) calc’d. for C26H50NaO2 [M+Na]+: 417.3703; found 417.3702 
IR (νmax): 2967, 2922, 2879, 1715, 1452, 1382, 1357, 1166, 1077, 803 cm1 
[𝛂]𝑫





In a flame-dried Schlenk tube, alkyne C10 (38 mg, 0.11 mmol, 1.00 equiv.) was dissolved in 
anhydrous THF (1.10 mL) at 78 °C under an atmosphere of nitrogen. A solution of n-BuLi 
(1.58 M in n-hexane, 0.29 mL, 0.46 mmol, 4.00 equiv.) was added dropwise and the reaction was 
stirred at 78 °C for 20 min. Methyl iodide (0.07 mL, 1.15 mmol, 10.00 equiv.) was added via 
syringe and the acetone/dry ice bath was removed. The reaction mixture was allowed to stir at 
room temperature for 3 h and a saturated aqueous solution of NH4Cl (2.00 mL) was added. The 
biphasic mixture was extracted with Et2O (3 × 2.00 mL). The organic layers were combined, 
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washed with brine, dried over MgSO4, filtered and concentrated to give alkyne 179 (40 mg, 
quant.) as a colourless liquid. 
TLC: Rf = 0.47 (n-pentane:CH2Cl2 95:5) 
1H NMR (400 MHz, Chloroform-d): δ 2.27 (2H, dqq, J = 8.8, 6.9, 2.4 Hz, H4), 1.86 (2H, dqd, 
J = 8.8, 6.9, 3.6 Hz, H8), 1.79 (6H, d, J = 2.4 Hz), 1.57 (2H, dqd, J = 8.8, 6.8, 3.6 Hz, H6), 1.51 
(2H, m, H12), 1.44 (2H, m, H10), 1.11 (6H, d, J = 6.9 Hz, H5), 0.80 – 0.67 (24H, m, 8 × CH3) 
ppm 
13C NMR (101 MHz, Chloroform-d): δ 84.2 (C3), 76.1 (C2), 39.2 (C6), 36.8 (C8), 35.5 (C12), 
35.4 (C10), 30.0 (C4), 19.0 (C5), 12.0 (CH3), 11.9 (CH3), 11.7(4) (CH3), 11.6(8) (CH3), 3.7 (C1) 
ppm 
HRMS (m/z): (MALDI+) calc’d. for C26H46Na [M+Na]+: 381.3492; found 381.3484 
IR (νmax): 2968, 2919, 2878, 1451, 1382, 1309, 1081, 1058, 1022, 936 cm1 
[𝛂]𝑫
𝟐𝟎: +10 (CHCl3, c = 1.0) 
 
((3R,4S,5R,6S,7R,8R,9S,10R,11S,12R)-3,4,5,6,7,8,9,10,11,12-Decamethyltetradeca-1,13-




In a flame-dried Schlenk tube, alkyne C10 (94 mg, 0.28 mmol, 1.00 equiv.) was dissolved in 
anhydrous THF (3.00 mL) at –78 °C under an atmosphere of nitrogen. A solution of n-BuLi 
(1.50 M in n-hexane, 0.19 mL, 0.28 mmol, 1.00 equiv.) was added dropwise and the reaction 
mixture was stirred at the same temperature for 30 min. After the dropwise addition of TIPSCl 
(0.06 mL, 0.28 mmol, 1.00 equiv.), the acetone/dry ice bath was removed and the reaction mix-
ture was stirred at room temperature for 1 h. A saturated aqueous solution of NH4Cl (2.00 mL) 
and water (2.00 mL) were successively added and the biphasic mixture was extracted with Et2O 
(3 × 5.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, filtered 
and concentrated. The residue was purified by flash column chromatography (pure n-pentane) to 







TLC: Rf = 0.60 (n-pentane:CH2Cl2 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 2.41 – 2.28 (2H, m, H5 & H23), 2.05 (1H, d, J = 2.4 Hz, 
H26), 1.97 (1H, m, H9), 1.88 (1H, m, H19), 1.69 – 1.56 (2H, m, H7 & H21), 1.53 – 1.39 (4H, m, 
H11, H13, H15 & H17), 1.20 – 1.17 (6H, m, H6 & H24), 1.08 – 1.00 (21H, m, H1 & H2), 0.79 
– 0.71 (24H, m, 8 × CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 113.5 (C4), 89.2 (C25), 80.7 (C3), 69.0 (C26), 38.6 (C7 
or C21), 38.6 (C21 or C7), 37.4 (C9), 37.1 (C19), 35.6 (CH), 35.4 (CH), 35.4 (CH), 35.4 (CH), 
31.4 (C5 or C23), 29.9 (C23 or C5), 19.4 (C6 or C24), 18.9 (C24 or C6), 18.8 (C1), 12.0 (CH3), 
12.0 (CH3), 11.9 (CH3), 11.9 (CH3), 11.9 (CH3), 11.7 (CH3), 11.6 (CH3), 11.6 (CH3), 11.5 (C2) 
ppm 
HRMS (m/z): (MALDI+) calc’d. for C33H62NaSi [M+Na]+: 509.4513; found 509.4519 
IR (νmax): 3312, 2967, 2940, 2865, 2162, 1453, 1383, 1083, 995, 883 cm1 
[𝛂]𝑫





TLC: Rf = 0.74 (n-pentane:CH2Cl2 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 2.35 (2H, dq, J = 9.2, 6.8 Hz, H5), 1.97 (2H, dqd, J = 8.8, 
6.8, 3.4 Hz, H9), 1.58 (2H, dqd, J = 9.2, 7.0, 3.4 Hz, H7), 1.50 – 1.39 (4H, m, H11 & H13), 1.19 




13C NMR (126 MHz, Chloroform-d): δ 113.5 (C4), 80.7 (C3), 38.5 (C7), 37.5 (C9), 35.5 (C11 
or C13), 35.4 (C13 or C11), 31.5 (C5), 19.6 (C6), 18.8 (CH3), 12.1 (CH3), 11.9 (CH3), 11.9 (CH3), 
11.6 (CH3), 11.5 (CH3) ppm 
HRMS (m/z): (MALDI+) calc’d. for C42H82Si2 [M+Na]+: 665.5847; found 665.5855 
IR (νmax): 2964, 2941, 2865, 2163, 1461, 1383, 1086, 996, 883 cm1 
[𝛂]𝑫





In a flame-dried Schlenk tube, alkyne 180a (26 mg, 0.05 mmol, 1.00 equiv.) was dissolved in 
anhydrous THF (0.50 mL) at –78 °C under an atmosphere of nitrogen. A solution of n-BuLi 
(1.50 M in n-hexane, 0.07 mL, 0.11 mmol, 2.00 equiv.) was added and the reaction mixture was 
stirred at the same temperature for 20 min. After the dropwise addition of MeI (0.02 mL, 
0.27 mmol, 5.00 equiv.), the acetone/dry ice bath was removed and the reaction was stirred at 
room temperature for 2 h. A saturated aqueous solution of NH4Cl (2.00 mL) and water (2.00 mL) 
were successively added and the biphasic mixture was extracted with Et2O (3 × 5.00 mL). The 
organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated. 
The residue was purified by flash column chromatography (pure n-pentane) to give alkyne 181 
(25 mg, 93%). 
TLC: Rf = 0.41 (n-pentane:CH2Cl2 95:5) 
m.p.: 75 – 79 °C (acetonitrile) 
1H NMR (500 MHz, Chloroform-d): δ 2.37 (1H, dq, J = 9.3, 6.8 Hz, H5), 2.25 (1H, dqq, J = 9.3, 
6.8, 2.3 Hz, H23), 1.96 (1H, m, H9), 1.88 (1H, m, H19), 1.79 (3H, d, J = 2.3 Hz, H27), 1.63 – 
1.55 (2H, m, H7 & H21), 1.52 – 1.39 (4H, m, H11, H13, H15 & H17), 1.19 (3H, d, J = 6.8 Hz, 
H6), 1.12 (3H, d, J = 6.8 Hz, H24), 1.08 – 0.98 (21H, m, H1 & H2), 0.80 – 0.69 (24H, m, 
8 × CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 113.6 (C4), 84.2 (C25), 80.6 (C3), 76.1 (C26), 39.1 (C7 
or C21), 38.6 (C21 or C7), 37.4 (C9), 37.0 (C19), 35.5 (CH), 35.5 (CH), 35.4 (CH), 35.3 (CH), 
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31.4 (C5), 30.1 (C23), 19.4 (C6), 19.2 (C24), 18.8 (C1), 12.0 (CH3), 12.0 (CH3), 12.0 (CH3), 11.9 
(CH3), 11.9 (CH3), 11.7 (CH3), 11.7 (CH3), 11.6 (CH3), 11.5 (C2), 3.7 (C27) ppm 
HRMS (m/z): (MALDI+) calc’d. for C34H64NaSi [M+Na]+: 523.4669; found 523.4661 
IR (νmax): 2967, 2941, 2865, 2162, 1457, 1382, 1260, 1079, 1017, 883, 803 cm1 
[𝛂]𝑫





In a vial were successively charged alkyne 181 (24 mg, 0.05 mmol, 1.00 equiv.), catecholborane 
(6 μL, 0.05 mmol, 1.10 equiv.) and a solution of 9-BBN (0.50 M in THF, 10 μL, 5 μmol, 
0.10 equiv.). The vial was capped and the reaction mixture was stirred at 80 °C for 16 h. The 
pale-yellow solution was cooled down to 0 °C and diluted with THF (0.30 mL). An aqueous 
solution of NaOH (2.00 M, 0.20 mL) was added, followed by an aqueous solution of H2O2 (30%, 
0.10 mL). The biphasic mixture was stirred at 0 °C for 2 h. A saturated aqueous solution of 
NH4Cl (1.00 mL) was added and the biphasic mixture was extracted with Et2O (3 × 2.00 mL). 
The organic layers were combined, washed with brine, dried over MgSO4, filtered and concen-
trated. The residue was purified by flash column chromatography (n-pentane:Et2O 98:2) to give 
ketone 182 (13 mg, 52% over 2 steps) as a colourless liquid. 
TLC: Rf = 0.38 (n-pentane:Et2O 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 2.49 (1H, dd, J = 15.5, 4.5 Hz, H25), 2.45 (1H, dq, 
J = 7.3, 6.8 Hz, H5), 2.18 (1H, dd, J = 15.5, 9.1 Hz, H25’), 2.13 (3H, s, H27), 2.07 (1H, ddqd, 
J = 9.1, 6.8, 6.7, 4.5 Hz, H23), 1.85 (1H, dqd, J = 7.1, 6.9, 4.8 Hz, H9), 1.59 (1H, dqd, J = 7.3, 
6.8, 4.8 Hz, H7), 1.52 – 1.38 (5H, m, 5 × CH), 1.31 (1H, m), 1.14 (3H, d, J = 6.8 Hz, H6), 1.10 
– 0.96 (21H, m, H1 & H2), 0.84 – 0.81 (6H, m, H8 & H24), 0.76 – 0.70 (21H, m, 7 × CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 209.5 (C26), 113.8 (C4), 80.4 (C3), 50.0 (C25), 39.0 
(C7), 38.5 (CH), 36.7 (C9), 36.4 (CH), 36.0 (CH), 35.7 (CH), 35.5 (CH), 35.4 (CH), 31.4 (C23), 
30.7 (C5), 30.6 (C27), 18.8 (C1), 18.3 (C6), 16.6 (C24), 12.2 (CH3), 12.1(3) (2 × CH3), 12.0(9) 
(CH3), 11.8(4) (CH3), 11.8(2) (CH3), 11.8(0) (CH3), 11.7 (CH3), 11.5 (C2) ppm 
HRMS (m/z): (MALDI+) calc’d. for C34H66NaOSi [M+Na]+: 541.4775; found 541.4779 
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IR (νmax): 2966, 2941, 2866, 2162, 1719, 1460, 1383, 1082, 883, 676 cm1 
[𝛂]𝑫





Alkyne 182 (10 mg, 0.02 mmol, 1.00 equiv.) was deprotected with TBAF (1.00 M in THF, 
0.02 mL, 0.02 mmol, 1.10 equiv.) according to GP5. The residue was purified by flash column 
chromatography (n-pentane:Et2O 100:0→95:5) to give ketone 183 (3 mg, 43%) as a colourless 
liquid. 
TLC: Rf = 0.44 (n-pentane:Et2O 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 2.48 (1H, dd, J = 15.6, 4.8 Hz, H23), 2.44 (1H, dqd, 
J = 7.0, 6.9, 2.4 Hz, H3), 2.20 (1H, dd, J = 15.6, 8.9 Hz, H23’), 2.13 (3H, s, H25), 2.09 (1H, 
dqdd, J = 8.9, 6.8, 5.9, 4.8 Hz, H21), 2.04 (1H, d, J = 2.4 Hz, H1), 1.77 (1H, m, H7), 1.61 (1H, 
dqd, J = 7.0, 6.9, 6.3 Hz, H5), 1.55 – 1.39 (5H, m, 5 × CH), 1.32 (1H, dqd, J = 7.0, 6.6, 5.9 Hz, 
H19), 1.13 (3H, d, J = 6.9 Hz, H4), 0.83 (3H, d, J = 6.9 Hz, H6), 0.82 (3H, d, J = 6.8 Hz, H22), 
0.77 – 0.69 (21H, m, 7 × CH3) ppm 
13C NMR (126 MHz, Chloroform-d): δ 209.5 (C24), 89.5 (C2), 68.7 (C1), 50.0 (C23), 39.2 (C5), 
38.6 (C19), 36.3 (CH), 36.2 (CH), 36.0 (CH), 35.7 (CH), 35.5 (CH), 35.4 (CH), 31.1 (C21), 30.6 
(C25), 29.0 (C3), 17.5 (C4), 16.2 (C22), 12.1(9) (CH3), 12.1(5) (CH3), 12.1 (CH3), 12.0 (CH3), 
11.8 (CH3), 11.7(5) (CH3), 11.7(4) (CH3), 11.6(9) (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C25H46NaO [M+Na]+: 385.3441; found 385.3446 
IR (νmax): 3311, 2969, 2926, 2879, 1717, 1453, 1383, 1083 cm1 
[𝛂]𝑫







In a vial, alcohol 175 (33 mg, 0.10 mmol, 1.00 equiv.) was suspended in anhydrous CH2Cl2 
(1.00 mL). Acetic anhydride (30 μL, 0.31 mmol, 3.00 equiv.) was added, followed by triethyla-
mine (43 μL, 0.31 mmol, 3.00 equiv.) and DMAP (3 mg, 0.02 mmol, 0.20 equiv.). The colourless 
solution was stirred at room temperature for 4 h. The reaction mixture was diluted with Et2O 
(10.00 mL), sequentially washed with an aqueous solution of HCl (0.50 M, 10.00 mL), a satu-
rated aqueous solution of NaHCO3 (10.00 mL) and brine, dried over MgSO4, filtered and con-
centrated. The crude residue was purified by flash column chromatography (n-pentane:Et2O 
90:10) to give diacetate 184 (40 mg, quantitative yield) as a colourless liquid. 
TLC: Rf = 0.30 (n-pentane:Et2O 90:10) 
1H NMR (400 MHz, Toluene-d8): δ 5.00 (2H, dq, J = 7.8, 6.3 Hz, H3), 1.83 (2H, dqd, J = 7.8, 
7.0, 4.2 Hz, H5), 1.73 (6H, s, H1), 1.60 (2H, dqd, J = 7.8, 6.7, 4.2 Hz, H7), 1.59 – 1.48 (4H, m, 
H9 & H11), 1.09 (6H, d, J = 6.3 Hz, H4), 0.80 (6H, d, J = 6.6 Hz, H10), 0.79 (6H, d, J = 6.2 Hz, 
H12), 0.76 (6H, d, J = 6.7 Hz, H8), 0.70 (6H, d, J = 7.0 Hz, H6) ppm 
13C NMR (101 MHz, Toluene-d8): δ 169.8 (C2), 72.5 (C3), 39.2 (C5), 36.3 (C9 or C11), 36.0 
(C11 or C9), 35.6 (C7), 21.2 (C1), 17.8 (C4), 12.4(0) (CH3), 12.3(6) (CH3), 12.2 (C10 or C12), 
11.0 (C6) ppm 
HRMS (m/z): (MALDI+) calc’d. for C24H46NaO4 [M+Na]+: 421.3288; found 421.3295 
IR (νmax): 2972, 2925, 2881, 1732, 1453, 1384, 1241, 1078, 1048, 1021, 946 cm1 
[𝛂]𝑫





Carbamate 187 (50 mg, 0.09 mmol, 1.00 equiv.) was dissolved in a mixture of MeOH and EtOAc 
(50:50, 4.00 mL) at room temperature under argon atmosphere. Palladium on activated charcoal 
(10% w/w, 9 mg, 0.01 mmol, 0.10 equiv.) was added and the black suspension was purged with 
argon for 20 min. The inert atmosphere was purged with hydrogen and the reaction mixture was 
stirred at room temperature for 4 h. Hydrogen was replaced with argon and the catalyst was re-
moved by filtration over Celite®. The filtrate was concentrated to give diamine 185 (23 mg, 81%) 
as a white solid. 
TLC: Rf = 0.05 (CH2Cl2:MeOH 80:20 + aq. NH3 35% [1 drop/10.00 mL]) 
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m.p.: 238 – 245 °C (dichloromethane/methanol) 
1H NMR (500 MHz, Toluene-d8): δ 2.59 (2H, dq, J = 7.9, 6.3 Hz, H2), 1.75 (2H, dqd, J = 8.3, 
6.8, 3.7 Hz, H6), 1.63 (2H, m, H10), 1.56 (2H, dqd, J = 8.3, 6.8, 3.3 Hz, H8), 1.35 (2H, dqd, 
J = 7.9, 6.9, 3.7 Hz, H4), 0.93 (6H, d, J = 6.3 Hz, H3), 0.84 – 0.79 (12H, m, H9 & H11), 0.75 
(6H, d, J = 6.8 Hz, H7), 0.74 (6H, d, J = 6.9 Hz, H5) ppm 
13C NMR (126 MHz, Toluene-d8): δ 49.2 (C2), 41.7 (C4), 35.7 (C8 or C10), 35.6 (C10 or C8), 
35.4 (C6), 22.2 (C3), 12.2 (CH3), 11.9(3) (CH3), 11.8(8) (CH3), 11.1 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d. for C20H45N2 [M+H]+: 313.3577; found 313.3581 
IR (νmax): 3457, 3369, 3279, 3176, 2966, 2921, 2878, 1580, 1452, 1382, 1080, 1014, 817 cm1 
[𝛂]𝑫





Potassium carbonate (19 mg, 0.14 mmol, 4.00 equiv.) was charged in a flame-dried vial under an 
atmosphere of nitrogen. A solution of diamine 185 (11 mg, 0.04 mmol, 1.00 equiv.) in anhydrous 
acetonitrile (0.20 mL) was added, followed by benzyl bromide (17 µL, 0.14 mmol, 4.00 equiv.). 
The vial was capped and the white suspension was stirred at 80 °C for 18 h. The reaction mixture 
was allowed to cool to room temperature, diluted with water (1.00 mL) and extracted with Et2O 
(3 × 1.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, filtered 
and concentrated. The residue was purified by flash column chromatography (n-pentane:Et2O 
99:1) to give diamine 186 (15 mg, 64%) as a colourless liquid. 
TLC: Rf = 0.67 (n-pentane:Et2O 90:10) 
1H NMR (500 MHz, Chloroform-d): δ 7.37 (8H, m, H3), 7.29 (8H, m, H2), 7.19 (4H, m, H1), 
3.73 (4H, d, J = 13.6 Hz, H5), 3.26 (4H, d, J = 13.6 Hz, H5’), 2.48 (2H, dq, J = 10.0, 6.5 Hz, 
H6), 2.04 (2H, dqd, J = 9.9, 6.8, 2.4 Hz, H10), 1.73 (2H, dqd, J = 10.0, 6.8, 2.4 Hz, H8), 1.42 – 
1.33 (4H, m, H12 & H14), 1.01 (6H, d, J = 6.5 Hz, H7), 0.63 (6H, d, J = 6.8 Hz, H13), 0.57 (6H, 
d, J = 6.8 Hz, H9), 0.56 (6H, m, H15), 0.22 (6H, d, J = 6.8 Hz, H11) ppm 
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13C NMR (126 MHz, Chloroform-d): δ 140.5 (C4), 129.2 (C3), 128.1 (C2), 126.8 (C1), 54.8 
(C6), 53.7 (C5), 36.5 (C8), 36.0 (C12 or C14), 35.4 (C14 or C12), 34.4 (C10), 12.5 (C9 or C15), 
12.2 (C13), 11.7 (C11), 11.6 (C15 or C9), 9.9 (C7) ppm 
HRMS (m/z): (MALDI+) calc’d. for C48H68N2Na [M+Na]+: 695.5275; found 695.5282 
IR (νmax): 3085, 3063, 3027, 2968, 2929, 2876, 2801, 1945, 1873, 1801, 1740, 1603, 1494, 1453, 
1381, 1028, 744, 730, 697 cm1 
[𝛂]𝑫
𝟐𝟒:  (CHCl3, c = 1.0) 
X-ray: Absolute configuration not determined. Occupancies of the disordered phenyl groups re-
fined with their sum set to equal 1. Restraints and constraints were applied to maintain sensible 
thermal and geometric parameters. The disordered diethyl ether occupancies were necessarily 
fixed at 0.5 as the disorder was across a symmetry element. Restraints and constraints were ap-
plied to maintain sensible thermal and geometric parameters. 
 
Identification code  186  
Empirical formula  C52H78N2O  
Formula weight  747.16  
Temperature/K  100(2)  
Crystal system  orthorhombic  
Space group  P21212  
a/Å  13.2858(3)  
b/Å  16.2747(4)  
c/Å  10.7159(3)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2317.02(10)  
Z  2  
ρcalc/g cm–3  1.071  
μ/mm–1  0.062  
F(000)  824.0  
Crystal size/mm3  0.557 × 0.295 × 0.251  
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Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  3.8 to 52.742  
Index ranges  -16 ≤ h ≤ 16, -20 ≤ k ≤ 20, -13 ≤ l ≤ 13  
Reflections collected  38291  
Independent reflections  4758 [Rint = 0.0668, Rsigma = 0.0409]  
Data/restraints/parameters  4758/242/309  
Goodness-of-fit on F2  1.223  
Final R indexes [I>=2σ (I)]  R1 = 0.0782, wR2 = 0.1619  
Final R indexes [all data]  R1 = 0.0829, wR2 = 0.1640  






Part A: In a flame-dried vial, potassium tert-butoxide (185 mg, 1.65 mmol, 11.00 equiv.) was 
dried under high vacuum at 100 °C for 4 h. The solid was allowed to cool to room temperature 
under argon atmosphere and a mixed solution of boronic ester 154 (80 mg, 0.15 mmol, 
1.00 equiv.) and freshly distilled methoxyamine (93 μL, 1.80 mmol, 12.00 equiv.) in anhydrous 
toluene (1.00 mL) was added. The vial was capped and the white suspension was stirred at 105 °C 
for 24 h. The reaction mixture was allowed to cool to room temperature before an aqueous solu-
tion of NaOH (3.00 M, 2.00 mL) was added. The biphasic mixture was vigorously stirred for 
30 min at room temperature and Na2SO4 (614 mg) was added. The white suspension was stirred 
for 30 min, layers were separated and the aqueous phase was extracted with EtOAc 
(5 × 2.00 mL). The organic layers were combined, sequentially washed with an aqueous solution 
of NaOH (3.00 M, 5.00 mL) and with brine, dried over MgSO4, filtered and concentrated. Part 
B: The crude residue was dissolved in anhydrous THF (0.50 mL) at 0 °C under an atmosphere 
of nitrogen. Diisopropylethylamine (0.105 mL, 0.60 mmol, 4.00 equiv.) was added, followed by 
benzyl chloroformate (44 μL, 0.32 mmol, 2.10 equiv.). The ice bath was removed and the sus-
pension was stirred at room temperature for 18 h. The reaction mixture was diluted with a satu-
rated aqueous solution of NH4Cl (2.00 mL) and extracted with Et2O (3 × 2.00 mL). The organic 
layers were combined, washed with brine, dried over MgSO4, filtered and concentrated. The res-
idue was purified by flash column chromatography (n-pentane:Et2O 90:10→80:20) to give car-
bamate 187 (54 mg, 62% over 2 steps) as a colourless liquid. 
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TLC: Rf = 0.17 (n-pentane:Et2O 70:30) 
1H NMR (500 MHz, Toluene-d8): δ 7.23 (4H, m, H3), 7.12 (4H, m, H2), 7.06 (2H, m, H1), 5.08 
(2H, d, J = 12.4 Hz, H5), 5.02 (2H, d, J = 12.4 Hz, H5’), 4.25 (2H, app. d, Japp. = 8.8 Hz, H7), 
3.82 (2H, app. pent, Japp. = 7.1 Hz, H8), 1.61 – 1.40 (8H, m, 8 × CH), 0.86 – 0.79 (12H, m, 
4 × CH3), 0.79 – 0.70 (12H, m, 4 × CH3), 0.60 (6H, d, J = 6.3 Hz, CH3) ppm 
13C NMR (126 MHz, Toluene-d8): δ 155.6 (C6), 137.7 (C4), 128.5(3) (C2 or C3), 128.4(8) (C3 
or C2), 128.0 (C1), 66.4 (C5), 48.7 (C8), 39.9 (CH), 35.9 (CH), 35.8 (CH), 35.6 (CH), 17.0 (CH3), 
12.1 (CH3), 12.0 (CH3), 11.9 (CH3), 11.3 (CH3) ppm 
HRMS (m/z): (MALDI+) calc’d. for C36H56N2NaO4 [M+Na]+: 603.4138; found 603.4132 
IR (νmax): 3332, 3066, 3033, 2970, 2939, 2879, 2479, 1693, 1532, 1452, 1420, 1383, 1327, 1237, 
1072, 733, 696 cm1 
[𝛂]𝑫




Carbamate 190 (66 mg, 0.14 mmol, 1.00 equiv.) was dissolved in a mixture of MeOH and EtOAc 
(50:50, 4.00 mL) at room temperature under argon atmosphere. Palladium on activated charcoal 
(10% w/w, 15 mg, 0.01 mmol, 0.10 equiv.) was added and the black suspension was purged with 
argon for 20 min. The inert atmosphere was purged with hydrogen and the reaction mixture was 
stirred at room temperature for 4 h. Hydrogen was replaced with argon and the catalyst was re-
moved by filtration over Celite®. The filtrate was concentrated to give diamine 188 (22 mg, 78%) 
as a colourless wax. 
TLC: Rf = 0.05 (CH2Cl2:MeOH 80:20 + aq. NH3 35% [1 drop/10.00 mL]) 
1H NMR (500 MHz, Toluene-d8): δ 2.58 (2H, dq, J = 8.0, 6.3 Hz, H2), 1.64 (2H, m, H6), 1.28 
(2H, dqd, J = 8.0, 6.9, 3.4 Hz, H4), 0.91 (6H, d, J = 6.3 Hz, H3), 0.73 (6H, m, H7), 0.71 (6H, d, 
J = 6.9 Hz, H5) ppm 
13C NMR (126 MHz, Toluene-d8): δ 49.0 (C2), 41.6 (C4), 35.2 (C6), 22.1 (C3), 11.8 (C7), 10.8 
(C5) ppm 
HRMS (m/z): (ESI+) calc’d. for C12H29N2 [M+H]+: 201.2325; found 201.2332 




𝟐𝟔: 6 (MeOH, c = 1.0) 
 
Dibenzyl ((2R,3S,4R,5R,6S,7R)-3,4,5,6-tetramethyloctane-2,7-diyl)dicarbamate (190) 
 
Part A: In a flame-dried vial, potassium tert-butoxide (293 mg, 2.61 mmol, 11.00 equiv.) was 
dried under high vacuum at 100 °C for 4 h. The solid was allowed to cool to room temperature 
under argon atmosphere and a mixed solution of boronic ester 152 (100 mg, 0.24 mmol, 
1.00 equiv.) and freshly distilled methoxyamine (0.15 mL, 2.84 mmol, 12.00 equiv.) in anhy-
drous toluene (2.00 mL) was added. The vial was capped and the white suspension was stirred at 
105 °C for 24 h. The reaction mixture was allowed to cool to room temperature before an aqueous 
solution of NaOH (3.00 M, 2.00 mL) was added. The biphasic mixture was vigorously stirred for 
30 min at room temperature and Na2SO4 (614 mg) was added. The white suspension was stirred 
for 30 min, layers were separated and the aqueous phase was extracted with EtOAc 
(5 × 2.00 mL). The organic layers were combined, sequentially washed with an aqueous solution 
of NaOH (3.00 M, 5.00 mL) and brine, dried over MgSO4, filtered and concentrated. Part B: The 
crude residue was dissolved in anhydrous THF (2.00 mL) and the solution was transferred to a 
flame-dried vial under an atmosphere of nitrogen. Diisopropylethylamine (0.17 mL, 0.96 mmol, 
4.00 equiv.) was added, followed by benzyl chloroformate (0.07 mL, 0.50 mmol, 2.10 equiv.). 
After the addition, the suspension was stirred at room temperature for 18 h. The reaction mixture 
was diluted with a saturated aqueous solution of NH4Cl (2.00 mL) and extracted with Et2O 
(3 × 2.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, filtered 
and concentrated. The crude residue was purified by flash column chromatography (n-pen-
tane:Et2O 100:0→60:40) to give carbamate 190 (66 mg, 59% over 2 steps) as a colourless liquid. 
TLC: Rf = 0.15 (n-pentane:Et2O 70:30) 
1H NMR (500 MHz, Chloroform-d): δ 7.42 – 7.29 (10H, m, H1, H2 & H3), 5.11 (2H, d, 
J = 12.2 Hz, H5), 5.05 (2H, d, J = 12.2 Hz, H5’), 4.49 (2H, m, H7), 3.71 (2H, m, H8), 1.56 (2H, 
m, H10), 1.48 (2H, m, H12), 1.05 (6H, d, J = 6.7 Hz, H9), 0.84 (6H, m, H13), 0.76 (6H, d, 
J = 6.9 Hz, H11) ppm 
13C NMR (126 MHz, Chloroform-d): δ 155.8 (C6), 136.8 (C4), 128.7 (CHAr), 128.3 (2 × CHAr), 
66.7 (C5), 48.6 (C8), 39.3 (C10), 35.6 (C12), 17.0 (C9), 11.7 (C13), 11.4 (C11) ppm 
HRMS (m/z): (MALDI+) calc’d. for C28H40N2NaO4 [M+Na]+: 491.2880; found 491.2889 
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IR (νmax): 3426, 3325, 3063, 3034, 2973, 2880, 1696, 1532, 1454, 1337, 1239, 1070, 697 cm1 
[𝛂]𝑫





Diamine 188 (2 mg, 0.01 mmol, 1.00 equiv.) was dissolved in methanol-d4 in an NMR tube. No-
nafluorobutanesulfonic acid (3 µL, 0.02 mmol, 2.00 equiv.) was added, the tube was capped and 
vigorously shaken to give 191 as a solution in methanol-d4. 
1H NMR (500 MHz, Methanol-d4) δ 3.25 (2H, qd, J = 6.6, 6.3 Hz, H2), 1.71 (2H, qdd, J = 6.9, 
6.3, 5.0 Hz, H4), 1.52 (2H, m, H6), 1.19 (6H, d, J = 6.6 Hz, H3), 0.88 (6H, d, J = 6.9 Hz, H5), 
0.86 (6H, m, H7) ppm 
13C NMR (126 MHz, Methanol-d4) δ 50.3 (C2), 39.8 (C4), 36.4 (C6), 16.1 (C3), 11.7 (C7), 10.7 
(C5) ppm 
 
3.3. Supplementary materials – Chapter 2 
3.3.1. General procedures 
General procedure 6 (GP6): In a round-bottomed flask, N-hydroxyphthalimide (1.0 or 
2.00 equiv.) or tetrachloro-N-hydroxyphthalimide (1.00 equiv.) or methyl-substituted N-hydrox-
yphthalimide 369 (1.00 equiv.) was suspended in ethanol-free CH2Cl2 (0.10 M) at room temper-
ature. Carboxylic acid (1.00 equiv.) was added, followed by diisopropylcarbodiimide (DIC) (1.0 
or 2.00 equiv.) and dimethylaminopyridine (DMAP) (0.00–0.40 equiv.). The reaction mixture 
was stirred at room temperature for 16 h. The white suspension was concentrated under reduced 
pressure and the crude residue was purified by flash column chromatography and/or recrystalli-
sation to give the desired product. 
 
General procedure 7 (GP7): In a round-bottomed flask, N-hydroxyphthalimide (1.00 equiv.) 
and carboxylic acid (1.00 equiv.) were suspended in THF (0.40 M) at room temperature. A solu-
tion of dicyclohexylcarbodiimide (DCC) (1.00 equiv.) in THF (0.40 M) was added and the reac-
tion mixture was stirred at room temperature for 48 h. The white suspension stored at 20 °C for 
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1 h and the white solid was removed by filtration. The filtrate was concentrated under reduced 
pressure and the crude residue was purified by flash column chromatography and/or recrystalli-
sation to give the desired product. 
 
General procedure 8 (GP8): Activated ester (1.00 equiv.) and B2cat2 (1.25 or 2.50 equiv.) were 
carefully weighed into a flame-dried 7-mL vial containing a small magnetic stirrer bar. DMAc 
(0.10 M) was added and the headspace of the vial was purged with a gentle stream of argon for 
approximately 10 seconds. The vial was tightly sealed and stirred under blue LED irradiation for 
14 h. Pinacol (4.0 or 8.00 equiv.) was added, followed by Et3N (0.45 mL) and the reaction mix-
ture was stirred for 1 h. The reaction mixture was transferred into a vial containing EtOAc 
(15 mL), water (3.00 mL) and a saturated aqueous solution of NH4Cl (3.00 mL). After vigorously 
shaking and allowing the two layers to separate, the top organic layer was carefully removed with 
a pipette. This was repeated twice more with EtOAc (5.00 mL). The organic layers were com-
bined and concentrated under reduced pressure. The crude residue was directly purified using a 
short silica gel column to yield the desired boronic ester. 
 
3.3.2. Experimental procedures and characterisation data 
1,3-Dioxoisoindolin-2-yl 4,4-difluorocyclohexane-1-carboxylate (305)  
 
Carboxylic acid 304 (250 mg, 1.52 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(248 mg, 1.52 mmol, 1.00 equiv.), DIC (0.24 mL, 1.52 mmol, 1.00 equiv.) and DMAP (18 mg, 
0.15 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 75:25) to give activated ester 305 (417 mg, 89%) as a white solid. 
TLC: Rf = 0.19 (n-pentane:EtOAc 90:10) 
m.p.: 109 – 112 °C (dichloromethane/methanol) 
1H NMR: (400 MHz, Chloroform-d) δ 7.89 (2H, m, H8 or H9), 7.80 (2H, m, H9 or H8), 2.89 
(1H, m, H4), 2.26 – 2.04 (6H, m, 2 × CHaHb & 2 × CH2), 1.97 – 1.84 (2H, m, 2 × CHaHb) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.6 (C5), 162.0 (C6), 135.0 (C8 or C9), 129.0 (C7), 
124.1 (C9 or C8), 122.3 (t, J = 241.3 Hz, C1), 37.9 (C4), 32.2 (t, J = 24.8 Hz, C2), 25.1 (t, 
J = 5.1 Hz, C3) ppm 
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19F NMR: (377 MHz, Chloroform-d) δ –95.6 (app. d, Japp. = 239.8 Hz), –98.4 (app. d, 
Japp. = 239.8 Hz) ppm 
HRMS (m/z): (ESI+) calc’d for C15H13F2NNaO4 [M+Na]+: 332.0705; found: 332.0708 
IR (νmax): 2973, 2948, 1809, 1782, 1740, 1374, 1360, 1147, 1114, 1115, 1079, 981, 947 cm–1 
 
2-(4,4-Difluorocyclohexyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (306)  
 
Activated ester 305 (40 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 95:5) to give boronic 
ester 306 (21 mg, 66%) as a colourless liquid. 
TLC: Rf = 0.51 (n-pentane:Et2O 85:15) 
1H NMR: (400 MHz, Chloroform-d) δ 1.99 (2H, m, 2 × CHaHb), 1.85 – 1.52 (6H, m, 2 × CHaHb 
& 2 × CH2), 1.23 (12H, s, H6), 0.97 (1H, m, H4) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 123.9 (t, J = 240.5 Hz, C1), 83.4 (C5), 34.5 (t, 
J = 23.2 Hz, C2), 24.9 (C6), 24.4 (m, C3) ppm 
The signal corresponding to C4 was not observed due to quadrupolar relaxation. 
19F NMR: (377 MHz, Chloroform-d) δ –91.6 (app. d, Japp. = 234.0 Hz), –98.7 (app. d, 
Japp. = 234.0 Hz) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
IR (νmax): 2878, 2938, 2870, 1414, 1388, 1369, 1320, 1145, 1108, 1093, 958, 852 cm–1 
 
1,3-Dioxoisoindolin-2-yl trans-2-phenylcyclopropane-1-carboxylate (308) 
 
Carboxylic acid 307 (1.00 g, 6.17 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(1.01 g, 6.17 mmol, 1.00 equiv.), DIC (0.95 mL, 6.17 mmol, 1.00 equiv.) and DMAP (75 mg, 
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0.62 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 80:20→60:40) to give activated ester 308 (1.55 g, 82%) as a white 
solid. 
TLC: Rf = 0.34 (n-pentane:Et2O 70:30) 
m.p.: 116 – 119 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 7.90 (2H, m, H11 or H12), 7.79 (2H, m, H12 or H11), 
7.34 (2H, m, H2 or H3), 7.27 (1H, m, H1), 7.28 (2H, m, H3 or H2), 2.79 (1H, ddd, J = 9.1, 6.9, 
4.0 Hz, H5), 2.23 (1H, ddd, J = 8.4, 5.2, 4.0 Hz, H7), 1.83 (1H, ddd, J = 9.1, 5.2, 4.9 Hz, H6), 
1.64 (1H, ddd, J = 8.4, 6.9, 4.9 Hz, H6’) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 169.8 (C8), 162.1 (C9), 138.6 (C4), 134.8 (C11 or C12), 
129.1 (C10), 128.8 (C2 or C3), 127.3 (C1), 126.5 (C3 or C2), 124.1 (C12 or C11), 28.4 (C5), 
21.1 (C7), 18.6 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C18H13NNaO4 [M+Na]+: 330.0737; found: 330.0748 
IR (νmax): 3518, 3065, 3031, 1806, 1778, 1738, 1401, 1360, 1186, 1100, 1072, 878, 757 cm–1 
 
4,4,5,5-Tetramethyl-2-(trans-2-phenylcyclopropyl)-1,3,2-dioxaborolane (309)  
 
Activated ester 308 (40 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 95:5) to give boronic 
ester 309 (19 mg, 60%, 98:2 d.r.) as a colourless liquid. 
TLC: Rf = 0.35 (n-pentane:Et2O 95:5) 
1H NMR: (400 MHz, Chloroform-d) δ 7.24 (2H, m, H2 or H3), 7.14 (1H, m, H1), 7.08 (2H, m, 
H3 or H2), 2.11 (1H, ddd, J = 8.1, 5.5, 5.2 Hz, H5), 1.26 (6H, s, H9), 1.24 (6H, s, H9’), 1.16 (1H, 
ddd, J = 8.1, 6.8, 3.7 Hz, H6), 1.01 (1H, ddd, J = 9.5, 5.2, 3.7 Hz, H6’), 0.31 (1H, ddd, J = 9.5, 
6.8, 5.5 Hz, H7) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 143.5 (C4), 128.4 (C2 or C3), 125.8 (C3 or C2), 125.7 
(C1), 83.3 (C8), 24.9 (C9), 24.8 (C9’), 22.0 (C5), 15.2 (C6) ppm 
The signal corresponding to C7 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (EI+) calc’d for C15H21BO2 [M]+: 244.1635; found: 244.1634 
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IR (νmax): 3518, 3065, 3031, 1806, 1778, 1738, 1467, 1401, 1360, 1186, 1100, 1072, 878 cm–1 
 
1,3-Dioxoisoindolin-2-yl 3-(pyridin-3-yl)propanoate (311)  
 
Carboxylic acid 310 (500 mg, 3.31 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(540 mg, 3.31 mmol, 1.00 equiv.) and DCC (682 mg, 3.31 mmol, 1.00 equiv.) according to GP7. 
The crude residue was purified by recrystallisation from EtOAc to afford activated ester 311 
(447 mg, 46%) as a pale yellow solid. 
TLC: Rf = 0.21 (n-pentane:acetone 30:70) 
m.p.: 111 – 115 °C (ethyl acetate) 
1H NMR: (400 MHz, Chloroform-d) δ 8.54 (1H, d, J = 2.3 Hz, H1), 8.50 (1H, dd, J = 4.9, 1.6 Hz, 
H2), 7.87 (2H, m, H11 or H12), 7.78 (2H, m, H12 or H11), 7.60 (1H, ddd, J = 7.8, 2.3, 1.6 Hz, 
H4), 7.26 (1H, dd, J = 7.8, 4.9 Hz, H3), 3.11 (2H, t, J = 7.4 Hz, H6), 2.99 (2H, t, J = 7.4 Hz, H7) 
ppm 
13C NMR: (101 MHz, Chloroform-d) δ 168.6 (C8), 161.9 (C9), 149.9 (C1), 148.4 (C2), 136.0 
(C4), 134.9 (C11 or C12), 134.6 (C5), 129.0 (C10), 124.1 (C12 or C11), 123.7 (C3), 32.4 (C7), 
27.9 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C16H12N2NaO4 [M+Na]+: 319.0689; found: 319.0692 
IR (νmax): 3055, 2943, 2324 (br.), 1812, 1783, 1741, 1714, 1188, 1135, 1079, 970, 876 cm–1 
 
3-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)pyridine (312)  
 
Activated ester 311 (77 mg, 0.26 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-hexane:acetone 90:10) to give bo-
ronic ester 312 (10 mg, 16%) as a colourless liquid. 
TLC: Rf = 0.54 (n-pentane:acetone 80:20) 
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1H NMR: (500 MHz, Chloroform-d) δ 8.48 (1H, app. br. s, H1), 8.41 (1H, app. d, Japp. = 4.8 Hz, 
H2), 7.52 (1H, app. d, Japp. = 7.7 Hz, H4), 7.18 (1H, dd, J = 7.7, 4.8 Hz, H3), 2.74 (2H, t, 
J = 8.0 Hz, H6), 1.21 (12H, s, H9 & H9’), 1.14 (2H, t, J = 8.0 Hz, H7) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 149.9 (C1), 147.2 (C2), 139.6 (C5), 135.6 (C4), 123.3 
(C3), 83.4 (C8), 29.8 (C7), 27.3 (C6), 24.9 (C9) ppm 
HRMS (m/z): (ESI+) calc’d for C13H20BNNaO2 [M+Na]+: 256.1482; found: 256.1480 
IR (νmax): 2978, 2929, 1575, 1479, 1422, 1372, 1311, 1144, 968, 849, 714 cm–1 
 
1,3-Dioxoisoindolin-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate (314) 
 
Carboxylic acid 313 (100 mg, 0.33 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(54 mg, 0.33 mmol, 1.00 equiv.), DIC (0.05 mL, 0.33 mmol, 1.00 equiv.) and DMAP (4 mg, 
0.03 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-pentane:Et2O 90:10) to give activated ester 314 (110 mg, 74%) as a colourless 
liquid. 
TLC: Rf = 0.15 (n-pentane:Et2O 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H23 or H24), 7.78 (2H, m, H24 or H23), 
5.50 – 5.29 (8H, m, 8 × CH), 2.87 – 2.80 (6H, m, H8, H11 & H14), 2.68 (2H, t, J = 7.4 Hz, H19), 
2.24 (2H, td, J = 7.3, 7.1 Hz, H17), 2.05 (2H, td, J = 7.0, 6.9 Hz, H5), 1.87 (2H, tt, J = 7.4, 
7.3 Hz, H18), 1.40 – 1.22 (6H, m, H2, H3 & H4), 0.88 (3H, t, J = 6.8 Hz, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 169.6 (C20), 162.0 (C21), 134.8 (C23 or C24), 130.6 
(CH), 129.8 (CH), 129.1 (C22), 128.7 (CH), 128.5 (CH), 128.3 (CH), 128.2 (CH), 128.0 (CH), 
127.7 (CH), 124.1 (C24 or C23), 31.6 (CH2), 30.5 (C19), 29.5 (CH2), 27.3 (C5), 26.3 (C17), 25.8 
(C8, C11 & C14), 24.7 (C18), 22.7 (CH2), 14.2 (C1) ppm 
HRMS (m/z): (ESI+) calc’d for C28H35NNaO4 [M+Na]+: 472.2458; found: 472.2460 









Activated ester 314 (58 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 95:5) to give boronic 
ester 315 (29 mg, 58%) as a colourless liquid. 
TLC: Rf = 0.50 (n-pentane:Et2O 95:5) 
1H NMR: (400 MHz, Chloroform-d) δ 5.48 – 5.24 (8H, m, 8 × CH), 2.92 – 2.73 (6H, m, H8, 
H11 & H14), 2.06 (4H, app. q, Japp. = 7.0 Hz, H5 & H17), 1.48 (2H, tt, J = 7.8, 7.7 Hz, H18), 
1.41 – 1.27 (6H, m, H2, H3 & H4), 1.24 (12H, s, H21), 0.89 (3H, t, J = 6.8 Hz, H1), 0.80 (2H, t, 
J = 7.9 Hz, H19) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 130.5 (CH), 130.2 (CH), 128.6 (CH), 128.5 (CH), 128.0 
(CH), 128.0 (CH), 127.9 (CH), 127.6 (CH), 82.9 (C20), 31.5 (CH2), 29.8 (C5 or C17), 29.3 (CH2), 
27.2 (C17 or C5), 25.6 (C8, C11 & C14), 24.8 (C21), 24.1 (C18), 22.6 (CH2), 14.1 (C1) ppm 
The signal corresponding to C19 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (EI+) calc’d for C25H43BO2 [M]+: 386.3356; found: 386.3338 
IR (νmax): 3012, 2977, 2958, 2927, 2858, 1459, 1371, 1316, 969, 846 cm–1 
 
Bis(1,3-dioxoisoindolin-2-yl) succinate (317) 
 
Succinic acid 316 (500 mg, 4.23 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(1.38 g, 8.46 mmol, 2.00 equiv.), DIC (2.64 mL, 8.46 mmol, 2.00 equiv.) and DMAP (102 mg, 
0.84 mmol, 0.20 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (CH2Cl2:Et2O 98:2) to give activated ester 317 (1.02 g, 59%) as a colourless wax. 
TLC: Rf = 0.21 (CH2Cl2:Et2O 98:2) 




13C NMR: (101 MHz, Dimethyl sulfoxide-d6) δ 168.8 (C5), 161.6 (C4), 135.5 (C1 or C2), 128.1 
(C3), 124.0 (C2 or C1), 25.3 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C20H12N2NaO8 [M+Na]+: 431.0486, found: 431.0484 
IR (νmax): 3058, 2939, 1788, 1732, 1467, 1375, 1301, 1186, 1140, 1076, 972, 882, 789, 728, 694, 
601, 519 cm1 
 
1,2-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethane (318)  
 
Activated ester 317 (53 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (80 mg, 
0.32 mmol, 2.50 equiv.), and pinacol (126 mg, 1.06 mmol, 8.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 100:0→90:10) to 
give boronic ester 318 (15 mg, 41%) as a colourless liquid. 
TLC: Rf = 0.37 (n-pentane:Et2O 85:15) 
1H NMR: (400 MHz, Chloroform-d) δ 1.23 (24H, s, H1), 0.84 (4H, s, H3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 83.0 (C2), 25.0 (C1), 4.6 (C3) ppm 
Spectral data were in accordance with that reported in the literature.293  
 
1,3-Dioxoisoindolin-2-yl (R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dime-
thylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate (320)  
 
Carboxylic acid 319 (1.00 g, 2.66 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(433 mg, 2.66 mmol, 1.00 equiv.), DIC (0.41 mL, 2.66 mmol, 1.00 equiv.) and DMAP (32 mg, 
0.27 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-




TLC: Rf = 0.42 (n-pentane:EtOAc 50:50) 
m.p.: 161 – 163 °C (ethyl acetate) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H28 or H29), 7.78 (2H, m, H29 or H28), 
3.62 (1H, dddd, J = 11.1, 11.0, 4.7, 4.6 Hz, H2), 2.71 (1H, ddd, J = 15.9, 9.6, 4.8 Hz, H24), 2.58 
(1H, ddd, J = 15.9, 9.0, 6.9 Hz, H24’), 2.05 – 1.93 (2H, m), 1.91 – 1.83 (2H, m), 1.81 – 1.70 (2H, 
m), 1.66 (1H, m), 1.61 – 1.46 (4H, m), 1.44 – 1.36 (5H, m), 1.35 – 1.21 (4H, m), 1.19 – 1.02 (5H, 
m), 1.01 – 0.95 (4H, m), 0.92 (3H, s, CH3), 0.67 (3H, s, CH3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 170.2 (C25), 162.1 (C26), 134.8 (C28 or C29), 129.1 
(C27), 124.1 (C29 or C28), 72.0 (C2), 56.6 (CH), 56.0 (CH), 43.0 (CIV), 42.2 (CH), 40.6 (CH), 
40.3 (CH2), 36.6 (CH2), 36.0 (CH), 35.5 (CH2), 35.4 (CH), 34.7 (CIV), 30.9 (CH2), 30.7 (CH2), 
28.3 (CH2), 28.2 (CH2), 27.3 (CH2), 26.6 (CH2), 24.3 (CH2), 23.5 (CH3), 21.0 (CH2), 18.4 (C21), 
12.2 (CH3) ppm 
HRMS (m/z): (ESI+) calc’d for C32H43NNaO5 [M+Na]+: 544.3033; found: 544.3032 
IR (νmax): 3366 (br.), 2929, 2863, 1816, 1788, 1741, 1467, 1365, 1186, 1067, 878, 732 cm–1 
[𝜶]𝑫
𝟐𝟒: +18 (CHCl3, c = 1.0) 
 
(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-4-(4,4,5,5-tetramethyl-1,3,2-diox-
aborolan-2-yl)butan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol (321)  
 
Activated ester 320 (68 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 60:40) to give bo-
ronic ester 321 (52 mg, 87%) as a white solid. 
TLC: Rf = 0.24 (n-pentane:Et2O 50:50) 
m.p.: 159 – 161 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 3.61 (1H, dddd, J = 11.1, 11.0, 4.7, 4.6 Hz, H2), 1.96 (1H, 
m), 1.91 – 1.70 (4H, m), 1.65 (1H, m), 1.60 – 1.46 (3H, m), 1.45 – 1.28 (7H, m), 1.28 – 1.17 
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(15H, m), 1.17 – 0.94 (7H, m), 0.91 (3H, s, CH3), 0.88 (3H, d, J = 6.5 Hz, H22), 0.79 (1H, ddd, 
J = 15.8, 10.7, 5.1 Hz, H24), 0.68 – 0.56 (4H, m, CH3 & H24’) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 82.9 (C25), 72.0 (C2), 56.7 (CH), 56.1 (CH), 42.8 (CIV), 
42.3 (CH), 40.6 (CH), 40.4 (CH2), 37.8 (CH), 36.7 (CH2), 36.0 (CH), 35.5 (CH2), 34.7 (CIV), 30.7 
(CH2), 29.9 (CH2), 28.4 (CH2), 27.4 (CH2), 26.6 (CH2), 25.0 (C26), 24.9 (C26’), 24.4 (CH2), 23.5 
(CH3), 21.0 (CH2), 18.2 (C22), 12.2 (CH3) ppm 
The signal corresponding to C24 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d for C29H51BNaO3 [M+Na]+: 481.3829; found: 481.3827 
IR (νmax): 3346, 2975, 2929, 2864, 1448, 1369, 1311, 1144, 1040, 966, 909, 848, 732 cm–1 
[𝜶]𝑫






Part A: To a 100-mL round-bottom flask was added lithocholic acid 322 (1.88 g, 5.00 mmol, 
1.00 equiv.) and dry DMF (13.00 mL) under nitrogen. To the stirring solution was added TBSCl 
(3.01 g, 20.00 mmol, 4.00 equiv.), followed by the portion-wise addition of imidazole (2.72 g, 
40.00 mmol, 8.00 equiv.). The suspension was heated to 50 °C for 4 hours and then cooled to 
room temperature. Brine (50.00 mL) was added and the crude reaction mixture was extracted 
with n-hexane (2 × 50.00 mL). The combined organic extracts were washed with cold 1.00 M 
HCl (20.00 mL), dried over MgSO4, filtered, and concentrated under reduced pressure to afford 
a viscous oil. The crude material was dissolved in a mixture of THF and MeOH (50:50, 34 mL), 
and an aqueous solution of K2CO3 (1.00 M, 17 mL) was added. The reaction was stirred at room 
temperature overnight, diluted with brine (30.00 mL), acidified to pH = 4 with an aqueous solu-
tion of KHSO4 (1.00 M), and extracted with CH2Cl2 (3 × 50.00 mL). The combined organic ex-
tracts were dried over MgSO4, filtered, and concentrated under reduced pressure. Part B: The 
intermediate was activated with N-hydroxyphthalimide (816 mg, 5.00 mmol, 1.00 equiv.), DIC 
(0.77 mL, 5.00 mmol, 1.00 equiv.) and DMAP (61 mg, 0.50 mmol, 0.10 equiv.) according to 
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GP6. The crude residue was purified by flash column chromatography (n-hexane:EtOAc 95:5) 
to give activated ester 323 (1.37 g, 43% over 2 steps) as a white solid. 
TLC: Rf = 0.55 (n-hexane:EtOAc 90:10) 
m.p.: 194 – 198 °C (dichloromethane/methanol) 
1H NMR: (400 MHz, Chloroform-d) δ 7.91 – 7.86 (2H, m, H30 or H31), 7.80 – 7.76 (2H, m, 
H31 or H30), 3.58 (1H, app. tt, Japp. = 11.0, 4.7 Hz, H4), 2.71 (1H, m, H26), 2.59 (1H, m, H26’), 
1.98 – 1.72 (6H, m), 1.58 – 0.86 (23H, m), 0.90 (3H, s, CH3), 0.89 (9H, s, H1), 0.67 (3H, s, CH3), 
0.06 (6H, s, H3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 170.2 (C27), 162.1 (C28), 134.8 (C30 or C31), 129.1 
(C29), 124.1 (C31 or C30), 73.0 (C4), 56.5 (CH), 56.1 (CH), 42.9 (CIV), 42.4 (CH), 40.4 (CH), 
40.3 (CH2), 37.1 (CH2), 36.0 (CH), 35.7 (CH2), 35.4 (CH), 34.7 (CIV), 31.2 (CH2), 30.9 (CH2), 
28.3 (CH2), 28.2 (CH2), 27.5 (CH2), 26.5 (CH2), 26.1 (C1), 24.4 (CH2), 23.5 (CH3), 21.0 (CH2), 
18.5 (C2), 18.4 (C23), 12.2 (CH3), 4.4 (C3) ppm 
HRMS (m/z): (ESI+) calc’d for C38H57BNO5SiNa [M+Na]+: 658.3898, found: 658.3888 
IR (νmax): 2930, 2860, 1744, 1065, 835, 781 cm1  
[𝜶]𝑫




yl)oxy)dimethylsilane (324)  
 
Activated ester 323 (83 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 95:5) to give boronic 
ester 324 (54 mg, 72%) as a viscous solid. 
TLC: Rf = 0.38 (n-pentane:Et2O 95:5) 
m.p.: 159 – 161 °C (diethyl ether) 
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1H NMR: (400 MHz, Chloroform-d) δ 3.57 (1H, dddd, J = 10.9, 10.7, 4.7, 4.5 Hz, H4), 1.95 (1H, 
m), 1.90 – 1.70 (4H, m), 1.59 – 1.50 (3H, m), 1.48 – 1.28 (8H, m), 1.28 – 1.17 (15H, m), 1.16 – 
0.98 (6H, m), 0.98 – 0.75 (17H, m), 0.69 – 0.54 (4H, m), 0.05 (6H, s, C3) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 82.9 (C27), 73.0 (C4), 56.6 (CH), 56.2 (CH), 42.9 (CIV), 
42.5 (CH), 40.4 (CH), 40.3 (CH2), 37.8 (CH), 37.1 (CH2), 36.1 (CH), 35.8 (CH2), 34.8 (CIV), 31.2 
(CH2), 29.9 (CH2), 28.4 (CH2), 27.5 (CH2), 26.6 (CH2), 26.2 (C1), 25.0 (C28), 24.9 (C28’), 24.4 
(CH2), 23.6 (CH3), 21.0 (CH2), 18.5 (CH), 18.2 (CH3), 12.2 (CH3), –4.4 (C3) ppm 
The signal corresponding to C26 was not observed due to quadrupolar relaxation. 
HRMS (m/z): (ESI+) calc’d for C35H65BNaO3Si [M+Na]+: 595.4695; found: 595.4690 
IR (νmax): 2927, 2856, 1470, 1370, 1312, 1251, 1146, 1095, 1080, 871, 835, 774 cm–1 
[𝜶]𝑫
𝟐𝟒: +17 (CHCl3, c = 1.0) 
 
1,3-Dioxoisoindolin-2-yl (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-
azabicyclo[3.2.0]heptane-2-carboxylate (326)  
 
Penicillin 325 (437 mg, 1.31 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(213 mg, 1.31 mmol, 1.00 equiv.) and DCC (270 mg, 1.31 mmol, 1.00 equiv.) according to GP7. 
The crude residue was recrystallised from EtOAc/n-pentane to give activated ester 326 (182 mg, 
29%) as a white solid. 
TLC: Rf = 0.38 (n-pentane:acetone 50:50) 
m.p.: decomp. 185 – 189 °C (ethyl acetate) 
1H NMR: (400 MHz, Chloroform-d) δ 7.87 (2H, m, H17 or H18), 7.79 (2H, m, H18 or H17), 
7.36 (2H, m, H2), 7.30 (1H, m, H1), 7.25 (2H, m, H3), 6.14 (1H, m, H7), 5.67 (1H, dd, J = 9.0, 
4.3 Hz, H8), 5.51 (1H, d, J = 4.3 Hz, H10), 4.69 (1H, s, H13), 3.62 (2H, s, H5), 1.71 (3H, s, 
H12), 1.53 (3H, s, H12’) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 173.5 (C9), 170.5 (C6), 164.3 (C14), 161.4 (C15), 135.1 
(C17 or C18), 133.9 (C4), 129.6 (C3), 129.3 (C2), 128.7 (C16), 127.8 (C1), 124.3 (C18 or C17), 
68.8 (C13), 68.4 (C10), 65.0 (C11), 59.0 (C8), 43.4 (C5), 31.4 (C12), 26.9 (C12’) ppm 
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HRMS (m/z): (ESI+) calc’d for C24H21N3NaO6S [M+Na]+: 502.1043; found: 502.1041 
IR (νmax): 3531, 3363, 3295, 3032, 2972, 2934, 1788, 1745, 1666, 1517, 1293, 1133, 967 cm–1 
[𝜶]𝑫
𝟐𝟒: +103 (CHCl3, c = 1.0) 
 
()-1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (329) 
 
Carboxylic acid 328 (1.00 g, 6.66 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(1.09 g, 6.66 mmol, 1.00 equiv.), DIC (1.03 mL, 6.66 mmol, 1.00 equiv.) and DMAP (81 mg, 
0.67 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-pentane:EtOAc 90:10) to give activated ester 329 (1.79 mg, 91%) as a colourless 
liquid. 
TLC: Rf = 0.16 (n-pentane:Et2O 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 7.86 (2H, m, H10 or H11), 7.77 (2H, m, 2H, H11 or H10), 
7.44 – 7.37 (4H, m, H2 & H3), 7.33 (1H, m, H1), 4.13 (1H, q, J = 7.2 Hz, H5), 1.68 (3H, d, 
J = 7.2 Hz, H6) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.9 (C7), 162.0 (C8), 138.5 (C4), 134.9 (C10 or C11), 
129.07 (C9), 129.06 (C2 or C3), 128.0 (C1), 127.7 (C3 or C2), 124.1 (C11 or C10), 43.1 (C5), 
19.1 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C17H13NNaO4 [M+Na]+: 318.0737, found: 318.0748 
IR (νmax): 2993, 2944, 1781, 1736, 1353, 1185, 1041, 875, 854, 792, 738, 692, 512 cm1 
 
1,3-Dioxoisoindolin-2-yl 2-chloro-2-phenylacetate (332)  
 
In a flame-dried Schlenk tube, 2-chloro-2-phenylacetic acid 331 (486 mg, 2.85 mmol, 
1.00 equiv.) was dissolved in anhydrous CH2Cl2 (10.00 mL) at 0 °C under an atmosphere of ni-
trogen. One drop of DMF was added to the reaction mixture, followed by oxalyl chloride 
(0.27 mL, 3.13 mmol, 1.10 equiv.). After the addition, the ice bath was removed and the reaction 
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mixture was stirred at room temperature. The colourless solution turned yellow. After 1.5 h, gas 
evolution ceased and volatiles were removed under reduced pressure to afford a bright yellow 
liquid. In parallel, N-hydroxyphthalimide (465 mg, 2.85 mmol, 1.00 equiv.) and DIPEA 
(0.75 mL, 4.27 mmol, 1.50 equiv.) were dissolved in a second flame-dried Schlenk tube in anhy-
drous CH2Cl2 (10.00 mL) at 0 °C under an atmosphere of nitrogen. Freshly prepared acyl chloride 
as a solution in anhydrous CH2Cl2 (2.00 mL) was then carefully added to the reaction mixture 
via syringe. After the addition, the ice bath was removed and the reaction mixture was stirred at 
room temperature for 16 h. The orange solution was then washed with water (4 × 10.00 mL), 
dried over MgSO4, filtered and concentrated to afford a yellow solid. The crude residue was 
purified by flash column chromatography (n-pentane:CH2Cl2 50:50→0:100) to give activated 
ester 332 (404 mg, 45%) as a white solid. 
TLC: Rf = 0.29 (n-pentane:CH2Cl2 50:50) 
m.p.: 59 – 61 °C (n-hexane) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H9 or H10), 7.80 (2H, m, H10 or H9), 7.61 
(2H, m, H2 or H3), 7.54 – 7.36 (3H, m, (H3 or H2) & H1), 5.74 (1H, s, H5) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 165.4 (C6), 161.4 (C7), 135.1 (C9 or C10), 134.2 (C4), 
130.1 (C1), 129.3 (C2 or C3), 128.9 (C8), 128.3 (C3 or C2), 124.3 (C10 or C9), 56.3 (C5) ppm 
HRMS (m/z): (ESI+) calc’d for C16H10ClNNaO4 [M+Na]+: 338.0191; found: 338.0190 
IR (νmax): 3523, 3066, 2998, 1819, 1788, 1740, 1467, 1349, 1183, 1079, 964, 873, 737 cm–1 
 
1,3-Dioxoisoindolin-2-yl 2-bromoacetate (335)  
 
In a flame-dried Schlenk tube, N-hydroxyphthalimide (808 mg, 4.95 mmol, 1.00 equiv.) and 
DIPEA (0.86 mL, 4.95 mmol, 1.00 equiv.) were dissolved in anhydrous CH2Cl2 (20.00 mL) at 
0 °C under an atmosphere of nitrogen. Bromoacetyl bromide 334 (0.43 mL, 4.95 mmol, 
1.00 equiv.) was slowly added via syringe. After the addition, the red solution turned colorless. 
The ice bath was removed and the reaction mixture was stirred at room temperature for 16 h. The 
reaction mixture was quenched with water (20.00 mL). The organic layer was separated, washed 
with water (3 × 15 mL), dried over MgSO4, filtered and concentrated under reduced pressure to 
afford a yellow solid. The product was recrystallised from EtOAc/n-pentane to give activated 
ester 335 (1.18 g, 84%) as an off-white solid. 
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TLC: Rf = 0.43 (n-pentane:Et2O 50:50) 
m.p.: 92 – 95 °C (n-hexane) 
1H NMR: (400 MHz, Chloroform-d) δ 7.90 (2H, m, H5 or H6), 7.81 (2H, m, H6 or H5), 4.16 
(2H, s, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 164.0 (C2), 161.4 (C3), 135.1 (C5 or C6), 128.9 (C10), 
124.3 (C6 or C5), 21.4 (C1) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 





Carboxylic acid 307 (1.00 g, 6.17 mmol, 1.00 equiv.) was activated with tetrachloro-N-hydroxy-
phthalimide (1.86 g, 6.17 mmol, 1.00 equiv.), DIC (0.95 mL, 6.17 mmol, 1.00 equiv.) and 
DMAP (75 mg, 0.62 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by 
flash column chromatography (n-pentane:EtOAc 100:0→0:100) to give activated ester 337 
(118 mg, 4%) as a white solid. Note: Product unstable on silica gel. 
TLC: Rf = 0.43 (n-pentane:Et2O 80:20) 
m.p.: 211 – 214 °C (ethyl acetate) 
1H NMR: (400 MHz, Chloroform-d) δ 7.35 (2H, m, H2 or H3), 7.26 (1H, m, H1), 7.16 (2H, m, 
H3 or H2), 2.79 (1H, ddd, J = 9.3, 7.0, 4.1 Hz, H5), 2.22 (1H, ddd, J = 8.4, 5.2, 4.1, H7), 1.84 
(1H, ddd, J = 9.3, 5.2, 4.9 Hz, H6), 1.67 (1H, ddd, J = 8.4, 7.0, 4.9 Hz, H6’) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 169.4 (C8), 157.7 (C9), 141.2 (2 × CAr), 138.3 (C4), 
130.6 (2 × CAr), 128.9 (C2 or C3), 127.4 (C1), 126.6 (C3 or C2), 124.9 (2 × CAr), 28.8 (C5), 21.0 
(C7), 18.5 (C6) ppm 
HRMS (m/z): (EI+) calc’d for C18H9Cl4NO4 [M]+: 442.9286; found: 442.9293 




1,3-Dioxoisoindolin-2-yl hept-6-enoate (339)  
 
Carboxylic acid 338 (150 mg, 1.17 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(191 mg, 1.17 mmol, 1.00 equiv.), DIC (0.18 mL, 1.17 mmol, 1.00 equiv.) and DMAP (15 mg, 
0.12 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-hexane:acetone 90:10) to give activated ester 339 (215 mg, 67%) as a colourless 
liquid. 
TLC: Rf = 0.27 (n-hexane:acetone 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H10 or H11), 7.78 (2H, m, H11 or H10), 
5.81 (1H, ddt, J = 17.0, 10.2, 6.7 Hz, H2), 5.04 (1H, ddt, J = 17.0, 2.2, 1.7 Hz, H1’), 4.98 (1H, 
ddt, J = 10.2, 2.2, 1.2 Hz, H1), 2.67 (2H, t, J = 7.4 Hz, H6), 2.12 (2H, dddt, J = 7.4, 6.7, 1.7, 
1.2 Hz, H3), 1.81 (2H, app. pent, Japp. = 7.4 Hz, H5), 1.55 (2H, app. pent, Japp. = 7.4 Hz, H4) 
ppm 
13C NMR: (101 MHz, Chloroform-d) δ 169.6 (C7), 162.1 (C8), 138.2 (C2), 134.9 (C10 or C11), 
129.1 (C9), 124.1 (C11 or C10), 115.2 (C1), 33.3 (C3), 31.0 (C6), 28.1 (C4), 24.2 (C5) ppm 
HRMS (m/z): (ESI+) calc’d for C15H15NNaO4 [M+Na]+: 296.0893; found: 296.0883 
IR (νmax): 3522, 3076, 2934, 2865, 1815, 1787, 1738, 1467, 1362, 1185, 1133, 1081, 877 cm–1 
 
2-(Hex-5-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (341a) and 2-(Cyclopentylme-
thyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (341b)  
 
Activated ester 339 (36 mg, 0.13 mmol, 1.00 equiv.) was borylated with B2cat2 (40 mg, 
0.16 mmol, 1.25 equiv.), and pinacol (63 mg, 0.53 mmol, 4.00 equiv.) according to GP8. The 
crude reside was purified by flash column chromatography (n-pentane:Et2O 100:0→90:10) to 
give a mixture of linear boronic ester 341a and cyclized boronic ester 341b (57:43, 21 mg, 77%) 
as a colourless liquid. Note: Both products are volatile. 
TLC: Rf = 0.55 (n-pentane:Et2O 95:5) 
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HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
2-(Hex-5-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (341a) 
 
1H NMR: (400 MHz, Chloroform-d) δ 5.81 (1H, ddt, J = 17.1, 10.1, 6.6 Hz, H2), 4.98 (1H, d, 
J = 17.1 Hz, H1’), 4.91 (1H, d, J = 10.1 Hz, H1), 2.04 (2H, td, J = 7.0, 6.6 Hz, H3), 1.45 – 1.34 
(4H, m, H4 & H5), 1.24 (12H, s, H8), 0.77 (2H, t, J = 7.3 Hz, H6) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 139.3 (C2), 114.2 (C1), 83.0 (C7), 33.7 (C3), 31.8 (C4 
or C5), 25.0 (C8), 23.7 (C5 or C4) ppm 




1H NMR: (400 MHz, Chloroform-d) δ 1.95 (1H, m, H3), 1.76 (2H, m), 1.60 (2H, m), 1.50 (2H, 
m), 1.05 (2H, m), 0.83 (2H, d, J = 7.4 Hz, H4) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 82.9 (C5), 36.3 (C3), 35.2 (C2), 25.3 (C1), 25.0 (C6) 
ppm 
The signal corresponding to C4 was not observed due to quadrupolar relaxation. 
 
1,3-Dioxoisoindolin-2-yl (tert-butoxycarbonyl)glycinate (353)  
 
 
(tert-Butoxycarbonyl)glycine 352 (2.50 g, 14.27 mmol, 1.00 equiv.) was activated with N-hy-
droxyphthalimide (2.33 g, 14.27 mmol, 1.00 equiv.) and DCC (2.94 g, 14.27 mmol, 1.00 equiv.) 
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according to GP7. The crude residue was purified by recrystallisation from EtOAc to give, after 
4 crops, activated ester 353 (1.81 g, 40%) as a white solid. 
TLC: Rf = 0.59 (n-pentane:EtOAc 50:50) 
m.p.: 184 – 188 °C (ethyl acetate) 
1H NMR: (500 MHz, Dimethyl sulfoxide-d6) δ 8.03 – 7.90 (4H, m, H9 & H10), 7.51 (1H, t, 
J = 6.1 Hz, H4), 4.17 (2H, d, J = 6.1 Hz, H5), 1.38 (9H, s, H1) ppm 
13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 168.4 (C6), 162.1 (C7), 156.2 (C3), 136.1 (C9 
or C10), 128.5 (C8), 124.5 (C10 or C9), 79.4 (C2), 40.3 (C5), 28.5 (C1) ppm 
HRMS (m/z): (ESI+) calc’d for C15H16N2NaO6 [M+Na]+: 343.0901; found: 343.0905 
IR (νmax): 3295, 2979, 2930, 2850, 1840, 1825, 1788, 1738, 1686, 1532, 1365, 1289, 1144, 1071, 
970, 878, 693 cm–1 
 
tert-Butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate (354)  
 
In a flame-dried Schlenk tube was diluted a solution of NaHMDS (1.00 M in THF, 1.00 mL, 
1.00 mmol, 1.00 equiv.) with anhydrous THF (5.00 mL) at 78 °C under an atmosphere of nitro-
gen. A solution of boronic ester 385 (176 mg, 1.00 mmol, 1.00 equiv.) in anhydrous THF 
(1.00 mL) was added dropwise and the reaction mixture was stirred at 78 °C for 20 min. The 
acetone/dry ice bath was removed and the reaction mixture was stirred at room temperature for 
2 h. The suspension was cooled to 0 °C and MeOH (81 μL, 2.00 mmol, 2.00 equiv.) was added. 
The reaction mixture was stirred at 0 °C for 1 h and Boc2O (262 mg, 1.20 mmol, 1.20 equiv.) 
was added. After the addition, the reaction mixture was stirred at room temperature for 3 days 
under an atmosphere of nitrogen. The suspension was concentrated and the crude residue was 
purified by flash column chromatography (oven-dried silica; petroleum ether 40–60:Et2O 
80:20→0:100) to give boronic ester 354 (97 mg, 38%) as a pale yellow liquid. 
TLC: Rf = 0.31 (n-pentane:EtOAc 50:50) 
1H NMR: (400 MHz, Chloroform-d) δ 4.63 (1H, s, H4), 2.77 (2H, d, J = 4.3 Hz, H3), 1.44 (9H, 
s, H7), 1.27 (12H, s, H1) ppm 




Spectral data were in accordance with that reported in the literature.274  
 
1,3-Dioxoisoindolin-2-yl (tert-butoxycarbonyl)-L-leucinate ((S)-356)  
 
Protected leucine (S)-355 (500 mg, 2.16 mmol, 1.00 equiv.) was activated with N-hydroxy-
phthalimide (353 mg, 2.16 mmol, 1.00 equiv.) and DCC (446 mg, 2.16 mmol, 1.00 equiv.) ac-
cording to GP7. The crude residue was triturated in cold EtOAc. The solid was removed by 
filtration, the filtrate was concentrated under reduced pressure and the resulting waxy solid was 
dried under high vacuum to afford activated ester (S)-356 (415 mg, 51%) as a colourless wax. 
TLC: Rf = 0.10 (n-hexane:EtOAc 90:10) 
1H NMR: (500 MHz, Chloroform-d) δ 7.89 (2H, m, H12 or H13), 7.79 (2H, m, H13 or H12), 
4.94 (1H, m, H4), 4.62 (1H, m, H5), 1.97 – 1.80 (2H, m, H6 & H7), 1.72 (1H, m, H6’), 1.48 (9H, 
m, H1), 1.02 (6H, m, H8) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.1 (C9), 161.7 (C10), 155.1 (C3), 134.9 (C12 or C13), 
129.0 (C11), 124.1 (C13 or C12), 80.7 (C2), 50.8 (C5), 42.0 (C6), 28.4 (C1), 24.9 (C7), 22.9 (C8) 
ppm 
HRMS (m/z): (ESI+) calc’d for C19H24N2NaO6 [M+Na]+: 399.1527; found: 399.1537 
IR (νmax): 3375, 2961, 2934, 2873, 1819, 1789, 1744, 1713, 1367, 1163, 1080, 697 cm–1 
[𝜶]𝑫
𝟐𝟒: 33 (CHCl3, c = 1.0) 
 
N-Benzyl-1,1,1-triphenylmethanamine (358)  
 
In a round-bottomed flask, benzylamine (0.20 mL, 1.87 mmol, 1.00 equiv.) was dissolved in an-
hydrous CH2Cl2 (6.00 mL) at room temperature. Ph3CCl (572 mg, 2.05 mmol, 1.10 equiv.) was 
added, followed by DMAP (23 mg, 0.19 mmol, 0.10 equiv.) and the reaction mixture was stirred 
at room temperature for 16 h. A saturated aqueous solution of NaHCO3 (9.00 mL) was added, 
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followed by water (1.00 mL). The aqueous layer was extracted with Et2O (3 × 5 mL). The or-
ganic phases were combined, washed with brine, dried over MgSO4, filtered and concentrated. 
The crude residue was purified by flash column chromatography (n-pentane:CH2Cl2 
80:20→60:40) to give amine 358 (317 mg, 49%) as a white solid. 
TLC: Rf = 0.38 (n-pentane:Et2O 80:20) 
1H NMR: (500 MHz, Chloroform-d) δ 7.58 (6H, m, H9 or H10), 7.41 (2H, m, H2 or H3), 7.37 – 
7.27 (9H, m, H1 & 8 × HAr), 7.22 (3H, m, H11), 3.36 (2H, s, H5), 1.87 (1H, s, H6) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 146.2 (C8), 141.2 (C4), 128.8 (CAr), 128.5 (CAr), 128.0 
(2 × CAr), 126.9 (CAr), 126.5 (C11), 71.1 (C7), 48.0 (C5) ppm 
Spectral data were in accordance with that reported in the literature.294  
 
Benzyl benzylcarbamate (359)  
 
In a round-bottomed flask, benzylamine (0.20 mL, 1.87 mmol, 1.00 equiv.) was dissolved in 
MeOH (4.00 mL) at room temperature. CbzCl (0.32 mL, 2.24 mmol, 1.20 equiv.) was added, 
followed by iodine (10 mg, 0.04 mmol, 0.02 equiv.) and the reaction mixture was stirred at room 
temperature for 16 h. The reaction mixture was diluted with Et2O (10.00 mL) and successively 
washed with a saturated aqueous solution of Na2S2O3 (5.00 mL), a saturated aqueous solution of 
NaHCO3 (5.00 mL) and brine. The organic layer was dried over MgSO4, filtered and concen-
trated. The crude residue was purified by flash column chromatography (n-pentane:Et2O 80:20) 
to give carbamate 359 (217 mg, 48%) as a white solid. 
TLC: Rf = 0.22 (n-pentane:Et2O 80:20) 
1H NMR: (500 MHz, Chloroform-d) δ 7.42 – 7.26 (10H, m, 10 × HAr), 5.14 (2H, s, H8), 5.08 
(1H, br. s, H6), 4.39 (2H, d, J = 6.0 Hz, H5) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 156.5 (C7), 138.5 (C4), 136.6 (C9), 128.8 (CAr), 128.7 
(2 × CAr), 128.3 (2 × CAr), 127.7 (CAr), 67.0 (C8), 45.3 (C5) ppm 






tert-Butyl benzylcarbamate (360)  
 
In a round-bottomed flask, benzylamine (0.20 mL, 1.87 mmol, 1.00 equiv.) was dissolved in 
EtOH (4.00 mL) at room temperature. Boc2O (448 mg, 2.05 mmol, 1.10 equiv.) was added and 
the reaction mixture was stirred at 30 °C for 4 h and at room temperature for 16 h. A saturated 
aqueous solution of NH4Cl (3.00 mL) was added, followed by water (1.00 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 5 mL). The organic layers were 
combined, washed with brine, dried over MgSO4, filtered and concentrated. The crude residue 
was purified by flash column chromatography (n-pentane:CH2Cl2 80:20→60:40) to give carba-
mate 360 (340 mg, 88%) as a white solid. 
TLC: Rf = 0.38 (n-pentane:Et2O 80:20) 
1H NMR: (500 MHz, Chloroform-d) δ 7.33 (2H, m, H2), 7.30 – 7.24 (3H, m, H1 & H3), 4.83 
(1H, m, H6), 4.32 (2H, d, J = 5.9 Hz, H5), 1.46 (9H, s, H9) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 156.0 (C7), 139.0 (C4), 128.7 (C2), 127.6 (C1), 127.4 
(C3), 79.6 (C8), 44.8 (C5), 28.5 (C9) ppm 
Spectral data were in accordance with that reported in the literature.296  
 
1,1,1-Trichloro-2-methylpropan-2-yl benzylcarbamate (361)  
 
In a round-bottomed flask, benzylamine (0.20 mL, 1.87 mmol, 1.00 equiv.) and Et3N (0.52 mL, 
3.73 mmol, 2.00 equiv.) were dissolved in CH2Cl2 (4.00 mL) at 0 °C. DMTrocCl (448 mg, 
1.87 mmol, 1.00 equiv.) was added portionwise. After the addition, the ice bath was removed and 
the reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted 
with EtOAc (10.00 mL) and a saturated aqueous solution of NH4Cl (10.00 mL) was added. The 
aqueous phase was extracted with EtOAc (3 × 5 mL). The organic layers were combined, washed 
with brine, dried over MgSO4, filtered and concentrated. The crude residue was purified by flash 
column chromatography (n-pentane:CH2Cl2 80:20→60:40) to give carbamate 361 (174 mg, 
30%) as a pale yellow solid. 
TLC: Rf = 0.43 (n-pentane:Et2O 80:20) 
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1H NMR: (500 MHz, Chloroform-d) δ 7.35 (2H, m, H2), 7.32 – 7.27 (3H, m, H1 & H3), 5.15 
(1H, br. s, H6), 4.36 (2H, d, J = 5.9 Hz, H5), 1.95 (6H, s, H9) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 154.2 (C7), 138.2 (C4), 128.9 (C2), 127.8 (C3), 127.3 
(C1), 106.7 (C10), 88.3 (C8), 45.1 (C5), 21.8 (C9) ppm 
Spectral data were in accordance with that reported in the literature.297  
 
N-Benzylacetamide (362)  
 
In a round-bottomed flask, benzylamine (0.20 mL, 1.87 mmol, 1.00 equiv.) and Et3N (0.52 mL, 
3.73 mmol, 2.00 equiv.) were dissolved in anhydrous CH2Cl2 (4.00 mL) at 0 °C. Ac2O (0.18 mL, 
1.87 mmol, 1.00 equiv.) was added, followed by DMAP (23 mg, 0.19 mmol, 0.10 equiv.). After 
5 min, the ice bath was removed and the reaction mixture was stirred at room temperature for 
16 h. The reaction mixture was diluted with Et2O (4.00 mL) and an aqueous solution of HCl 
(0.20 M, 10.00 mL) was added. The aqueous phase was extracted with Et2O (3 × 5 mL). The 
organic layers were combined, washed with brine, dried over MgSO4, filtered and concentrated. 
The crude residue was purified by flash column chromatography (n-pentane:EtOAc 
50:50→25:75) to give acetamide 362 (206 mg, 74%) as a white solid. 
TLC: Rf = 0.16 (n-pentane:EtOAc 50:50) 
1H NMR: (500 MHz, Chloroform-d) δ 7.33 (2H, m, H2), 7.30 – 7.26 (3H, m, H1 & H3), 5.79 
(1H, br. s, H6), 4.43 (2H, d, J = 5.7 Hz, H5), 2.02 (3H, s, H8) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.0 (C7), 138.3 (C4), 128.9 (C2), 128.0 (C3), 127.7 
(C1), 43.9 (C5), 23.4 (C8) ppm 




Alanine (S)-364 (1.00 g, 11.22 mmol, 1.00 equiv.) was dissolved in an aqueous solution of NaOH 
(2.00 M, 6.00 mL) at room temperature. Benzaldehyde (1.15 mL, 11.22 mmol, 1.00 equiv.) was 
added, and the biphasic mixture was stirred at room temperature for 1 h. The colourless solution 
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was cooled to 0 °C and NaBH4 (212 mg, 5.61 mmol, 0.50 equiv.) was added portionwise. After 
the addition, the reaction mixture was stirred at room temperature for 30 min before benzalde-
hyde (1.15 mL, 11.22 mmol, 1.00 equiv.) and NaBH4 (212 mg, 5.61 mmol, 0.50 equiv.) were 
added. The reaction mixture was stirred for 1 h and Et2O (10.00 mL) was added. The biphasic 
mixture was vigorously stirred for 16 h. The layers were separated and the aqueous phase was 
washed with Et2O (2 × 10.00 mL), acidified to pH 7 and concentrated under reduced pressure. 
The white precipitate was triturated in cold water, collected by filtration and dried under high 
vacuum to give benzylalanine (S)-365 (738 mg, 37%) as a white solid. 
TLC: Rf = 0.10 (CH2Cl2:MeOH 80:20) 
1H NMR: (500 MHz, Deuterium Oxide) δ 7.56 – 7.42 (5H, m, H1, H2 & H3), 4.26 (1H, d, 
J = 13.0 Hz, H5), 4.22 (1H, d, J = 13.0 Hz, H5’), 3.71 (1H, q, J = 7.2 Hz, H7), 1.51 (3H, d, 
J = 7.2 Hz, H8) ppm 
13C NMR: (126 MHz, Deuterium Oxide) δ 174.7 (C9), 130.9 (C4), 129.8 (C2), 129.6 (C1), 129.2 
(C3), 57.3 (C7), 49.8 (C5), 15.2 (C8) ppm 
Spectral data were in accordance with that reported in the literature.299  
 
1,3-Dioxoisoindolin-2-yl N-benzyl-N-(tert-butoxycarbonyl)-L-alaninate ((S)-366)  
 
Part A: Benzylalanine (S)-365 (695 mg, 3.88 mmol, 1.00 equiv.) was dissolved in a mixture of 
watrer and dioxane (50:50, 12.00 mL) by addition of Et3N (1.62 mL, 11.63 mmol, 3.00 equiv.) 
at room temperature. Boc2O (846 mg, 3.88 mmol, 1.00 equiv.) was added, and the reaction mix-
ture was stirred at room temperature for 16 h. The colourless solution was cooled to 0 °C and an 
aqueous solution of HCl (2.00 M) was carefully added to bring pH to 4. The solution was ex-
tracted with EtOAc (3 × 10.00 mL), washed with brine, dried over MgSO4, filtered and concen-
trated. Part B: The crude residue was coupled with N-hydroxyphthalimide (542 mg, 3.32 mmol, 
1.00 equiv.), DIC (0.51 mL, 3.32 mmol, 1.00 equiv.) and DMAP (41 mg, 0.33 mmol, 
0.10 equiv.) according to GP6. The crude residue was purified by flash column chromatography 
(n-pentane:Et2O 80:20→50:50) to give activated ester (S)-366 (1.08 g, 76% over 2 steps) as a 
colourless wax. 
TLC: Rf = 0.30 (n-pentane:Et2O 70:30) 
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1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H14 or H15), 7.78 (2H, m, H15 or H14), 
7.38 – 7.27 (5H, m, H6, H7 & H8), 5.07 – 4.29 (3H, m, H4 & H9), 1.67 – 1.36 (12H, m, H1 & 
H10) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 168.9 (C11), 161.7 (C12), 155.2 (C3), 138.1 (C5), 134.9 
(C14 or C15), 129.1 (C13), 128.7 (C7), 128.0 (C6), 127.6 (C8), 124.1 (C15 or C14), 82.2 (C2), 
54.1 (C9), 51.0 (C4), 28.3 (C1), 16.4 (C10) ppm 
HRMS (m/z): (ESI+) calc’d for C23H24N2NaO6 [M+Na]+: 447.1527; found: 447.1534 




In a microwave vial, 5-methylisobenzofuran-1,3-dione 368 (4.00 g, 24.67 mmol, 1.00 equiv.) 
and hydroxylamine hydrochloride (3.40 g, 48.93 mmol, 2.00 equiv.) were dissolved in pyridine 
(20.00 mL) at room temperature. After stirring at room temperature for 5 min, the vial was sealed 
and the reaction mixture was stirred at 100 °C under microwave irradiation for 5 min. The yellow 
solution was allowed to cool to room temperature and was poured onto an aqueous solution of 
HCl (1.00 M, 40.00 mL) at 0 °C. The white precipitate was collected by filtration, washed with 
water and dried under high vacuum for 16 h to give compound 369 (3.80 g, 87%) as a white solid. 
TLC: Rf = 0.33 (n-hexane:EtOAc 50:50) 
1H NMR: (500 MHz, Dimethyl sulfoxide-d6) δ 10.83 (1H, br. s, H6), 7.70 (1H, d, J = 7.5 Hz, 
H9), 7.64 (1H, br. s, H3), 7.61 (1H, d, J = 7.5 Hz, H10), 2.45 (3H, s) ppm 
13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 164.5 (C5 or C7), 164.4 (C7 or C5), 145.7 (C2), 
134.9 (C10), 129.1 (C4 or C8), 126.1 (C8 or C4), 123.7 (C3), 123.1 (C9), 21.6 (C1) ppm 
Spectral data were in accordance with that reported in the literature.273  
 




Carboxylic acid 328 (500 mg, 2.64 mmol, 1.00 equiv.) was activated with methyl-substituted 
N-hydroxyphthalimide 369 (468 mg, 2.64 mmol, 1.00 equiv.) and DIC (0.41 mL, 2.64 mmol, 
1.00 equiv.) (no DMAP) according to GP6. The crude residue was purified by flash column 
chromatography (n-pentane:Et2O 50:50) to give activated ester (S)-371 (681 mg, 74%) as a col-
ourless liquid. 
TLC: Rf = 0.28 (n-pentane:Et2O 50:50) 
Compound (S)-371 exists as a 50:50 mixture of rotamers. 
1H NMR: (500 MHz, Dimethyl sulfoxide-d6) δ 7.84 (0.5H, d, J = 7.7 Hz, H14), 7.79 (0.5H, s, 
H10), 7.74 (0.5H, d, J = 7.7 Hz, H13), 7.70 (0.5H, d, J = 7.6 Hz, H14), 7.65 (0.5H, s, H10), 7.62 
(0.5H, d, J = 7.6 Hz, H13), 7.27 (0.5H, d, J = 6.5 Hz, H4), 7.07 (0.5H, d, J = 7.6 Hz, H4), 4.46 
(0.5H, app. pent, Japp. = 7.3 Hz, H5), 3.90 (0.5H, app. pent, Japp. = 7.4 Hz, H5), 2.50 (1.5H, s, 
H12), 2.45 (1.5H, s, H12), 1.45 (1.5H, d, J = 7.4 Hz, H6), 1.39 (4.5H, s, H1), 1.36 (4.5H, s, H1), 
1.21 (1.5H, d, J = 7.4 Hz, H6) ppm 
13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 174.9 (C7), 170.7 (C7), 164.4 (C8 or C16), 164.4 
(C16 or C8), 162.0 (C8 or C16), 161.9 (C16 or C8), 155.5 (C3), 155.3 (C3), 147.0 (C11), 145.7 
(C11), 136.0 (C13), 135.0 (C13), 129.1 (C9 or C15), 128.6 (C9 or C15), 126.1 (C15 or C9), 125.6 
(C15 or C9), 124.6 (C10), 124.2 (C14), 123.7 (C10), 123.1 (C14), 79.0 (C2), 78.2 (C2), 49.0 
(C5), 47.7 (C5), 28.4 (C1), 28.3 (C1), 21.7 (C12), 21.6 (C12), 17.2 (C6), 17.1 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C17H20N2NaO6 [M+Na]+: 371.1214; found: 371.1225 
IR (νmax): 3675, 3384, 2988, 2972, 2901, 1731, 1452, 1406, 1394, 1230, 1057, 869 cm–1 
 
(/)-5-Methyl-1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (373) 
 
Carboxylic acid 328 (500 mg, 3.33 mmol, 1.00 equiv.) was activated with methyl-substituted N-
hydroxyphthalimide 369 (590 mg, 3.33 mmol, 1.00 equiv.) and DIC (0.52 mL, 3.33 mmol, 
1.00 equiv.) (no DMAP) according to GP6. The crude residue was purified by flash column 
chromatography (n-pentane:Et2O 80:20) to give activated ester 373 (811 mg, 79%) as a colour-
less liquid. 
TLC: Rf = 0.51 (n-pentane:Et2O 50:50) 
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1H NMR: (500 MHz, Chloroform-d) δ 7.69 (1H, d, J = 7.7 Hz, H14), 7.61 (1H, s, H10), 7.52 
(1H, d, J = 7.7 Hz, H13), 7.39 – 7.32 (4H, m, H2 & H3), 7.28 (1H, m, H1), 4.07 (1H, q, 
J = 7.2 Hz, H5), 2.47 (3H, s, H12), 1.62 (3H, d, J = 7.2 Hz, H6) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.9 (C7), 162.2 (C8 or C16), 162.0 (C16 or C8), 146.3 
(C11), 138.4 (C4), 135.3 (C13), 129.2 (C9 or C15), 128.9 (C2 or C3), 127.8 (C1), 127.6 (C3 or 
C2), 126.2 (C15 or C9), 124.5 (C10), 123.9 (C14), 43.0 (C5), 22.2 (C12), 19.0 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C18H16NO4 [M+H]+: 310.1074; found: 310.1077 
IR (νmax): 3675, 2988, 2972, 2901, 1807, 1780, 1734, 1702, 1407, 1394, 1224, 1066, 1047 cm–1 
 
Benzyl (tert-butoxycarbonyl)glycinate (374)  
 
(tert-Butoxycarbonyl)-glycine 352 (200 mg, 1.14 mmol, 1.00 equiv.) and Cs2CO3 (371 mg, 
1.14 mmol, 1.00 equiv.) were suspended in DMF (2.00 mL) at room temperature. Benzyl bro-
mide (0.14 mL, 1.14 mmol, 1.00 equiv.) was added and the reaction mixture was stirred for 16 h. 
Water (7.00 mL) was added and the resulting suspension was extracted with a mixture n-hex-
ane:EtOAc (50:50, 2.00 mL), then with pure n-hexane (3 × 2.00 mL). The organic layers were 
combined, washed with water (7.00 mL) and brine, dried over MgSO4, filtered and concentrated 
to give ester 374 (275 mg, 91%) as a colourless liquid. 
TLC: Rf = 0.14 (n-hexane:EtOAc 90:10) 
1H NMR: (500 MHz, Chloroform-d) δ 7.42 – 7.30 (5H, m, H9, H10 & H11), 5.18 (2H, s, H7), 
4.73 (1H, m, H4), 3.90 (2H, m, H5), 1.45 (9H, s, H1) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 170.4 (C6), 155.8 (C3), 135.4 (C8), 128.8 (C10), 128.6 
(C11), 128.5 (C9), 80.2 (C2), 67.2 (C7), 42.7 (C5), 28.5 (C1) ppm 








Benzyl (N,N-bis(tert-butoxycarbonyl))glycinate (375)  
 
Benzyl ester 374 (275 mg, 1.04 mmol, 1.00 equiv.) was dissolved in anhydrous MeCN (2.00 mL) 
at room temperature under an atmosphere of nitrogen. DMAP (25 mg, 0.21 mmol, 0.20 equiv.) 
was added, followed by Boc2O (227 mg, 1.04 mmol, 1.00 equiv.). The yellow solution was 
stirred at room temperature for 16 h and was concentrated under reduced pressure. The crude 
residue was purified by flash column chromatography (petroleum ether 40–60:EtOAc 95:5) to 
give compound 375 (372 mg, 98%) as a colourless liquid. 
TLC: Rf = 0.30 (n-hexane:EtOAc 90:10) 
1H NMR: (500 MHz, Chloroform-d) δ 7.40 – 7.29 (5H, m, H8, H9 & H10), 5.18 (2H, s, H6), 
4.37 (2H, s, H4), 1.46 (18H, s, H1) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 169.2 (C5), 152.0 (C3), 135.6 (C7), 128.7 (C9), 128.5 
(C10), 128.5 (C8), 83.3 (C2), 67.0 (C6), 47.5 (C2), 28.1 (C1) ppm 
Spectral data were in accordance with that reported in the literature.301  
 
N,N-Bis(tert-butoxycarbonyl))glycine (376)  
 
Benzyl ester 375 (370 mg, 1.01 mmol, 1.00 equiv.) and palladium on activated charcoal (10% 
w/w, 99 mg, 0.10 mmol, 0.10 equiv.) were suspended in MeOH (10.00 mL) at room temperature 
under argon atmosphere. The black suspension was purged with argon for 20 min. The inert at-
mosphere was purged with hydrogen and the reaction mixture was stirred for 4 h. The hydrogen 
atmosphere was replaced with argon and the black solid was removed by filtration over Celite®. 
The filtrate was concentrated and the residue was dried under high vacuum to give compound 
376 (207 mg, 74%) as a white solid. 
TLC: Rf = 0.13 (CH2Cl2:MeOH 95:5) 
1H NMR: (500 MHz, Chloroform-d) δ 4.39 (2H, s, H4), 1.50 (18H, s, H1) ppm 
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13C NMR: (126 MHz, Chloroform-d) δ 174.5 (C5), 152.0 (C3), 83.5 (C2), 47.2 (C4), 28.1 (C1) 
ppm 
Spectral data were in accordance with that reported in the literature.302  
 
1,3-Dioxoisoindolin-2-yl (N,N-bis(tert-butoxycarbonyl))glycinate (377)  
 
Carboxylic acid 376 (207 mg, 0.75 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(122 mg, 0.75 mmol, 1.00 equiv.) and DCC (155 mg, 0.75 mmol, 1.00 equiv.) according to GP7. 
The crude residue was purified by flash column chromatography (petroleum ether 40–60:EtOAc 
80:20) to give activated ester 377 (296 mg, 94%) as a white solid. 
TLC: Rf = 0.64 (n-hexane:EtOAc 50:50) 
m.p.: 124 – 128 °C (diethyl ether) 
1H NMR: (500 MHz, Chloroform-d) δ 7.96 – 7.85 (2H, m, H8 or H9), 7.85 – 7.73 (2H, m, H9 
or H8), 4.75 (2H, s, H4), 1.54 (18H, s, H1) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 166.1 (C5), 161.6 (C6), 150.9 (C3), 135.0 (C8 or C9), 
129.0 (C7), 124.2 (C9 or C8), 84.2 (C2), 45.5 (C4), 28.0 (C1) ppm 
HRMS (m/z): (ESI+) calc’d for C20H24N2NaO8 [M+Na]+: 443.1425; found: 443.1437 
IR (νmax): 2980, 2934, 1832, 1794, 1747, 1369, 1343, 1228, 1145, 1116, 1092, 697 cm–1 
 
Benzyl (tert-butoxycarbonyl)-L-leucinate ((S)-379)  
 
(tert-Butoxycarbonyl)-L-leucine (S)-355 (200 mg, 0.86 mmol, 1.00 equiv.) and Cs2CO3 (282 mg, 
0.86 mmol, 1.00 equiv.) were suspended in DMF (2.00 mL) at room temperature. Benzyl bro-
mide (0.10 mL, 0.86 mmol, 1.00 equiv.) was added and the reaction mixture was stirred for 4 h. 
Water (7.00 mL) was added and the resulting suspension was extracted with n-hexane 
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(4 × 2.00 mL). The organic layers were combined, washed with water (7.00 mL) and brine, dried 
over MgSO4, filtered and concentrated to give ester (S)-379 (250 mg, 90%) as a colourless liquid. 
TLC: Rf = 0.33 (n-pentane:EtOAc 90:10) 
1H NMR: (500 MHz, Chloroform-d) δ 7.43 – 7.29 (5H, m, H12, H13 & H14), 5.19 (1H, d, 
J = 12.4 Hz, H10), 5.13 (1H, d, J = 12.4 Hz, H10’), 4.75 (1H, m, H4), 4.25 (1H, m, H5), 1.70 
(1H, m, H7), 1.62 (1H, m, H6), 1.49 (1H, ddd, J = 13.5, 9.2, 5.7 Hz, H6’), 1.43 (9H, s, H1), 0.92 
(6H, m, H8) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 173.5 (C9), 155.5 (C3), 135.7 (C11), 128.7 (CAr), 128.5 
(CAr), 128.3 (CAr), 80.0 (C2), 67.0 (C10), 52.3 (C5), 41.9 (C6), 28.5 (C1), 24.9 (C7), 23.0 (C8), 
22.0 (C8’) ppm 
Spectral data were in accordance with that reported in the literature.303  
 
Benzyl (N,N-bis(tert-butoxycarbonyl))-L-leucinate ((S)-380)  
 
Benzyl ester (S)-379 (250 mg, 0.78 mmol, 1.00 equiv.) was dissolved in anhydrous MeCN 
(1.00 mL) at room temperature under an atmosphere of nitrogen. DMAP (19 mg, 0.16 mmol, 
0.20 equiv.) was added, followed by Boc2O (188 mg, 0.86 mmol, 1.10 equiv.). The orange solu-
tion was stirred at room temperature for 16 h. Boc2O (94 mg, 0.43 mmol, 0.50 equiv.) was added 
and the reaction mixture was stirred at room temperature for 16 h. The orange solution was con-
centrated and the crude residue was purified by flash column chromatography (n-hexane:Et2O 
95:5) to give compound (S)-380 (267 mg, 81%) as a colourless liquid. 
TLC: Rf = 0.39 (n-hexane:EtOAc 90:10) 
1H NMR: (500 MHz, Chloroform-d) δ 7.36 – 7.27 (5H, m, H11, H12 & H13), 5.16 (1H, d, 
J = 12.5 Hz, H9), 5.13 (1H, d, J = 12.5 Hz, H9’), 4.96 (1H, dd, J = 9.6, 5.1 Hz, H4), 1.92 (1H, 
ddd, J = 14.3, 9.2, 5.1 Hz, H5), 1.86 (1H, ddd, J = 14.3, 9.6, 4.8 Hz, H5’), 1.63 (1H, dheptd, 
J = 9.2, 6.7, 4.8 Hz, H6), 1.44 (18H, s, H1), 0.91 (6H, m, H7) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 171.4 (C8), 152.4 (C3), 135.9 (C10), 128.6 (C12), 128.2 
(C13), 128.1 (C11), 83.1 (C2), 66.8 (C9), 56.8 (C4), 38.5 (C5), 28.1 (C1), 25.2 (C6), 23.4 (C7), 
21.9 (C7’) ppm 
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Spectral data were in accordance with that reported in the literature.301  
 
N,N-Bis(tert-butoxycarbonyl)-L-leucine ((S)-381)  
 
Benzyl ester (S)-380 (265 mg, 0.63 mmol, 1.00 equiv.) and palladium on activated charcoal (10% 
w/w, 335 mg, 0.32 mmol, 0.51 equiv.) were suspended in MeOH (10.00 mL) at room temperature 
under argon atmosphere. The black suspension was purged with argon for 20 min. The inert at-
mosphere was purged with hydrogen and the reaction mixture was stirred for 6 h. The hydrogen 
atmosphere was replaced with argon and the black solid was removed by filtration over Celite®. 
The filtrate was concentrated and the residue was dried under high vacuum to give compound 
(S)-381 (192 mg, 92%) as a white solid. 
TLC: Rf = 0.16 (CH2Cl2:MeOH 95:5) 
1H NMR: (500 MHz, Chloroform-d) δ 4.96 (1H, dd, J = 9.4, 5.2 Hz, H4), 1.88 (1H, ddd, 
J = 14.2, 9.1, 5.2 Hz, H5), 1.83 (1H, ddd, J = 14.2, 9.4, 4.8 Hz, H5’), 1.62 (1H, dheptd, J = 9.1, 
6.7, 4.8 Hz, H6), 1.50 (18H, s, H1), 0.93 (6H, m, H7) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 176.7 (C8), 152.4 (C3), 83.4 (C2), 56.7 (C4), 38.7 (C5), 
28.1 (C1), 25.2 (C6), 23.3 (C7), 22.0 (C7’) ppm 
Spectral data were in accordance with that reported in the literature.301  
 
1,3-Dioxoisoindolin-2-yl (N,N-bis(tert-butoxycarbonyl))-L-leucinate ((S)-382)  
 
Carboxylic acid (S)-381 (190 mg, 0.57 mmol, 1.00 equiv.) was activated with N-hydroxy-
phthalimide (94 mg, 0.57 mmol, 1.00 equiv.) and DCC (118 mg, 0.57 mmol, 1.00 equiv.) ac-
cording to GP7. The crude residue was concentrated and triturated in cold EtOAc. The solid was 
removed by filtration and the filtrate was concentrated under reduced pressure. The resulting 
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residue was dried under high vacuum to give activated ester (S)-382 (215 mg, 79%) as a pale 
yellow solid. 
TLC: Rf = 0.25 (n-hexane:EtOAc 80:20) 
m.p.: 96 – 98 °C (diethyl ether) 
1H NMR: (500 MHz, Chloroform-d) δ 7.87 (2H, m, H11 or H12), 7.78 (2H, m, H12 or H11), 
5.37 (1H, m, H4), 1.99 (2H, m, H5), 1.70 (1H, m, H6), 1.55 (18H, s, H1), 0.98 (6H, m, H7) ppm 
13C NMR: (126 MHz, Chloroform-d) δ 167.9 (C8), 161.7 (C9), 151.4 (C3), 134.8 (C11 or C12), 
129.1 (C10), 124.0 (C12 or C11), 84.2 (C2), 55.1 (C4), 38.9 (C5), 28.0 (C1), 25.0 (C6), 23.3 
(C7), 21.9 (C7’) ppm 
HRMS (m/z): (ESI+) calc’d for C24H32N2NaO8 [M+Na]+: 499.2051; found: 499.2057 
IR (νmax): 3511, 3211, 2981, 2937, 1757, 1732, 1699, 1368, 1338, 1228, 1144, 1111, 965, 853, 
787 cm1 
[𝜶]𝑫
𝟐𝟒:  (CHCl3, c = 2.0) 
 
2-(Chloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (385)  
 
In a flame-dried Schlenk tube, 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4.08 mL, 
20.00 mmol, 1.00 equiv.) and bromochloromethane (1.43 mL, 22.00 mmol, 1.10 equiv.) were 
dissolved in anhydrous THF (20.00 mL) at 78 °C under an atmosphere of nitrogen. A solution 
of n-BuLi (1.54 M in n-hexane, 14.29 mL, 22.00 mmol, 1.10 equiv.) was added dropwise and the 
reaction mixture was stirred at 78 °C for 30 min. TMSCl (3.05 mL, 24.00 mmol, 1.20 equiv.) 
was added and the reaction mixture was stirred at 78 °C for 10 min. The acetone/dry ice bath 
was removed and the reaction mixture was stirred at room temperature for 16 h. Water (25 mL) 
was added, layers were separated and the aqueous phase was extracted with Et2O (3 × 10.00 mL). 
The organic layers were combined, washed with brine, dried over MgSO4, filtered and concen-
trated. The crude residue was purified by distillation (60 mbar; 95–100 °C at the top of the col-
umn) to obtain boronic ester 385 (1.88 g, 53%) as a colourless liquid. 
TLC: Unstable on silica. 
1H NMR: (400 MHz, Chloroform-d) δ 2.95 (2H, s, H3), 1.28 (12H, s, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 84.8 (C2), 24.8 (C1), 23.8* (C3) ppm 
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*shift value determined by HSQC correlation. 
Spectral data were in accordance with that reported in the literature.304  
 
3-Oxo-13-benzo[d][1,2]iodaoxol-1(3H)-yl acetate (387) 
 
In a round-bottomed flask, 2-iodobenzoic acid 404 (1.24 g, 5.00 mmol, 1.00 equiv.) was dis-
solved in a mixture of AcOH and Ac2O (50:50, 40.00 mL) at room temperature. m-CPBA (77% 
w/w, 1.23 g, 5.50 mmol, 1.10 equiv.) was added and the reaction mixture was stirred at 60 °C for 
48 h. The yellow solution was allowed to cool to room temperature and Et2O (40.00 mL) was 
added, followed by n-pentane (40.00 mL). The suspension was stored at 20 °C for 16 h and the 
white precipitate was collected by filtration to obtain compound 387 (742 mg, 48%) as a pale 
yellow solid. 
TLC: Unstable on silica. 
1H NMR: (400 MHz, Dimethyl sulfoxide-d6) δ 8.01 (1H, dd, J = 7.5, 1.5 Hz, H4 or H7), 7.96 
(1H, ddd, J = 8.2, 7.2, 1.5 Hz, H5 or H6), 7.83 (1H, dd, J = 8.2, 1.0 Hz, H7 or H4), 7.70 (1H, 
ddd, J = 7.5, 7.2, 1.0 Hz, H6 or H5), 1.90 (3H, s, H1) ppm 
13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 172.3 (C2), 168.1 (C9), 134.8 (C5 or C6), 131.5 
(C3 or C8), 131.3 (C4 or C7), 130.6 (C6 or C5), 126.4 (C7 or C4), 120.6 (C8 or C3), 21.2 (C1) 
ppm 
Spectral data were in accordance with that reported in the literature.276  
 
3-Oxo-13-benzo[d][1,2]iodaoxol-1(3H)-yl trans-2-phenylcyclopropane-1-carboxylate (405)  
 
In a round-bottomed flask, acetate 387 (200 mg, 0.65 mmol, 1.00 equiv.) and trans-2-phenylcy-
clopropane-1-carboxylic acid 307 (106 mg, 0.65 mmol, 1.00 equiv.) were suspended in xylenes 
(7.00 mL) at room temperature. The suspension was heated at 75 °C under reduced pressure 
(~200 mbar). After complete removal of the solvent, the white residual powder was suspended 
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in petroleum ether 40–60 (4.00 mL), collected by filtration, washed with n-pentane and dried 
under high vacuum to obtain compound 405 (97 mg, 37%) as a white solid. 
TLC: Unstable on silica. 
m.p.: 201 – 205 °C (xylenes) 
1H NMR: (500 MHz, Dimethyl sulfoxide-d6) δ 8.01 (1H, dd, J = 7.5, 1.4 Hz, H10 or H13), 7.96 
(1H, ddd, J = 8.2, 7.2, 1.4 Hz, H11 or H12), 7.83 (1H, dd, J = 8.2, 1.0 Hz, H13 or H10), 7.70 
(1H, ddd, J = 7.5, 7.4, 1.0 Hz, H12 or H11), 7.26 (2H, m, H2 or H3), 7.18 (1H, m, H1), 7.14 (2H, 
m, H3 or H2), 2.36 (1H, ddd, J = 9.3, 6.4, 4.2 Hz, H5), 1.78 (1H, ddd, J = 8.4, 5.3, 4.2 Hz, H7), 
1.41 (1H, ddd, J = 9.3, 5.3, 4.4 Hz, H6b), 1.32 (1H, ddd, J = 8.4, 6.4, 4.4 Hz, H6a) ppm 
13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 174.2 (C8), 168.1 (C15), 140.4 (C4), 134.8 (C11 
or C12), 131.5 (C9 or C14), 131.3 (C10 or C13), 130.6 (C12 or C11), 128.6 (C2 or C3), 126.5 
(C13 or C10 or C1), 126.4 (C1 or C13 or C10), 126.1 (C3 or C2), 120.6 (C14 or C9), 25.5 (C5), 
24.4 (C7), 16.8 (C6) ppm 
HRMS (m/z): Despite repeated attempts, a HRMS could not be obtained. 
IR (νmax): 3670, 3085, 3059, 2989, 2903, 2756, 2647, 2547, 2414, 1688, 1620, 1442, 1341, 1230, 
1117, 742, 696, 546 cm–1 
 
1-Chloro-13-benzo[d][1,2]iodaoxol-3(1H)-one (412)  
 
In a round-bottomed flask, 2-iodobenzoic acid 404 (2.00 g, 7.90 mmol, 1.00 equiv.) was dis-
solved in anhydrous MeCN (75.00 mL) at 75 °C under an atmosphere of nitrogen. A solution of 
trichloroisocyanuric acid (637 mg, 2.67 mmol, 0.34 equiv.) in anhydrous MeCN (3.00 mL) was 
added dropwise and the reaction mixture was stirred at 75 °C for 5 min. The white precipitate 
was removed by filtration over Celite® in a pre-heated sintered funnel and the filtrate was con-
centrated to afford a yellow suspension, which was allowed to cool to room temperature. The 
resulting white solid was collected by filtration and dried under high vacuum to give, after two 
crops, compound 412 (1.25 g, 56%) as a white solid. 
TLC: Unstable on silica. 
1H NMR: (500 MHz, Dimethyl sulfoxide-d6) δ 7.96 (1H, d, J = 7.9 Hz, H3 or H6), 7.69 (1H, d, 
J = 7.7 Hz, H6 or H3), 7.47 (1H, dd, J = 7.7, 7.5 Hz, H4 or H5), 7.22 (1H, dd, J = 7.9, 7.5 Hz, 
H5 or H4) ppm 
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13C NMR: (126 MHz, Dimethyl sulfoxide-d6) δ 168.4 (C1), 140.7 (C3 or C6), 137.1 (C2 or C7), 
132.7 (C4 or C5), 130.2 (C6 or C3), 128.4 (C5 or C4), 94.2 (C7 or C2) ppm 
Spectral data were in accordance with that reported in the literature.277  
 
1-(tert-Butyl) 2-(1,3-dioxoisoindolin-2-yl) (2S,4S)-4-fluoropyrrolidine-1,2-dicarboxylate 
(414)  
 
Carboxylic acid 413 (117 mg, 0.50 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(82 mg, 0.50 mmol, 1.00 equiv.), DIC (0.08 mL, 0.50 mmol, 1.00 equiv.) and DMAP (6 mg, 
0.05 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-hexane:EtOAc 70:30) to give activated ester 414 (175 mg, 93%) as a white solid. 
TLC: Rf = 0.37 (n-hexane:EtOAc 50:50) 
m.p.: 126 – 128 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H11 or H12), 7.78 (2H, m, H12 or H11), 
5.29 (1H, app. dt, Japp. = 52.1, 4.0 Hz, H5), 4.80 (1H, dd, J = 10.1, 1.5 Hz, H7), 3.94 (1H, ddd, 
J = 25.3, 13.1, 1.9 Hz, H4), 3.70 (1H, ddd, J = 35.2, 13.1, 4.2 Hz, H4’), 2.82 (1H, m, H6), 2.60 
(1H, dddd, J = 39.8, 14.6, 10.1, 4.0 Hz, H6’), 1.51 (9H, m, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 168.3 (C8), 161.7 (C9), 153.4 (C3), 134.9 (C11 or C12), 
129.1 (C10), 124.1 (C12 or C11), 90.9 (d, J = 179.2 Hz, C5), 81.8 (C2), 56.0 (C7), 53.1 (d, 
J = 24.4 Hz, C4), 37.8 (d, J = 22.6 Hz, C6), 28.2 (C1) ppm 
19F NMR (377 MHz, Chloroform-d) δ 173.0 (ddddd, J = 52.1, 39.8, 35.2, 25.3, 18.4 Hz) ppm 
HRMS (m/z): (ESI+) calc’d for C18H19FN2NaO6 [M+Na]+: 401.1119; found: 401.1136 
IR (νmax): 2977, 1828, 1791, 1742, 1701, 1392, 1366, 1040, 877, 697 cm–1 
[𝜶]𝑫







1-(tert-Butyl) 2-(1,3-dioxoisoindolin-2-yl) (S)-4,4-difluoropyrrolidine-1,2-dicarboxylate 
((S)-417)  
 
Carboxylic acid (S)-416 (125 mg, 0.50 mmol, 1.00 equiv.) was activated with N-hydroxy-
phthalimide (82 mg, 0.50 mmol, 1.00 equiv.), DIC (0.08 mL, 0.50 mmol, 1.00 equiv.) and 
DMAP (6 mg, 0.05 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by 
flash column chromatography (n-hexane:EtOAc 70:30) to give activated ester (S)-417 (169 mg, 
85%) as a white solid. 
TLC: Rf = 0.61 (n-hexane:EtOAc 50:50) 
m.p.: 116 – 119 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 7.89 (2H, m, H11 or H12), 7.80 (2H, m, H12 or H11), 
4.85 (1H, m, H7), 4.02 – 3.78 (2H, m, H4 & H4’), 2.95 (1H, m, H6), 2.82 (1H, m, H6’), 1.51 
(9H, m, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 167.9 (C8), 161.6 (C9), 152.8 (C3), 135.1 (C11 or C12), 
129.0 (C10), 124.2 (C12 or C11), 82.7 (C2), 55.4 (C7), 52.9 (t, J = 31.8 Hz, C4), 39.0 (t, 
J = 26.5 Hz, C6), 28.1 (C1) ppm 
Due to its low intensity, the expected triplet corresponding to C5 could not be distinguished from 
the baseline. 
19F NMR: (377 MHz, Chloroform-d) δ 99.8 (2F, m) ppm 
HRMS (m/z): (ESI+) calc’d for C18H18F2N2NaO6 [M+Na]+: 419.1040; found: 419.1025 
IR (νmax): 2979, 1824, 1792, 1745, 1710, 1394, 1369, 1153, 1104, 1079, 697 cm–1 
[𝜶]𝑫
𝟐𝟑: 55 (CHCl3, c = 1.0) 
 
(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (419)  
 
(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (131 mg, 1.00 mmol, 1.00 equiv.) was sus-
pended in a mixture of THF and water (2:1, 3.00 mL) at room temperature. An aqueous solution 
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of NaOH (10% w/w, 0.50 mL) was added, followed by Boc2O (327 mg, 1.50 mmol, 1.50 equiv.). 
The reaction mixture was stirred at room temperature for 2 days and pH was brought to 3 by 
addition of an aqueous solution of HCl (2.00 M) and the reaction mixture was extracted with 
EtOAc (3 × 3.00 mL). The organic layers were combined, washed with brine, dried over MgSO4, 
filtered and concentrated. The crude residue was purified by flash column chromatography 
(n-hexane:Et2O 80:20) to give compound 419 (229 mg, 99%) as a white solid. 
TLC: Rf = 0.12 (CH2Cl2:MeOH 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 4.51 – 4.27 (2H, m, H5 & H8), 3.65 – 3.34 (2H, m, H4), 
2.38 – 2.05 (2H, m, H7), 1.41 (9H, m, H1) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 176.1 (C9), 154.3 (C3), 80.5 (C2), 69.3 (C5 or C8), 58.0 
(C8 or C5), 54.6 (C4), 39.2 (C7), 28.4 (C1) ppm 
Spectral data were in accordance with that reported in the literature.305  
 
(2S,4R)-1-(tert-Butoxycarbonyl)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-2-carboxylic 
acid (420)  
 
Proline derivative 419 (229 mg, 0.99 mmol, 1.00 equiv.) and imidazole (297 mg, 4.36 mmol, 
4.40 equiv.) were dissolved in DMF (3.00 mL) at room temperature. TBSCl (328 mg, 2.18 mmol, 
2.20 equiv.) was added portionwise and the resulting mixture was stirred at room temperature for 
16 h. Water (3.00 mL) was added and the pH was brought to 3 by addition of an aqueous solution 
of citric acid (10% w/w). The reaction mixture was extracted with EtOAc (3 × 5.00 mL). The 
organic layers were combined, washed with water (3 × 5.00 mL) and brine, dried over MgSO4, 
filtered and concentrated. The residue was purified by flash column chromatography (n-hex-
ane:EtOAc 80:20→50:50) to give compound 420 (265 mg, 77%) as a colourless liquid. 
TLC: Rf = 0.28 (CH2Cl2:MeOH 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 9.78 (1H, br. s, H12), 4.55 – 4.27 (2H, m, H5 & H10), 
3.67 – 3.26 (2H, m, H4), 2.40 – 1.99 (2H, m, H9), 1.44 (9H, m, H1), 0.86 (9H, s, H8), 0.06 (6H, 
s, H6) ppm 
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13C NMR: (101 MHz, Chloroform-d) δ 179.1 (C11), 154.0 (C3), 80.7 (C2), 69.9 (C5 or C10), 
58.1 (C10 or C5), 55.1 (C4), 39.9 (C9), 28.5 (C1), 25.8 (C8), 18.0 (C7), 4.6 (C6), 4.8 (C6’) 
ppm 
Spectral data were in accordance with that reported in the literature.306  
 
1-(tert-Butyl) 2-(1,3-dioxoisoindolin-2-yl) (2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrroli-
dine-1,2-dicarboxylate (421)  
 
Carboxylic acid 420 (265 mg, 0.77 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(125 mg, 0.77 mmol, 1.00 equiv.), DIC (0.12 mL, 0.77 mmol, 1.00 equiv.) and DMAP (9 mg, 
0.08 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-hexane:EtOAc 80:20) to give activated ester 421 (332 mg, 88%) as a white solid. 
TLC: Rf = 0.57 (n-hexane:EtOAc 50:50) 
m.p.: 142 – 145 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H14 or H15), 7.77 (2H, m, H15 or H14), 
4.70 (1H, m, H10), 4.51 (1H, m, H5), 3.62 (1H, m, H4), 3.13 (1H, m, H4’), 2.49 – 2.32 (3H, m, 
H9), 1.49 (9H, m, H1), 0.87 (9H, m, H8), 0.08 (6H, m, H6) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 169.8 (C11), 161.8 (C12), 153.8 (C3), 134.9 (C14 or 
C15), 129.0 (C13), 124.1 (C15 or C14), 81.5 (C2), 69.7 (C5), 56.4 (C10), 54.5 (C4), 40.4 (C9), 
28.2 (C1), 25.8 (C8), 18.1 (C7), 4.7 (C6) ppm 
HRMS (m/z): (ESI+) calc’d for C24H34N2NaO7Si [M+Na]+: 513.2027; found: 513.2010 
IR (νmax): 2954, 2931, 2886, 2858, 1820, 1791, 1745, 1707, 1392, 1367, 1254, 1161, 1119, 1080, 
877, 836, 778, 696 cm–1 
[𝜶]𝑫







(2S,3aS,7aS)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid (423)  
 
(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid (102 mg, 0.60 mmol, 1.00 equiv.) was dis-
solved in CH2Cl2 (2.00 mL) by addition of Et3N (0.17 mL, 1.20 mmol, 2.00 equiv.) at room tem-
perature. Boc2O (144 mg, 0.66 mmol, 1.10 equiv.) was added and the reaction mixture was 
stirred at room temperature for 2 days. CH2Cl2 (3.00 mL) was added and the reaction mixture 
was washed with an aqueous solution of HCl (1.00 M, 6.00 mL). The layers were separated and 
the aqueous phase was extracted with CH2Cl2 (3 × 5.00 mL). The organic layers were combined, 
dried over MgSO4, filtered and concentrated. The crude residue was purified by flash column 
chromatography (n-hexane:Et2O 90:10, then CH2Cl2:MeOH 95:5) to give compound 423 
(147 mg, 91%) as a white solid. 
TLC: Rf = 0.49 (CH2Cl2:MeOH 90:10) 
1H NMR: (400 MHz, Chloroform-d) δ 9.81 (1H, br. s, H13), 4.27 (1H, br. s, H11), 3.80 (1H, br. 
s, H4), 2.43 – 1.82 (4H, m 4 × CH), 1.77 – 1.56 (3H, m, 3 × CH), 1.52 – 1.37 (10H, m, H1 & 
CH), 1.36 – 1.21 (2H, m, 2 × CH), 1.20 – 1.04 (1H, m, CH) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 176.0 (C12), 156.1 (C3), 81.2 (C2), 59.2 (C11), 58.0 
(C4), 36.6 (C9), 30.7 (CH2), 28.5 (C1), 28.0 (CH2), 25.9 (CH2), 23.8 (CH2), 20.6 (CH2) ppm 
Spectral data were in accordance with that reported in the literature.307  
 
1-(tert-Butyl) 2-(1,3-dioxoisoindolin-2-yl) (2S,3aS,7aS)-octahydro-1H-indole-1,2-dicarbox-
ylate (424)  
 
Carboxylic acid 423 (147 mg, 0.55 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(89 mg, 0.55 mmol, 1.00 equiv.), DIC (0.08 mL, 0.55 mmol, 1.00 equiv.) and DMAP (7 mg, 
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0.06 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-hexane:EtOAc 80:20) to give activated ester 424 (168 mg, 74%) as a colourless 
wax. 
TLC: Rf = 0.22 (n-hexane:EtOAc 80:20) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H15 or H16), 7.77 (2H, m, H16 or H15), 
4.59 (1H, m, H11), 3.86 (1H, m, H4), 2.48 – 2.22 (3H, m, H9 & CH2), 2.04 (1H, m, CH), 1.78 
(1H, m, CH), 1.72 – 1.62 (2H, m, 2 × CH), 1.53 – 1.44 (10H, m, H1 & CH), 1.43 – 1.28 (2H, m, 
2 × CH), 1.15 (1H, m, CH) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 170.3 (C12), 161.9 (C13), 153.2 (C3), 134.9 (C15 or 
C16), 129.1 (C14), 124.0 (C16 or C15), 81.1 (C2), 57.4 (C4), 57.2 (C11), 36.7 (C9), 33.3 (C10), 
28.3 (C1), 27.7 (CH2), 25.9 (CH2), 23.7 (CH2), 20.6 (CH2) ppm 
HRMS (m/z): (ESI+) calc’d for C22H26N2NaO6 [M+Na]+: 437.1683; found: 437.1689 
IR (νmax): 2974, 2930, 1819, 1790, 1742, 1697, 1391, 1366, 1163, 1081, 972, 877, 696 cm1 
[𝜶]𝑫
𝟐𝟐: 38 (CHCl3, c = 1.0) 
 
(/)-1-(tert-Butyl) 2-(1,3-dioxoisoindolin-2-yl) piperidine-1,2-dicarboxylate (427)  
 
Carboxylic acid 426 (229 mg, 1.00 mmol, 1.00 equiv.) was activated with N-hydroxyphthalimide 
(163 mg, 1.00 mmol, 1.00 equiv.), DIC (0.15 mL, 1.00 mmol, 1.00 equiv.) and DMAP (12 mg, 
0.10 mmol, 0.10 equiv.) according to GP6. The crude residue was purified by flash column chro-
matography (n-hexane:EtOAc 80:20) to give activated ester 427 (328 mg, 88%) as a white solid. 
TLC: Rf = 0.24 (n-hexane:EtOAc 80:20) 
m.p.: 96 – 99 °C (diethyl ether) 
1H NMR: (400 MHz, Chloroform-d) δ 7.88 (2H, m, H12 or H13), 7.78 (2H, m, H13 or H12), 
5.26 (1H, m, H8), 4.02 (1H, m, H4), 3.07 (1H, m, H4’), 2.36 (1H, m, CH), 1.94 – 1.64 (3H, m, 
3 × CH), 1.57 – 1.39 (11H, m, H1 & 2 × CH) ppm 
13C NMR: (101 MHz, Chloroform-d) δ 168.9 (C9), 161.8 (C10), 155.3 (C3), 134.9 (C12 or C13), 
129.1 (C11), 124.1 (C13 or C12), 81.2 (C2), 53.7 (C8), 41.3 (C5), 28.3 (C1), 27.3 (CH2), 24.5 
(CH2), 20.4 (CH2) ppm 
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HRMS (m/z): (ESI+) calc’d for C19H22N2NaO6 [M+Na]+: 397.1370; found: 397.1379 
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